curator	date	ev_json	id	pa_hash	pa_json	source	source_hash	tag	text	english	agent_info
bachmanjohn@gmail.com	Fri, 06 Nov 2020 20:46:17 GMT		7910	28299852913714059		EMMAA	8586142641221157529	agent_conditions	Consistent with the results obtained for RT4-NF2.17 cells, overexpression of merlin in SKOV3 and HEI193 cells significantly reduced the levels of p-MLK3, p-B-RAF, p-ERK and p-JNK (XREF_FIG).	Modified NF2 decreases the amount of MAP3K11.	{'HGNC:7773': {'name': 'NF2', 'synonyms': ['ACN', 'BANF', 'Gene Product, NF2', 'Merlin', 'Moesin Ezrin Radixin Like Protein', 'Moesin-Ezrin-Radixin-Like Protein', 'Moesin-ezrin-radixin-like protein', 'NF2', 'NF2 Gene Product', 'NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor', 'Neurofibromatosis 2 Gene Product', 'Neurofibromatosis Type 2 Protein', 'Neurofibromin 2', 'Neurofibromin-2', 'Protein, Schwannomin', 'SCH', 'Schwannomerlin', 'Schwannomin', 'Schwannomin Protein', 'bilateral acoustic neurofibromatosis', 'merlin', 'merlin-1', 'moesin-ezrin-radixin like', 'schwannomin'], 'definition': None, 'syn_in_text': 'Merlin', 'syn_in_stmt': 'NF2'}, 'HGNC:6850': {'name': 'MAP3K11', 'synonyms': ['MAP3K11', 'MEKK11', 'MLK3', 'Mitogen-Activated Protein Kinase Kinase Kinase 11', 'Mitogen-activated protein kinase kinase kinase 11', 'Mixed Lineage Kinase 3', 'Mixed Lineage Kinase-3', 'Mixed lineage kinase 3', 'PTK1', 'SPRK', 'Src-homology 3 domain-containing proline-rich kinase', 'mitogen-activated protein kinase kinase kinase 11', 'p-MLK3'], 'definition': None, 'syn_in_text': 'p-MLK3', 'syn_in_stmt': 'MAP3K11'}}
ben.gyori@gmail.com	Mon, 02 Nov 2020 14:50:42 GMT		7534	-26034361313042826		EMMAA	8800969654052280400	other	In fact , SARS-CoV has been shown to be poorly sensitive to the antiviral action of IFN-alpha and - gamma when used singularly but is strongly inhibited by the combination of these two cytokines ( Stroher et al ., 2004 , Hensley et al ., 2004 , Antonelli et al ., 2003 and present results ) , as observed with many other viruses .	Cytokine inhibits SARS Virus.	{'EFO:0003786': {'name': 'cytokine', 'synonyms': ['cytokine', 'combination of these two cytokines'], 'definition': None, 'syn_in_text': 'cytokine', 'syn_in_stmt': 'cytokine'}, 'MESH:D045473': {'name': 'SARS Virus', 'synonyms': ['Coronavirus, SARS-Associated', 'Coronavirus, SARS-Related', 'Coronavirus, Urbani SARS-Associated', 'HCoV-SARS', 'SARS Associated Coronavirus', 'SARS Related Coronavirus', 'SARS Virus', 'SARS like coronavirus', 'SARS-Associated Coronavirus', 'SARS-Associated Coronavirus, Urbani', 'SARS-CoV-1', 'SARS-Related Coronavirus', 'SARS-like coronavirus', 'SARS-like coronaviruses', 'SARSr-CoV', 'SARSrCoV', 'SARSrCoVs', 'Severe acute respiratory syndrome related coronavirus', 'Severe acute respiratory syndrome-related coronavirus', 'Urbani SARS Associated Coronavirus', 'Urbani SARS-Associated Coronavirus', 'SARS-CoV'], 'definition': None, 'syn_in_text': 'SARS-CoV', 'syn_in_stmt': 'SARS Virus'}}
chai.molina@gmail.com	Tue, 02 Aug 2022 14:22:43 GMT	{'annotations': {'agents': {'raw_text': ['calcium chloride', 'calcium']}, 'content_source': 'pubmed', 'found_by': 'Positive_activation_syntax_2_verb', 'prior_uuids': ['aa67b69b-a723-45bd-9951-050f3ca5d395']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '2414953', 'source_api': 'reach', 'source_hash': 6225126704922768000, 'text': 'In bile duct ligated TPTX rats, liver calcium content was not significantly increased by a single ip injection of calcium chloride (4.0 mg Ca2 +/100 g body weight).', 'text_refs': {'DOI': '10.1530/ACTA.0.1100239', 'DOI_ID': 'ACTA.0.1100239', 'DOI_NS': 1530, 'PMID': '2414953', 'PMID_NUM': 2414953, 'READER': 'REACH', 'RID': 10100006422653, 'SOURCE': 'pubmed', 'TCID': 6422653, 'TRID': 10336982}}	13488	7727306582692214	{'belief': 1, 'id': '24b578ea-ebfa-4db9-bb70-c60979e40428', 'matches_hash': '7727306582692214', 'obj': {'db_refs': {'CAS': '14127-61-8', 'CHEBI': 'CHEBI:29108', 'HMDB': 'HMDB0000464', 'PUBCHEM': '271', 'TEXT': 'calcium'}, 'name': 'calcium(2+)'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'CAS': '10043-52-4', 'CHEBI': 'CHEBI:3312', 'CHEMBL': 'CHEMBL1200668', 'DRUGBANK': 'DB01164', 'PUBCHEM': '5284359', 'TEXT': 'CaCl2'}, 'name': 'calcium dichloride'}, 'type': 'Activation'}	DB REST API	6225126704922768738	other	In bile duct ligated TPTX rats, liver calcium content was not significantly increased by a single ip injection of calcium chloride (4.0 mg Ca2 +/100 g body weight).	Calcium dichloride activates calcium(2+).	{'CHEBI:CHEBI:3312': {'name': 'calcium dichloride', 'synonyms': ['CaCl2', 'Calcium chloride anhydrous', '[CaCl2]', 'calcium chloride', 'calcium chloride anhydrous', 'calcium dichloride'], 'definition': None, 'syn_in_text': 'calcium chloride', 'syn_in_stmt': 'calcium dichloride'}, 'CHEBI:CHEBI:29108': {'name': 'calcium(2+)', 'synonyms': ['CALCIUM ION', 'Ca', 'Ca(2+)', 'Ca2+', 'calcium', 'calcium(2+)', 'calcium(2+) ion', 'calcium(II) cation', 'calcium, doubly charged positive ion'], 'definition': None, 'syn_in_text': 'calcium', 'syn_in_stmt': 'calcium'}}
bachmanjohn@gmail.com	Sun, 15 Dec 2019 00:32:21 GMT		409	21634894993301822		bioexp_paper_tsv	947202408938575961	other	To further explore the specificity and generality of these results, we tested an independent stop codon reporter in an additional cell type : Jmjd4 or eRF1 siRNA in A549 cells also increased readthrough of a stop codon within a leaky termination sequence when using a beta-galactosidase : stop : firefly reporter.	ETF1 activates MAP6.	{'HGNC:3477': {'name': 'ETF1', 'synonyms': ['ERF', 'ERF1', 'ETF1', 'Eukaryotic peptide chain release factor subunit 1', 'Eukaryotic release factor 1', 'Protein Cl1', 'RF1', 'SUP45L1', 'TB3-1', 'eRF1', 'eukaryotic translation termination factor 1', 'polypeptide chain release factor 1', 'sup45 (yeast omnipotent suppressor 45) homolog-like 1'], 'definition': None, 'syn_in_text': 'ERF1', 'syn_in_stmt': 'ETF1'}, 'HGNC:6868': {'name': 'MAP6', 'synonyms': ['FLJ41346', 'KIAA1878', 'MAP-6', 'MAP6', 'MAP6-N', 'Microtubule-associated protein 6', 'STOP', 'Stable tubule-only polypeptide', 'microtubule associated protein 6', 'stop'], 'definition': None, 'syn_in_text': 'STOP', 'syn_in_stmt': 'MAP6'}}
bachmanjohn@gmail.com	Wed, 18 Dec 2019 21:00:56 GMT		815	645545594255186		bioexp_paper_reach	915260829859187331	other	We demonstrated that lentiviral mediated STMN1 short hairpin RNA (shRNA) specifically and efficiently downregulated STMN1 expression in Eca109 and TE-1 cells.	STMN1 decreases the amount of STMN1.	{'HGNC:6510': {'name': 'STMN1', 'synonyms': ['C1orf215', 'FLJ32206', 'LAP18', 'Lag', 'Lap18 Protein', 'Leukemia Associated Phosphoprotein p18', 'Leukemia-Associated Phosphoprotein p18', 'Leukemia-associated phosphoprotein p18', 'Metablastin', 'OP18', 'Oncoprotein 18', 'Op18', 'Op18 Phosphoprotein', 'PP17', 'PP19', 'PR22', 'Phosphoprotein p18', 'Phosphoprotein p19', 'Phosphoprotein, Op18', 'Prosolin', 'Protein Pr22', 'SMN', 'STMN1', 'Stathmin', 'oncoprotein 18', 'p18, Leukemia-Associated Phosphoprotein', 'p18, Phosphoprotein', 'p19, Phosphoprotein', 'pp17', 'pp19', 'stathmin 1'], 'definition': None, 'syn_in_text': 'STMN1', 'syn_in_stmt': 'STMN1'}}
bachmanjohn@gmail.com	Sun, 15 Dec 2019 00:32:28 GMT		498	19359448326975886		bioexp_paper_tsv	-3516957396123589612	other	Based on our findings that EVI1 binds and up regulates SIRT1, one may envision a role for SIRT1 in EVI1 mediated neoplastic transformation.	SIRT1 binds CCR7.	{'HGNC:14929': {'name': 'SIRT1', 'synonyms': ['NAD-dependent protein deacetylase sirtuin-1', 'NAD-dependent protein deacylase sirtuin-1', 'Regulatory protein SIR2 homolog 1', 'SIR2-like protein 1', 'SIR2L1', 'SIRT1', 'Silent Mating Type Information Regulation 2 Homolog 1', 'Sirt1', 'Sirtuin 1', 'hSIR2', 'hSIRT1', 'sirtuin 1'], 'definition': None, 'syn_in_text': 'SIRT1', 'syn_in_stmt': 'SIRT1'}, 'HGNC:1608': {'name': 'CCR7', 'synonyms': ['BLR2', 'C-C CKR-7', 'C-C chemokine receptor type 7', 'C-C motif chemokine receptor 7', 'CC-CKR-7', 'CCR-7', 'CCR7', 'CD antigen CD197', 'CD197', 'CDw197', 'CMKBR7', 'EBI1', 'EBV-induced G-protein coupled receptor 1', 'EVI1', 'Epstein-Barr virus-induced G-protein coupled receptor 1', 'MIP-3 beta receptor'], 'definition': None, 'syn_in_text': 'EVI1', 'syn_in_stmt': 'CCR7'}}
ben.gyori@gmail.com	Fri, 01 Jul 2022 15:24:59 GMT		13473	9753849323558217		EMMAA	4943977683962885259	other	The agonist increased cMet ( 1.86-fold , p =0 .029 ) , alpha-SMA ( 1.20-fold , p =0 .018 ) , and VEGF ( 1.68-fold , p =0 .029 ) expression but suppressed CD68 ( 1.25-fold , p =0 .043 ) , TFG-beta ( 1.25-fold , p =0 .022 ) , and MMP-2 ( 2.59-fold , p =0 .029 ) expression .	Agonist activates MET.	{'CHEBI:CHEBI:48705': {'name': 'agonist', 'synonyms': ['agonist', 'agonista', 'agoniste', 'agonists'], 'definition': None, 'syn_in_text': 'agonist', 'syn_in_stmt': 'agonist'}, 'HGNC:7029': {'name': 'MET', 'synonyms': ['DFNB97', 'HGF Receptor', 'HGF receptor', 'HGF/SF receptor', 'HGFR', 'Hepatocyte Growth Factor Receptor', 'Hepatocyte growth factor receptor', 'MET', 'MET Proto Oncogene, Receptor Tyrosine Kinase', 'MET Proto-Oncogene, Receptor Tyrosine Kinase', 'MET Receptor Tyrosine Kinase', 'MET proto-oncogene, receptor tyrosine kinase', 'Met', 'Proto Oncogene Proteins c met', 'Proto-Oncogene Proteins c-met', 'Proto-Oncogene Proteins, met', 'Proto-oncogene c-Met', 'RCCP2', 'Receptor, HGF', 'Receptor, Hepatocyte Growth Factor', 'Receptor, Scatter Factor', 'SF receptor', 'Scatter Factor Receptor', 'Scatter factor receptor', 'Tyrosine-protein kinase Met', 'c Met Receptor Tyrosine Kinase', 'c met Proteins', 'c-MET', 'c-Met', 'c-Met Receptor Tyrosine Kinase', 'c-met', 'c-met Proteins', 'cMet receptor', 'hepatocyte growth factor receptor', 'met Proto Oncogene Proteins', 'met Proto-Oncogene Proteins', 'cMet'], 'definition': None, 'syn_in_text': 'cMet', 'syn_in_stmt': 'MET'}}
ben.gyori@gmail.com	Sun, 01 Nov 2020 21:09:36 GMT		7477	-765727008864805		bioexp_refinements	3636000160503188911	other	We found a significant increase of phosphorylated ERK1/2 in the whole pancreatic extracts of 2-day-old animals treated with KGF 20 minutes before the sacrifice (XREF_FIG).	FGF7 activates phosphorylated ERK.	{'HGNC:3685': {'name': 'FGF7', 'synonyms': ['FGF-7', 'FGF7', 'Fibroblast Growth Factor 7', 'Fibroblast growth factor 7', 'HBGF-7', 'Heparin-binding growth factor 7', 'KGF', 'Keratinocyte Growth Factor', 'Keratinocyte growth factor', 'fibroblast growth factor 7', 'keratinocyte growth factor'], 'definition': None, 'syn_in_text': 'KGF', 'syn_in_stmt': 'FGF7'}, 'FPLX:ERK': {'name': 'ERK', 'synonyms': ['ERK', 'ERK 1/2', 'ERK MAP Kinase', 'ERK MAP Kinases', 'ERK MAPK', 'ERK mitogen-activated protein kinase', 'ERK-1/2', 'ERK1/2', 'ERK1/2 MAPK', 'ERKs', 'Erk', 'Erk1/2', 'Extracellular Signal Regulated Kinase', 'Extracellular Signal Regulated Kinases', 'Extracellular Signal Regulated MAP Kinase', 'Extracellular Signal Regulated MAP Kinases', 'Extracellular Signal-Regulated Kinase', 'Extracellular Signal-Regulated Kinases', 'Extracellular Signal-Regulated MAP Kinase', 'Extracellular Signal-Regulated MAP Kinases', 'Kinase, ERK MAP', 'Kinase, Extracellular Signal-Regulated', 'Kinases, Extracellular Signal-Regulated', 'MAP Kinase, ERK', 'MAP Kinases, Extracellular Signal Regulated', 'MAP Kinases, Extracellular Signal-Regulated', 'Signal-Regulated Kinase, Extracellular', 'extracellular signal-regulated kinase', 'p42 and p38 MAP kinases', 'p42 and p38 MAPK', 'p42 and p38 MAPKs', 'p42 and p44', 'p42 and p44 MAPK', 'p42 and p44MAP kinase', 'p42(mapk) and p44(mapk)', 'p42/44', 'p44 and p42', 'phospho-ERK1/2'], 'definition': None, 'syn_in_text': 'ERK', 'syn_in_stmt': 'ERK'}}
ben.gyori@gmail.com	Mon, 22 Feb 2021 04:50:24 GMT		11108	20720012852693651		DB REST API	7906196421264258610	other	Consequently , the expression of M protein prevents the formation of TRAF3.TANK.TBK1 / IKKepsilon complex and thereby inhibits TBK1 / IKKepsilon-dependent activation of IRF3 / IRF7 transcription factors .	Protein inhibits TBK1.	{'CHEBI:CHEBI:36080': {'name': 'protein', 'synonyms': ['PR', 'protein', 'proteins', 'expression of M protein'], 'definition': None, 'syn_in_text': 'protein', 'syn_in_stmt': 'protein'}, 'HGNC:11584': {'name': 'TBK1', 'synonyms': ['NAK', 'NF-kappa-B-activating kinase', 'Serine/threonine-protein kinase TBK1', 'T2K', 'TANK binding kinase 1', 'TANK-binding kinase 1', 'TBK1'], 'definition': None, 'syn_in_text': 'TBK1', 'syn_in_stmt': 'TBK1'}}
ben.gyori@gmail.com	Mon, 14 Jun 2021 11:55:25 GMT		12056	13710271415468405	{'belief': 1, 'id': 'bdca0c32-328c-464c-ba8c-a17e7e060b18', 'matches_hash': '13710271415468405', 'obj': {'db_refs': {'FPLX': 'NFkappaB', 'IP': 'IPR000451', 'MESH': 'D016328', 'NCIT': 'C17380', 'TEXT': 'NF-kB'}, 'name': 'NFkappaB'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'CAS': '657-24-9', 'CHEBI': 'CHEBI:6801', 'CHEMBL': 'CHEMBL1431', 'DRUGBANK': 'DB00331', 'HMDB': 'HMDB0001921', 'HMS-LINCS': '10622', 'MESH': 'D008687', 'PUBCHEM': '4091', 'TEXT': 'metformin'}, 'name': 'metformin'}, 'type': 'Activation'}	EMMAA	3609580799138457141	no_relation	By targeting electron transport chain complex 1 and independently of AMP activated protein kinase (AMPK) or NF-kappaB, metformin blocked LPS induced and ATP dependent mitochondrial (mt) DNA synthesis and generation of oxidized mtDNA, an NLRP3 ligand.	Metformin activates NFkappaB.	{'CHEBI:CHEBI:6801': {'name': 'metformin', 'synonyms': ['1,1-dimethylbiguanide', 'Dimethylbiguanidine', 'Dimethylguanylguanidine', 'LA 6023', 'LA-6023', 'MT', 'Metformin', 'N(1),N(1)-dimethylbiguanide', 'N,N-dimethylbiguanide', 'N,N-dimethyldiguanide', 'N,N-dimethylguanylguanidine', 'N,N-dimethylimidodicarbonimidic diamide', 'N,N-dimethyltriimidodicarbonic diamide', 'dimethylbiguanide', 'dimethyldiguanide', 'metformin', 'metformina', 'metformine', 'metforminum'], 'definition': None, 'syn_in_text': 'MT', 'syn_in_stmt': 'Metformin'}, 'FPLX:NFkappaB': {'name': 'NFkappaB', 'synonyms': ['Enhancer-Binding Protein, Immunoglobulin', 'Factor NF-kB, Transcription', 'Factor-Kappab, Nuclear', 'Immunoglobulin Enhancer Binding Protein', 'Immunoglobulin Enhancer-Binding Protein', 'NF kB', 'NF kappaB', 'NF-kB', 'NF-kB, Transcription Factor', 'NF-kappa B', 'NF-kappaB', 'NF-kappaB Factors', 'NF-kappaB TFs', 'NF-kappaB complexes', 'NF-kappaB dimers', 'NF-kappaB factors', 'NF-kappaB genes', 'NF-kappaB subunits', 'NF-kappaBs', 'NF-kappabeta', 'NF-κB', 'NF-κB Factors', 'NF-κB TFs', 'NF-κB complexes', 'NF-κB dimers', 'NF-κB factors', 'NF-κB genes', 'NF-κB subunits', 'NF-κBs', 'NF-κβ', 'NFkappaB', 'NFkappaB complexes', 'NFκB', 'NFκB complexes', 'Nuclear Factor Kappab', 'Nuclear Factor kappa B', 'Nuclear Factor-Kappab', 'Transcription Factor NF kB', 'Transcription Factor NF-kB', 'kappa B Enhancer Binding Protein'], 'definition': None, 'syn_in_text': 'NF-kappaB', 'syn_in_stmt': 'NFkappaB'}}
bachmanjohn@gmail.com	Fri, 06 Nov 2020 20:54:30 GMT		7928	-35566770759269073		EMMAA	-5341998212692257997	no_relation	Based on previous studies implicating mTOR signaling and Raf signaling in NF1 mutant cells, we tested the therapeutic effect of the rapamycin analog RAD001 [XREF_BIBR], an mTOR inhibitor, and Sorafenib, a multi targeted kinase inhibitor that was originally developed as a raf kinase inhibitor [XREF_BIBR], in this model.	MTOR activates mutated NF1.	{'HGNC:3942': {'name': 'MTOR', 'synonyms': ['FK506 binding protein 12-rapamycin associated protein 2', 'FK506-binding protein 12-rapamycin complex-associated protein 1', 'FKBP-rapamycin associated protein', 'FKBP12-rapamycin complex-associated protein', 'FKBP12-rapamycin complex-associated protein 1', 'FLJ44809', 'FRAP', 'FRAP1', 'FRAP2', 'MTOR', 'Mammalian target of rapamycin', 'Mechanistic target of rapamycin', 'RAFT1', 'RAPT1', 'Rapamycin and FKBP12 target 1', 'Rapamycin target protein 1', 'Serine/threonine-protein kinase mTOR', 'dJ576K7.1 (FK506 binding protein 12-rapamycin associated protein 1)', 'mTOR', 'mammalian target of rapamycin', 'mechanistic target of rapamycin kinase', 'rapamycin and FKBP12 target 1', 'rapamycin associated protein FRAP2', 'rapamycin target protein'], 'definition': None, 'syn_in_text': 'MTOR', 'syn_in_stmt': 'MTOR'}, 'HGNC:7765': {'name': 'NF1', 'synonyms': ['NF 1 Protein', 'NF-1 Protein', 'NF1', 'NF1 GAP Related Protein', 'NF1 GRP', 'NF1 Protein', 'NF1-GAP-Related Protein', 'Neurofibromatosis Type 1 Gene Product', 'Neurofibromatosis Type 1 Protein', 'Neurofibromatosis-related protein NF-1', 'Neurofibromin', 'Neurofibromin 1', 'Watson disease', 'neurofibromatosis', 'neurofibromin 1', 'von Recklinghausen disease'], 'definition': None, 'syn_in_text': 'NF1', 'syn_in_stmt': 'NF1'}}
ben.gyori@gmail.com	Sun, 22 Nov 2020 03:09:34 GMT		8848	25100903704980427		EMMAA	-7779615150802742793	no_relation	Considering that they are all induced by immune imbalance, inflammation, etc., there may be some correlation in the mechanism, and many clues showed that both diseases are associated with activation of the PI3K-AKT-mTOR signaling pathway.	AKT binds PI3K and MTOR.	{'FPLX:AKT': {'name': 'AKT', 'synonyms': ['AKT', 'AKT family', 'Akt', 'PKB', 'PKB-Akt', 'PKB/Akt'], 'definition': None, 'syn_in_text': 'AKT', 'syn_in_stmt': 'AKT'}, 'FPLX:PI3K': {'name': 'PI3K', 'synonyms': ['PI 3-kinase', 'PI 3-kinases', 'PI-3-K', 'PI3 K', 'PI3-K', 'PI3-Kinase', 'PI3-kinase', 'PI3K', 'PI3Kinase', 'PI3Ks', 'Phosphoinositide 3-kinase', 'Ptdins 3-Kinase', 'Ptdins 3-kinase', 'phosphatidylinositol 3-kinase', 'phosphoinositide 3-kinase', 'phosphoinositide-3 kinase'], 'definition': None, 'syn_in_text': 'PI3K', 'syn_in_stmt': 'PI3K'}, 'HGNC:3942': {'name': 'MTOR', 'synonyms': ['FK506 binding protein 12-rapamycin associated protein 2', 'FK506-binding protein 12-rapamycin complex-associated protein 1', 'FKBP-rapamycin associated protein', 'FKBP12-rapamycin complex-associated protein', 'FKBP12-rapamycin complex-associated protein 1', 'FLJ44809', 'FRAP', 'FRAP1', 'FRAP2', 'MTOR', 'Mammalian target of rapamycin', 'Mechanistic target of rapamycin', 'RAFT1', 'RAPT1', 'Rapamycin and FKBP12 target 1', 'Rapamycin target protein 1', 'Serine/threonine-protein kinase mTOR', 'dJ576K7.1 (FK506 binding protein 12-rapamycin associated protein 1)', 'mTOR', 'mammalian target of rapamycin', 'mechanistic target of rapamycin kinase', 'rapamycin and FKBP12 target 1', 'rapamycin associated protein FRAP2', 'rapamycin target protein'], 'definition': None, 'syn_in_text': 'MTOR', 'syn_in_stmt': 'MTOR'}}
bachmanjohn@gmail.com	Wed, 17 Jun 2020 16:36:06 GMT		5510	30894142389841139		bioexp_paper_sparser	-4667847593963671390	no_relation	This suggested that the sequential interactions of Dna2 and FEN1 differ in the human and yeast systems.	DNA2 binds FEN1.	{'HGNC:2939': {'name': 'DNA2', 'synonyms': ['DNA replication ATP-dependent helicase-like homolog', 'DNA replication ATP-dependent helicase/nuclease DNA2', 'DNA replication helicase/nuclease 2', 'DNA2', 'DNA2L', 'KIAA0083', 'hDNA2', 'Dna2'], 'definition': None, 'syn_in_text': 'DNA2', 'syn_in_stmt': 'DNA2'}, 'HGNC:3650': {'name': 'FEN1', 'synonyms': ['DNase IV', 'FEN-1', 'FEN1', 'Flap endonuclease 1', 'Flap structure-specific endonuclease 1', 'MF1', 'Maturation factor 1', 'RAD2', 'flap structure-specific endonuclease 1', 'hFEN-1', 'maturation factor-1'], 'definition': None, 'syn_in_text': 'FEN1', 'syn_in_stmt': 'FEN1'}}
ben.gyori@gmail.com	Wed, 03 Jun 2020 01:47:04 GMT		4637	-24303970487614590		bioexp_paper_sparser	-1957014360619179028	no_relation	The immunoprecipitation assay in the present study showed that MIA2 and MIA are bound to integrins α 4 and α 5; however, MIA2 showed higher affinity to integrin α 4 than to integrin α 5.	MIA2 binds MIA.	{'HGNC:18432': {'name': 'MIA2', 'synonyms': ['CTAGE family member 5 ER export factor', 'CTAGE5', 'Cutaneous T-cell lymphoma-associated antigen 5', 'FLJ22404', 'MEA11', 'MEA6', 'MGEA', 'MGEA11', 'MGEA6', 'MIA SH3 domain ER export factor 2', 'MIA protein 2', 'MIA2', 'Melanoma inhibitory activity protein 2', 'Meningioma-expressed antigen 6/11', 'TALI', 'TANGO1-like', 'cTAGE-5A', 'cTAGE-5B', 'cTAGE-5C', 'cTAGE-5D'], 'definition': None, 'syn_in_text': 'MIA2', 'syn_in_stmt': 'MIA2'}, 'HGNC:7076': {'name': 'MIA', 'synonyms': ['CD-RAP', 'MIA', 'MIA SH3 domain containing', 'MIA1', 'Melanoma inhibitory activity protein', 'Melanoma-derived growth regulatory protein'], 'definition': None, 'syn_in_text': 'MIA', 'syn_in_stmt': 'MIA'}}
ben.gyori@gmail.com	Fri, 05 Nov 2021 01:07:01 GMT		12482	-3798420624778508	{'belief': 1, 'id': '2344c14a-9da2-4786-a563-e4590b6d6d7e', 'matches_hash': '-3798420624778508', 'obj': {'db_refs': {'HGNC': '7106', 'MESH': 'D000067699', 'TEXT': 'atx3', 'UP': 'P54252'}, 'name': 'ATXN3'}, 'subj': {'db_refs': {'HGNC': '7106', 'MESH': 'D000067699', 'TEXT': 'atx3', 'UP': 'P54252'}, 'mods': [{'is_modified': True, 'mod_type': 'phosphorylation', 'position': '12', 'residue': 'S'}], 'name': 'ATXN3'}, 'type': 'DecreaseAmount'}	DB REST API	-5244028975738364134	no_relation	Neurons expressing GFP-atx3 84Q S12D show no difference in the number of excitatory glutamatergic synapses (XREF_FIG) and inhibitory postsynaptic terminals (XREF_FIG) compared with GFP-atx3 28Q WT, suggesting that atx3 phosphorylation at S12 rescues the deleterious outcomes of expanded atx3 expression.	ATXN3 phosphorylated on S12 decreases the amount of ATXN3.	{'HGNC:7106': {'name': 'ATXN3', 'synonyms': ['ATX3', 'ATXN3', 'ATXN3 Protein', 'Ataxin 3', 'Ataxin 3 Protein', 'Ataxin-3', 'Ataxin-3 Protein', 'JOS', 'MJD', 'MJD1', 'Machado Joseph Disease Protein', 'Machado-Joseph Disease Protein', 'Machado-Joseph disease protein 1', 'SCA3', 'SCA3 Protein', 'Spinocerebellar Ataxia 3 Protein', 'Spinocerebellar ataxia type 3 protein', 'ataxin 3', 'atx3'], 'definition': None, 'syn_in_text': 'ATX3', 'syn_in_stmt': 'ATXN3'}}
ben.gyori@gmail.com	Tue, 04 Aug 2020 14:20:20 GMT		6013	15004896787277068		EMMAA	-6461565675419944045	no_relation	To date, two SARS strains have been reported to cause epidemics: (1) SARS-CoV, identified in 2002–2004, and (2) SARS-CoV-2, also known as the novel coronavirus that emerged as a potential threat in late 2019 [6].	Severe Acute Respiratory Syndrome activates SARS Virus.	{'MESH:D045169': {'name': 'Severe Acute Respiratory Syndrome', 'synonyms': ['Respiratory Syndrome, Acute, Severe', 'Respiratory Syndrome, Severe Acute', 'SARS', 'SARS (Severe Acute Respiratory Syndrome)', 'SARS ASSOC CORONAVIRUS', 'SARS coronavirus caused disease or disorder', 'SARS coronavirus disease or disorder', 'SARS coronavirus infectious disease', 'SARS-CoV infection', 'SARS-associated coronavirus', 'Severe Acute Respiratory Syndrome', 'Severe acute respiratory syndrome (disorder)', 'acute respiratory coronavirus infection', 'severe acute respiratory syndrome'], 'definition': None, 'syn_in_text': 'SARS', 'syn_in_stmt': 'SARS'}, 'MESH:D045473': {'name': 'SARS Virus', 'synonyms': ['Coronavirus, SARS-Associated', 'Coronavirus, SARS-Related', 'Coronavirus, Urbani SARS-Associated', 'HCoV-SARS', 'SARS Associated Coronavirus', 'SARS Related Coronavirus', 'SARS Virus', 'SARS like coronavirus', 'SARS-Associated Coronavirus', 'SARS-Associated Coronavirus, Urbani', 'SARS-CoV-1', 'SARS-Related Coronavirus', 'SARS-like coronavirus', 'SARS-like coronaviruses', 'SARSr-CoV', 'SARSrCoV', 'SARSrCoVs', 'Severe acute respiratory syndrome related coronavirus', 'Severe acute respiratory syndrome-related coronavirus', 'Urbani SARS Associated Coronavirus', 'Urbani SARS-Associated Coronavirus', 'SARS-CoV'], 'definition': None, 'syn_in_text': 'SARS-CoV', 'syn_in_stmt': 'SARS Virus'}}
marta.iannuccelli@gmail.com	Thu, 12 Jun 2025 07:31:38 GMT		17352	-1283908581838350	{'belief': 1, 'enz': {'db_refs': {'HGNC': '10430', 'MESH': 'D038744', 'TEXT': 'RSK1', 'UP': 'Q15418'}, 'name': 'RPS6KA1'}, 'id': '374ac515-928f-4cda-89df-c6530e7ffd56', 'matches_hash': '-1283908581838350', 'position': '36', 'residue': 'S', 'sub': {'db_refs': {'HGNC': '7797', 'MESH': 'D000072000', 'TEXT': 'IkappaBalpha', 'UP': 'P25963'}, 'name': 'NFKBIA'}, 'type': 'Phosphorylation'}	signor_phos	3301910195404833805	no_relation	As shown in Figure 6A, these Rsk1 immunoprecipitates phosphorylated S32 but not S36 of IkappaBalpha.	RPS6KA1 phosphorylates NFKBIA on S36.	{'HGNC:10430': {'name': 'RPS6KA1', 'synonyms': ['90 kDa ribosomal protein S6 kinase 1', 'HU-1', 'MAP kinase-activated protein kinase 1a', 'MAPK-activated protein kinase 1a', 'MAPKAP kinase 1a', 'MAPKAPK-1a', 'MAPKAPK1', 'MAPKAPK1A', 'RPS6KA1', 'RSK-1', 'RSK1', 'Ribosomal S6 kinase 1', 'Ribosomal protein S6 kinase alpha-1', 'S6K-alpha-1', 'p90-RSK 1', 'p90RSK1', 'p90Rsk', 'p90S6K', 'ribosomal protein S6 kinase A1'], 'definition': None, 'syn_in_text': 'RSK1', 'syn_in_stmt': 'RPS6KA1'}, 'HGNC:7797': {'name': 'NFKBIA', 'synonyms': ['I Kappa B alpha Protein', 'I Kappa B-alpha Protein', 'I-kappa-B-alpha', 'IKBA', 'IKappaB alpha', 'IKappaB-alpha', 'IKappaBalpha', 'IkB-alpha', 'IkappaB-alpha', 'IkappaBalpha', 'Inhibitor alpha, NF-KappaB', 'IκB-α', 'IκBα', 'MAD-3', 'MAD3', 'Major Histocompatibility Complex Enhancer Binding Protein MAD3', 'Major Histocompatibility Complex Enhancer-Binding Protein MAD3', 'Major histocompatibility complex enhancer-binding protein MAD3', 'NF KappaB Inhibitor alpha', 'NF-KappaB Inhibitor alpha', 'NF-kappa-B inhibitor alpha', 'NFKB inhibitor alpha', 'NFKBI', 'NFKBIA', 'alpha, NF-KappaB Inhibitor', 'p40 Protein (IKappaB-alpha)'], 'definition': None, 'syn_in_text': 'IKappaBalpha', 'syn_in_stmt': 'NFKBIA'}}
bachmanjohn@gmail.com	Thu, 10 Dec 2020 18:06:35 GMT		10130	17510250703456670		bioexp_biogrid	-6034223320138787786	no_relation	Two independent groups reported significant association of liver transcript levels of  CELSR2, PSRC1 , and  SORT1  with the strongest regulatory effect observed for  SORT1  mRNA.	SORT1 binds PSRC1 and CELSR2.	{'HGNC:11186': {'name': 'SORT1', 'synonyms': ['100 kDa NT receptor', 'Glycoprotein 95', 'Gp95', 'NT3', 'NTR3', 'Neurotensin receptor 3', 'SORT1', 'Sortilin', 'sortilin', 'sortilin 1'], 'definition': None, 'syn_in_text': 'SORT1', 'syn_in_stmt': 'SORT1'}, 'HGNC:24472': {'name': 'PSRC1', 'synonyms': ['DDA3', 'PSRC1', 'Proline/serine-rich coiled-coil protein 1', 'differential display and activated by p53', 'proline and serine rich coiled-coil 1'], 'definition': None, 'syn_in_text': 'PSRC1', 'syn_in_stmt': 'PSRC1'}, 'HGNC:3231': {'name': 'CELSR2', 'synonyms': ['ADGRC2', 'CDHF10', 'CELSR2', 'Cadherin EGF LAG seven-pass G-type receptor 2', 'Cadherin family member 10', 'EGF-like protein 2', 'EGFL2', 'Epidermal growth factor-like protein 2', 'Flamingo homolog 3', 'Flamingo1', 'KIAA0279', 'MEGF3', 'Multiple EGF-like domains protein 3', 'Multiple epidermal growth factor-like domains protein 3', 'adhesion G protein-coupled receptor C2', 'cadherin EGF LAG seven-pass G-type receptor 2', 'multiple EGF like domains 3'], 'definition': None, 'syn_in_text': 'CELSR2', 'syn_in_stmt': 'CELSR2'}}
ben.gyori@gmail.com	Wed, 16 Sep 2020 01:34:39 GMT		6326	-4272781968305111		DB REST API	-6279139919106890330	no_relation	Such disproportionate production levels in antigen-experienced CD4 T cell-derived IL-10 and IFN-γ were associated with enhanced patient antitumor immune responses and clinical responses and may suggest a potentially important determinant in the balance between effective and ineffective immunotherapeutics.	CD4 binds IFNG and IL10.	{'HGNC:1678': {'name': 'CD4', 'synonyms': ['Antigen, CD4', 'Antigens, CD4', 'Antigens, T-Cell T4', 'CD antigen CD4', 'CD4', 'CD4 Antigen', 'CD4 Antigens', 'CD4 Molecule', 'CD4 Receptor', 'CD4 Receptor, Surface', 'CD4 Receptors', 'CD4 Receptors, Surface', 'CD4 molecule', 'Leu-3', 'Receptor, CD4', 'Receptors, CD4', 'Receptors, Surface CD4', 'Surface CD4 Receptor', 'Surface CD4 Receptors', 'T-Cell T4 Antigens', 'T-cell surface antigen T4/Leu-3', 'T-cell surface glycoprotein CD4', 'T4', 'T4 Antigens, T Cell', 'T4 Antigens, T-Cell'], 'definition': None, 'syn_in_text': 'CD4', 'syn_in_stmt': 'CD4'}, 'HGNC:5438': {'name': 'IFNG', 'synonyms': ['IFN-gamma', 'IFN-γ', 'IFNG', 'IFNgamma', 'IFNγ', 'Immune Interferon', 'Immune interferon', 'Interferon Type II', 'Interferon gamma', 'Interferon, Immune', 'Interferon, Type II', 'Interferon, gamma', 'Interferon-gamma', 'Type II Interferon', 'gamma-Interferon', 'interferon gamma'], 'definition': None, 'syn_in_text': 'IFN-γ', 'syn_in_stmt': 'IFNG'}, 'HGNC:5962': {'name': 'IL10', 'synonyms': ['CSIF', 'CSIF-10', 'Cytokine Synthesis Inhibitory Factor', 'Cytokine synthesis inhibitory factor', 'IL-10', 'IL10', 'IL10A', 'Interleukin 10', 'Interleukin-10', 'T-cell growth inhibitory factor', 'TGIF', 'cytokine synthesis inhibitory factor', 'interleukin 10'], 'definition': None, 'syn_in_text': 'IL-10', 'syn_in_stmt': 'IL10'}}
bachmanjohn@gmail.com	Thu, 11 Jun 2020 19:24:03 GMT		4982	11079649413561672		bioexp_paper_multi	3655033237740304020	no_relation	CB1 activation of the GTP binding protein, Gi/o contributes to CB1 mediated TRPV1 dephosphorylation leading to TRPV1 desensitization, declines in TRPV1-induced increases in currents and pro-inflammatory signaling events.	TRPV1 inhibits TRPV1.	{'HGNC:12716': {'name': 'TRPV1', 'synonyms': ['Capsaicin Receptor', 'Capsaicin Receptors', 'Capsaicin receptor', 'Cation Channels, TRPV', 'Channels, TRPV Cation', 'OTRPC1', 'Osm-9-like TRP channel 1', 'Receptor, Capsaicin', 'Receptor, Vanilloid', 'Receptors, Capsaicin', 'Receptors, Vanilloid', 'TRPV Cation Channels', 'TRPV1', 'Transient receptor potential cation channel subfamily V member 1', 'TrpV1', 'VR1', 'Vanilloid Receptor', 'Vanilloid Receptors', 'Vanilloid receptor 1', 'transient receptor potential cation channel subfamily V member 1'], 'definition': None, 'syn_in_text': 'TRPV1', 'syn_in_stmt': 'TRPV1'}}
ben.gyori@gmail.com	Thu, 31 Mar 2022 22:26:09 GMT	{'annotations': {'agents': {'raw_text': ['apoptotic process', 'BAD']}, 'content_source': 'pubmed', 'found_by': 'Positive_activation_syntax_1_verb', 'prior_uuids': ['abf1be6a-0cd3-4392-8155-502e4c80dabf']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '15466700', 'source_api': 'reach', 'source_hash': -731712538092168300, 'text': 'The Sph induced apoptotic process associated with activation of caspase 3 and release of PKCdelta KD (SDK1) may promote the proapoptotic effect of BAD or BAX through an increase of phosphorylated 14-3-3.', 'text_refs': {'DOI': '10.1073/PNAS.0406536101', 'DOI_ID': 'PNAS.0406536101', 'DOI_NS': 1073, 'PMCID': 'PMC522055', 'PMCID_NUM': 522055, 'PMID': '15466700', 'PMID_NUM': 15466700, 'READER': 'REACH', 'RID': 10100011017002, 'SOURCE': 'pubmed', 'TCID': 11017002, 'TRID': 17339067}}	12863	-12165656364805254	{'belief': 1, 'id': '06ac28f2-10c8-4f65-a106-390b44668775', 'matches_hash': '-12165656364805254', 'obj': {'db_refs': {'HGNC': '936', 'TEXT': 'BAD', 'UP': 'Q92934'}, 'name': 'BAD'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'GO': 'GO:0006915', 'MESH': 'D017209', 'TEXT': 'apoptosis'}, 'name': 'apoptotic process'}, 'type': 'Activation'}	DB REST API	-731712538092168310	no_relation	The Sph induced apoptotic process associated with activation of caspase 3 and release of PKCdelta KD (SDK1) may promote the proapoptotic effect of BAD or BAX through an increase of phosphorylated 14-3-3.	Apoptotic process activates BAD.	{'GO:GO:0006915': {'name': 'apoptotic process', 'synonyms': ['Apoptosis', 'Apoptosis, Classic', 'Apoptosis, Classical', 'Classic Apoptoses', 'Classic Apoptosis', 'Classical Apoptosis', 'PA', 'Programmed Cell Death, Type I', 'apoptosis', 'apoptosis activator activity', 'apoptotic cell death', 'apoptotic process', 'apoptotic programmed cell death', 'caspase-dependent programmed cell death', 'commitment to apoptosis', 'induction of apoptosis', 'induction of apoptosis by p53', 'programmed cell death by apoptosis', 'signaling (initiator) caspase activity'], 'definition': None, 'syn_in_text': 'PA', 'syn_in_stmt': 'apoptotic process'}, 'HGNC:936': {'name': 'BAD', 'synonyms': ['BAD', 'BBC2', 'BBC6', 'BCL2 associated agonist of cell death', 'BCL2L8', 'Bad', 'Bcl-2-binding component 6', 'Bcl-2-like protein 8', 'Bcl-xL/Bcl-2-associated death promoter', 'Bcl2 antagonist of cell death', 'Bcl2-L-8', 'Bcl2-associated agonist of cell death'], 'definition': None, 'syn_in_text': 'BAD', 'syn_in_stmt': 'BAD'}}
ben.gyori@gmail.com	Wed, 10 Nov 2021 00:32:38 GMT		12497	25973262655644885		EMMAA	1511533984969084001	no_relation	From the point of view of OS and drug metabolism, there is a significant association with cytochrome P450 function, there are many interactions between cytochrome P450 and drugs as substrates and/or inducers: e.g., 5-fluorouracil, atorvastatin, axitinib, cortisol, cyclophosphamide, daunorubicin, docetaxel, etoposide, irinotecan, ibrutinib, nortriptyline, oxycodone, pazopanib, prednisone, sunitinib, and venlafaxine.	Atorvastatin binds nortriptyline.	{'CHEBI:CHEBI:39548': {'name': 'atorvastatin', 'synonyms': ['(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid', '(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-4-phenyl-2-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid', '(R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid', '7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID', 'Atorlip', 'Atorvastatin', 'atorvastatin', 'atorvastatina', 'atorvastatine', 'atorvastatinum'], 'definition': None, 'syn_in_text': 'Atorvastatin', 'syn_in_stmt': 'Atorvastatin'}, 'CHEBI:CHEBI:7640': {'name': 'nortriptyline', 'synonyms': ['10,11-dihydro-N-methyl-5H-dibenzo[a,d]cycloheptene-Delta(5,gamma)-propylamine', '3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1-amine', '3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine', 'Ateben', 'Avantyl', 'Aventyl', 'Desitriptyline', 'Desmethylamitriptylin', 'Noritren', 'Nortriptyline', 'Psychostyl', 'Sensaval', 'demethylamitriptyline', 'desmethylamitriptyline', 'nortriptylina', 'nortriptyline', 'nortriptylinum'], 'definition': None, 'syn_in_text': 'Nortriptyline', 'syn_in_stmt': 'Nortriptyline'}}
ben.gyori@gmail.com	Thu, 21 May 2020 19:10:02 GMT		3585	-8695562449706436		EMMAA	-168469251880846246	no_relation	The government has implemented the social-distancing campaign , enhanced the infection prevention and control practices in hospitals , conducted drive-through testing , and postponed the schedule of school activities .	Government inhibits Hospitals.	{'MESH:D006076': {'name': 'Government', 'synonyms': ['Government', 'Governments', 'government'], 'definition': None, 'syn_in_text': 'Government', 'syn_in_stmt': 'Government'}, 'MESH:D006761': {'name': 'Hospitals', 'synonyms': ['Hospital', 'Hospitals', 'hospitals'], 'definition': None, 'syn_in_text': 'Hospitals', 'syn_in_stmt': 'Hospitals'}}
bachmanjohn@gmail.com	Tue, 03 Nov 2020 18:47:03 GMT		7765	12162414799357591		EMMAA	-2474954038692960671	no_relation	Expression of class 3 BRAF mutants enhanced the binding of BRAF but not CRAF to mutant NRAS (XREF_FIG).	Mutated BRAF activates BRAF.	{'HGNC:1097': {'name': 'BRAF', 'synonyms': ['B-Raf', 'B-Raf proto-oncogene, serine/threonine kinase', 'BRAF', 'BRAF-1', 'BRAF1', 'Proto-oncogene B-Raf', 'RAFB1', 'Serine/threonine-protein kinase B-raf', 'p94', 'v-Raf murine sarcoma viral oncogene homolog B1'], 'definition': None, 'syn_in_text': 'BRAF', 'syn_in_stmt': 'BRAF'}}
ben.gyori@gmail.com	Mon, 14 Dec 2020 04:50:34 GMT		10168	9770818549980568		EMMAA	-546886247674883751	no_relation	mchr2 phenotype can be rescued in adult fish by knocking-out pomc, the gene coding for the precursor of alpha-MSH, demonstrating the relevance of the antagonistic activity between MCH and alpha-MSH in the control of melanosome organization.	POMC activates MCHR2.	{'HGNC:9201': {'name': 'POMC', 'synonyms': ['ACTH', 'ACTH Endorphin Precursor', 'ACTH beta Lipotropin Precursor', 'ACTH-Endorphin Precursor', 'ACTH-beta-Lipotropin Precursor', 'CLIP', 'Corticotropin beta Lipotropin Precursor', 'Corticotropin-beta-Lipotropin Precursor', 'Corticotropin-lipotropin', 'Endorphin ACTH Precursor', 'Endorphin-ACTH Precursor', 'LPH', 'MSH', 'NPP', 'POC', 'POMC', 'Pro ACTH Endorphin', 'Pro Opio Melanocortin', 'Pro Opiocortin', 'Pro Opiomelanocortin', 'Pro-ACTH-Endorphin', 'Pro-Opio-Melanocortin', 'Pro-Opiocortin', 'Pro-Opiomelanocortin', 'Pro-opiomelanocortin', 'Proopiocortin', 'Proopiomelanocortin', 'adrenocorticotropic hormone', 'adrenocorticotropin', 'alpha-melanocyte stimulating hormone', 'beta-endorphin', 'beta-lipotropin', 'beta-melanocyte stimulating hormone', 'opiomelanocortin prepropeptide', 'proopiomelanocortin', 'pomc'], 'definition': None, 'syn_in_text': 'POMC', 'syn_in_stmt': 'POMC'}, 'HGNC:20867': {'name': 'MCHR2', 'synonyms': ['G-protein coupled receptor 145', 'GPR145', 'GPRv17', 'MCH receptor 2', 'MCH-2R', 'MCH-R2', 'MCH2', 'MCH2R', 'MCHR-2', 'MCHR2', 'Melanin-concentrating hormone receptor 2', 'SLT', 'melanin concentrating hormone receptor 2', 'mchr2'], 'definition': None, 'syn_in_text': 'MCHR2', 'syn_in_stmt': 'MCHR2'}}
thomaslim6793@gmail.com	Mon, 31 Mar 2025 19:06:17 GMT		15687	-32264902383785903	{'belief': 1, 'id': 'fdd411fe-23d1-40a4-b26d-bd90dbc769a0', 'matches_hash': '-32264902383785903', 'obj': {'db_refs': {'FPLX': 'TGFB', 'IP': 'IPR015615', 'MESH': 'D016212', 'TEXT': 'TGF-β'}, 'name': 'TGFB'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'FPLX': 'COL4', 'GO': 'GO:0005587', 'IP': 'IPR001442', 'MESH': 'D024141', 'NCIT': 'C16448', 'TEXT': 'collagen IV'}, 'name': 'COL4'}, 'type': 'Activation'}	preassembled_stmts_REACH_2025-03-31-14.pkl	-5521672673784582746	no_relation	Because Boucher et al. reported that LRP1 is tightly involved in the pathogenesis of atherosclerosis by regulating signaling of TGFbeta and PDGF, and their receptors XREF_BIBR, XREF_BIBR, knockdown analysis using LRP1 siRNAs was perfomed to examine the role of LRP1 in the regulatory effect of PDGF induced Col4 expression and PDGF activated TGFbeta signaling pathway in MCs.	COL4 activates TGFB.	{'FPLX:COL4': {'name': 'COL4', 'synonyms': ['Col4', 'ColIV', 'Collagen Type IV', 'Collagen, Type IV', 'Type IV (Basement Membrane) Collagen', 'Type IV Collagen', 'collagen IV', 'collagen type IV', 'COL4'], 'definition': None, 'syn_in_text': 'Col4', 'syn_in_stmt': 'Col4'}, 'FPLX:TGFB': {'name': 'TGFB', 'synonyms': ['Bone Derived Transforming Growth Factor', 'Bone-Derived Transforming Growth Factor', 'Factor, Milk Growth', 'Growth Factor, Milk', 'Milk Growth Factor', 'Platelet Transforming Growth Factor', 'TGF beta', 'TGF β', 'TGF-b', 'TGF-beta', 'TGF-beta family', 'TGF-β', 'TGFB', 'TGFB family', 'TGFbeta', 'TGFβ', 'Transforming Growth Factor beta', 'transforming growth factor beta', 'transforming growth factor β', 'transforming growth factor-beta', 'transforming growth factor-β'], 'definition': None, 'syn_in_text': 'TGFbeta', 'syn_in_stmt': 'TGFB'}}
ben.gyori@gmail.com	Wed, 25 Nov 2020 03:46:55 GMT		9061	16640197842767839		EMMAA	9183250448268702259	no_relation	Shogaol inhibits alpha-MSH-induced melanogenesis by accelerating the ERK and PI3k and serine-threonine kinase (Akt) pathways in B16F10 melanoma cells [XREF_BIBR] and was also found to downregulate MITF expression.	ERK increases the amount of MITF.	{'FPLX:ERK': {'name': 'ERK', 'synonyms': ['ERK', 'ERK 1/2', 'ERK MAP Kinase', 'ERK MAP Kinases', 'ERK MAPK', 'ERK mitogen-activated protein kinase', 'ERK-1/2', 'ERK1/2', 'ERK1/2 MAPK', 'ERKs', 'Erk', 'Erk1/2', 'Extracellular Signal Regulated Kinase', 'Extracellular Signal Regulated Kinases', 'Extracellular Signal Regulated MAP Kinase', 'Extracellular Signal Regulated MAP Kinases', 'Extracellular Signal-Regulated Kinase', 'Extracellular Signal-Regulated Kinases', 'Extracellular Signal-Regulated MAP Kinase', 'Extracellular Signal-Regulated MAP Kinases', 'Kinase, ERK MAP', 'Kinase, Extracellular Signal-Regulated', 'Kinases, Extracellular Signal-Regulated', 'MAP Kinase, ERK', 'MAP Kinases, Extracellular Signal Regulated', 'MAP Kinases, Extracellular Signal-Regulated', 'Signal-Regulated Kinase, Extracellular', 'extracellular signal-regulated kinase', 'p42 and p38 MAP kinases', 'p42 and p38 MAPK', 'p42 and p38 MAPKs', 'p42 and p44', 'p42 and p44 MAPK', 'p42 and p44MAP kinase', 'p42(mapk) and p44(mapk)', 'p42/44', 'p44 and p42', 'phospho-ERK1/2'], 'definition': None, 'syn_in_text': 'ERK', 'syn_in_stmt': 'ERK'}, 'HGNC:7105': {'name': 'MITF', 'synonyms': ['BHLHE32', 'Class E basic helix-loop-helix protein 32', 'MI', 'MITF', 'MITF Protein', 'MITF Transcription Factor', 'Microphthalmia Associated Transcription Factor', 'Microphthalmia, Transcription Factor', 'Microphthalmia-Associated Transcription Factor', 'Microphthalmia-associated transcription factor', 'Transcription Factor Microphthalmia', 'Transcription Factor, Microphthalmia-Associated', 'WS2', 'WS2A', 'bHLHe32', 'homolog of mouse microphthalmia', 'melanocyte inducing transcription factor'], 'definition': None, 'syn_in_text': 'MITF', 'syn_in_stmt': 'MITF'}}
ben.gyori@gmail.com	Thu, 03 Dec 2020 20:35:00 GMT		9222	-29569982243125498		bioexp_biogrid	-8680022327660619096	no_relation	HSP27 overexpression was associated with preservation of E-cadherin and β-catenin at the cell membrane.	CDH1 binds CTNNB1 and HSPB1.	{'HGNC:1748': {'name': 'CDH1', 'synonyms': ['CAM 120/80', 'CD antigen CD324', 'CD324', 'CDH1', 'CDHE', 'Cadherin-1', 'E-Cadherin', 'E-cadherin', 'Epithelial cadherin', 'UVO', 'Uvomorulin', 'cadherin 1', 'uvomorulin'], 'definition': None, 'syn_in_text': 'E-Cadherin', 'syn_in_stmt': 'CDH1'}, 'HGNC:2514': {'name': 'CTNNB1', 'synonyms': ['Beta-catenin', 'CTNNB', 'CTNNB1', 'Catenin beta-1', 'Catenin, beta', 'armadillo', 'beta Catenin', 'beta-Catenin', 'beta-catenin', 'catenin beta 1', 'β-catenin'], 'definition': None, 'syn_in_text': 'β-catenin', 'syn_in_stmt': 'CTNNB1'}, 'HGNC:5246': {'name': 'HSPB1', 'synonyms': ['28 kDa heat shock protein', 'CMT2F', 'Estrogen-regulated 24 kDa protein', 'HSP 27', 'HSP27', 'HSP27 Heat Shock Proteins', 'HSP27 Heat-Shock Proteins', 'HSP27 Protein', 'HSP27 Proteins', 'HSP28', 'HSPB1', 'Heat Shock Protein 27', 'Heat Shock Protein beta 1', 'Heat Shock Protein beta-1', 'Heat Shock Proteins 27', 'Heat shock 27 kDa protein', 'Heat shock protein beta-1', 'Heat shock protein family B member 1', 'Heat-Shock Protein 27', 'Heat-Shock Proteins 27', 'Heat-Shock Proteins, HSP27', 'Hs.76067', 'Hsp25', 'HspB1', 'Protein 27, Heat-Shock', 'SRP27', 'Stress-responsive protein 27', 'heat shock protein family B (small) member 1'], 'definition': None, 'syn_in_text': 'HSP27', 'syn_in_stmt': 'HSPB1'}}
ben.gyori@gmail.com	Thu, 03 Dec 2020 20:04:15 GMT		9187	-15503324061960961		bioexp_biogrid	-885931975335702696	no_relation	In order to analyze if microtubule nucleation at the Golgi apparatus was involved in the mechanism by which AKAP350 participates in apical polarity development in HepG2 cells, we specifically inhibited the formation of Golgi nucleated microtubules by decreasing expression of CLASP1 and CLASP2, as previously described by others ( xref ).	CLASP2 binds CLASP1 and WHAMM.	{'HGNC:17078': {'name': 'CLASP2', 'synonyms': ['CLASP2', 'CLIP-associating protein 2', 'Cytoplasmic linker-associated protein 2', 'KIAA0627', 'Protein Orbit homolog 2', 'cytoplasmic linker associated protein 2', 'hOrbit2'], 'definition': None, 'syn_in_text': 'CLASP2', 'syn_in_stmt': 'CLASP2'}, 'HGNC:17088': {'name': 'CLASP1', 'synonyms': ['CLASP1', 'CLIP-associating protein 1', 'Cytoplasmic linker-associated protein 1', 'KIAA0622', 'MAST1', 'Multiple asters homolog 1', 'Protein Orbit homolog 1', 'cytoplasmic linker associated protein 1', 'hOrbit1', 'multiple asters 1'], 'definition': None, 'syn_in_text': 'CLASP1', 'syn_in_stmt': 'CLASP1'}, 'HGNC:30493': {'name': 'WHAMM', 'synonyms': ['KIAA1971', 'WAS protein homology region 2 domain-containing protein 1', 'WASP homolog associated with actin, golgi membranes and microtubules', 'WASP homolog-associated protein with actin, membranes and microtubules', 'WH2 domain-containing protein 1', 'WHAMM', 'WHAMM1', 'WHDC1', 'microtubules'], 'definition': None, 'syn_in_text': 'microtubules', 'syn_in_stmt': 'WHAMM'}}
marta.iannuccelli@gmail.com	Mon, 09 Jun 2025 07:46:51 GMT		17234	-26790412389596277	{'belief': 1, 'enz': {'db_refs': {'HGNC': '8987', 'TEXT': 'PIM2', 'UP': 'Q9P1W9'}, 'name': 'PIM2'}, 'id': 'f9a5f7a9-6eb2-4f3d-b6b6-0a3a84a5d0e4', 'matches_hash': '-26790412389596277', 'sub': {'db_refs': {'HGNC': '12862', 'MESH': 'D051816', 'TEXT': 'TTP', 'UP': 'P26651'}, 'name': 'ZFP36'}, 'type': 'Phosphorylation'}	signor_phos	-7110278881369678653	no_relation	Our data demonstrated that PIM2 did not phosphorylate TTP invitro, whereas it phosphorylated the known PIM2 kinase substrate PKM2 (Yu etal., 2013), under the same conditions.	PIM2 phosphorylates ZFP36.	{'HGNC:8987': {'name': 'PIM2', 'synonyms': ['PIM2', 'Pim-2 proto-oncogene, serine/threonine kinase', 'Pim-2h', 'Serine/threonine-protein kinase pim-2'], 'definition': None, 'syn_in_text': 'PIM2', 'syn_in_stmt': 'PIM2'}, 'HGNC:12862': {'name': 'ZFP36', 'synonyms': ['G0 G1 Switch Regulatory Protein 24', 'G0-G1 Switch Regulatory Protein 24', 'G0/G1 switch regulatory protein 24', 'G0S24', 'Growth factor-inducible nuclear protein NUP475', 'NUP475', 'RNF162A', 'TIS11', 'TIS11A', 'TTP', 'Tristetraprolin', 'Tristetraprolin Protein', 'ZFP36', 'ZFP36 ring finger protein', 'Zfp-36', 'Zinc Finger Protein 36', 'Zinc finger protein 36', 'mRNA decay activator protein ZFP36', 'tristetraprolin'], 'definition': None, 'syn_in_text': 'TTP', 'syn_in_stmt': 'ZFP36'}}
bachmanjohn@gmail.com	Wed, 18 Nov 2020 14:50:06 GMT		8743	17003554225921494		EMMAA	7680641989692867347	no_relation	Since MAP kinase signaling pathways represent a potential target for therapeutic intervention for cancers, XREF_BIBR here we revealed that flaccidoside II facilitates apoptosis in MPNSTs via regulating the activation of p38 MAPK and ERK-1/2, but not JNK pathway, which gave us a hint that flaccidoside II could be considered as a novel pharmacotherapeutic approach to MPNSTs based on its regulation of MAPK pathways.	JNK activates p38.	{'FPLX:JNK': {'name': 'JNK', 'synonyms': ['JNK', 'JNK MAPK', 'JNK1/2', 'JNKs', 'SAPK', 'c-JNK', 'c-Jun N-terminal kinase', 'c-Jun NH2-terminal kinase'], 'definition': None, 'syn_in_text': 'JNK', 'syn_in_stmt': 'JNK'}, 'FPLX:p38': {'name': 'p38', 'synonyms': ['MAP Kinase, p38', 'MAPK p38', 'MAPK, p38', 'Mitogen Activated Protein Kinase p38', 'Mitogen-Activated Protein Kinase p38', 'P38', 'P38 MAPK', 'Protein Kinase, p38', 'RK', 'p-38', 'p38', 'p38 MAP Kinase', 'p38 MAPK', 'p38 MAPKs', 'p38 Mitogen Activated Protein Kinase', 'p38 Mitogen Activated Protein Kinases', 'p38 Mitogen-Activated Protein Kinase', 'p38 Mitogen-Activated Protein Kinases', 'p38 Protein Kinase', 'p38 SAPK', 'p38-MAPK', 'p38MAPK'], 'definition': None, 'syn_in_text': 'P38', 'syn_in_stmt': 'P38'}}
imke.ditters@gmail.com	Tue, 05 Apr 2022 08:46:25 GMT	{'annotations': {'agents': {'raw_text': ['CI-MPR', 'CD-MPR']}, 'content_source': 'manuscripts', 'found_by': 'BINDING', 'prior_uuids': ['8cad4579-12cf-4b68-88ec-4f5946372a82']}, 'pmid': '19801188', 'source_api': 'sparser', 'source_hash': -6541628902343470000, 'text': 'Unlike the CI-MPR, the CD-MPR does not bind ligands at the cell surface.', 'text_refs': {'DOI': '10.1016/J.SBI.2009.09.002', 'DOI_ID': 'J.SBI.2009.09.002', 'DOI_NS': 1016, 'MANUSCRIPT_ID': 'NIHMS150346', 'PMCID': 'PMC2771201', 'PMCID_NUM': 2771201, 'PMID': '19801188', 'PMID_NUM': 19801188, 'READER': 'SPARSER', 'RID': 20300019682613, 'SOURCE': 'manuscripts', 'TCID': 19682613, 'TRID': 25144959}}	12928	12966424962568	{'belief': 1, 'id': 'cc4ced92-ae67-4e81-9402-1cd1f535697f', 'matches_hash': '12966424962568', 'members': [{'db_refs': {'HGNC': '5467', 'MESH': 'D017527', 'TEXT': 'CI-MPR', 'UP': 'P11717'}, 'name': 'IGF2R'}, {'db_refs': {'HGNC': '6752', 'TEXT': 'CD-MPR', 'UP': 'P20645'}, 'name': 'M6PR'}], 'type': 'Complex'}	DB REST API	-6541628902343469661	no_relation	Unlike the CI-MPR, the CD-MPR does not bind ligands at the cell surface.	IGF2R binds M6PR.	{'HGNC:5467': {'name': 'IGF2R', 'synonyms': ['300 kDa mannose 6-phosphate receptor', 'CD antigen CD222', 'CD222', 'CI Man-6-P receptor', 'CI-M6PR', 'CI-MPR', 'CIMPR', 'Cation-independent mannose-6-phosphate receptor', 'IGF 2 Receptor', 'IGF II Receptor', 'IGF Type 2 Receptor', 'IGF-2 Receptor', 'IGF-2 Receptors', 'IGF-II Receptor', 'IGF-II receptor', 'IGF2R', 'Insulin Like Growth Factor II Receptor', 'Insulin-Like-Growth-Factor II Receptor', 'Insulin-like growth factor 2 receptor', 'Insulin-like growth factor II receptor', 'M6P-R', 'M6P/IGF2 receptor', 'M6P/IGF2R', 'M6PR', 'MPR 300', 'MPR1', 'MPR300', 'MPRI', 'Mannose 6 Phosphate Receptor', 'Mannose-6-Phosphate Receptor', 'Receptor, IGF II', 'Receptor, IGF Type 2', 'Receptor, IGF-2', 'Receptor, IGF-II', 'Receptor, Insulin Like Growth Factor II', 'Receptor, Insulin Like Growth Factor Type 2', 'Receptor, Insulin-Like Growth Factor II', 'Receptor, Insulin-Like Growth Factor Type 2', 'Receptor, Insulin-Like-Growth-Factor II', 'Receptor, Mannose 6 Phosphate', 'Receptor, Mannose-6-Phosphate', 'Receptors, IGF 2', 'Receptors, IGF-2', 'Receptors, Insulin Like Growth Factor II', 'Receptors, Insulin-Like Growth Factor II', 'cation-independent mannose-6 phosphate receptor', 'insulin like growth factor 2 receptor'], 'definition': None, 'syn_in_text': 'CI-MPR', 'syn_in_stmt': 'IGF2R'}, 'HGNC:6752': {'name': 'M6PR', 'synonyms': ['46 kDa mannose 6-phosphate receptor', 'CD Man-6-P receptor', 'CD-M6PR', 'CD-MPR', 'Cation-dependent mannose-6-phosphate receptor', 'M6PR', 'MPR 46', 'MPR46', 'MPRD', 'cation-dependent mannose-6-phosphate receptor', 'mannose-6-phosphate receptor, cation dependent'], 'definition': None, 'syn_in_text': 'CD-MPR', 'syn_in_stmt': 'M6PR'}}
ben.gyori@gmail.com	Fri, 14 Aug 2020 12:34:19 GMT		6092	-12495483273237634		EMMAA	7247119429678001064	no_relation	Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) had been declared as a global pandemic by WHO.	Severe Acute Respiratory Syndrome Coronavirus 2 activates SARS-CoV-2.	{'MESH:C000656484': {'name': 'SARS-CoV-2', 'synonyms': ['SARS-CoV-2'], 'definition': None, 'syn_in_text': 'SARS-CoV-2', 'syn_in_stmt': 'SARS-CoV-2'}}
ben.gyori@gmail.com	Sun, 17 Jan 2021 05:57:31 GMT		10637	-21302515449837122		EMMAA	1475097856159584993	no_relation	Furthermore, we showed that interfering with ORF9c degradation by either proteasome inhibition or inhibition of the ATPase VCP blunted the effects of ORF9c.	Proteasome inhibits VCP.	{'FPLX:Proteasome': {'name': 'Proteasome', 'synonyms': ['proteasome', 'proteasome endopeptidase', 'Proteasome'], 'definition': None, 'syn_in_text': 'proteasome', 'syn_in_stmt': 'proteasome'}, 'HGNC:12666': {'name': 'VCP', 'synonyms': ['15S Mg(2+)-ATPase p97 subunit', 'CDC48', 'HEL-220', 'HEL-S-70', 'IBMPFD', 'TER ATPase', 'TERA', 'Transitional endoplasmic reticulum ATPase', 'VCP', 'Valosin-containing protein', 'p97', 'transitional endoplasmic reticulum ATPase', 'valosin containing protein'], 'definition': None, 'syn_in_text': 'VCP', 'syn_in_stmt': 'VCP'}}
ben.gyori@gmail.com	Tue, 21 Apr 2020 17:38:31 GMT		2511	19508020044018636		EMMAA	3207498325181783170	no_relation	Whether TP53 mutation is associated with EGFR mutation in advanced NSCLC remains uncertain.	TP53 binds EGFR.	{'HGNC:11998': {'name': 'TP53', 'synonyms': ['Antigen NY-CO-13', 'Cellular Tumor Antigen p53', 'Cellular tumor antigen p53', 'LFS1', 'Li-Fraumeni syndrome', 'Oncoprotein p53', 'P53', 'Phosphoprotein p53', 'Phosphoprotein, pp53', 'TP53', 'TP53 Protein', 'TRP53 Protein', 'Tumor Suppressor Protein p53', 'Tumor suppressor p53', 'mutp53', 'p53', 'p53 Antigen', 'p53 Tumor Suppressor Protein', 'pp53 Phosphoprotein', 'tumor protein p53'], 'definition': None, 'syn_in_text': 'TP53', 'syn_in_stmt': 'TP53'}, 'HGNC:3236': {'name': 'EGFR', 'synonyms': ['EGF receptor', 'EGFR', 'EGFRvIII', 'ERBB', 'ERBB1', 'ERRP', 'Epidermal growth factor receptor', 'HER1', 'Proto-oncogene c-ErbB-1', 'Receptor tyrosine-protein kinase erbB-1', 'epidermal growth factor receptor', 'epidermal growth factor receptor VIII', 'erb-b2 receptor tyrosine kinase 1', 'erythroblastic leukemia viral (v-erb-b) oncogene homolog (avian)'], 'definition': None, 'syn_in_text': 'EGFR', 'syn_in_stmt': 'EGFR'}}
bachmanjohn@gmail.com	Tue, 06 Oct 2020 19:21:50 GMT		6507	22534876378571652		DB REST API	4915383526151645851	no_relation	Of the different isoforms, SIK2 had the highest level of activity in mouse macrophages (XREF_FIG), contributing ~ 90% of the total SIK activity towards the peptide substrate used in the present study, whereas SIK3 contributes ~ 10% and SIK1 only ~ 1% in BMDMs (XREF_FIG).	SIK3 activates SIK1.	{'HGNC:29165': {'name': 'SIK3', 'synonyms': ['FLJ12240', 'KIAA0999', 'L19', 'QSK', 'SIK family kinase 3', 'SIK-3', 'SIK3', 'Salt-inducible kinase 3', 'Serine/threonine-protein kinase QSK', 'Serine/threonine-protein kinase SIK3', 'salt-inducible kinase 3'], 'definition': None, 'syn_in_text': 'SIK3', 'syn_in_stmt': 'SIK3'}, 'HGNC:11142': {'name': 'SIK1', 'synonyms': ['SIK', 'SIK-1', 'SIK1', 'SNF1LK', 'Salt-inducible kinase 1', 'Serine/threonine-protein kinase SIK1', 'Serine/threonine-protein kinase SNF1-like kinase 1', 'Serine/threonine-protein kinase SNF1LK', 'msk', 'myocardial SNF1-like kinase', 'salt inducible kinase 1'], 'definition': None, 'syn_in_text': 'SIK', 'syn_in_stmt': 'SIK1'}}
ben.gyori@gmail.com	Wed, 11 Mar 2020 19:35:04 GMT		2118	34873778256664260		DB REST API	-6789574055272947992	no_relation	NZBWF1 (lupus) and NZW and LacJ (control) mice were treated with hydroxychloroquine 10 mg/kg per day by oral gavage, or with tempol and apocynin in the drinking water, for 5 weeks.	Hydroxychloroquine activates lupus.	{'CHEBI:CHEBI:5801': {'name': 'hydroxychloroquine', 'synonyms': ['(+-)-hydroxychloroquine', '2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol', '2-(N-(4-(7-chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol', '2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol', '7-chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline', '7-chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline', '7-chloro-4-[4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline', '7-chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline', 'HC', 'HCs', 'Hydroxychlorochin', 'Hydroxychloroquine', 'NSC4375', 'Oxychlorochin', 'Oxychloroquine', 'Polirreumin', 'hidroxicloroquina', 'hydroxychloroquine', 'hydroxychloroquinum', 'oxichlorochine', 'oxichloroquine'], 'definition': None, 'syn_in_text': 'Hydroxychloroquine', 'syn_in_stmt': 'Hydroxychloroquine'}}
ben.gyori@gmail.com	Fri, 25 Dec 2020 02:38:24 GMT		10589	27794633127348955		EMMAA	-7059859444526017669	no_relation	Abbreviations other than those described in the text are NADPH, reduced form of nicotinamide adenine dinucleotide phosphate; O2-HO-, a form of active oxygen species or free radical; AKT, protein kinase B; MEK 1, dual threonine and tyrosine recognition kinase that phosphorylates and activates mitogen-activated protein kinase (MAPK); ERK 1 and ERK 2, mitogen-activated protein or extracellular signal-regulated kinase p44ERK1 and p42ERK2Fig.	MAPK inhibits AKT.	{'FPLX:MAPK': {'name': 'MAPK', 'synonyms': ['Kinase, Mitogen-Activated Protein', 'Kinases, Mitogen-Activated Protein', 'MAP kinase', 'MAP kinases', 'MAPK', 'MAPKs', 'Mitogen Activated Protein Kinase', 'Mitogen Activated Protein Kinases', 'Mitogen-Activated Protein Kinase', 'Mitogen-Activated Protein Kinases', 'Protein Kinase, Mitogen-Activated', 'Protein Kinases, Mitogen-Activated', 'mitogen activated protein kinase', 'mitogen activated protein kinases', 'mitogen-activated protein kinase', 'mitogen-activated protein kinases'], 'definition': None, 'syn_in_text': 'MAPK', 'syn_in_stmt': 'MAPK'}, 'FPLX:AKT': {'name': 'AKT', 'synonyms': ['AKT', 'AKT family', 'Akt', 'PKB', 'PKB-Akt', 'PKB/Akt'], 'definition': None, 'syn_in_text': 'AKT', 'syn_in_stmt': 'AKT'}}
bachmanjohn@gmail.com	Wed, 18 Nov 2020 20:08:08 GMT		8770	-35916055458124257		DB REST API	-6389484457720966127	no_relation	Induction of chemical LTP is associated with elevated Rac1 and JNK kinase activity.	JNK binds RAC1 and LTP.	{'FPLX:JNK': {'name': 'JNK', 'synonyms': ['JNK', 'JNK MAPK', 'JNK1/2', 'JNKs', 'SAPK', 'c-JNK', 'c-Jun N-terminal kinase', 'c-Jun NH2-terminal kinase'], 'definition': None, 'syn_in_text': 'JNK', 'syn_in_stmt': 'JNK'}, 'HGNC:9801': {'name': 'RAC1', 'synonyms': ['Cell migration-inducing gene 5 protein', 'GTP-Binding Protein, TC-25', 'GTP-Binding Protein, rac1', 'RAC1', 'Rac', 'Rac family small GTPase 1', 'Rac-1', 'Rac1', 'Ras-like protein TC25', 'Ras-related C3 botulinum toxin substrate 1', 'TC 25 GTP Binding Protein', 'TC-25', 'TC-25 GTP-Binding Protein', 'TC25', 'p21-Rac1', 'rac1 GTP Binding Protein', 'rac1 GTP-Binding Protein', 'rac1 Protein', 'ras Related C3 Botulinum Toxin Substrate 1', 'ras-Related C3 Botulinum Toxin Substrate 1'], 'definition': None, 'syn_in_text': 'RAC1', 'syn_in_stmt': 'RAC1'}}
marta.iannuccelli@gmail.com	Mon, 18 Mar 2024 08:33:17 GMT		14110	-15925204235730270	{'belief': 1, 'enz': {'db_refs': {'HGNC': '9588', 'TEXT': 'PTEN', 'UP': 'P60484'}, 'name': 'PTEN'}, 'id': '43e946fc-2cb1-44c6-9ad5-6c7cb5339d85', 'matches_hash': '-15925204235730270', 'sub': {'db_refs': {'HGNC': '2514', 'TEXT': 'beta-catenin', 'UP': 'P35222'}, 'name': 'CTNNB1'}, 'type': 'Dephosphorylation'}	signor_dephos	1257659391261743558	no_relation	These results were further supported by our in vivo data, which myeloid specific PTEN knockout increased Akt and beta-catenin phosphorylation but decreased nuclear Foxo1 activity, leading to inhibition of TLR4 mediated lung inflammation even though rHMGB1 treatment.	PTEN leads to the dephosphorylation of CTNNB1.	{'HGNC:9588': {'name': 'PTEN', 'synonyms': ['BZS', 'Inositol polyphosphate 3-phosphatase', 'MHAM', 'MMAC1', 'Mutated in multiple advanced cancers 1', 'PTEN', 'PTEN1', 'Phosphatase and tensin homolog', 'Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN', 'Pten', 'TEP1', 'mutated in multiple advanced cancers 1', 'phosphatase and tensin homolog'], 'definition': None, 'syn_in_text': 'PTEN', 'syn_in_stmt': 'PTEN'}, 'HGNC:2514': {'name': 'CTNNB1', 'synonyms': ['Beta-catenin', 'CTNNB', 'CTNNB1', 'Catenin beta-1', 'Catenin, beta', 'armadillo', 'beta Catenin', 'beta-Catenin', 'beta-catenin', 'catenin beta 1', 'β-catenin'], 'definition': None, 'syn_in_text': 'Beta-catenin', 'syn_in_stmt': 'CTNNB1'}}
ben.gyori@gmail.com	Thu, 11 Jun 2020 03:48:09 GMT		4862	34996316771479219		bioexp_paper_sparser	1328121402985565113	no_relation	Furthermore, an additive effect on the proliferation of Foxp3 + cells was found in the exogenous administration of CXCL14 plus IL-2 (Fig. xref F), indicating that CXCL14 directly mediated CD4 + CD25 + Foxp3 + Treg activation and expansion in vitro.	IL2RA activates FOXP3.	{'HGNC:6008': {'name': 'IL2RA', 'synonyms': ['CD antigen CD25', 'CD25', 'IDDM10', 'IL-2 receptor subunit alpha', 'IL-2-RA', 'IL-2R subunit alpha', 'IL2-RA', 'IL2R', 'IL2RA', 'Interleukin-2 receptor subunit alpha', 'TAC antigen', 'interleukin 2 receptor subunit alpha', 'p55'], 'definition': None, 'syn_in_text': 'CD25', 'syn_in_stmt': 'IL2RA'}, 'HGNC:6106': {'name': 'FOXP3', 'synonyms': ['AIID', 'DIETER', 'FOXP3', 'Forkhead box protein P3', 'IPEX', 'JM2', 'PIDX', 'SCURFIN', 'Scurfin', 'XPID', 'forkhead box P3', 'Foxp3'], 'definition': None, 'syn_in_text': 'FOXP3', 'syn_in_stmt': 'FOXP3'}}
ben.gyori@gmail.com	Thu, 12 Nov 2020 14:37:47 GMT		8303	-16979509580947980		EMMAA	-2057173411961051684	no_relation	In our study, NF1 loss specifically caused upregulation of Akt and PI3Kinase but not Erk.	ERK activates PI3K.	{'FPLX:ERK': {'name': 'ERK', 'synonyms': ['ERK', 'ERK 1/2', 'ERK MAP Kinase', 'ERK MAP Kinases', 'ERK MAPK', 'ERK mitogen-activated protein kinase', 'ERK-1/2', 'ERK1/2', 'ERK1/2 MAPK', 'ERKs', 'Erk', 'Erk1/2', 'Extracellular Signal Regulated Kinase', 'Extracellular Signal Regulated Kinases', 'Extracellular Signal Regulated MAP Kinase', 'Extracellular Signal Regulated MAP Kinases', 'Extracellular Signal-Regulated Kinase', 'Extracellular Signal-Regulated Kinases', 'Extracellular Signal-Regulated MAP Kinase', 'Extracellular Signal-Regulated MAP Kinases', 'Kinase, ERK MAP', 'Kinase, Extracellular Signal-Regulated', 'Kinases, Extracellular Signal-Regulated', 'MAP Kinase, ERK', 'MAP Kinases, Extracellular Signal Regulated', 'MAP Kinases, Extracellular Signal-Regulated', 'Signal-Regulated Kinase, Extracellular', 'extracellular signal-regulated kinase', 'p42 and p38 MAP kinases', 'p42 and p38 MAPK', 'p42 and p38 MAPKs', 'p42 and p44', 'p42 and p44 MAPK', 'p42 and p44MAP kinase', 'p42(mapk) and p44(mapk)', 'p42/44', 'p44 and p42', 'phospho-ERK1/2'], 'definition': None, 'syn_in_text': 'ERK', 'syn_in_stmt': 'ERK'}, 'FPLX:PI3K': {'name': 'PI3K', 'synonyms': ['PI 3-kinase', 'PI 3-kinases', 'PI-3-K', 'PI3 K', 'PI3-K', 'PI3-Kinase', 'PI3-kinase', 'PI3K', 'PI3Kinase', 'PI3Ks', 'Phosphoinositide 3-kinase', 'Ptdins 3-Kinase', 'Ptdins 3-kinase', 'phosphatidylinositol 3-kinase', 'phosphoinositide 3-kinase', 'phosphoinositide-3 kinase'], 'definition': None, 'syn_in_text': 'PI3Kinase', 'syn_in_stmt': 'PI3K'}}
petar.v.todorov@gmail.com	Tue, 24 Nov 2020 13:09:27 GMT		8968	-17032186421232173		DB REST API	3753294313820890009	no_relation	Inhibitory vGAT + interneurons from these mice did not produce endogenous ErbB4.	SLC32A1 inhibits ERBB4.	{'HGNC:11018': {'name': 'SLC32A1', 'synonyms': ['GABA and glycine transporter', 'SLC32A1', 'Solute carrier family 32 member 1', 'VGAT', 'VGAT transporter', 'VIAAT', 'Vesicular GABA transporter', 'Vesicular inhibitory amino acid transporter', 'bA122O1.1', 'hVIAAT', 'solute carrier family 32 member 1', 'vesicular GABA transporter', 'vGAT'], 'definition': None, 'syn_in_text': 'VGAT', 'syn_in_stmt': 'SLC32A1'}, 'HGNC:3432': {'name': 'ERBB4', 'synonyms': ['ALS19', 'ERBB4', 'ErbB 4 Receptor', 'ErbB-4 Receptor', 'HER 4 Proto oncogene Protein', 'HER-4 Proto-oncogene Protein', 'HER-4, Proto-oncogene Protein', 'HER4', 'Protein HER-4, Proto-oncogene', 'Protein, HER-4 Proto-oncogene', 'Proto oncogene Protein HER 4', 'Proto-oncogene Protein HER-4', 'Proto-oncogene Protein, HER-4', 'Proto-oncogene-like protein c-ErbB-4', 'Receptor Protein tyrosine Kinase ErbB 4', 'Receptor Protein-tyrosine Kinase ErbB-4', 'Receptor Tyrosine protein Kinase ErbB 4', 'Receptor Tyrosine-protein Kinase ErbB-4', 'Receptor tyrosine-protein kinase erbB-4', 'Receptor, ErbB-4', 'Tyrosine kinase-type cell surface receptor HER4', 'c ErbB 4 Protein', 'c-ErbB-4 Protein', 'erb-b2 receptor tyrosine kinase 4', 'human epidermal growth factor receptor 4', 'p180erbB4', 'v-erb-a Erythroblastic Leukemia Viral Oncogene Homolog 4 (avian) Protein', 'ErbB4'], 'definition': None, 'syn_in_text': 'ERBB4', 'syn_in_stmt': 'ERBB4'}}
cthoyt@gmail.com	Mon, 06 Sep 2021 10:46:51 GMT	{'annotations': {'agents': {'raw_text': ['SULT1A1', 'SULT1A3']}, 'content_source': 'manuscripts', 'found_by': 'BIO-FORM', 'prior_uuids': ['d9b9755d-dc65-4c3e-9862-a66d6e706e84']}, 'pmid': '22744891', 'source_api': 'sparser', 'source_hash': -8524869116387976000, 'text': 'The results indicate that the molecular bases of stereospecificity of the enzymes reflected by the docking results are consistent with experimentally determined stereospecificity, as the ( S , R )-MF-SULT complexes formed with SULT1A1 and SULT1A3 had the lowest MolDocScore values.', 'text_refs': {'DOI': '10.1002/CHIR.22072', 'DOI_ID': 'CHIR.22072', 'DOI_NS': 1002, 'MANUSCRIPT_ID': 'NIHMS739571', 'PMCID': 'PMC6131691', 'PMCID_NUM': 6131691, 'PMID': '22744891', 'PMID_NUM': 22744891, 'READER': 'SPARSER', 'RID': 20300022439324, 'SOURCE': 'manuscripts', 'TCID': 22439324, 'TRID': 21017493}}	12427	33521971092919745	{'belief': 1, 'id': '3f2fbb46-4d84-49a8-9f84-b0ef32b0afa2', 'matches_hash': '33521971092919745', 'members': [{'db_refs': {'HGNC': '11453', 'TEXT': 'SULT1A1', 'UP': 'P50225'}, 'name': 'SULT1A1'}, {'db_refs': {'HGNC': '11455', 'TEXT': 'SULT1A3', 'UP': 'P0DMM9'}, 'name': 'SULT1A3'}], 'type': 'Complex'}	DB REST API	-8524869116387976268	no_relation	The results indicate that the molecular bases of stereospecificity of the enzymes reflected by the docking results are consistent with experimentally determined stereospecificity, as the ( S , R )-MF-SULT complexes formed with SULT1A1 and SULT1A3 had the lowest MolDocScore values.	SULT1A1 binds SULT1A3.	{'HGNC:11453': {'name': 'SULT1A1', 'synonyms': ['Aryl sulfotransferase 1', 'HAST1/HAST2', 'P-PST', 'P-PST 1', 'Phenol sulfotransferase 1', 'Phenol-sulfating phenol sulfotransferase 1', 'ST1A1', 'ST1A3', 'STP', 'STP1', 'SULT1A1', 'Sulfotransferase 1A1', 'Thermostable phenol sulfotransferase', 'Ts-PST', 'sulfotransferase family 1A member 1'], 'definition': None, 'syn_in_text': 'SULT1A1', 'syn_in_stmt': 'SULT1A1'}, 'HGNC:11455': {'name': 'SULT1A3', 'synonyms': ['Aryl sulfotransferase 1A3/1A4', 'Catecholamine-sulfating phenol sulfotransferase', 'HAST3', 'M-PST', 'M-PST enzyme', 'Monoamine-sulfating phenol sulfotransferase', 'Placental estrogen sulfotransferase', 'ST1A3', 'STM', 'SULT1A3', 'Sulfotransferase 1A3', 'Sulfotransferase 1A3/1A4', 'Sulfotransferase, monoamine-preferring', 'TL-PST', 'Thermolabile phenol sulfotransferase', 'monoamine-sulfating phenol sulfotransferase', 'sulfotransferase family 1A member 3'], 'definition': None, 'syn_in_text': 'SULT1A3', 'syn_in_stmt': 'SULT1A3'}}
ben.gyori@gmail.com	Fri, 14 Aug 2020 12:30:02 GMT		6089	-5151335174702139		EMMAA	287618365020404017	no_relation	Projections based on this type of calculations would allow governments to make rational decisions about reopening their economy .	Projection activates Government.	{'MESH:D011385': {'name': 'Projection', 'synonyms': ['Projection', 'Projections'], 'definition': None, 'syn_in_text': 'Projections', 'syn_in_stmt': 'Projection'}, 'MESH:D006076': {'name': 'Government', 'synonyms': ['Government', 'Governments', 'governments'], 'definition': None, 'syn_in_text': 'Governments', 'syn_in_stmt': 'Government'}}
cthoyt@gmail.com	Mon, 11 Apr 2022 09:18:19 GMT		13012	-34578691550515279	{'belief': 1, 'id': '11fcddf1-76df-44a4-9afa-83447c557d99', 'matches_hash': '-34578691550515279', 'obj': {'db_refs': {'GO': 'GO:0006914', 'MESH': 'D001343', 'TEXT': 'autophagy'}, 'name': 'autophagy'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'ECCODE': '2.7.11.24', 'FPLX': 'ERK', 'IP': 'IPR008349', 'MESH': 'D020928', 'NCIT': 'C16376', 'TEXT': 'ERK'}, 'name': 'ERK'}, 'type': 'Activation'}	CoGEx	1564651806772100530	no_relation	However, we found no involvement of JNK and ERK in ER stress induced autophagy in P2 fibroblasts.	ERK activates autophagy.	{'FPLX:ERK': {'name': 'ERK', 'synonyms': ['ERK', 'ERK 1/2', 'ERK MAP Kinase', 'ERK MAP Kinases', 'ERK MAPK', 'ERK mitogen-activated protein kinase', 'ERK-1/2', 'ERK1/2', 'ERK1/2 MAPK', 'ERKs', 'Erk', 'Erk1/2', 'Extracellular Signal Regulated Kinase', 'Extracellular Signal Regulated Kinases', 'Extracellular Signal Regulated MAP Kinase', 'Extracellular Signal Regulated MAP Kinases', 'Extracellular Signal-Regulated Kinase', 'Extracellular Signal-Regulated Kinases', 'Extracellular Signal-Regulated MAP Kinase', 'Extracellular Signal-Regulated MAP Kinases', 'Kinase, ERK MAP', 'Kinase, Extracellular Signal-Regulated', 'Kinases, Extracellular Signal-Regulated', 'MAP Kinase, ERK', 'MAP Kinases, Extracellular Signal Regulated', 'MAP Kinases, Extracellular Signal-Regulated', 'Signal-Regulated Kinase, Extracellular', 'extracellular signal-regulated kinase', 'p42 and p38 MAP kinases', 'p42 and p38 MAPK', 'p42 and p38 MAPKs', 'p42 and p44', 'p42 and p44 MAPK', 'p42 and p44MAP kinase', 'p42(mapk) and p44(mapk)', 'p42/44', 'p44 and p42', 'phospho-ERK1/2'], 'definition': None, 'syn_in_text': 'ERK', 'syn_in_stmt': 'ERK'}, 'GO:GO:0006914': {'name': 'autophagy', 'synonyms': ['Autophagocytosis', 'Autophagy', 'Autophagy, Cellular', 'Cellular Autophagy', 'autophagy'], 'definition': None, 'syn_in_text': 'Autophagy', 'syn_in_stmt': 'Autophagy'}}
ben.gyori@gmail.com	Wed, 03 Jun 2020 01:44:48 GMT		4633	-25655970173329808		bioexp_paper_sparser	825366547021190712	no_relation	There was no significant association of the −400C/A and −468G/A polymorphisms with vWF activity, however, there was a significant association of the −425A/C polymorphism and a borderline association of Leu33Pro with vWF activity, as shown in  Table 3 .	VWF binds GLS2.	{'HGNC:12726': {'name': 'VWF', 'synonyms': ['F8VWF', 'Factor VIII Related Antigen', 'Factor VIII related antigen', 'Factor VIII-Related Antigen', 'Factor VIIIR Ag', 'Factor VIIIR RCo', 'Factor VIIIR-Ag', 'Factor VIIIR-RCo', 'Ristocetin Cofactor', 'Ristocetin Willebrand Factor', 'Ristocetin-Willebrand Factor', 'VWF', 'vWF', 'von Willebrand Factor', 'von Willebrand Protein', 'von Willebrand factor'], 'definition': None, 'syn_in_text': 'VWF', 'syn_in_stmt': 'VWF'}, 'HGNC:29570': {'name': 'GLS2', 'synonyms': ['GA', 'GLS', 'GLS2', 'Glutaminase liver isoform, mitochondrial', 'L-glutaminase', 'L-glutamine amidohydrolase', 'LGA', 'glutaminase 2', 'hLGA', 'G/A'], 'definition': None, 'syn_in_text': 'G/A', 'syn_in_stmt': 'GLS2'}}
ben.gyori@gmail.com	Wed, 02 Feb 2022 03:22:07 GMT		12724	21772605789657818		EMMAA	4830573421490033926	no_relation	During one-lung anesthesia in otherwise normal subjects , adequate oxygenation is achieved despite one-lung ventilation due to a high inspired oxygen concentration .	Dioxygen activates One-Lung Ventilation.	{'CHEBI:CHEBI:15379': {'name': 'dioxygen', 'synonyms': ['Disauerstoff', 'E 948', 'E-948', 'E948', 'O2', 'OXYGEN MOLECULE', 'Oxygen', 'Oxygen 16', 'Oxygen-16', '[OO]', 'dioxygen', 'dioxygene', 'molecular oxygen', 'oxygen', 'high inspired oxygen concentration'], 'definition': None, 'syn_in_text': 'Oxygen', 'syn_in_stmt': 'dioxygen'}, 'MESH:D061810': {'name': 'One-Lung Ventilation', 'synonyms': ['One Lung Ventilation', 'One-Lung Ventilation', 'Single Lung Ventilation', 'Single-Lung Ventilation', 'Single-Lung Ventilations', 'Ventilation, One-Lung', 'Ventilation, Single-Lung', 'Ventilations, Single-Lung', 'one-lung ventilation'], 'definition': None, 'syn_in_text': 'One-Lung Ventilation', 'syn_in_stmt': 'One-Lung Ventilation'}}
ben.gyori@gmail.com	Sun, 22 Nov 2020 03:41:41 GMT		8901	22898183937865329		DB REST API	-1724804438311972319	no_relation	Inhibition of SHP-2 expression by Shp-2 siRNA inhibited cell growth, transformation and altered morphology of these EGFRvIII transformed GBM cells.	PTPN11 activates EGFR.	{'HGNC:9644': {'name': 'PTPN11', 'synonyms': ['BPTP3', 'NS1', 'PTP-1D', 'PTP-2C', 'PTP2C', 'PTPN11', 'Phosphatase, SHP2', 'Phosphotyrosine Phosphatase Syp', 'Protein Tyrosine Phosphatase 2C', 'Protein Tyrosine Phosphatase PTP3', 'Protein Tyrosine Phosphatase, Non Receptor Type 11', 'Protein Tyrosine Phosphatase, Non-Receptor Type 11', 'Protein-Tyrosine-Phosphatase 2C', 'Protein-tyrosine phosphatase 1D', 'Protein-tyrosine phosphatase 2C', 'SH-PTP2', 'SH-PTP3', 'SH2 domain-containing protein tyrosine phosphatase 2', 'SHP-2', 'SHP-2 Protein-Tyrosine Phosphatase', 'SHP2', 'SHP2 Phosphatase', 'SHPTP2', 'Shp 2 Tyrosine Phosphatase', 'Shp-2 Tyrosine Phosphatase', 'Shp2', 'Tyrosine Phosphatase, Shp-2', 'Tyrosine-protein phosphatase non-receptor type 11', 'protein tyrosine phosphatase non-receptor type 11'], 'definition': None, 'syn_in_text': 'SHP-2', 'syn_in_stmt': 'PTPN11'}, 'HGNC:3236': {'name': 'EGFR', 'synonyms': ['EGF receptor', 'EGFR', 'EGFRvIII', 'ERBB', 'ERBB1', 'ERRP', 'Epidermal growth factor receptor', 'HER1', 'Proto-oncogene c-ErbB-1', 'Receptor tyrosine-protein kinase erbB-1', 'epidermal growth factor receptor', 'epidermal growth factor receptor VIII', 'erb-b2 receptor tyrosine kinase 1', 'erythroblastic leukemia viral (v-erb-b) oncogene homolog (avian)'], 'definition': None, 'syn_in_text': 'EGFRvIII', 'syn_in_stmt': 'EGFR'}}
diana_kolusheva@hms.harvard.edu	Wed, 15 Jul 2020 01:29:41 GMT		5830	-33901154764738631		EMMAA	8864570561099361507	no_relation	In terms of eLCV new registration shares in 2018 , Germany leads with 1.93 % and is followed by France ( 1.81 % ) , Sweden ( 1.40 % ) , the Netherlands ( 1.17 % ) and Luxembourg ( 1.08 % ) .	Germany activates Luxembourg.	{'MESH:D005858': {'name': 'Germany', 'synonyms': ['Germany'], 'definition': None, 'syn_in_text': 'Germany', 'syn_in_stmt': 'Germany'}, 'MESH:D008189': {'name': 'Luxembourg', 'synonyms': ['Luxemborg', 'Luxembourg', 'Luxemburg'], 'definition': None, 'syn_in_text': 'Luxembourg', 'syn_in_stmt': 'Luxembourg'}}
bachmanjohn@gmail.com	Wed, 24 Feb 2021 18:31:37 GMT		11258	-399050361334209		bioexp_biogrid	8340312260422626439	no_relation	In the genotyping for tagging single nucleotide polymorphisms (SNPs) of 1769 DNA samples from the peripheral blood of prediabetic Europeans [ xref ], two SNPs in the HGK locus were found to be associated with increased glucose levels in patients, while two other HGK SNPs were associated with reduced insulin release only in lean subjects (BMI < 25) [ xref ].	INS binds MAP4K4.	{'HGNC:6081': {'name': 'INS', 'synonyms': ['IDDM1', 'IDDM2', 'INS', 'Insulin', 'PI', 'insulin'], 'definition': None, 'syn_in_text': 'Insulin', 'syn_in_stmt': 'INS'}, 'HGNC:6866': {'name': 'MAP4K4', 'synonyms': ['FLH21957', 'HGK', 'HPK/GCK-like kinase', 'HPK/GCK-like kinase HGK', 'KIAA0687', 'MAP4K4', 'MAPK/ERK kinase kinase kinase 4', 'MEK kinase kinase 4', 'MEKKK 4', 'Mitogen-activated protein kinase kinase kinase kinase 4', 'NIK', 'Nck-interacting kinase', 'hepatocyte progenitor kinase-like/germinal center kinase-like kinase', 'mitogen-activated protein kinase kinase kinase kinase 4'], 'definition': None, 'syn_in_text': 'HGK', 'syn_in_stmt': 'MAP4K4'}}
bachmanjohn@gmail.com	Mon, 18 May 2020 21:42:08 GMT		2892	16365254440578378		bioexp_paper_rlimsp	-8393296982833238954	no_relation	Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor. PTP1B is a protein tyrosine phosphatase that negatively regulates insulin sensitivity by dephosphorylating the insulin receptor. Akt is a ser/thr kinase effector of insulin signaling that phosphorylates substrates at the consensus motif RXRXXS/T. Interestingly, PTP1B contains this motif (RYRDVS(50)), and wild-type PTP1B (but not mutants with substitutions for Ser(50)) was significantly phosphorylated by Akt in vitro. To determine whether PTP1B is a substrate for Akt in intact cells, NIH-3T3(IR) cells transfected with either wild-type PTP1B or PTP1B-S50A were labeled with [(32)P]-orthophosphate. Insulin stimulation caused a significant increase in phosphorylation of wild-type PTP1B that could be blocked by pretreatment of cells with wortmannin or cotransfection of a dominant inhibitory Akt mutant. Similar results were observed with endogenous PTP1B in untransfected HepG2 cells. Cotransfection of constitutively active Akt caused robust phosphorylation of wild-type PTP1B both in the absence and presence of insulin. By contrast, PTP1B-S50A did not undergo phosphorylation in response to insulin. We tested the functional significance of phosphorylation at Ser(50) by evaluating insulin receptor autophosphorylation in transfected Cos-7 cells.	INSR phosphorylates PTPN1 on S50.	{'HGNC:6091': {'name': 'INSR', 'synonyms': ['CD antigen CD220', 'CD220', 'HIR', 'INSR', 'IR', 'Insulin Receptor', 'Insulin Receptor Protein Tyrosine Kinase', 'Insulin Receptor Protein-Tyrosine Kinase', 'Insulin Receptors', 'Insulin receptor', 'Insulin-Dependent Tyrosine Protein Kinase', 'Receptor, Insulin', 'Receptors, Insulin', 'insulin receptor'], 'definition': None, 'syn_in_text': 'IR', 'syn_in_stmt': 'INSR'}, 'HGNC:9642': {'name': 'PTPN1', 'synonyms': ['PTP-1B', 'PTP1B', 'PTPN1', 'Protein-tyrosine phosphatase 1B', 'Tyrosine-protein phosphatase non-receptor type 1', 'protein tyrosine phosphatase non-receptor type 1'], 'definition': None, 'syn_in_text': 'PTP1B', 'syn_in_stmt': 'PTPN1'}}
bachmanjohn@gmail.com	Fri, 20 Nov 2020 18:54:38 GMT		8820	-24824230803284925		EMMAA	-3303392792084739507	no_relation	Abrogation of mTOR by siRNA interference inhibits phosphorylation of its downstream targets p70S6K and 4EBP1 and induces apoptosis [XREF_BIBR].	EIF4EBP1 activates apoptotic process.	{'HGNC:3288': {'name': 'EIF4EBP1', 'synonyms': ['4E-BP1', '4EBP1', 'EIF4EBP1', 'Eukaryotic translation initiation factor 4E-binding protein 1', 'PHAS-I', 'Phosphorylated heat- and acid-stable protein regulated by insulin 1', 'eIF4E-binding protein 1', 'eukaryotic translation initiation factor 4E binding protein 1', 'phosphorylated heat- and acid-stable protein regulated by insulin 1'], 'definition': None, 'syn_in_text': '4EBP1', 'syn_in_stmt': 'EIF4EBP1'}, 'GO:GO:0006915': {'name': 'apoptotic process', 'synonyms': ['Apoptosis', 'Apoptosis, Classic', 'Apoptosis, Classical', 'Classic Apoptoses', 'Classic Apoptosis', 'Classical Apoptosis', 'PA', 'Programmed Cell Death, Type I', 'apoptosis', 'apoptosis activator activity', 'apoptotic cell death', 'apoptotic process', 'apoptotic programmed cell death', 'caspase-dependent programmed cell death', 'commitment to apoptosis', 'induction of apoptosis', 'induction of apoptosis by p53', 'programmed cell death by apoptosis', 'signaling (initiator) caspase activity'], 'definition': None, 'syn_in_text': 'Apoptosis', 'syn_in_stmt': 'apoptotic process'}}
ben.gyori@gmail.com	Tue, 12 May 2020 20:08:29 GMT		2809	-6239844335570439		EMMAA	-4815230883544792534	no_relation	Throughout history , surgeons like Guy de Chauliac , James Lind , John Hunter , John Snow , and Walter Reed have led scientific campaigns to understand , prevent , and treat epidemics like the bubonic plague , scurvy , syphilis , cholera , and yellow fever .	Surgeons activates Yellow Fever.	{'MESH:D066231': {'name': 'Surgeons', 'synonyms': ['Surgeons', 'surgeons like Guy de Chauliac, James Lind, John Hunter, John Snow, and Walter Reed'], 'definition': None, 'syn_in_text': 'Surgeons', 'syn_in_stmt': 'Surgeons'}, 'MESH:D015004': {'name': 'Yellow Fever', 'synonyms': ['Fever, Yellow', 'Fevers, Yellow', 'Sylvatic yellow fever', 'Yellow Fever', 'Yellow Fevers', 'Yellow fever, sylvan', 'jungle yellow fever', 'urban yellow fever', 'yellow fever'], 'definition': None, 'syn_in_text': 'Yellow Fever', 'syn_in_stmt': 'Yellow Fever'}}
ben.gyori@gmail.com	Mon, 01 Jun 2020 16:37:52 GMT		4215	4892297814252386		bioexp_paper_trips	-8411817182685504642	no_relation	RKIP physically interacted with four kinases of the NF-kappaB activation pathway, NF-kappaB-inducing kinase, transforming growth factor beta-activated kinase 1, IKKalpha, and IKKbeta.	TGFB activates CHUK.	{'FPLX:TGFB': {'name': 'TGFB', 'synonyms': ['Bone Derived Transforming Growth Factor', 'Bone-Derived Transforming Growth Factor', 'Factor, Milk Growth', 'Growth Factor, Milk', 'Milk Growth Factor', 'Platelet Transforming Growth Factor', 'TGF beta', 'TGF β', 'TGF-b', 'TGF-beta', 'TGF-beta family', 'TGF-β', 'TGFB', 'TGFB family', 'TGFbeta', 'TGFβ', 'Transforming Growth Factor beta', 'transforming growth factor beta', 'transforming growth factor β', 'transforming growth factor-beta', 'transforming growth factor-β'], 'definition': None, 'syn_in_text': 'Transforming Growth Factor beta', 'syn_in_stmt': 'TGFB'}, 'HGNC:1974': {'name': 'CHUK', 'synonyms': ['CHUK', 'Conserved helix-loop-helix ubiquitous kinase', 'I-kappa-B kinase', 'I-kappa-B kinase 1', 'I-kappa-B kinase alpha', 'IKK-1', 'IKK-A', 'IKK-alpha', 'IKK1', 'IKKA', 'IKKalpha', 'IKKα', 'IkBKA', 'IkappaB kinase', 'Inhibitor of nuclear factor kappa-B kinase subunit alpha', 'NFKBIKA', 'Nuclear factor NF-kappa-B inhibitor kinase alpha', 'TCF-16', 'TCF16', 'Transcription factor 16', 'component of inhibitor of nuclear factor kappa B kinase complex', 'inhibitor of nuclear factor kappa-B kinase subunit alpha'], 'definition': None, 'syn_in_text': 'IKKalpha', 'syn_in_stmt': 'CHUK'}}
bachmanjohn@gmail.com	Fri, 30 Oct 2020 18:12:45 GMT		7418	28532267370494337		EMMAA	917564561852426740	no_relation	A recent study showed that acetylation of K-RAS at lysine104 attenuates its transforming activity in cancer cells and both SIRT2 and HDAC6 deacetylate K-RAS [XREF_BIBR].	Acetylated KRAS leads to the acetylation of KRAS.	{'HGNC:6407': {'name': 'KRAS', 'synonyms': ['GTPase KRas', 'K-Ras', 'K-Ras 2', 'K-Ras4B', 'KRAS', 'KRAS proto-oncogene, GTPase', 'KRAS1', 'KRAS2', 'Ki-Ras', 'Kras', 'RASK2', 'c-K-ras', 'c-Ki-ras', 'K-RAS'], 'definition': None, 'syn_in_text': 'K-Ras', 'syn_in_stmt': 'KRAS'}}
ben.gyori@gmail.com	Tue, 29 Mar 2022 15:33:34 GMT		12836	3707434609588574	{'belief': 1.0, 'id': '4fed1056-99da-455e-84b2-3ff8286c7ad2', 'matches_hash': '3707434609588574', 'members': [{'db_refs': {'GO': 'GO:0006351', 'MESH': 'D014158', 'TEXT': 'RT'}, 'name': 'transcription, DNA-templated'}, {'db_refs': {'MESH': 'C000705129', 'TEXT': 'LAMP'}, 'name': 'LAMP assay'}], 'type': 'Complex'}	CoGEx	5596001812217037803	no_relation	For all 573 samples, RT-LAMP with primers to human RNA positive control (RNaseP) correctly turned positive (yellow).	Transcription, DNA-templated binds LAMP assay.	{'GO:GO:0006351': {'name': 'transcription, DNA-templated', 'synonyms': ['DNA-dependent transcription', 'DNA-templated transcription', 'Genetic Transcription', 'RT', 'RTs', 'Transcription, Genetic', 'transcription', 'transcription, DNA-dependent', 'transcription, DNA-templated'], 'definition': None, 'syn_in_text': 'RT', 'syn_in_stmt': 'transcription'}, 'MESH:C000705129': {'name': 'LAMP assay', 'synonyms': ['LAMP assay', 'LAMP loop-mediated isothermal amplification', 'LAMP technique', 'isothermal amplification loop-mediated', 'loop mediated isothermal amplification', 'loop-mediated isothermal amplification', 'loop-mediated isothermal amplification LAMP', 'loop-mediated isothermal amplification technique', 'LAMP'], 'definition': None, 'syn_in_text': 'LAMP', 'syn_in_stmt': 'LAMP'}}
ben.gyori@gmail.com	Wed, 25 Aug 2021 05:01:04 GMT	{'annotations': {'agents': {'raw_text': ['JAK3', 'JAK2']}, 'content_source': 'pmc_oa', 'found_by': 'Negative_activation_syntax_3_noun', 'prior_uuids': ['c3fde51a-f442-4049-b9f8-e441ece4b0c7']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '23990909', 'source_api': 'reach', 'source_hash': -3028623290866142000, 'text': 'While caveats must be applied to observations obtained using overexpressed proteins, our results revealed a striking specificity in the ability of SOCS5 to regulate JAK, with selective inhibition of JAK1 and JAK2, but not JAK3 or TYK2 phosphorylation.', 'text_refs': {'DOI': '10.1371/JOURNAL.PONE.0070536', 'DOI_ID': 'JOURNAL.PONE.0070536', 'DOI_NS': 1371, 'PMCID': 'PMC3749136', 'PMCID_NUM': 3749136, 'PMID': '23990909', 'PMID_NUM': 23990909, 'READER': 'REACH', 'RID': 10100018344417, 'SOURCE': 'pmc_oa', 'TCID': 18344417, 'TRID': 9439256}}	12405	2018352169437950	{'belief': 1, 'id': 'd4996855-e79c-4df6-9c6b-25bcf8308dcf', 'matches_hash': '2018352169437950', 'obj': {'db_refs': {'HGNC': '6192', 'MESH': 'D053614', 'TEXT': 'JAK 2', 'UP': 'O60674'}, 'name': 'JAK2'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '6193', 'MESH': 'D053616', 'TEXT': 'JAK 3', 'UP': 'P52333'}, 'name': 'JAK3'}, 'type': 'Inhibition'}	DB REST API	-3028623290866142006	no_relation	While caveats must be applied to observations obtained using overexpressed proteins, our results revealed a striking specificity in the ability of SOCS5 to regulate JAK, with selective inhibition of JAK1 and JAK2, but not JAK3 or TYK2 phosphorylation.	JAK3 inhibits JAK2.	{'HGNC:6193': {'name': 'JAK3', 'synonyms': ['JAK 3 Protein Tyrosine Kinase', 'JAK-3', 'JAK-3 Protein Tyrosine Kinase', 'JAK3', 'JAK3 Protein Tyrosine Kinase', 'JAK3_HUMAN', 'JAKL', 'Janus Kinase 3', 'Janus kinase 3', 'Kinase 3, Janus', 'L-JAK', 'LJAK', 'Leukocyte janus kinase', 'Tyrosine-protein kinase JAK3', 'leukocyte Janus kinase', 'tyrosine-protein kinase JAK3', 'JAK 3'], 'definition': None, 'syn_in_text': 'JAK3', 'syn_in_stmt': 'JAK3'}, 'HGNC:6192': {'name': 'JAK2', 'synonyms': ['JAK 2 Protein Tyrosine Kinase', 'JAK-2', 'JAK-2 Protein Tyrosine Kinase', 'JAK2', 'JAK2 Protein Tyrosine Kinase', 'JTK10', 'Janus Kinase 2', 'Janus kinase 2', 'Tyrosine-protein kinase JAK2', 'JAK 2'], 'definition': None, 'syn_in_text': 'JAK2', 'syn_in_stmt': 'JAK2'}}
ben.gyori@gmail.com	Thu, 17 Sep 2020 20:11:49 GMT		6376	10735435378022186		EMMAA	-3667853527090114178	no_relation	On March 17, 2020, with only 387 confirmed cases and 5 deaths reported, the ER began to accept only suspicious or confirmed cases of SARS-CoV-2.	ER activates severe acute respiratory syndrome coronavirus 2.	{'MESH:C000656484': {'name': 'severe acute respiratory syndrome coronavirus 2', 'synonyms': ['severe acute respiratory syndrome coronavirus 2', 'SARS-CoV-2'], 'definition': None, 'syn_in_text': 'SARS-CoV-2', 'syn_in_stmt': 'severe acute respiratory syndrome coronavirus 2'}}
ben.gyori@gmail.com	Mon, 04 May 2020 18:34:44 GMT		2717	-13163647216385940		EMMAA	685664434524764878	act_vs_amt	It has also been reported that pioglitazone inhibits the secretion of pro inflammatory cytokines (e.g. IL-1b, IL-6, and IL-8) and can increase the anti-inflammatory ones (e.g. IL-4 and IL-10) in astrocytes stimulated with lipopolysaccharide XREF_BIBR.	Pioglitazone activates IL10.	{'CHEBI:CHEBI:8228': {'name': 'pioglitazone', 'synonyms': ['(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione', '5-(4-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione', '5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione', 'Pioglitazone', 'pioglitazona', 'pioglitazone', 'pioglitazonum'], 'definition': None, 'syn_in_text': 'Pioglitazone', 'syn_in_stmt': 'Pioglitazone'}, 'HGNC:5962': {'name': 'IL10', 'synonyms': ['CSIF', 'CSIF-10', 'Cytokine Synthesis Inhibitory Factor', 'Cytokine synthesis inhibitory factor', 'IL-10', 'IL10', 'IL10A', 'Interleukin 10', 'Interleukin-10', 'T-cell growth inhibitory factor', 'TGIF', 'cytokine synthesis inhibitory factor', 'interleukin 10'], 'definition': None, 'syn_in_text': 'IL-10', 'syn_in_stmt': 'IL10'}}
ben.gyori@gmail.com	Thu, 06 Feb 2020 15:24:48 GMT		1601	5653037783762100		bioexp_paper_reach	4504171860332102718	act_vs_amt	Apelin synthesis in adipocytes is strongly upregulated by insulin, and plasma apelin level markedly increases in obese and hyperinsulinemic mice and humans [XREF_BIBR] its excretion is induced by hypoxia [XREF_BIBR].	INS activates APLN.	{'HGNC:6081': {'name': 'INS', 'synonyms': ['IDDM1', 'IDDM2', 'INS', 'Insulin', 'PI', 'insulin'], 'definition': None, 'syn_in_text': 'Insulin', 'syn_in_stmt': 'INS'}, 'HGNC:16665': {'name': 'APLN', 'synonyms': ['APEL', 'APJ endogenous ligand', 'APLN', 'Apelin', 'XNPEP2', 'apelin'], 'definition': None, 'syn_in_text': 'Apelin', 'syn_in_stmt': 'APLN'}}
ben.gyori@gmail.com	Mon, 22 Feb 2021 14:07:53 GMT		11131	-22259624311126628		DB REST API	-4148529131354867493	act_vs_amt	As its underlying molecular mechanism, we demonstrated for the first time that zoledronic acid post-transcriptionally downregulates STAT1 expression.	Zoledronic acid inhibits STAT1.	{'CHEBI:CHEBI:46557': {'name': 'zoledronic acid', 'synonyms': ['(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid', '(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid', '2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid', 'Reclast', 'ZOL', 'ZOLEDRONIC ACID', 'Zoledronic Acid', '[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)', 'zoledronic acid', 'Zoledronic acid'], 'definition': None, 'syn_in_text': 'ZOL', 'syn_in_stmt': 'ZOL'}, 'HGNC:11362': {'name': 'STAT1', 'synonyms': ['Gamma Activated Factor, 91 kDa', 'Gamma-Activated Factor, 91 kDa', 'ISGF-3', 'STAT 91 Protein', 'STAT 91 Transcription Factor', 'STAT-91 Protein', 'STAT-91 Transcription Factor', 'STAT1', 'STAT1 Protein', 'STAT1 Transcription Factor', 'STAT91', 'STAT91 Transcription Factor', 'Signal Transducer and Activator of Transcription 1', 'Signal transducer and activator of transcription 1-alpha/beta', 'Transcription Factor STAT91', 'Transcription Factor, STAT-91', 'Transcription Factor, STAT1', 'Transcription Factor, STAT91', 'Transcription factor ISGF-3 components p91/p84', 'signal transducer and activator of transcription 1', 'transcription factor ISGF-3 components p91/p84'], 'definition': None, 'syn_in_text': 'STAT1', 'syn_in_stmt': 'STAT1'}}
ben.gyori@gmail.com	Mon, 23 Mar 2020 23:37:33 GMT		2332	21510737931805366		EMMAA	7239174269503844610	act_vs_amt	In conclusion, our findings uncover an important role for the NRF2 regulated antioxidant system in KRAS mediated P53 suppression.	KRAS inhibits TP53.	{'HGNC:6407': {'name': 'KRAS', 'synonyms': ['GTPase KRas', 'K-Ras', 'K-Ras 2', 'K-Ras4B', 'KRAS', 'KRAS proto-oncogene, GTPase', 'KRAS1', 'KRAS2', 'Ki-Ras', 'Kras', 'RASK2', 'c-K-ras', 'c-Ki-ras'], 'definition': None, 'syn_in_text': 'KRAS', 'syn_in_stmt': 'KRAS'}, 'HGNC:11998': {'name': 'TP53', 'synonyms': ['Antigen NY-CO-13', 'Cellular Tumor Antigen p53', 'Cellular tumor antigen p53', 'LFS1', 'Li-Fraumeni syndrome', 'Oncoprotein p53', 'P53', 'Phosphoprotein p53', 'Phosphoprotein, pp53', 'TP53', 'TP53 Protein', 'TRP53 Protein', 'Tumor Suppressor Protein p53', 'Tumor suppressor p53', 'mutp53', 'p53', 'p53 Antigen', 'p53 Tumor Suppressor Protein', 'pp53 Phosphoprotein', 'tumor protein p53', 'Tp53'], 'definition': None, 'syn_in_text': 'P53', 'syn_in_stmt': 'TP53'}}
ben.gyori@gmail.com	Tue, 05 May 2020 05:32:14 GMT		2721	30647420939355112		EMMAA	-5988830525806128602	act_vs_amt	Also, estrogen result in decrease pro inflammatory cytokine IFN, IL-2, IL-6 TNF a production, and increased anti- inflammatory cytokine IL-4 and IL-5 production XREF_BIBR.	Estrogen activates IL5.	{'CHEBI:CHEBI:50114': {'name': 'estrogen', 'synonyms': ['Agents, Estrogenic', 'Agonists, Estrogen Receptor', 'Compounds, Estrogenic', 'Estrogen', 'Estrogen Receptor Agonists', 'Estrogene', 'Estrogenic Agents', 'Estrogenic Compounds', 'Estrogens', 'Oestrogen', 'Oestrogene', 'Receptor Agonists, Estrogen', 'estrogen', 'estrogene', 'estrogenes', 'estrogenes Hormon', 'estrogeno', 'estrogenos', 'estrogens', 'oestrogen', 'oestrogene', 'oestrogenes', 'oestrogens'], 'definition': None, 'syn_in_text': 'Estrogen', 'syn_in_stmt': 'Estrogen'}, 'HGNC:6016': {'name': 'IL5', 'synonyms': ['B Cell Growth Factor II', 'B cell differentiation factor I', 'B-Cell Growth Factor-II', 'B-cell differentiation factor I', 'BCGF-II', 'Differentiation Factor, Eosinophil', 'EDF', 'Eosinophil Differentiation Factor', 'Eosinophil differentiation factor', 'IL-5', 'IL5', 'Interleukin 5', 'Interleukin-5', 'Replacing Factor, T-Cell', 'T Cell Replacing Factor', 'T-Cell Replacing Factor', 'T-Cell-Replacing Factor', 'T-cell replacing factor', 'TRF', 'colony-stimulating factor, eosinophil', 'eosinophil differentiation factor', 'interleukin 5', 'interleukin-5'], 'definition': None, 'syn_in_text': 'IL-5', 'syn_in_stmt': 'IL5'}}
ben.gyori@gmail.com	Tue, 09 Feb 2021 03:21:54 GMT		10795	15108864299385019		EMMAA	-8297562552656824560	act_vs_amt	Alongside this , other studies also reported that omalizumab significantly attenuated the production of TGF-beta by bronchial epithelial cells [ 38 ] as well as induced a reduction effect on MMP-9 serum level [ 39 ] ( Table 2 ) .	Omalizumab inhibits TGFB.	{'MESH:D000069444': {'name': 'Omalizumab', 'synonyms': ['Omalizumab', 'omalizumab'], 'definition': None, 'syn_in_text': 'Omalizumab', 'syn_in_stmt': 'Omalizumab'}, 'FPLX:TGFB': {'name': 'TGFB', 'synonyms': ['Bone Derived Transforming Growth Factor', 'Bone-Derived Transforming Growth Factor', 'Factor, Milk Growth', 'Growth Factor, Milk', 'Milk Growth Factor', 'Platelet Transforming Growth Factor', 'TGF beta', 'TGF β', 'TGF-b', 'TGF-beta', 'TGF-beta family', 'TGF-β', 'TGFB', 'TGFB family', 'TGFbeta', 'TGFβ', 'Transforming Growth Factor beta', 'transforming growth factor beta', 'transforming growth factor β', 'transforming growth factor-beta', 'transforming growth factor-β', 'production of TGF-β'], 'definition': None, 'syn_in_text': 'TGF-beta', 'syn_in_stmt': 'TGFB'}}
ben.gyori@gmail.com	Fri, 14 Aug 2020 01:38:26 GMT		6083	-9415830559865206		DB REST API	2339131210367283004	act_vs_amt	These results indicate that EGF mediated, Erk1/2 dependent downregulation of LIFR has the ability to alter signaling by cytokines which signal through the LIFR.	ERK inhibits LIFR.	{'FPLX:ERK': {'name': 'ERK', 'synonyms': ['ERK', 'ERK 1/2', 'ERK MAP Kinase', 'ERK MAP Kinases', 'ERK MAPK', 'ERK mitogen-activated protein kinase', 'ERK-1/2', 'ERK1/2', 'ERK1/2 MAPK', 'ERKs', 'Erk', 'Erk1/2', 'Extracellular Signal Regulated Kinase', 'Extracellular Signal Regulated Kinases', 'Extracellular Signal Regulated MAP Kinase', 'Extracellular Signal Regulated MAP Kinases', 'Extracellular Signal-Regulated Kinase', 'Extracellular Signal-Regulated Kinases', 'Extracellular Signal-Regulated MAP Kinase', 'Extracellular Signal-Regulated MAP Kinases', 'Kinase, ERK MAP', 'Kinase, Extracellular Signal-Regulated', 'Kinases, Extracellular Signal-Regulated', 'MAP Kinase, ERK', 'MAP Kinases, Extracellular Signal Regulated', 'MAP Kinases, Extracellular Signal-Regulated', 'Signal-Regulated Kinase, Extracellular', 'extracellular signal-regulated kinase', 'p42 and p38 MAP kinases', 'p42 and p38 MAPK', 'p42 and p38 MAPKs', 'p42 and p44', 'p42 and p44 MAPK', 'p42 and p44MAP kinase', 'p42(mapk) and p44(mapk)', 'p42/44', 'p44 and p42', 'phospho-ERK1/2'], 'definition': None, 'syn_in_text': 'ERK', 'syn_in_stmt': 'ERK'}, 'HGNC:6597': {'name': 'LIFR', 'synonyms': ['CD antigen CD118', 'CD118', 'LIF Receptors', 'LIF receptor', 'LIF receptor subunit alpha', 'LIF-R', 'LIFR', 'Leukemia Inhibitory Factor Oncostatin M Shared Receptor', 'Leukemia Inhibitory Factor Receptor', 'Leukemia Inhibitory Factor Receptors', 'Leukemia Inhibitory Factor-Oncostatin M Shared Receptor', 'Leukemia inhibitory factor receptor', 'OSM-LIF Receptors', 'Oncostatin M Leukemia Inhibitory Factor Shared Receptor', 'Oncostatin M Type I Receptor', 'Oncostatin M-Leukemia Inhibitory Factor Shared Receptor', 'Receptors, LIF', 'Receptors, Leukemia Inhibitory Factor', 'Receptors, OSM LIF', 'Receptors, OSM-LIF'], 'definition': None, 'syn_in_text': 'LIFR', 'syn_in_stmt': 'LIFR'}}
ben.gyori@gmail.com	Thu, 12 Nov 2020 14:38:21 GMT		8307	-18916220586140714		EMMAA	-2833867759313603861	act_vs_amt	Stat3 transcriptionally represses Gsk3beta and the SWI and SNF complex subunit Arid1b, thereby activating beta-catenin in SCPs - resulting in neurofibroma initiation and maintenance.	STAT3 inhibits GSK3B.	{'HGNC:11364': {'name': 'STAT3', 'synonyms': ['APRF', 'APRF Transcription Factor', 'Acute Phase Response Factor', 'Acute-Phase Response Factor', 'Acute-phase response factor', 'IL6 Response Factor', 'IL6-Response Factor', 'LIF Response Factor', 'LIF-Response Factor', 'Response Factor, Acute-Phase', 'STAT3', 'STAT3 Protein', 'STAT3 Transcription Factor', 'Signal Transducer and Activator of Transcription 3', 'Signal transducer and activator of transcription 3', 'Stat3', 'Transcription Factor, APRF', 'Transcription Factor, STAT3', 'signal transducer and activator of transcription 3'], 'definition': None, 'syn_in_text': 'STAT3', 'syn_in_stmt': 'STAT3'}, 'HGNC:4617': {'name': 'GSK3B', 'synonyms': ['GSK 3beta', 'GSK-3 beta', 'GSK-3beta', 'GSK-3β', 'GSK3B', 'GSK3B Protein', 'GSK3beta', 'GSK3β', 'Glycogen Synthase Kinase 3 beta', 'Glycogen synthase kinase-3 beta', 'Serine/threonine-protein kinase GSK3B', 'glycogen synthase kinase 3 beta'], 'definition': None, 'syn_in_text': 'GSK3beta', 'syn_in_stmt': 'GSK3B'}}
ben.gyori@gmail.com	Tue, 24 Nov 2020 21:58:20 GMT		9034	-11319518326180426		EMMAA	-9054434511246946187	act_vs_amt	Because scopoletin stimulated melanin production via increased expression of MITF and tyrosinase, we investigated the effect of scopoletin on the cAMP pathway.	Scopoletin activates Melanin.	{'CHEBI:CHEBI:17488': {'name': 'scopoletin', 'synonyms': ['6-Methoxy-7-hydroxycoumarin', '6-Methylesculetin', '6-O-Methylesculetin', '7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one', '7-hydroxy-6-methoxy-2H-chromen-2-one', '7-hydroxy-6-methoxycoumarin', 'Acid, Chrysotropic', 'Acid, Gelseminic', 'Chrysotropic Acid', 'Gelseminic Acid', 'Methylesculetin', 'Scopoletin', 'scopoletin'], 'definition': None, 'syn_in_text': 'Scopoletin', 'syn_in_stmt': 'Scopoletin'}, 'CHEBI:CHEBI:89634': {'name': 'Melanin', 'synonyms': ['Melanin', 'Melanins', 'melanin'], 'definition': None, 'syn_in_text': 'Melanin', 'syn_in_stmt': 'Melanin'}}
ben.gyori@gmail.com	Sun, 14 Jun 2020 15:11:04 GMT		5183	-32483244831176476		bioexp_paper_medscan	-7032468747073044919	act_vs_amt	MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6	MIR320C1 inhibits CDK6.	{'HGNC:35248': {'name': 'MIR320C1', 'synonyms': ['MIR320C1', 'MIRN320C1', 'hsa-mir-320c-1', 'microRNA 320c-1', 'MicroRNA-320c'], 'definition': None, 'syn_in_text': 'MicroRNA-320c', 'syn_in_stmt': 'MIR320C1'}, 'HGNC:1777': {'name': 'CDK6', 'synonyms': ['CDK6', 'CDK6 Protein', 'CDKN6', 'Cdk6 Protein Kinase', 'Cell Division Protein Kinase 6', 'Cell division protein kinase 6', 'Cyclin Dependent Kinase 6', 'Cyclin-Dependent Kinase 6', 'Cyclin-dependent kinase 6', 'PLSTIRE', 'PLSTIRE Protein', 'Protein Kinase, Cdk6', 'Serine/threonine-protein kinase PLSTIRE', 'cyclin dependent kinase 6'], 'definition': None, 'syn_in_text': 'Cyclin-Dependent Kinase 6', 'syn_in_stmt': 'CDK6'}}
bachmanjohn@gmail.com	Sat, 14 Nov 2020 18:22:18 GMT		8330	12096544611175209		EMMAA	-6341049979917252630	act_vs_amt	Gene amplification of the downstream MAPK1 and ERK2 target AURKA resulted in AURKA over-expression in MPNST.	MAPK1 activates AURKA.	{'HGNC:6871': {'name': 'MAPK1', 'synonyms': ['ERK', 'ERK-2', 'ERK2', 'ERT1', 'Extracellular Signal Regulated Kinase 2', 'Extracellular Signal-Regulated Kinase 2', 'Extracellular signal-regulated kinase 2', 'MAP Kinase 2', 'MAP Kinase, p42', 'MAP kinase 1', 'MAP kinase 2', 'MAP kinase isoform p42', 'MAPK 1', 'MAPK 2', 'MAPK1', 'MAPK1 Mitogen Activated Protein Kinase', 'MAPK1 Mitogen-Activated Protein Kinase', 'MAPK2', 'MAPK2 Mitogen Activated Protein Kinase', 'MAPK2 Mitogen-Activated Protein Kinase', 'Mitogen Activated Protein Kinase 1', 'Mitogen Activated Protein Kinase 2', 'Mitogen-Activated Protein Kinase 1', 'Mitogen-Activated Protein Kinase 2', 'Mitogen-activated protein kinase 1', 'Mitogen-activated protein kinase 2', 'PRKM1', 'PRKM2', 'mitogen-activated protein kinase 1', 'p41mapk', 'p42', 'p42 MAP Kinase', 'p42 MAPK', 'p42(Mapk)', 'p42(Mapk) Kinase', 'p42(Mitogen-Activated Protein Kinase)', 'p42-MAPK'], 'definition': None, 'syn_in_text': 'ERK2', 'syn_in_stmt': 'MAPK1'}, 'HGNC:11393': {'name': 'AURKA', 'synonyms': ['AIK', 'AIRK1', 'ARK-1', 'ARK1', 'AURA', 'AURKA', 'AURORA2 Protein', 'AYK1', 'AurA', 'Aurora 2', 'Aurora A Kinase', 'Aurora A Kinases', 'Aurora Kinase A', 'Aurora Kinases A', 'Aurora kinase A', 'Aurora-A Kinase', 'Aurora-A kinase', 'Aurora-related kinase 1', 'Aurora/IPL1-related kinase 1', 'AuroraA Kinase', 'BTAK', 'BTAK Protein', 'Breast Tumor Amplified Kinase', 'Breast tumor-amplified kinase', 'Breast-Tumor-Amplified Kinase', 'IAK1', 'Ipl1- and aurora-related kinase 1', 'PPP1R47', 'STK15', 'STK15 Kinase', 'STK6', 'STK7', 'Serine Threonine Protein Kinase 15', 'Serine-Threonine Protein Kinase 15', 'Serine/threonine-protein kinase 15', 'Serine/threonine-protein kinase 6', 'Serine/threonine-protein kinase Ayk1', 'Serine/threonine-protein kinase aurora-A', 'aurora kinase A', 'protein phosphatase 1, regulatory subunit 47'], 'definition': None, 'syn_in_text': 'AURKA', 'syn_in_stmt': 'AURKA'}}
ben.gyori@gmail.com	Thu, 30 Apr 2020 01:06:42 GMT		2649	-13913543096071437		EMMAA	-7646462520635910601	act_vs_amt	In March 11, 2020, XREF_BIBR reported the hypothesis that ibuprofen can increase the risk of developing severe and fatal COVID-19 since ibuprofen is known to upregulate ACE2 receptors.	Ibuprofen activates ACE2 receptors.	{'CHEBI:CHEBI:5855': {'name': 'ibuprofen', 'synonyms': ['(+-)-2-(p-isobutylphenyl)propionic acid', '(+-)-alpha-methyl-4-(2-methylpropyl)benzeneacetic acid', '(+-)-ibuprofen', '(+-)-p-isobutylhydratropic acid', '(4-isobutylphenyl)-alpha-methylacetic acid', '(RS)-ibuprofen', '2-(4-isobutylphenyl)propanoic acid', '2-[4-(2-methylpropyl)phenyl]propanoic acid', '4-isobutylhydratropic acid', 'Adran', 'Advil', 'Amibufen', 'Anco', 'Anflagen', 'Apsifen', 'Benzeneacetic Acid, alpha-methyl-4-(2-methylpropyl)- trimethylsilyl ester', 'Bluton', 'Brufen', 'Brufort', 'Buburone', 'Butylenin', 'Dolgin', 'Dolgirid', 'Dolgit', 'Dolo-Dolgit', 'Ebufac', 'Epobron', 'Femadon', 'Haltran', 'Ibu-Attritin', 'Ibumetin', 'Ibuprocin', 'Ibuprofen', 'Ibutid', 'Inabrin', 'Inoven', 'Lamidon', 'Lebrufen', 'Liptan', 'Medipren', 'Motrin', 'Mynosedin', 'Nobfen', 'Nobgen', 'Nuprin', 'Nurofen', 'Pediaprofen', 'Roidenin', 'Rufen', 'Seclodin', 'Suspren', 'Tabalon', 'Trendar', 'Urem', 'alpha-(4-isobutylphenyl)propionic acid', 'alpha-(p-isobutylphenyl)propionic acid', 'alpha-Methyl-4-(2-methylpropyl)benzeneacetic Acid', 'ibuprofen'], 'definition': None, 'syn_in_text': 'Ibuprofen', 'syn_in_stmt': 'Ibuprofen'}}
ben.gyori@gmail.com	Mon, 23 Mar 2020 23:36:06 GMT		2320	3811858138886432		EMMAA	5666022615107119967	act_vs_amt	CI + Abeta decreased the serum concentration of BDNF.	APP inhibits BDNF.	{'HGNC:620': {'name': 'APP', 'synonyms': ['A4', 'ABPP', 'AD1', 'APP', 'APPI', 'Abeta', 'Alzheimer disease amyloid A4 protein homolog', 'Alzheimer disease amyloid protein', 'Amyloid A4 Protein Precursor', 'Amyloid Protein Precursor', 'Amyloid beta Precursor Protein', 'Amyloid beta Protein Precursor', 'Amyloid beta-Protein Precursor', 'Amyloid precursor protein', 'Amyloid-beta (A4) precursor protein', 'Amyloid-beta A4 protein', 'Amyloid-beta precursor protein', 'Aβ', 'CVAP', 'Cerebral vascular amyloid peptide', 'Nexin 2, Protease', 'Nexin II, Protease', 'PN-II', 'PreA4', 'Protease Nexin 2', 'Protease Nexin II', 'Protease nexin-II', 'alpha-sAPP', 'amyloid beta', 'amyloid beta precursor protein', 'amyloid β', 'beta Amyloid Protein Precursor', 'beta-Amyloid Protein Precursor', 'beta-Protein Precursor, Amyloid', 'peptidase nexin-II'], 'definition': None, 'syn_in_text': 'Abeta', 'syn_in_stmt': 'APP'}, 'HGNC:1033': {'name': 'BDNF', 'synonyms': ['Abrineurin', 'BDNF', 'Brain-derived neurotrophic factor', 'brain derived neurotrophic factor', 'neurotrophin'], 'definition': None, 'syn_in_text': 'BDNF', 'syn_in_stmt': 'BDNF'}}
bachmanjohn@gmail.com	Fri, 23 Oct 2020 14:12:41 GMT		7035	18334778860223615		bioexp_refinements	-7462221171272857117	act_vs_amt	The results from Gankyrin reporter activity, real-time polymerase chain reaction, or immunoblotting further confirmed the up-regulation of Gankyrin by IL-1beta and IRAK-1 inflammatory signaling.	IL1B activates PSMD10.	{'HGNC:5992': {'name': 'IL1B', 'synonyms': ['Catabolin', 'IL-1 beta', 'IL-1B', 'IL-1beta', 'IL-1β', 'IL1-BETA', 'IL1B', 'IL1F2', 'Interleukin 1 beta', 'Interleukin 1beta', 'Interleukin-1 beta', 'Interleukin-1beta', 'interleukin 1 beta'], 'definition': None, 'syn_in_text': 'IL-1beta', 'syn_in_stmt': 'IL1B'}, 'HGNC:9555': {'name': 'PSMD10', 'synonyms': ['26S proteasome non-ATPase regulatory subunit 10', '26S proteasome regulatory subunit p28', 'Gankyrin', 'PSMD10', 'gankyrin', 'p28', 'p28(GANK)', 'proteasome 26S subunit, non-ATPase 10'], 'definition': None, 'syn_in_text': 'Gankyrin', 'syn_in_stmt': 'PSMD10'}}
ben.gyori@gmail.com	Thu, 18 Jun 2020 02:06:13 GMT		5577	-32024036869512595		bioexp_paper_medscan	-1550638897361748088	act_vs_amt	Collectively, we demonstrated that miR-146a post-transcriptionally regulates the 3' untranslated region of RhoA mRNA and inhibits expression of RhoA protein, ultimately leading to suppress the migratory capacity of MDA-MB-231 cells.	MIR146A inhibits RHOA.	{'HGNC:31533': {'name': 'MIR146A', 'synonyms': ['MIR146A', 'MIRN146', 'MIRN146A', 'hsa-mir-146', 'hsa-mir-146a', 'microRNA 146a', 'MicroRNA-146a'], 'definition': None, 'syn_in_text': None, 'syn_in_stmt': 'MIR146A'}, 'HGNC:667': {'name': 'RHOA', 'synonyms': ['ARH12', 'ARHA', 'ARHA GTP Binding Protein', 'ARHA GTP-Binding Protein', 'GTP-Binding Protein, ARHA', 'GTP-Binding Protein, rho12', 'GTP-Binding Protein, rhoA', 'RHO12', 'RHOA', 'RHOH12', 'Ras Homolog Family Member A', 'Rho', 'Rho cDNA clone 12', 'Rho12', 'RhoA', 'Transforming protein RhoA', 'h12', 'ras homolog family member A', 'rho12 GTP Binding Protein', 'rho12 GTP-Binding Protein', 'rho12 Protein', 'rhoA GTP Binding Protein', 'rhoA GTP-Binding Protein', 'rhoA P21 Protein', 'rhoA Protein'], 'definition': None, 'syn_in_text': 'RHOA', 'syn_in_stmt': 'RHOA'}}
ben.gyori@gmail.com	Tue, 15 Dec 2020 06:35:28 GMT		10328	-35927189011274475		EMMAA	-5769741408460270950	act_vs_amt	In addition, IL-12 has been also shown to induce production of TNF-a (Aste-Amezaga et al., 1994).	IL12 activates TNF.	{'FPLX:IL12': {'name': 'IL12', 'synonyms': ['Cytotoxic Lymphocyte Maturation Factor', 'IL 12', 'IL-12', 'IL-12 p70', 'IL12', 'Interleukin 12', 'Interleukin 12 p70', 'Interleukin-12', 'Interleukin-12 p70', 'Natural Killer Cell Stimulatory Factor'], 'definition': None, 'syn_in_text': 'IL-12', 'syn_in_stmt': 'IL12'}, 'HGNC:11892': {'name': 'TNF', 'synonyms': ['Cachectin', 'Cachectin Tumor Necrosis Factor', 'Cachectin-Tumor Necrosis Factor', 'DIF', 'TNF', 'TNF Superfamily, Member 2', 'TNF superfamily, member 2', 'TNF-a', 'TNF-alpha', 'TNF-α', 'TNFA', 'TNFSF2', 'TNFalpha', 'TNFα', 'Tumor Necrosis Factor', 'Tumor Necrosis Factor Ligand Superfamily Member 2', 'Tumor Necrosis Factor alpha', 'Tumor Necrosis Factor-alpha', 'Tumor necrosis factor', 'Tumor necrosis factor ligand superfamily member 2', 'tumor necrosis factor'], 'definition': None, 'syn_in_text': 'TNF-a', 'syn_in_stmt': 'TNF'}}
ben.gyori@gmail.com	Mon, 07 Jun 2021 20:23:58 GMT	{'annotations': {'agents': {'raw_text': ['HOXA13', 'EphA6']}, 'content_source': 'pubmed', 'found_by': 'Positive_activation_syntax_1_verb', 'prior_uuids': ['738c5910-f1bd-4bd6-b7b9-0099a91658fb']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '17304517', 'source_api': 'reach', 'source_hash': 4753587855559507000, 'text': 'Together these findings indicate that HOXA13 directly regulates EphA6 and EphA7 in the developing GT and identifies the GT vascular endothelia as a novel site for HOXA13 dependent expression of EphA6 and EphA7.', 'text_refs': {'DOI': '10.1002/DVDY.21077', 'DOI_ID': 'DVDY.21077', 'DOI_NS': 1002, 'PMID': '17304517', 'PMID_NUM': 17304517, 'READER': 'REACH', 'RID': 10100005618369, 'SOURCE': 'pubmed', 'TCID': 5618369, 'TRID': 9010498}}	12042	34381893538341253	{'belief': 1, 'id': '0ec47ae4-99fb-4d6b-a63e-b3da1b3606ac', 'matches_hash': '34381893538341253', 'obj': {'db_refs': {'HGNC': '19296', 'TEXT': 'EphA6', 'UP': 'Q9UF33'}, 'name': 'EPHA6'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '5102', 'TEXT': 'HOXA13', 'UP': 'P31271'}, 'name': 'HOXA13'}, 'type': 'Activation'}	DB REST API	4753587855559506975	act_vs_amt	Together these findings indicate that HOXA13 directly regulates EphA6 and EphA7 in the developing GT and identifies the GT vascular endothelia as a novel site for HOXA13 dependent expression of EphA6 and EphA7.	HOXA13 activates EPHA6.	{'HGNC:5102': {'name': 'HOXA13', 'synonyms': ['HOX1', 'HOX1J', 'HOXA13', 'Homeobox protein Hox-1J', 'Homeobox protein Hox-A13', 'Hoxa 13 protein', 'Hoxa-13 protein', 'Hoxa13 protein', 'homeo box 1J protein', 'homeo box A13', 'homeobox A13', 'homeobox protein HOXA13', 'transcription factor HOXA13'], 'definition': None, 'syn_in_text': 'HOXA13', 'syn_in_stmt': 'HOXA13'}, 'HGNC:19296': {'name': 'EPHA6', 'synonyms': ['EHK-2', 'EHK2', 'EK12', 'EPH homology kinase 2', 'EPH receptor A6', 'EPH-like kinase 12', 'EPHA6', 'Ephrin type-A receptor 6', 'FLJ35246', 'HEK12', 'EphA6'], 'definition': None, 'syn_in_text': 'EPHA6', 'syn_in_stmt': 'EPHA6'}}
ben.gyori@gmail.com	Tue, 09 Feb 2021 16:30:17 GMT		10875	-8420389304453881		EMMAA	7159916758635703976	act_vs_amt	IL-6 upregulates cathepsin L production [ 8] , which then cleaves the virus , enabling it to infect pulmonary epithelial 8 cells [ 7 ] .	IL6 activates Cathepsin.	{'HGNC:6018': {'name': 'IL6', 'synonyms': ['B Cell Differentiation Factor', 'B Cell Differentiation Factor 2', 'B Cell Stimulatory Factor 2', 'B Cell Stimulatory Factor-2', 'B-Cell Differentiation Factor', 'B-Cell Differentiation Factor-2', 'B-Cell Stimulatory Factor 2', 'B-Cell Stimulatory Factor-2', 'B-cell stimulatory factor 2', 'BSF-2', 'BSF2', 'CDF', 'CTL differentiation factor', 'Differentiation Factor 2, B Cell', 'Differentiation Factor, B Cell', 'Differentiation Factor, B-Cell', 'Differentiation Factor-2, B-Cell', 'Differentiation-Inducing Protein, Myeloid', 'Growth Factor, Hybridoma', 'Growth Factor, Plasmacytoma', 'HGF', 'HSF', 'Hepatocyte Stimulating Factor', 'Hepatocyte-Stimulating Factor', 'Hybridoma Growth Factor', 'Hybridoma growth factor', 'IFN-beta 2', 'IFN-beta-2', 'IFNB2', 'IL-6', 'IL6', 'Interferon beta 2', 'Interferon beta-2', 'Interleukin 6', 'Interleukin-6', 'MGI-2', 'Myeloid Differentiation Inducing Protein', 'Myeloid Differentiation-Inducing Protein', 'Plasmacytoma Growth Factor', 'beta-2, Interferon', 'interferon, beta 2', 'interleukin 6'], 'definition': None, 'syn_in_text': 'IL-6', 'syn_in_stmt': 'IL6'}, 'FPLX:Cathepsin': {'name': 'Cathepsin', 'synonyms': ['Cathepsin', 'Cathepsins', 'cathepsin', 'cathepsins', 'cathepsin L production'], 'definition': None, 'syn_in_text': 'Cathepsin', 'syn_in_stmt': 'Cathepsin'}}
bachmanjohn@gmail.com	Fri, 23 Oct 2020 14:58:11 GMT		7066	-21405829622669033		bioexp_refinements	5242238075514145534	act_vs_amt	When we examined the first instance, PPARalpha knockdown with siRNAs failed to increase PPARgamma expression (XREF_FIG), which indicates PPARalpha inhibition of PPARgamma activation does not occur through regulation of PPARgamma activity.	PPARA decreases the amount of PPARG.	{'HGNC:9232': {'name': 'PPARA', 'synonyms': ['NR1C1', 'Nuclear receptor subfamily 1 group C member 1', 'PPAR', 'PPAR alpha', 'PPAR-alpha', 'PPARA', 'PPARalpha', 'Peroxisome Proliferator Activated Receptor alpha', 'Peroxisome Proliferator-Activated Receptor alpha', 'Peroxisome proliferator-activated receptor alpha', 'hPPAR', 'peroxisome proliferator activated receptor alpha'], 'definition': None, 'syn_in_text': 'PPARalpha', 'syn_in_stmt': 'PPARA'}, 'HGNC:9236': {'name': 'PPARG', 'synonyms': ['NR1C3', 'Nuclear receptor subfamily 1 group C member 3', 'PPAR gamma', 'PPAR-gamma', 'PPAR-γ', 'PPARG', 'PPARG1', 'PPARG2', 'PPARgamma', 'PPARγ', 'Peroxisome Proliferator Activated Receptor gamma', 'Peroxisome Proliferator-Activated Receptor gamma', 'Peroxisome proliferator-activated receptor gamma', 'Receptor, Thiazolidinedione', 'Thiazolidinedione Receptor', 'peroxisome proliferator activated receptor gamma'], 'definition': None, 'syn_in_text': 'PPARgamma', 'syn_in_stmt': 'PPARG'}}
bachmanjohn@gmail.com	Thu, 15 Jul 2021 21:19:59 GMT	{'annotations': {'agents': {'raw_text': ['DDIAS', 'MEF2B', 'p300']}, 'content_source': 'elsevier', 'found_by': 'INTERACT', 'prior_uuids': ['fccba42a-eb62-4f2a-8f8a-188f6366acfd']}, 'pmid': '27412911', 'source_api': 'sparser', 'source_hash': 5373535187846383000, 'text': 'We also investigated whether MEF2B interacts with the p300 coactivator to enhance the transcription of DDIAS.', 'text_refs': {'DOI': '10.1016/J.BBAGRM.2016.07.003', 'DOI_ID': 'J.BBAGRM.2016.07.003', 'DOI_NS': 1016, 'PII': 'S1874-9399(16)30135-3', 'PMID': '27412911', 'PMID_NUM': 27412911, 'READER': 'SPARSER', 'RID': 20300022550388, 'SOURCE': 'elsevier', 'TCID': 22550388, 'TRID': 12190892}}	12166	10703833895442223	{'belief': 1, 'id': 'af281a89-6ba9-4b1c-8353-a29715d600a0', 'matches_hash': '10703833895442223', 'members': [{'db_refs': {'HGNC': '26351', 'TEXT': 'DDIAS', 'UP': 'Q8IXT1'}, 'name': 'DDIAS'}, {'db_refs': {'HGNC': '3373', 'TEXT': 'p300', 'UP': 'Q09472'}, 'name': 'EP300'}, {'db_refs': {'HGNC': '6995', 'TEXT': 'MEF2B', 'UP': 'Q02080'}, 'name': 'MEF2B'}], 'type': 'Complex'}	DB REST API	5373535187846382456	hypothesis	We also investigated whether MEF2B interacts with the p300 coactivator to enhance the transcription of DDIAS.	DDIAS binds EP300 and MEF2B.	{'HGNC:26351': {'name': 'DDIAS', 'synonyms': ['C11orf82', 'DDIAS', 'DNA damage induced apoptosis suppressor', 'DNA damage-induced apoptosis suppressor protein', 'FLJ25416', 'FLJ38838', 'NOXIN', 'Nitric oxide-inducible gene protein', 'nitric oxide-inducible', 'noxin'], 'definition': None, 'syn_in_text': 'DDIAS', 'syn_in_stmt': 'DDIAS'}, 'HGNC:3373': {'name': 'EP300', 'synonyms': ['E1A binding protein p300', 'E1A-associated protein p300', 'EP300', 'Histone acetyltransferase p300', 'Histone butyryltransferase p300', 'Histone crotonyltransferase p300', 'KAT3B', 'P300', 'Protein 2-hydroxyisobutyryltransferase p300', 'Protein lactyltransferas p300', 'Protein propionyltransferase p300', 'histone acetyltransferase p300', 'p300', 'p300 HAT'], 'definition': None, 'syn_in_text': 'P300', 'syn_in_stmt': 'EP300'}, 'HGNC:6995': {'name': 'MEF2B', 'synonyms': ['MEF2B', 'Myocyte-specific enhancer factor 2B', 'RSRFR2', 'Serum response factor-like protein 2', 'XMEF2', 'myocyte enhancer factor 2B'], 'definition': None, 'syn_in_text': 'MEF2B', 'syn_in_stmt': 'MEF2B'}}
ben.gyori@gmail.com	Mon, 08 Feb 2021 02:24:29 GMT		10740	-7878130765945507		EMMAA	-6838219382425493937	hypothesis	Therefore, we hypothesized that EGFR directly and rapidly phosphorylates ACTN4.	EGFR phosphorylates ACTN4.	{'HGNC:3236': {'name': 'EGFR', 'synonyms': ['EGF receptor', 'EGFR', 'EGFRvIII', 'ERBB', 'ERBB1', 'ERRP', 'Epidermal growth factor receptor', 'HER1', 'Proto-oncogene c-ErbB-1', 'Receptor tyrosine-protein kinase erbB-1', 'epidermal growth factor receptor', 'epidermal growth factor receptor VIII', 'erb-b2 receptor tyrosine kinase 1', 'erythroblastic leukemia viral (v-erb-b) oncogene homolog (avian)'], 'definition': None, 'syn_in_text': 'EGFR', 'syn_in_stmt': 'EGFR'}, 'HGNC:166': {'name': 'ACTN4', 'synonyms': ['ACTN4', 'Alpha-actinin-4', 'FSGS1', 'Non-muscle alpha-actinin 4', 'actinin alpha 4'], 'definition': None, 'syn_in_text': 'ACTN4', 'syn_in_stmt': 'ACTN4'}}
bachmanjohn@gmail.com	Fri, 10 Jan 2020 21:01:34 GMT		1418	14195022091937216		DB REST API	7518313371639616062	hypothesis	We initially hypothesized that pVHL, USP9X, and HUWE1 interact with each other.	USP9X binds VHL and HUWE1.	{'HGNC:12632': {'name': 'USP9X', 'synonyms': ['DFFRX', 'Deubiquitinating enzyme FAF-X', 'FAF', 'FAF-X', 'FAFs', 'FAM', 'Fat facets in mammals', 'Fat facets protein-related, X-linked', 'MRX99', 'USP9', 'USP9X', 'Ubiquitin carboxyl-terminal hydrolase 9X', 'Ubiquitin thioesterase FAF-X', 'Ubiquitin-specific protease 9, X chromosome', 'Ubiquitin-specific-processing protease FAF-X', 'fat facets-like, X-linked', 'hFAM', 'ubiquitin specific peptidase 9 X-linked'], 'definition': None, 'syn_in_text': 'USP9X', 'syn_in_stmt': 'USP9X'}, 'HGNC:12687': {'name': 'VHL', 'synonyms': ['Protein G7', 'VHL', 'VHL1', 'pVHL', 'von Hippel-Lindau disease tumor suppressor', 'von Hippel-Lindau tumor suppressor'], 'definition': None, 'syn_in_text': 'pVHL', 'syn_in_stmt': 'VHL'}, 'HGNC:30892': {'name': 'HUWE1', 'synonyms': ['ARF-BP1', 'ARF-binding protein 1', 'E3 ubiquitin-protein ligase HUWE1', 'HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1', 'HECT, UBA and WWE domain-containing protein 1', 'HECT-type E3 ubiquitin transferase HUWE1', 'HUWE1', 'HectH9', 'Homologous to E6AP carboxyl terminus homologous protein 9', 'Ib772', 'KIAA0312', 'KIAA1578', 'LASU1', 'Large structure of UREB1', 'Mcl-1 ubiquitin ligase E3', 'Mule', 'URE-B1', 'URE-binding protein 1', 'UREB1', 'Upstream regulatory element-binding protein 1'], 'definition': None, 'syn_in_text': 'HUWE1', 'syn_in_stmt': 'HUWE1'}}
rphair@integrativebioinformatics.com	Sun, 21 Jun 2020 01:44:13 GMT		5615	18425000907059888		DB REST API	1273299778715233851	hypothesis	At first we wanted to confirm that overexpression of beta-arrestin1 diminishes IFNgamma induced transcription of a STAT1 dependent reporter gene in HeLa cells.	Modified ARRB1 decreases the amount of IFNG.	{'HGNC:711': {'name': 'ARRB1', 'synonyms': ['ARR1', 'ARRB1', 'ARRB1 Protein', 'Arrestin 2', 'Arrestin beta-1', 'Arrestin, beta 1', 'Arrestin-2', 'Beta-arrestin-1', 'Non-visual arrestin-2', 'arrestin 2', 'arrestin beta 1', 'beta 1 Arrestin', 'beta Arrestin 1', 'beta-Arrestin 1', 'beta-arrestin1'], 'definition': None, 'syn_in_text': 'beta-arrestin1', 'syn_in_stmt': 'ARRB1'}, 'HGNC:5438': {'name': 'IFNG', 'synonyms': ['IFN-gamma', 'IFN-γ', 'IFNG', 'IFNgamma', 'IFNγ', 'Immune Interferon', 'Immune interferon', 'Interferon Type II', 'Interferon gamma', 'Interferon, Immune', 'Interferon, Type II', 'Interferon, gamma', 'Interferon-gamma', 'Type II Interferon', 'gamma-Interferon', 'interferon gamma'], 'definition': None, 'syn_in_text': 'IFNgamma', 'syn_in_stmt': 'IFNG'}}
cthoyt@gmail.com	Tue, 05 Apr 2022 19:37:57 GMT		12951	24477639752946169	{'belief': 1, 'id': 'e5a4fe51-df38-455a-856c-6f64815ed559', 'matches_hash': '24477639752946169', 'obj': {'db_refs': {'HGNC': '3821', 'MESH': 'D000071316', 'TEXT': 'FoxO3a', 'UP': 'O43524'}, 'name': 'FOXO3'}, 'subj': {'db_refs': {'HGNC': '31542', 'MIRBASE': 'MI0000681', 'TEXT': 'miR-155'}, 'name': 'MIR155'}, 'type': 'DecreaseAmount'}	CoGEx	3018264425732011305	hypothesis	Furthermore, novel research also indicates that FOXO3 expression may be negatively regulated by miR-155, miR-223, and miR-29b [XREF_BIBR].	MIR155 decreases the amount of FOXO3.	{'HGNC:31542': {'name': 'MIR155', 'synonyms': ['MIR155', 'MIRN155', 'hsa-mir-155', 'miR-155', 'microRNA 155'], 'definition': None, 'syn_in_text': 'miR-155', 'syn_in_stmt': 'MIR155'}, 'HGNC:3821': {'name': 'FOXO3', 'synonyms': ['AF6q21', 'AF6q21 protein', 'FKHRL1', 'FOXO2', 'FOXO3', 'FOXO3 Protein', 'FOXO3A', 'FOXO3a', 'Forkhead Box Protein O3', 'Forkhead box protein O3', 'Forkhead in Rhabdomyosarcoma Like 1 Protein', 'Forkhead in Rhabdomyosarcoma-Like 1 Protein', 'Forkhead in rhabdomyosarcoma-like 1', 'FoxO3a', 'Protein, FOXO3', 'forkhead box O3'], 'definition': None, 'syn_in_text': 'FOXO3', 'syn_in_stmt': 'FOXO3'}}
ben.gyori@gmail.com	Tue, 05 May 2020 13:13:37 GMT		2727	-14248997257329062		EMMAA	3753327322913705665	negative_result	It has also been shown that decreased estrogen and testosterone level in elderly patient is unable to downregulate IL-6 gene expression XREF_BIBR, XREF_BIBR, XREF_BIBR.	Testosterone inhibits IL6.	{'CHEBI:CHEBI:17347': {'name': 'testosterone', 'synonyms': ['17 beta Hydroxy 4 Androsten 3 one', '17-beta-Hydroxy-4-Androsten-3-one', '17beta-Hydroxy-4-androsten-3-one', '17beta-hydroxy-4-androsten-3-one', '17beta-hydroxyandrost-4-en-3-one', '4-androsten-17beta-ol-3-one', 'Androderm', 'TESTOSTERONE', 'TS', 'Testosteron', 'Testosterone', 'testosterona', 'testosterone', 'testosteronum'], 'definition': None, 'syn_in_text': 'TESTOSTERONE', 'syn_in_stmt': 'TESTOSTERONE'}, 'HGNC:6018': {'name': 'IL6', 'synonyms': ['B Cell Differentiation Factor', 'B Cell Differentiation Factor 2', 'B Cell Stimulatory Factor 2', 'B Cell Stimulatory Factor-2', 'B-Cell Differentiation Factor', 'B-Cell Differentiation Factor-2', 'B-Cell Stimulatory Factor 2', 'B-Cell Stimulatory Factor-2', 'B-cell stimulatory factor 2', 'BSF-2', 'BSF2', 'CDF', 'CTL differentiation factor', 'Differentiation Factor 2, B Cell', 'Differentiation Factor, B Cell', 'Differentiation Factor, B-Cell', 'Differentiation Factor-2, B-Cell', 'Differentiation-Inducing Protein, Myeloid', 'Growth Factor, Hybridoma', 'Growth Factor, Plasmacytoma', 'HGF', 'HSF', 'Hepatocyte Stimulating Factor', 'Hepatocyte-Stimulating Factor', 'Hybridoma Growth Factor', 'Hybridoma growth factor', 'IFN-beta 2', 'IFN-beta-2', 'IFNB2', 'IL-6', 'IL6', 'Interferon beta 2', 'Interferon beta-2', 'Interleukin 6', 'Interleukin-6', 'MGI-2', 'Myeloid Differentiation Inducing Protein', 'Myeloid Differentiation-Inducing Protein', 'Plasmacytoma Growth Factor', 'beta-2, Interferon', 'interferon, beta 2', 'interleukin 6'], 'definition': None, 'syn_in_text': 'IL-6', 'syn_in_stmt': 'IL6'}}
ben.gyori@gmail.com	Fri, 24 Jan 2025 15:27:18 GMT	{'annotations': {'agents': {'raw_text': ['p38MAPK and MKK3', 'JNK or ERK']}, 'content_source': 'pmc_oa', 'prior_uuids': ['b1f49eba-62d9-4ceb-91a5-42bf42f45a89']}, 'pmid': '23922727', 'source_api': 'sparser', 'source_hash': -5574079916290575000, 'text': 'In this study, the interaction between MKK3 and p38MAPK also showed high specificity, as only MKK3 phosphorylated p38MAPK and MKK3 did not phosphorylated JNK or ERK.', 'text_refs': {'DOI': '10.1371/JOURNAL.PONE.0069510', 'DOI_ID': 'JOURNAL.PONE.0069510', 'DOI_NS': 1371, 'PMCID': 'PMC3726695', 'PMCID_NUM': 3726695, 'PMID': '23922727', 'PMID_NUM': 23922727, 'READER': 'SPARSER', 'RID': 20300018392363, 'SOURCE': 'pmc_oa', 'TCID': 18392363, 'TRID': 16143775}}	14586	30558299440093054	{'belief': 1, 'enz': {'db_refs': {'HGNC': '6843', 'MESH': 'D048371', 'TEXT': 'MKK3', 'UP': 'P46734'}, 'name': 'MAP2K3'}, 'id': '713baaf0-a72f-4d0b-9ea5-7250dc7fd31d', 'matches_hash': '30558299440093054', 'sub': {'db_refs': {'FPLX': 'JNK', 'IP': 'IPR008351', 'MESH': 'D048031', 'TEXT': 'JNK'}, 'name': 'JNK'}, 'type': 'Phosphorylation'}	DB REST API	-5574079916290575595	negative_result	In this study, the interaction between MKK3 and p38MAPK also showed high specificity, as only MKK3 phosphorylated p38MAPK and MKK3 did not phosphorylated JNK or ERK.	MAP2K3 phosphorylates JNK.	{'HGNC:6843': {'name': 'MAP2K3', 'synonyms': ['Dual Specificity Mitogen Activated Protein Kinase Kinase 3', 'Dual Specificity Mitogen-Activated Protein Kinase Kinase 3', 'Dual specificity mitogen-activated protein kinase kinase 3', 'MAP Kinase Kinase 3', 'MAP kinase kinase 3', 'MAP2K3', 'MAPK/ERK kinase 3', 'MAPKK 3', 'MAPKK3', 'MEK 3', 'MEK 3 Protein Kinase', 'MEK-3 Protein Kinase', 'MEK3', 'MEK3 Protein Kinase', 'MKK 3 Protein Kinase', 'MKK-3 Protein Kinase', 'MKK3', 'MKK3 Protein Kinase', 'Mitogen Activated Protein Kinase Kinase 3', 'Mitogen-Activated Protein Kinase Kinase 3', 'PRKMK3', 'Protein Kinase, MEK3', 'Protein Kinase, MKK-3', 'Protein Kinase, MKK3', 'SAPK kinase 2', 'SAPKK-2', 'SAPKK2', 'SKK2', 'Stress-activated protein kinase kinase 2', 'dual specificity mitogen activated protein kinase kinase 3', 'mitogen-activated protein kinase kinase 3', 'stress-activated protein kinase kinase 2'], 'definition': None, 'syn_in_text': 'MKK3', 'syn_in_stmt': 'MAP2K3'}, 'FPLX:JNK': {'name': 'JNK', 'synonyms': ['JNK', 'JNK MAPK', 'JNK1/2', 'JNKs', 'SAPK', 'c-JNK', 'c-Jun N-terminal kinase', 'c-Jun NH2-terminal kinase'], 'definition': None, 'syn_in_text': 'JNK', 'syn_in_stmt': 'JNK'}}
bachmanjohn@gmail.com	Tue, 08 Dec 2020 22:42:03 GMT		9878	29792466325400532		bioexp_psp	-7375036829692942830	negative_result	In comparison, phosphorylation of Aurora BT179A by Chk1 was similar to Aurora BWT (Fig. 1, C and D).	CHEK1 phosphorylates AURKB on T179.	{'HGNC:1925': {'name': 'CHEK1', 'synonyms': ['CHEK1', 'CHK1', 'CHK1 checkpoint homolog', 'Cell cycle checkpoint kinase', 'Checkpoint Kinase 1', 'Checkpoint kinase-1', 'Checkpoint-1 Kinase', 'Chk1', 'Chk1 Kinase', 'Chk1 Protein Kinase', 'Chkl', 'Protein Kinase, Chk1', 'Serine/threonine-protein kinase Chk1', 'checkpoint kinase 1'], 'definition': None, 'syn_in_text': 'CHK1', 'syn_in_stmt': 'CHEK1'}, 'HGNC:11390': {'name': 'AURKB', 'synonyms': ['AIK2', 'AIM-1', 'AIM1', 'AIRK2', 'ARK-2', 'ARK2', 'AURKB', 'Aik2', 'AurB', 'Aurora 1', 'Aurora B Kinase', 'Aurora B Kinases', 'Aurora Kinase B', 'Aurora Kinases B', 'Aurora Related Kinase 2', 'Aurora kinase B', 'Aurora- and IPL1-like midbody-associated protein 1', 'Aurora-Related Kinase 2', 'Aurora-related kinase 2', 'Aurora/IPL1-related kinase 2', 'B Kinase, Aurora', 'IPL1', 'Kinase, Aurora B', 'PPP1R48', 'STK-1', 'STK1', 'STK12', 'STK5', 'Serine Threonine Protein Kinase 12', 'Serine-Threonine Protein Kinase 12', 'Serine/threonine-protein kinase 12', 'Serine/threonine-protein kinase 5', 'Serine/threonine-protein kinase aurora-B', 'aurora kinase B', 'aurora- and Ipl1-like midbody-associated protein 1 homolog (rat)', 'aurora-1', 'aurora-B', 'protein phosphatase 1, regulatory subunit 48', 'Aurora B'], 'definition': None, 'syn_in_text': 'Aurora B', 'syn_in_stmt': 'AURKB'}}
bachmanjohn@gmail.com	Fri, 24 Jul 2020 21:03:05 GMT		5907	34278505926108194		DB REST API	-2989610743262262247	negative_result	In contrast, PKCalpha and the mitogen activated protein kinase ERK2 did not phosphorylate TERT (data not shown), in accordance with the lack of pharmacological inhibition of ERK1/2 or PKC to significantly alter telomerase activity in HUVEC.	MAPK1 phosphorylates TERT.	{'HGNC:6871': {'name': 'MAPK1', 'synonyms': ['ERK', 'ERK-2', 'ERK2', 'ERT1', 'Extracellular Signal Regulated Kinase 2', 'Extracellular Signal-Regulated Kinase 2', 'Extracellular signal-regulated kinase 2', 'MAP Kinase 2', 'MAP Kinase, p42', 'MAP kinase 1', 'MAP kinase 2', 'MAP kinase isoform p42', 'MAPK 1', 'MAPK 2', 'MAPK1', 'MAPK1 Mitogen Activated Protein Kinase', 'MAPK1 Mitogen-Activated Protein Kinase', 'MAPK2', 'MAPK2 Mitogen Activated Protein Kinase', 'MAPK2 Mitogen-Activated Protein Kinase', 'Mitogen Activated Protein Kinase 1', 'Mitogen Activated Protein Kinase 2', 'Mitogen-Activated Protein Kinase 1', 'Mitogen-Activated Protein Kinase 2', 'Mitogen-activated protein kinase 1', 'Mitogen-activated protein kinase 2', 'PRKM1', 'PRKM2', 'mitogen-activated protein kinase 1', 'p41mapk', 'p42', 'p42 MAP Kinase', 'p42 MAPK', 'p42(Mapk)', 'p42(Mapk) Kinase', 'p42(Mitogen-Activated Protein Kinase)', 'p42-MAPK', 'PKCα and the mitogen-activated protein kinase ERK2'], 'definition': None, 'syn_in_text': 'ERK2', 'syn_in_stmt': 'MAPK1'}, 'HGNC:11730': {'name': 'TERT', 'synonyms': ['EST2', 'HEST2', 'Reverse Transcriptase, Telomerase', 'TCS1', 'TERT', 'TP2', 'TRT', 'Telomerase', 'Telomerase Reverse Transcriptase', 'Telomerase catalytic subunit', 'Telomerase reverse transcriptase', 'Telomerase-associated protein 2', 'Transcriptase, Telomerase Reverse', 'hEST2', 'hTERT', 'telomerase', 'telomerase reverse transcriptase'], 'definition': None, 'syn_in_text': 'TERT', 'syn_in_stmt': 'TERT'}}
bachmanjohn@gmail.com	Mon, 16 Dec 2019 16:45:11 GMT		653	-33584033074123684		bioexp_paper_reach	2813169539777170890	negative_result	Of note, neither monomeric p19-VHL nor HMW VHL interacted with RalBP1-RBD under any of the conditions tested.	VHL binds RALBP1.	{'HGNC:12687': {'name': 'VHL', 'synonyms': ['Protein G7', 'VHL', 'VHL1', 'pVHL', 'von Hippel-Lindau disease tumor suppressor', 'von Hippel-Lindau tumor suppressor', 'p19-VHL'], 'definition': None, 'syn_in_text': 'VHL', 'syn_in_stmt': 'VHL'}, 'HGNC:9841': {'name': 'RALBP1', 'synonyms': ['76 kDa Ral-interacting protein', 'DNP-SG ATPase', 'Dinitrophenyl S-glutathione ATPase', 'RALBP1', 'RIP', 'RIP1', 'RLIP', 'RLIP1', 'RLIP76', 'Ral-interacting protein 1', 'RalA-binding protein 1', 'RalBP1', 'ralA binding protein 1'], 'definition': None, 'syn_in_text': 'RALBP1', 'syn_in_stmt': 'RALBP1'}}
ben.gyori@gmail.com	Thu, 21 May 2020 17:27:26 GMT		3583	28601712862817277		EMMAA	5590193952515718674	negative_result	While it is unlikely that viruses cause all of these diseases , identifying causative agents in even a modest number of disorders will have profound implications for understanding , diagnosis , and treatment of these conditions .	Viruses activates Disease.	{'MESH:D014780': {'name': 'Viruses', 'synonyms': ['Virus', 'Viruses', '.2The viruses'], 'definition': None, 'syn_in_text': 'Viruses', 'syn_in_stmt': 'Viruses'}, 'MESH:D004194': {'name': 'Disease', 'synonyms': ['Disease', 'Diseases', 'Homo sapiens disease', 'condition', 'disease', 'disease or disorder', 'disease or disorder, non-neoplastic', 'diseases', 'diseases and disorders', 'disorder', 'disorders', 'human disease', 'medical condition', 'other disease'], 'definition': None, 'syn_in_text': 'Diseases', 'syn_in_stmt': 'Disease'}}
rphair@integrativebioinformatics.com	Mon, 15 Jun 2020 23:24:49 GMT		5258	33886067145566501		DB REST API	4162965904546401729	negative_result	reported that TGF-beta, but not IFN-gamma, induces phosphorylation of IDO1 ITIM domains, which then recruit and activate SHP-1 and SHP-2 phosphatases.	IFNG leads to the phosphorylation of IDO1.	{'HGNC:5438': {'name': 'IFNG', 'synonyms': ['IFN-gamma', 'IFN-γ', 'IFNG', 'IFNgamma', 'IFNγ', 'Immune Interferon', 'Immune interferon', 'Interferon Type II', 'Interferon gamma', 'Interferon, Immune', 'Interferon, Type II', 'Interferon, gamma', 'Interferon-gamma', 'Type II Interferon', 'gamma-Interferon', 'interferon gamma'], 'definition': None, 'syn_in_text': 'IFN-gamma', 'syn_in_stmt': 'IFNG'}, 'HGNC:6059': {'name': 'IDO1', 'synonyms': ['IDO', 'IDO-1', 'IDO1', 'INDO', 'Indoleamine 2,3-dioxygenase 1', 'Indoleamine-pyrrole 2,3-dioxygenase', 'indoleamine 2,3-dioxygenase 1'], 'definition': None, 'syn_in_text': 'IDO1', 'syn_in_stmt': 'IDO1'}}
ben.gyori@gmail.com	Thu, 03 Dec 2020 20:17:24 GMT		9207	8135842803616978		bioexp_biogrid	1934160128879877963	negative_result	As shown in xref , HIF-1α and N-Myc do not form a physical interaction.	HIF1A binds MYCN.	{'HGNC:4910': {'name': 'HIF1A', 'synonyms': ['ARNT-interacting protein', 'BHLHE78', 'Basic-helix-loop-helix-PAS protein MOP1', 'Class E basic helix-loop-helix protein 78', 'HIF-1-alpha', 'HIF-1alpha', 'HIF-1alpha protein', 'HIF-1α', 'HIF-1α protein', 'HIF1', 'HIF1-alpha', 'HIF1A', 'HIF1alpha', 'HIF1alpha protein', 'HIF1α', 'HIF1α protein', 'Hypoxia-inducible factor 1-alpha', 'MOP1', 'Member of PAS protein 1', 'PAS domain-containing protein 8', 'PASD8', 'bHLHe78', 'hypoxia inducible factor 1 subunit alpha'], 'definition': None, 'syn_in_text': 'HIF-1α', 'syn_in_stmt': 'HIF1A'}, 'HGNC:7559': {'name': 'MYCN', 'synonyms': ['BHLHE37', 'BHLHE37 Protein', 'Class E Basic Helix Loop Helix Protein 37', 'Class E Basic Helix-Loop-Helix Protein 37', 'Class E basic helix-loop-helix protein 37', 'MYCN', 'MYCN Protein', 'MYCN proto-oncogene, bHLH transcription factor', 'MYCNOT', 'N Myc Protein', 'N Myc Proto Oncogene Protein', 'N-Myc', 'N-Myc Protein', 'N-Myc Proto-Oncogene Protein', 'N-myc', 'N-myc proto-oncogene protein', 'NMYC', 'NMYC Protein', 'Proto-Oncogene Protein, N-Myc', 'bHLHe37'], 'definition': None, 'syn_in_text': 'N-Myc', 'syn_in_stmt': 'MYCN'}}
ben.gyori@gmail.com	Fri, 08 Nov 2019 22:20:49 GMT		322	-24565028232699238		DB REST API	8523297364125196033	negative_result	The voltage gated sodium channel family is comprised of ten members : SCN1A (Nav1.1), SCN2A (Nav1.2; SCN2A1 in mouse), SCN3A (Nav1.3), SCN4A (Nav1.4), SCN8A (Nav1.6), and SCN9A (Nav1.7) are blocked by tetrodotoxin, whereas SCN5A (Nav1.5), SCN7A (Nax), SCN10A (Nav1.8), and SCN11A (Nav1.9) are not blocked by tetrodotoxin [XREF_BIBR, XREF_BIBR, XREF_BIBR].	Tetrodotoxin inhibits SCN11A.	{'CHEBI:CHEBI:9506': {'name': 'tetrodotoxin', 'synonyms': ['(1R,5R,6R,7R,9S,11R,12R,13S,14S)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1(7,11).0(1,6)]tetradecane-5,9,12,13,14-pentol', 'BJT 1', 'Babylonia japonica toxin 1', 'Fugu Toxin', 'TTX', 'Tarichatoxin', 'Tetradotoxin', 'Tetrodotoxin', 'Toxin, Fugu', 'fugu poison', 'maculotoxin', 'octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10aH-[1,3]dioxocino[6,5-d]pyrimidine-4,7,10,11,12-pentol', 'spheroidine', 'tarichatoxin', 'tetrodontoxin', 'tetrodotoxin', 'tetrodotoxine'], 'definition': None, 'syn_in_text': 'Tetrodotoxin', 'syn_in_stmt': 'Tetrodotoxin'}, 'HGNC:10583': {'name': 'SCN11A', 'synonyms': ['NaN', 'Nav1.9', 'PN5', 'Peripheral nerve sodium channel 5', 'SCN11A', 'SCN12A', 'SNS-2', 'SNS2', 'Sensory neuron sodium channel 2', 'Sodium channel protein type 11 subunit alpha', 'Sodium channel protein type XI subunit alpha', 'Voltage-gated sodium channel subunit alpha Nav1.9', 'hNaN', 'sodium voltage-gated channel alpha subunit 11'], 'definition': None, 'syn_in_text': 'SCN11A', 'syn_in_stmt': 'SCN11A'}}
ben.gyori@gmail.com	Sun, 22 Nov 2020 03:23:50 GMT		8858	-24279950499658802		EMMAA	824745270549433856	negative_result	Furthermore, HER2 was undetectable in c-Cbl immunoprecipitates, confirming that c-Cbl does not interact with EGFR-HER2 heterodimers.	CBL binds EGFR and ERBB2.	{'HGNC:1541': {'name': 'CBL', 'synonyms': ['CBL', 'CBL E3 Ubiquitin Protein Ligase', 'CBL2', 'Casitas B-lineage lymphoma proto-oncogene', 'Cbl', 'Cbl proto-oncogene', 'E3 ubiquitin-protein ligase CBL', 'Proto Oncogene Protein c cbl', 'Proto Oncogene Proteins c cbl', 'Proto-Oncogene Protein c-cbl', 'Proto-Oncogene Protein, c-cbl', 'Proto-Oncogene Protein, cbl', 'Proto-Oncogene Proteins c-cbl', 'Proto-oncogene c-Cbl', 'RING Finger Protein 55', 'RING finger protein 55', 'RING-type E3 ubiquitin transferase CBL', 'RNF55', 'RNF55 Protein', 'Signal transduction protein CBL', 'c cbl Proto Oncogene Protein', 'c-Cbl', 'c-Cbl protein', 'c-cbl Protein', 'c-cbl Proto-Oncogene Protein', 'c-cbl, Proto-Oncogene Protein', 'c-cbl, Proto-Oncogene Proteins', 'cbl Proto Oncogene Protein', 'cbl Proto-Oncogene Protein', 'oncogene CBL2', 'wild type c-Cbl'], 'definition': None, 'syn_in_text': 'c-Cbl', 'syn_in_stmt': 'CBL'}, 'HGNC:3236': {'name': 'EGFR', 'synonyms': ['EGF receptor', 'EGFR', 'EGFRvIII', 'ERBB', 'ERBB1', 'ERRP', 'Epidermal growth factor receptor', 'HER1', 'Proto-oncogene c-ErbB-1', 'Receptor tyrosine-protein kinase erbB-1', 'epidermal growth factor receptor', 'epidermal growth factor receptor VIII', 'erb-b2 receptor tyrosine kinase 1', 'erythroblastic leukemia viral (v-erb-b) oncogene homolog (avian)'], 'definition': None, 'syn_in_text': 'EGFR', 'syn_in_stmt': 'EGFR'}, 'HGNC:3430': {'name': 'ERBB2', 'synonyms': ['Antigens, CD340', 'CD antigen CD340', 'CD340', 'CD340 Antigen', 'CD340 Antigens', 'ERBB2', 'Erb b2 Receptor Tyrosine Kinases', 'Erb-b2 Receptor Tyrosine Kinases', 'ErbB-2 Receptor', 'ErbB2', 'HER 2 Proto Oncogene Protein', 'HER-2', 'HER-2 Proto-Oncogene Protein', 'HER2', 'HER2 receptor', 'MLN 19', 'MLN-19', 'MLN19', 'Metastatic Lymph Node Gene 19 Protein', 'Metastatic lymph node gene 19 protein', 'NEU', 'NGL', 'Neu Receptor', 'Oncogene Protein HER 2', 'Oncogene Protein HER-2', 'Proto Oncogene Protein HER 2', 'Proto Oncogene Proteins c erbB 2', 'Proto-Oncogene Protein HER-2', 'Proto-Oncogene Protein p185(neu)', 'Proto-Oncogene Protein, HER-2', 'Proto-Oncogene Protein, erbB-2', 'Proto-Oncogene Protein, neu', 'Proto-Oncogene Proteins c-erbB-2', 'Proto-oncogene Neu', 'Proto-oncogene Protein Neu', 'Proto-oncogene c-ErbB-2', 'Receptor tyrosine-protein kinase erbB-2', 'Receptor, ErbB-2', 'Receptor, Neu', 'Receptors, erbB-2', 'Tyrosine Kinase type Cell Surface Receptor HER2', 'Tyrosine Kinase-type Cell Surface Receptor HER2', 'Tyrosine kinase-type cell surface receptor HER2', 'c erbB 2 Protein', 'c-ERB-2', 'c-ERB2', 'c-erbB-2 Protein', 'erb-b2 receptor tyrosine kinase 2', 'erbB 2 Proto Oncogene Protein', 'erbB 2 Receptor Protein Tyrosine Kinase', 'erbB-2 Proto-Oncogene Protein', 'erbB-2 Receptor Protein-Tyrosine Kinase', 'erbB-2 Receptors', 'human epidermal growth factor receptor 2', 'metastatic lymph node gene 19', 'neu Proto Oncogene Protein', 'neu Proto-Oncogene Protein', 'neuro/glioblastoma derived oncogene homolog', 'p185(c-neu)', 'p185(erbB2)', 'p185erbB2', 'p185erbB2 Protein'], 'definition': None, 'syn_in_text': 'HER2', 'syn_in_stmt': 'ERBB2'}}
imke.ditters@gmail.com	Sun, 10 Apr 2022 09:16:50 GMT		13002	-18522364038485772	{'belief': 1, 'id': '56f0ff76-0b8a-4f9b-9357-e02602f59e6c', 'matches_hash': '-18522364038485772', 'obj': {'db_refs': {'FPLX': 'mTORC1', 'GO': 'GO:0031931', 'MESH': 'D000076222', 'NCIT': 'C96314', 'TEXT': 'mTORC1'}, 'name': 'mTORC1'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '12363', 'MESH': 'D000077005', 'TEXT': 'TSC2', 'UP': 'P49815'}, 'name': 'TSC2'}, 'type': 'Activation'}	CoGEx	6951124780064280506	negative_result	AKT activates mTORC1 through the inhibitory phosphorylation of the tuberous sclerosis complex 2 (TSC2 T1426); AMPK mediated phosphorylation of TSC2 S1387 leads to its activation and suppression of mTORC1 (Inoki etal, 2003; Huang & Manning, 2008; Sengupta etal, 2010).	TSC2 activates mTORC1.	{'HGNC:12363': {'name': 'TSC2', 'synonyms': ['LAM', 'PPP1R160', 'TSC complex subunit 2', 'TSC2', 'TSC4', 'Tuberin', 'Tuberous Sclerosis 2 Protein', 'Tuberous Sclerosis Complex 2 Protein', 'Tuberous sclerosis 2 protein', 'protein phosphatase 1, regulatory subunit 160', 'tuberin'], 'definition': None, 'syn_in_text': 'TSC2', 'syn_in_stmt': 'TSC2'}, 'FPLX:mTORC1': {'name': 'mTORC1', 'synonyms': ['Complex, mTORC1', 'Mechanistic Target of Rapamycin Complex 1', 'TOR Complex 1', 'TORC1', 'Target of Rapamycin Complex 1', 'mTORC1', 'mTORC1 Complex'], 'definition': None, 'syn_in_text': 'mTORC1', 'syn_in_stmt': 'mTORC1'}}
bachmanjohn@gmail.com	Tue, 08 Dec 2020 23:02:17 GMT		9892	19688475051662742		bioexp_psp	2992278842630331197	negative_result	Akt1, but not Akt2, phosphorylates EMSY at Ser209, relieving EMSY mediated ISG repression.	AKT2 phosphorylates EMSY on S209.	{'HGNC:392': {'name': 'AKT2', 'synonyms': ['AKT serine/threonine kinase 2', 'AKT2', 'Akt2', 'PKB beta', 'PKBβ', 'Protein kinase Akt-2', 'Protein kinase B beta', 'RAC protein kinase beta', 'RAC-PK-beta', 'RAC-beta serine/threonine-protein kinase'], 'definition': None, 'syn_in_text': 'AKT2', 'syn_in_stmt': 'AKT2'}, 'HGNC:18071': {'name': 'EMSY', 'synonyms': ['BRCA2-interacting transcriptional repressor EMSY', 'C11orf30', 'EMSY', 'EMSY transcriptional repressor, BRCA2 interacting'], 'definition': None, 'syn_in_text': 'EMSY', 'syn_in_stmt': 'EMSY'}}
ben.gyori@gmail.com	Thu, 29 May 2025 02:12:11 GMT	{'annotations': {'agents': {'raw_text': ['Lats1', 'Cdc25B']}, 'content_source': 'pmc_oa', 'found_by': 'Phosphorylation_syntax_1a_verb', 'prior_uuids': ['043a3d8d-a18d-40eb-bbdb-bed84d280043']}, 'epistemics': {'direct': True, 'section_type': None}, 'pmid': '26530630', 'source_api': 'reach', 'source_hash': 7100862127896289000, 'text': 'Notably, Lats1 did not phosphorylate Cdc25B.', 'text_refs': {'DOI': '10.1038/SREP16173', 'DOI_ID': 'SREP16173', 'DOI_NS': 1038, 'PMCID': 'PMC4632022', 'PMCID_NUM': 4632022, 'PMID': '26530630', 'PMID_NUM': 26530630, 'READER': 'REACH', 'RID': 10100019296490, 'SOURCE': 'pmc_oa', 'TCID': 19296490, 'TRID': 17599890}}	16969	-19463426697817341	{'belief': 1, 'enz': {'db_refs': {'HGNC': '6514', 'TEXT': 'Lats1', 'UP': 'O95835'}, 'name': 'LATS1'}, 'id': '71a5a0ae-1549-4b82-8c6b-c69b6e4ec358', 'matches_hash': '-19463426697817341', 'sub': {'db_refs': {'HGNC': '1726', 'TEXT': 'Cdc25B', 'UP': 'P30305'}, 'name': 'CDC25B'}, 'type': 'Phosphorylation'}	DB REST API	7100862127896289374	negative_result	Notably, Lats1 did not phosphorylate Cdc25B.	LATS1 phosphorylates CDC25B.	{'HGNC:6514': {'name': 'LATS1', 'synonyms': ['LATS1', 'Large tumor suppressor homolog 1', 'Serine/threonine-protein kinase LATS1', 'WARTS', 'WARTS protein kinase', 'h-warts', 'large tumor suppressor kinase 1', 'Lats1'], 'definition': None, 'syn_in_text': 'LATS1', 'syn_in_stmt': 'LATS1'}, 'HGNC:1726': {'name': 'CDC25B', 'synonyms': ['CDC25 homolog B (S. pombe)', 'CDC25B', 'CDC25HU2', 'Dual specificity phosphatase Cdc25B', 'M-phase inducer phosphatase 2', 'cell division cycle 25B', 'Cdc25B'], 'definition': None, 'syn_in_text': 'CDC25B', 'syn_in_stmt': 'CDC25B'}}
ben.gyori@gmail.com	Thu, 17 Sep 2020 15:18:01 GMT		6369	16238026961313820		DB REST API	8523297364125196033	negative_result	The voltage gated sodium channel family is comprised of ten members : SCN1A (Nav1.1), SCN2A (Nav1.2; SCN2A1 in mouse), SCN3A (Nav1.3), SCN4A (Nav1.4), SCN8A (Nav1.6), and SCN9A (Nav1.7) are blocked by tetrodotoxin, whereas SCN5A (Nav1.5), SCN7A (Nax), SCN10A (Nav1.8), and SCN11A (Nav1.9) are not blocked by tetrodotoxin [XREF_BIBR, XREF_BIBR, XREF_BIBR].	Tetrodotoxin inhibits SCN10A.	{'CHEBI:CHEBI:9506': {'name': 'tetrodotoxin', 'synonyms': ['(1R,5R,6R,7R,9S,11R,12R,13S,14S)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1(7,11).0(1,6)]tetradecane-5,9,12,13,14-pentol', 'BJT 1', 'Babylonia japonica toxin 1', 'Fugu Toxin', 'TTX', 'Tarichatoxin', 'Tetradotoxin', 'Tetrodotoxin', 'Toxin, Fugu', 'fugu poison', 'maculotoxin', 'octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10aH-[1,3]dioxocino[6,5-d]pyrimidine-4,7,10,11,12-pentol', 'spheroidine', 'tarichatoxin', 'tetrodontoxin', 'tetrodotoxin', 'tetrodotoxine'], 'definition': None, 'syn_in_text': 'Tetrodotoxin', 'syn_in_stmt': 'Tetrodotoxin'}, 'HGNC:10582': {'name': 'SCN10A', 'synonyms': ['NAV1.8 Voltage Gated Sodium Channel', 'NAV1.8 Voltage-Gated Sodium Channel', 'Nav1.8', 'PN3', 'PN3 Sodium Channel', 'Peripheral Nerve Sodium Channel 3', 'Peripheral nerve sodium channel 3', 'SCN10A', 'SNS', 'Sodium Channel Protein Type X', 'Sodium Channel, PN3', 'Sodium channel protein type 10 subunit alpha', 'Sodium channel protein type X subunit alpha', 'Type 10 Voltage Gated Sodium Channel', 'Type 10 Voltage-Gated Sodium Channel', 'Voltage Gated Sodium Channel Type 10', 'Voltage-Gated Sodium Channel Type 10', 'Voltage-gated sodium channel subunit alpha Nav1.8', 'hPN3', 'peripheral nerve sodium channel 3', 'sensory neuron sodium channel', 'sodium voltage-gated channel alpha subunit 10'], 'definition': None, 'syn_in_text': 'SCN10A', 'syn_in_stmt': 'SCN10A'}}
bachmanjohn@gmail.com	Fri, 23 Oct 2020 12:54:24 GMT		7001	6256110371831554		bioexp_refinements	6100736649314484509	negative_result	However, insulin given to the cells does not activate STAT6 indicating that also other signaling molecules are involved in the regulation of collagen synthesis.	INS activates STAT6.	{'HGNC:6081': {'name': 'INS', 'synonyms': ['IDDM1', 'IDDM2', 'INS', 'Insulin', 'PI', 'insulin'], 'definition': None, 'syn_in_text': 'Insulin', 'syn_in_stmt': 'INS'}, 'HGNC:11368': {'name': 'STAT6', 'synonyms': ['D12S1644', 'IL-4 Stat', 'IL-4-STAT', 'STAT6', 'STAT6 Protein', 'STAT6 Transcription Factor', 'Signal Transducer and Activator of Transcription 6', 'Signal transducer and activator of transcription 6', 'Transcription Factor, STAT6', 'signal transducer and activator of transcription 6'], 'definition': None, 'syn_in_text': 'STAT6', 'syn_in_stmt': 'STAT6'}}
eirini.tsirvouli@ntnu.no	Wed, 19 Jan 2022 11:31:43 GMT	{'annotations': {'agents': {'raw_text': ['C/EBPbeta', 'AP-1']}, 'content_source': 'elsevier', 'found_by': 'Positive_activation_syntax_3_noun', 'prior_uuids': ['40c11b04-eff8-4c9c-88a4-89ad61fa4820']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '15683721', 'source_api': 'reach', 'source_hash': -3278011751777383400, 'text': 'Again TNF-alpha alone induced the activation of AP-1 and NF-kappaB but not C/EBPbeta and GAS.', 'text_refs': {'DOI': '10.1016/J.FREERADBIOMED.2004.11.021', 'DOI_ID': 'J.FREERADBIOMED.2004.11.021', 'DOI_NS': 1016, 'PMID': '15683721', 'PMID_NUM': 15683721, 'READER': 'REACH', 'RID': 10100022517748, 'SOURCE': 'elsevier', 'TCID': 22517748, 'TRID': 9231073}}	12715	-31464898902439886	{'belief': 1, 'id': '13dfcdd2-02c8-4e1b-a67d-b8f4601fa97d', 'matches_hash': '-31464898902439886', 'obj': {'db_refs': {'FPLX': 'AP1', 'MESH': 'D018808', 'NCIT': 'C17450', 'TEXT': 'AP-1'}, 'name': 'AP1'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '1834', 'MESH': 'D022782', 'TEXT': 'C/EBPbeta', 'UP': 'P17676'}, 'name': 'CEBPB'}, 'type': 'Activation'}	DB REST API	-3278011751777383387	negative_result	Again TNF-alpha alone induced the activation of AP-1 and NF-kappaB but not C/EBPbeta and GAS.	CEBPB activates AP1.	{'HGNC:1834': {'name': 'CEBPB', 'synonyms': ['2, C-EBP-Related Protein', '40-C-EBP Protein', 'AGP EBP Transcription Factor', 'AGP-EBP Transcription Factor', 'C EBP Related Protein 2', 'C EBP beta', 'C EBPbeta', 'C-EBP beta', 'C-EBP-Related Protein 2', 'C-EBP-beta', 'C-EBPbeta', 'C/EBP beta', 'C/EBP-beta', 'C/EBPbeta', 'C/EBPβ', 'CCAAT Enhancer Binding Protein beta', 'CCAAT enhancer binding protein beta', 'CCAAT-Enhancer-Binding Protein-beta', 'CCAAT/enhancer-binding protein beta', 'CEBPB', 'CRP2', 'CRP2 Protein', 'IL 6 Dependent DNA Binding Protein', 'IL-6 DBP', 'IL-6-Dependent DNA Binding Protein', 'IL6DBP', 'Interleukin 6 Nuclear Factor', 'Interleukin-6 Nuclear Factor', 'LAP', 'LAP Transcription Factor', 'LIP', 'Liver activator protein', 'Liver-enriched inhibitory protein', 'NF-IL6', 'NFIL6', 'Nuclear Factor, Interleukin-6', 'Nuclear factor NF-IL6', 'Protein-beta, CCAAT-Enhancer-Binding', 'TCF-5', 'TCF5', 'Transcription Factor, AGP-EBP', 'Transcription Factor, LAP', 'Transcription factor 5', 'interleukin 6-dependent DNA-binding protein', 'liver-enriched transcriptional activator protein', 'nuclear factor of interleukin 6'], 'definition': None, 'syn_in_text': 'C/EBPbeta', 'syn_in_stmt': 'CEBPB'}, 'FPLX:AP1': {'name': 'AP1', 'synonyms': ['AP 1 Enhancer Binding Protein', 'AP-1', 'AP-1 Enhancer Binding Protein', 'AP-1 Enhancer-Binding Protein', 'AP1', 'Activator Protein 1', 'Activator Protein-1', 'Enhancer-Binding Protein, AP-1', 'Transcription Factor AP 1', 'Transcription Factor AP-1'], 'definition': None, 'syn_in_text': 'AP-1', 'syn_in_stmt': 'AP1'}}
ben.gyori@gmail.com	Mon, 07 Dec 2020 00:34:06 GMT		9645	-13900092968064535		DB REST API	4197007547053776577	grounding	We present evidence that the key components of the membrane for this interaction are the phosphatidylinositols and we have investigated a specific interaction between AT 1 R-H8 and the phosphatidylinositol phosphate lipids (PIPs – referring collectively to all species).	Phosphatidylinositol binds SLC33A1.	{'CHEBI:CHEBI:28874': {'name': 'phosphatidylinositol', 'synonyms': ['PI', 'PtdIns', 'phosphatidylinositol', 'phosphatidylinositols'], 'definition': None, 'syn_in_text': 'phosphatidylinositol', 'syn_in_stmt': 'phosphatidylinositol'}, 'HGNC:95': {'name': 'SLC33A1', 'synonyms': ['ACATN', 'AT-1', 'AT1', 'Acetyl-CoA transporter 1', 'Acetyl-coenzyme A transporter 1', 'SLC33A1', 'SPG42', 'Solute carrier family 33 member 1', 'solute carrier family 33 member 1', 'AT 1'], 'definition': None, 'syn_in_text': 'AT 1', 'syn_in_stmt': 'SLC33A1'}}
ben.gyori@gmail.com	Tue, 09 Feb 2021 03:13:58 GMT		10789	-5414431635278461		EMMAA	-2775470960477945971	grounding	Can Activation of NRF2 Be a Strategy against COVID-19?	PPP3 activates NFE2L2.	{'FPLX:PPP3': {'name': 'PPP3', 'synonyms': ['CaN', 'Calcineurin', 'PP2B', 'Phosphatase 3, Protein', 'Protein Phosphatase 2B', 'Protein Phosphatase 3', 'Protein Phosphatase-2B', 'calcineurin', 'protein phosphatase 2B', 'PPP3'], 'definition': None, 'syn_in_text': 'CaN', 'syn_in_stmt': 'PPP3'}, 'HGNC:7782': {'name': 'NFE2L2', 'synonyms': ['HEBP1', 'NF E2 Related Factor 2', 'NF-E2-Related Factor 2', 'NF-E2-related factor 2', 'NFE2 like bZIP transcription factor 2', 'NFE2-related factor 2', 'NFE2L2', 'NRF-2', 'NRF2', 'Nfe2l2 Protein', 'Nrf-2', 'Nrf2', 'Nuclear Factor (Erythroid-Derived 2)-Like 2 Protein', 'Nuclear Factor E2 Related Factor 2', 'Nuclear Factor E2-Related Factor 2', 'Nuclear factor erythroid 2-related factor 2', 'Nuclear factor, erythroid derived 2, like 2', 'nrf-2'], 'definition': None, 'syn_in_text': 'NRF2', 'syn_in_stmt': 'NFE2L2'}}
ben.gyori@gmail.com	Tue, 22 Sep 2020 13:22:25 GMT		6450	-19062244090455847		EMMAA	-2086602462252065471	grounding	Vaccines Immunogenicity and Protective Efficacy in Mice and Hamsters of a b-Propiolactone Inactivated Whole Virus SARS-CoV Vaccine.The immunogenicity and efficacy of b-propiolactone (BPL) inactivated whole virion SARS-CoV (WI-SARS) vaccine was evaluated in BALB/c mice and golden Syrian hamsters.	Casp14 inhibits SARS Virus.	{'UP:O89094': {'name': 'Casp14', 'synonyms': ['CASP-14', 'Casp14', 'Caspase-14', 'MICE', 'Mini-ICE', 'mice'], 'definition': None, 'syn_in_text': 'MICE', 'syn_in_stmt': 'Casp14'}, 'MESH:D045473': {'name': 'SARS Virus', 'synonyms': ['Coronavirus, SARS-Associated', 'Coronavirus, SARS-Related', 'Coronavirus, Urbani SARS-Associated', 'HCoV-SARS', 'SARS Associated Coronavirus', 'SARS Related Coronavirus', 'SARS Virus', 'SARS like coronavirus', 'SARS-Associated Coronavirus', 'SARS-Associated Coronavirus, Urbani', 'SARS-CoV-1', 'SARS-Related Coronavirus', 'SARS-like coronavirus', 'SARS-like coronaviruses', 'SARSr-CoV', 'SARSrCoV', 'SARSrCoVs', 'Severe acute respiratory syndrome related coronavirus', 'Severe acute respiratory syndrome-related coronavirus', 'Urbani SARS Associated Coronavirus', 'Urbani SARS-Associated Coronavirus', 'SARS-CoV'], 'definition': None, 'syn_in_text': 'SARS-CoV', 'syn_in_stmt': 'SARS Virus'}}
bachmanjohn@gmail.com	Fri, 10 Jul 2020 15:33:49 GMT		5795	15515879855221292		EMMAA	-6566480272232232431	grounding	Plasma abundance of LMAN2 (or VIP36) was associated with the BMI-GRS (positively) and the eGFR-GRS (inversely).	BCL2A1 binds Glomerular Filtration Rate.	{'HGNC:991': {'name': 'BCL2A1', 'synonyms': ['A1 Bcl-2 homolog', 'ACC-1', 'ACC-2', 'ACC1', 'ACC2', 'BCL2 related protein A1', 'BCL2-related protein A1', 'BCL2A1', 'BCL2L5', 'BFL1', 'Bcl-2-like protein 5', 'Bcl-2-related protein A1', 'Bcl2-L-5', 'GRS', 'HBPA1', 'Hemopoietic-specific early response protein', 'Protein BFL-1', 'Protein GRS'], 'definition': None, 'syn_in_text': 'GRS', 'syn_in_stmt': 'BCL2A1'}, 'MESH:D005919': {'name': 'Glomerular Filtration Rate', 'synonyms': ['Filtration Rate, Glomerular', 'Filtration Rates, Glomerular', 'GFR', 'Glomerular Filtration Rate', 'Glomerular Filtration Rates', 'Rate, Glomerular Filtration', 'Rates, Glomerular Filtration', 'glomerular filtration rate', 'eGFR'], 'definition': None, 'syn_in_text': 'GFR', 'syn_in_stmt': 'Glomerular Filtration Rate'}}
ben.gyori@gmail.com	Mon, 07 Dec 2020 17:56:35 GMT		9814	16942243190029144		DB REST API	-8883074584366316621	grounding	We then applied MDS to examine causal interactions between M1 and CPu.	GS26575 binds CPB2.	{'CHEBI:CHEBI:51079': {'name': 'GS26575', 'synonyms': ['2-methylthio-4-tert-butylamino-6-amino-s-triazine', 'GS26575', 'M1', 'N-tert-butyl-6-(methylsulfanyl)-1,3,5-triazine-2,4-diamine', 'deethylterbutryne'], 'definition': None, 'syn_in_text': 'M1', 'syn_in_stmt': 'GS26575'}, 'HGNC:2300': {'name': 'CPB2', 'synonyms': ['Arginine Carboxypeptidase', 'CPB2', 'CPU', 'Carboxypeptidase B2', 'Carboxypeptidase B2, Plasma', 'Carboxypeptidase R', 'Carboxypeptidase U', 'PCPB', 'Plasma Carboxypeptidase B2', 'Plasma carboxypeptidase B', 'TAFI', 'Thrombin Activatable Fibrinolysis Inhibitor', 'Thrombin-Activatable Fibrinolysis Inhibitor', 'Thrombin-Activatable Fibrinolysis Inhibitor (TAFI)', 'Thrombin-activable fibrinolysis inhibitor', 'carboxypeptidase B2', 'carboxypeptidase R', 'carboxypeptidase U', 'pCPB', 'plasma carboxypeptidase B', 'thrombin-activatable fibrinolysis inhibitor', 'CPu'], 'definition': None, 'syn_in_text': 'CPU', 'syn_in_stmt': 'CPB2'}}
bachmanjohn@gmail.com	Tue, 08 Dec 2020 23:08:16 GMT		9896	11823141560077119		bioexp_psp	5786341366301809586	grounding	Moreover, recombinant ribosomal S6 kinase phosphorylated IRS-1 C-terminal fragment on Ser-1101, which was prevented by mutations of this site or when a kinase-inactive mutant of ribosomal S6 kinase was used.	RPS6KA2 leads to the phosphorylation of IRS1 on S1101.	{'HGNC:10431': {'name': 'RPS6KA2', 'synonyms': ['90 kDa ribosomal protein S6 kinase 2', 'HU-2', 'MAP kinase-activated protein kinase 1c', 'MAPK-activated protein kinase 1c', 'MAPKAP kinase 1c', 'MAPKAPK-1c', 'MAPKAPK1C', 'RPS6KA2', 'RSK-3', 'RSK3', 'Ribosomal S6 kinase 3', 'Ribosomal protein S6 kinase alpha-2', 'S6K-alpha-2', 'p90-RSK 2', 'p90RSK2', 'pp90RSK3', 'ribosomal protein S6 kinase A2', 'ribosomal S6 kinase'], 'definition': None, 'syn_in_text': 'ribosomal S6 kinase', 'syn_in_stmt': 'RPS6KA2'}, 'HGNC:6125': {'name': 'IRS1', 'synonyms': ['HIRS-1', 'IRS-1', 'IRS1', 'Insulin receptor substrate 1', 'insulin receptor substrate 1'], 'definition': None, 'syn_in_text': 'IRS-1', 'syn_in_stmt': 'IRS1'}}
jschaul@ppmlab.net	Fri, 09 Aug 2024 09:20:45 GMT	{'annotations': {'agents': {'raw_text': ['AE', 'PLB']}, 'content_source': 'pmc_oa', 'found_by': 'Positive_activation_syntax_3_noun', 'prior_uuids': ['e17b34ec-63b4-4809-9a25-096c0c50ff63']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '33401611', 'source_api': 'reach', 'source_hash': 563843662952443460, 'text': 'In this research, there were 450 AE signals of PLB under two groupings.', 'text_refs': {'DOI': '10.3390/S21010272', 'DOI_ID': 'S21010272', 'DOI_NS': 3390, 'PII': 'E272', 'PMCID': 'PMC7795722', 'PMCID_NUM': 7795722, 'PMID': '33401611', 'PMID_NUM': 33401611, 'READER': 'REACH', 'RID': 10100058979529, 'SOURCE': 'pmc_oa', 'TCID': 58979529, 'TRID': 32617968}}	14391	28821232613297141	{'belief': 1, 'id': '7c11880b-a06f-4261-be3f-96176917e452', 'matches_hash': '28821232613297141', 'obj': {'db_refs': {'HGNC': '9080', 'TEXT': 'PLB', 'UP': 'P26678'}, 'name': 'PLN'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'IP': 'IPR003020', 'TEXT': 'AE'}, 'name': 'AE'}, 'type': 'Activation'}	DB REST API	563843662952443432	grounding	In this research, there were 450 AE signals of PLB under two groupings.	AE activates PLN.	{'HGNC:9080': {'name': 'PLN', 'synonyms': ['CMD1P', 'Cardiac phospholamban', 'PLB', 'PLN', 'phospholamban'], 'definition': None, 'syn_in_text': 'PLB', 'syn_in_stmt': 'PLN'}}
ben.gyori@gmail.com	Sat, 22 Jan 2022 23:18:44 GMT		12720	23569233870455003	{'belief': 1, 'id': '334eee4c-a71d-443c-94ab-e5a74a8f9ea7', 'matches_hash': '23569233870455003', 'members': [{'db_refs': {'FPLX': 'PDH', 'TEXT': 'PDH'}, 'name': 'PDH'}, {'db_refs': {'HGNC': '8816', 'TEXT': 'PDK', 'UP': 'O15530'}, 'name': 'PDPK1'}], 'type': 'Complex'}	EMMAA	-5402894430845068697	grounding	Our results suggest that PDHK1-PDH phosphorylation is a causative factor of glycolytic phenotypes found in BAP1 mutant UM and propose a therapeutic opportunity for BAP1 mutant UM patients.	PDH binds PDPK1.	{'FPLX:PDH': {'name': 'PDH', 'synonyms': ['PDH', 'pyruvate dehydrogenase (acetyl-transferring)'], 'definition': None, 'syn_in_text': 'PDH', 'syn_in_stmt': 'PDH'}, 'HGNC:8816': {'name': 'PDPK1', 'synonyms': ['3-phosphoinositide dependent protein kinase 1', '3-phosphoinositide-dependent protein kinase 1', 'PDK', 'PDK1', 'PDPK1', 'PkB kinase', 'hPDK1'], 'definition': None, 'syn_in_text': None, 'syn_in_stmt': 'PDPK1'}}
ben.gyori@gmail.com	Tue, 19 Jul 2022 17:06:23 GMT		13480	8955052922241884	{'belief': 1, 'id': '2680bae5-1db9-4bba-8cb6-d0966cb00822', 'matches_hash': '8955052922241884', 'obj': {'db_refs': {'HGNC': '5981', 'MESH': 'D020381', 'TEXT': 'IL-17', 'UP': 'Q16552'}, 'name': 'IL17A'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'PF': 'PF02005', 'TEXT': 'Trm'}, 'name': 'Trm'}, 'type': 'Activation'}	EMMAA	-6605855146358475131	grounding	Corroborating transcriptional profiles, CD8 + CD103 + CD49a - Trm cells produced IL-17 while CD8 + CD103 + CD49a + Trm cells excelled in IFN-gamma production upon stimulation with phorbol 12-myristate 13-acetate and ionomycin (XREF_FIG A-6C).	Trm activates IL17A.	{'HGNC:5981': {'name': 'IL17A', 'synonyms': ['CTLA-8', 'CTLA8', 'Cytotoxic T-lymphocyte-associated antigen 8', 'IL-17', 'IL-17A', 'IL17', 'IL17A', 'Interleukin 17', 'Interleukin-17', 'Interleukin-17A', 'cytotoxic T-lymphocyte-associated protein 8', 'interleukin 17A'], 'definition': None, 'syn_in_text': 'IL-17', 'syn_in_stmt': 'IL17A'}}
ben.gyori@gmail.com	Tue, 03 Nov 2020 15:32:49 GMT		7736	35980181477766081		EMMAA	-1326064565218410488	grounding	The full length and the N-terminal fragment of TIMAP - containing the nuclear localization signal, the PP1c binding motif and the five ANK repeats - interacted with merlin, but the C-terminal fragment of TIMAP was not able to bind the endogenous merlin.	TNF binds NF2.	{'HGNC:11892': {'name': 'TNF', 'synonyms': ['Cachectin', 'Cachectin Tumor Necrosis Factor', 'Cachectin-Tumor Necrosis Factor', 'DIF', 'TNF', 'TNF Superfamily, Member 2', 'TNF superfamily, member 2', 'TNF-a', 'TNF-alpha', 'TNF-α', 'TNFA', 'TNFSF2', 'TNFalpha', 'TNFα', 'Tumor Necrosis Factor', 'Tumor Necrosis Factor Ligand Superfamily Member 2', 'Tumor Necrosis Factor alpha', 'Tumor Necrosis Factor-alpha', 'Tumor necrosis factor', 'Tumor necrosis factor ligand superfamily member 2', 'tumor necrosis factor', 'N-terminal fragment'], 'definition': None, 'syn_in_text': 'N-terminal fragment', 'syn_in_stmt': 'TNF'}, 'HGNC:7773': {'name': 'NF2', 'synonyms': ['ACN', 'BANF', 'Gene Product, NF2', 'Merlin', 'Moesin Ezrin Radixin Like Protein', 'Moesin-Ezrin-Radixin-Like Protein', 'Moesin-ezrin-radixin-like protein', 'NF2', 'NF2 Gene Product', 'NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor', 'Neurofibromatosis 2 Gene Product', 'Neurofibromatosis Type 2 Protein', 'Neurofibromin 2', 'Neurofibromin-2', 'Protein, Schwannomin', 'SCH', 'Schwannomerlin', 'Schwannomin', 'Schwannomin Protein', 'bilateral acoustic neurofibromatosis', 'merlin', 'merlin-1', 'moesin-ezrin-radixin like', 'schwannomin'], 'definition': None, 'syn_in_text': 'Merlin', 'syn_in_stmt': 'NF2'}}
ben.gyori@gmail.com	Wed, 18 Mar 2020 21:17:13 GMT		2205	-20840627924053337		DB REST API	-2151680921234325560	grounding	We hypothesize that Ang II suppresses ACE2 by increasing TNF-alpha converting enzyme (TACE) activity and ACE2 cleavage.	AGT inhibits ACE2.	{'HGNC:333': {'name': 'AGT', 'synonyms': ['AGT', 'Ang II', 'AngII', 'Angiotensinogen (Serpin A8) -angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]', 'SERPINA8', 'alpha-1 antiproteinase, antitrypsin', 'angiotensinogen'], 'definition': None, 'syn_in_text': 'Ang II', 'syn_in_stmt': 'AGT'}, 'HGNC:13557': {'name': 'ACE2', 'synonyms': ['ACE Related Carboxypeptidase', 'ACE-Related Carboxypeptidase', 'ACE-related carboxypeptidase', 'ACE2', 'ACE2 Angiotensin Converting Enzyme Protein 2', 'ACE2 Angiotensin-Converting Enzyme Protein 2', 'ACE2 Enzyme', 'ACE2 Protein', 'ACEH', 'Angiotensin Converting Enzyme 2', 'Angiotensin Converting Enzyme Related Carboxypeptidase', 'Angiotensin-Converting Enzyme 2', 'Angiotensin-Converting Enzyme-Related Carboxypeptidase', 'Angiotensin-converting enzyme 2', 'Angiotensin-converting enzyme homolog', 'Angiotensin-converting enzyme-related carboxypeptidase', 'Carboxypeptidase, ACE-Related', 'Carboxypeptidase, Angiotensin-Converting Enzyme-Related', 'Metalloprotease MPROT15', 'angiotensin converting enzyme 2', 'peptidyl-dipeptidase A'], 'definition': None, 'syn_in_text': 'ACE2', 'syn_in_stmt': 'ACE2'}}
bachmanjohn@gmail.com	Sun, 15 Nov 2020 02:59:05 GMT		8369	19227942594835096		EMMAA	1185808879414708233	grounding	Treatment of En2(-/-) mice with lovastatin, an indirect inhibitor of ERK phosphorylation, markedly reduced ERK phosphorylation in the dentate gyrus, but was unable to rescue learning deficits in MWM-trained mutant mice.	ERK phosphorylates ESR1.	{'FPLX:ERK': {'name': 'ERK', 'synonyms': ['ERK', 'ERK 1/2', 'ERK MAP Kinase', 'ERK MAP Kinases', 'ERK MAPK', 'ERK mitogen-activated protein kinase', 'ERK-1/2', 'ERK1/2', 'ERK1/2 MAPK', 'ERKs', 'Erk', 'Erk1/2', 'Extracellular Signal Regulated Kinase', 'Extracellular Signal Regulated Kinases', 'Extracellular Signal Regulated MAP Kinase', 'Extracellular Signal Regulated MAP Kinases', 'Extracellular Signal-Regulated Kinase', 'Extracellular Signal-Regulated Kinases', 'Extracellular Signal-Regulated MAP Kinase', 'Extracellular Signal-Regulated MAP Kinases', 'Kinase, ERK MAP', 'Kinase, Extracellular Signal-Regulated', 'Kinases, Extracellular Signal-Regulated', 'MAP Kinase, ERK', 'MAP Kinases, Extracellular Signal Regulated', 'MAP Kinases, Extracellular Signal-Regulated', 'Signal-Regulated Kinase, Extracellular', 'extracellular signal-regulated kinase', 'p42 and p38 MAP kinases', 'p42 and p38 MAPK', 'p42 and p38 MAPKs', 'p42 and p44', 'p42 and p44 MAPK', 'p42 and p44MAP kinase', 'p42(mapk) and p44(mapk)', 'p42/44', 'p44 and p42', 'phospho-ERK1/2'], 'definition': None, 'syn_in_text': 'ERK', 'syn_in_stmt': 'ERK'}, 'HGNC:3467': {'name': 'ESR1', 'synonyms': ['E2 receptor alpha', 'ER', 'ER-alpha', 'ERalpha', 'ERα', 'ESR', 'ESR1', 'Era', 'Estradiol receptor', 'Estrogen receptor', 'NR3A1', 'Nuclear receptor subfamily 3 group A member 1', 'estradiol receptor', 'estrogen receptor', 'estrogen receptor 1', 'estrogen receptor alpha', 'nuclear receptor subfamily 3 group A member 1', 'oestrogen receptor alpha'], 'definition': None, 'syn_in_text': 'ER', 'syn_in_stmt': 'ESR1'}}
ben.gyori@gmail.com	Fri, 12 Nov 2021 14:50:32 GMT	{'annotations': {'agents': {'raw_text': ['ES', 'differentiation']}, 'content_source': 'pmc_oa', 'found_by': 'Positive_activation_syntax_5_verb', 'prior_uuids': ['6d04b52f-3b0a-4651-8f80-2d1393547d5f']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '29472610', 'source_api': 'reach', 'source_hash': 7397543295268472000, 'text': 'To obtain a dataset with a larger degree of heterogeneity than observed in ES cells, we prepared a second dataset obtained from serum grown ES cells that we removed from LIF for 3 days to initiate differentiation into embryoid bodies (EBs).', 'text_refs': {'DOI': '10.1038/S41467-018-03149-4', 'DOI_ID': 'S41467-018-03149-4', 'DOI_NS': 1038, 'PMCID': 'PMC5823944', 'PMCID_NUM': 5823944, 'PMID': '29472610', 'PMID_NUM': 29472610, 'READER': 'REACH', 'RID': 10100019595730, 'SOURCE': 'pmc_oa', 'TCID': 19595730, 'TRID': 28409426}}	12508	8781595177610841	{'belief': 1, 'id': '696db9d7-e678-406e-b9db-2aa56ab432de', 'matches_hash': '8781595177610841', 'obj': {'db_refs': {'GO': 'GO:0030154', 'MESH': 'D002454', 'TEXT': 'differentiation'}, 'name': 'cell differentiation'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'CHEBI': 'CHEBI:73509', 'HMDB': 'HMDB0028828', 'PUBCHEM': '6995653', 'TEXT': 'ES'}, 'name': 'Glu-Ser'}, 'type': 'Activation'}	DB REST API	7397543295268471340	grounding	To obtain a dataset with a larger degree of heterogeneity than observed in ES cells, we prepared a second dataset obtained from serum grown ES cells that we removed from LIF for 3 days to initiate differentiation into embryoid bodies (EBs).	Glu-Ser activates cell differentiation.	{'CHEBI:CHEBI:73509': {'name': 'Glu-Ser', 'synonyms': ['Glu-Ser', 'L-Glu-L-Ser', 'L-alpha-glutamyl-L-serine', 'alpha-Glu-Ser', 'alpha-glutamylserine', 'glutamylserine', 'ES'], 'definition': None, 'syn_in_text': 'ES', 'syn_in_stmt': 'Glu-Ser'}, 'GO:GO:0030154': {'name': 'cell differentiation', 'synonyms': ['Cell Differentiation', 'Cell Differentiations', 'Differentiation, Cell', 'Differentiations, Cell', 'cell differentiation', 'differentiation'], 'definition': None, 'syn_in_text': 'differentiation', 'syn_in_stmt': 'differentiation'}}
ben.gyori@gmail.com	Tue, 11 Jan 2022 01:26:42 GMT		12628	-14921250903138871	{'belief': 1, 'id': '4e470be5-f38e-4909-bb56-bf9ff44a0242', 'matches_hash': '-14921250903138871', 'members': [{'db_refs': {'CAS': '7782-44-7', 'CHEBI': 'CHEBI:15379', 'CHEMBL': 'CHEMBL1234886', 'DRUGBANK': 'DB09140', 'HMDB': 'HMDB0001377', 'MESH': 'D010100', 'PUBCHEM': '977', 'TEXT': 'oxygen'}, 'name': 'dioxygen'}, {'db_refs': {'HGNC': '2665', 'MESH': 'D018958', 'TEXT': 'Cr', 'UP': 'P08174'}, 'name': 'CD55'}], 'type': 'Complex'}	panacea_enzyme	343426303220368932	grounding	The binding of Cr (III) to oxygen ligands is usually strong and often involves coordinate covalent bonds [XREF_BIBR].	Dioxygen binds CD55.	{'CHEBI:CHEBI:15379': {'name': 'dioxygen', 'synonyms': ['Disauerstoff', 'E 948', 'E-948', 'E948', 'O2', 'OXYGEN MOLECULE', 'Oxygen', 'Oxygen 16', 'Oxygen-16', '[OO]', 'dioxygen', 'dioxygene', 'molecular oxygen', 'oxygen'], 'definition': None, 'syn_in_text': 'Oxygen', 'syn_in_stmt': 'dioxygen'}, 'HGNC:2665': {'name': 'CD55', 'synonyms': ['Antigens, CD55', 'CD antigen CD55', 'CD55', 'CD55 Antigen', 'CD55 Antigens', 'CD55 molecule (Cromer blood group)', 'CR', 'CROM', 'Complement Decay Accelerating Factor', 'Complement Decay-Accelerating Factor', 'Complement decay-accelerating factor', 'DAF', 'Decay Accelerating Factor', 'Decay-Accelerating Factor', 'Decay-Accelerating Factor, Complement', 'TC', 'Cr'], 'definition': None, 'syn_in_text': 'CR', 'syn_in_stmt': 'CD55'}}
ben.gyori@gmail.com	Wed, 30 Sep 2020 14:48:06 GMT		6470	33863195157696346		EMMAA	3035207134033090360	grounding	In anin vitro study, chloroquine 500 mg twice daily and hydroxychloroquine 400–600 mgtwice a day loading followed by 400–600 mg blocked SARS-CoV-2 cell entry invitro.	Magnesium atom inhibits severe acute respiratory syndrome coronavirus 2.	{'CHEBI:CHEBI:25107': {'name': 'magnesium atom', 'synonyms': ['12Mg', 'Magnesium', 'Mg', 'magnesio', 'magnesium', 'magnesium atom', 'mg'], 'definition': None, 'syn_in_text': 'Mg', 'syn_in_stmt': 'Magnesium'}, 'MESH:C000656484': {'name': 'severe acute respiratory syndrome coronavirus 2', 'synonyms': ['severe acute respiratory syndrome coronavirus 2', 'SARS-CoV-2'], 'definition': None, 'syn_in_text': 'SARS-CoV-2', 'syn_in_stmt': 'severe acute respiratory syndrome coronavirus 2'}}
samuel_bunga@hms.harvard.edu	Mon, 19 Oct 2020 01:17:21 GMT		6696	5098023124561818		DB REST API	-8078364234735386371	grounding	These results indicated that removal of the Da-N1 region specifically prevented the functional interaction between Da and NICD that is necessary for NTC-bHLH A transcriptional synergy, but did not block the ability to activate via A sites when dimerized with Achaete.	2'-deoxyadenosine binds NOTCH1.	"{'CHEBI:CHEBI:17256': {'name': ""2'-deoxyadenosine"", 'synonyms': ['(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol', ""2'-Deoxyadenosine"", ""2'-deoxyadenosine"", '2-deoxyadenosine', '5-(6-AMINO-PURIN-9-YL)-2-HYDROXYMETHYL-TETRAHYDRO-FURAN-3-OL', '9-(2-Deoxy-beta-D-erythro-pentofuranosyl)adenine', '9-(2-deoxy-beta-D-ribofuranosyl)-9H-purin-6-amine', 'Deoxyadenosine', 'adenine deoxyribonucleoside', 'adenyldeoxyriboside', 'dA', 'deoxyadenosine', 'Da'], 'definition': None, 'syn_in_text': 'dA', 'syn_in_stmt': ""2'-Deoxyadenosine""}, 'HGNC:7881': {'name': 'NOTCH1', 'synonyms': ['NOTCH1', 'Neurogenic locus notch homolog protein 1', 'Notch 1', 'Notch1', 'TAN1', 'Translocation-associated notch protein TAN-1', 'hN1', 'notch receptor 1', 'NICD'], 'definition': None, 'syn_in_text': 'NICD', 'syn_in_stmt': 'NOTCH1'}}"
imke.ditters@gmail.com	Tue, 12 Apr 2022 15:40:50 GMT	{'annotations': {'agents': {'raw_text': [None, 'GAA']}, 'content_source': 'pmc_oa', 'prior_uuids': ['84342681-ee3a-4a53-9218-d6d7753ac54b']}, 'pmid': '27625674', 'source_api': 'sparser', 'source_hash': -9208977352073191000, 'text': 'The X. strumarium STLs belong to the class of C7–C8 lactones, and thus their biosynthesis requires a C8-hydroxylation of GAA.', 'text_refs': {'DOI': '10.3389/FPLS.2016.01317', 'DOI_ID': 'FPLS.2016.01317', 'DOI_NS': 3389, 'PMCID': 'PMC5003840', 'PMCID_NUM': 5003840, 'PMID': '27625674', 'PMID_NUM': 27625674, 'READER': 'SPARSER', 'RID': 20300018919567, 'SOURCE': 'pmc_oa', 'TCID': 18919567, 'TRID': 13235492}}	13110	-13092604026977350	{'belief': 1, 'id': '290fa7f4-8fa3-417a-b287-e3f6281ab42c', 'matches_hash': '-13092604026977350', 'position': '8', 'residue': 'C', 'sub': {'db_refs': {'HGNC': '4065', 'TEXT': 'GAA', 'UP': 'P10253'}, 'name': 'GAA'}, 'type': 'Hydroxylation'}	DB REST API	-9208977352073191138	grounding	The X. strumarium STLs belong to the class of C7–C8 lactones, and thus their biosynthesis requires a C8-hydroxylation of GAA.	GAA is hydroxylated on C8.	{'HGNC:4065': {'name': 'GAA', 'synonyms': ['Acid maltase', 'Aglucosidase alfa', 'GAA', 'Lysosomal alpha-glucosidase', 'Pompe disease', 'alpha glucosidase', 'glycogen storage disease type II'], 'definition': None, 'syn_in_text': 'GAA', 'syn_in_stmt': 'GAA'}}
ben.gyori@gmail.com	Wed, 23 Feb 2022 03:04:30 GMT	{'annotations': {'agents': {'raw_text': ['Htt', 'Drp1']}, 'content_source': 'manuscripts', 'found_by': 'binding1b', 'prior_uuids': ['6da19998-d8cb-4714-a5cd-e63ddceb1e70']}, 'context': {'cell_type': {'db_refs': {'CL': 'CL:0000540'}, 'name': None}, 'location': {'db_refs': {'GO': 'GO:0005739'}, 'name': None}, 'species': {'db_refs': {'TAXONOMY': '10090'}, 'name': None}, 'type': 'bio'}, 'epistemics': {'direct': True, 'section_type': None}, 'pmid': '23159640', 'source_api': 'reach', 'source_hash': -6404927141768070000, 'text': 'For instance, Htt aggregates directly bind to Drp1 in vitro and stimulate its GTPase activity [XREF_BIBR] (XREF_FIG).', 'text_refs': {'DOI': '10.1016/J.TCB.2012.10.006', 'DOI_ID': 'J.TCB.2012.10.006', 'DOI_NS': 1016, 'MANUSCRIPT_ID': 'NIHMS422789', 'PII': 'S0962-8924(12)00184-5', 'PMCID': 'PMC3558617', 'PMCID_NUM': 3558617, 'PMID': '23159640', 'PMID_NUM': 23159640, 'READER': 'REACH', 'RID': 10100019733536, 'SOURCE': 'manuscripts', 'TCID': 19733536, 'TRID': 21510572}}	12743	15912772398809293	{'belief': 1, 'id': '929d804c-0c2b-49a4-9724-b425f070b53c', 'matches_hash': '15912772398809293', 'members': [{'db_refs': {'HGNC': '11050', 'TEXT': 'Htt', 'UP': 'P31645'}, 'name': 'SLC6A4'}, {'db_refs': {'HGNC': '2973', 'TEXT': 'Drp1', 'UP': 'O00429'}, 'name': 'DNM1L'}], 'type': 'Complex'}	DB REST API	-6404927141768069825	grounding	For instance, Htt aggregates directly bind to Drp1 in vitro and stimulate its GTPase activity [XREF_BIBR] (XREF_FIG).	SLC6A4 binds DNM1L.	{'HGNC:11050': {'name': 'SLC6A4', 'synonyms': ['5-HTT', '5HT transporter', '5HTT', 'HTT', 'OCD1', 'SERT', 'SERT1', 'SLC6A4', 'Sodium-dependent serotonin transporter', 'Solute carrier family 6 member 4', 'serotonin transporter 1', 'solute carrier family 6 member 4', 'Htt'], 'definition': None, 'syn_in_text': 'HTT', 'syn_in_stmt': 'SLC6A4'}, 'HGNC:2973': {'name': 'DNM1L', 'synonyms': ['DLP1', 'DNM1L', 'DRP1', 'DVLP', 'DYMPLE', 'Dnm1p/Vps1p-like protein', 'Drp-1', 'Dymple', 'Dynamin family member proline-rich carboxyl-terminal domain less', 'Dynamin-1-like protein', 'Dynamin-like protein', 'Dynamin-like protein 4', 'Dynamin-like protein IV', 'Dynamin-related protein 1', 'HDYNIV', 'HdynIV', 'VPS1', 'dynamin 1 like', 'Drp1'], 'definition': None, 'syn_in_text': 'DRP1', 'syn_in_stmt': 'DNM1L'}}
bachmanjohn@gmail.com	Wed, 28 Oct 2020 21:22:42 GMT		7214	23240444658731553		EMMAA	-3252416735206684605	grounding	The suspected pathophysiology for topographic GCL-IPL atrophy corresponding to an optic tract lesion is retrograde degeneration.	PHLDA2 binds GCA.	{'HGNC:12385': {'name': 'PHLDA2', 'synonyms': ['BWR1C', 'Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein', 'HLDA2', 'IPL', 'Imprinted in placenta and liver protein', 'PHLDA2', 'Pleckstrin homology-like domain family A member 2', 'TSSC3', 'Tumor-suppressing STF cDNA 3 protein', 'Tumor-suppressing subchromosomal transferable fragment candidate gene 3 protein', 'p17-BWR1C', 'p17-Beckwith-Wiedemann region 1 C', 'pleckstrin homology like domain family A member 2'], 'definition': None, 'syn_in_text': 'IPL', 'syn_in_stmt': 'PHLDA2'}, 'HGNC:15990': {'name': 'GCA', 'synonyms': ['GCA', 'GCL', 'Grancalcin', 'grancalcin'], 'definition': None, 'syn_in_text': 'GCL', 'syn_in_stmt': 'GCA'}}
bachmanjohn@gmail.com	Mon, 20 Jul 2020 18:08:14 GMT		5837	-27513640483681390		DB REST API	1899152107290405357	grounding	A Phase I/II trial and subsequent long-term follow-up and extension study in patients with high- or intermediate-risk primary or post-PV/ET MF showed that the majority of evaluable patients treated with momelotinib had durable spleen response and symptom improvement, with a median treatment duration of 507 days.	Momelotinib activates Met-Phe.	{'CHEBI:CHEBI:91407': {'name': 'momelotinib', 'synonyms': ['CYT 11387', 'CYT 387', 'CYT-11387', 'CYT-387', 'CYT387', 'GS-0387', 'LM-1149', 'Momelotinib', 'N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide', 'N-(cyanomethyl)-4-(2-((4-(morpholin-4-yl)phenyl)amino)pyrimidin-4-yl)benzamide', 'N-(cyanomethyl)-4-(2-((4-morpholinophenyl)-amino)pyrimidin-4-yl)benzamide', 'N-(cyanomethyl)-4-[2-[4-(4-morpholinyl)anilino]-4-pyrimidinyl]benzamide', 'N-(cyanomethyl)-4-{2-[4-(morpholin-4-yl)anilino]pyrimidin-4-yl}benzamide', 'momelotinib', 'momelotinibum'], 'definition': None, 'syn_in_text': 'Momelotinib', 'syn_in_stmt': 'Momelotinib'}, 'CHEBI:CHEBI:74708': {'name': 'Met-Phe', 'synonyms': ['L-Met-L-Phe', 'L-methionyl-L-phenylalanine', 'Met-Phe', 'Methionyl-Phenylalanine', 'methionylphenylalanine', 'MF'], 'definition': None, 'syn_in_text': 'MF', 'syn_in_stmt': 'Met-Phe'}}
ben.gyori@gmail.com	Mon, 07 Dec 2020 16:38:17 GMT		9754	-18146793694875622		DB REST API	4909629576698090556	grounding	The LHb is directly targeted by the MHb, but the MHb is not targeted by the LHb.	MHb activates LHB.	{'HGNC:6584': {'name': 'LHB', 'synonyms': ['CGB4', 'LH-B', 'LHB', 'LSH-B', 'LSH-beta', 'Luteinizing hormone subunit beta', 'Lutropin beta chain', 'Lutropin subunit beta', 'hLHB', 'interstitial cell stimulating hormone, beta chain', 'luteinizing hormone subunit beta', 'lutropin, beta chain', 'LHb'], 'definition': None, 'syn_in_text': 'LHB', 'syn_in_stmt': 'LHB'}}
samuel_bunga@hms.harvard.edu	Sun, 18 Oct 2020 23:50:53 GMT		6691	1461848325129603		DB REST API	-990710972968590380	grounding	Similar to female predominance of arrhythmia in the acquired setting, which suggests interactions between hERG, dofetilide and oestradiol, the female predominance of inherited arrhythmia linked the the G604S mutations, suggests that oestradiol may differentially interact with the mutant hERG channel compared to WT.	17beta-estradiol binds KCNH2.	{'CHEBI:CHEBI:16469': {'name': '17beta-estradiol', 'synonyms': ['(17beta)-estra-1,3,5(10)-triene-3,17-diol', '17 beta Estradiol', '17 beta Oestradiol', '17 beta-Estradiol', '17 beta-Oestradiol', '17beta oestradiol', '17beta-estra-1,3,5(10)-triene-3,17-diol', '17beta-estradiol', '17beta-oestradiol', '17β-Estradiol', '17β-estradiol', 'ESTRADIOL', 'Estradiol', 'Estradiol 17 beta', 'Estradiol 17beta', 'Estradiol Anhydrous', 'Estradiol-17 beta', 'Estradiol-17beta', 'Oestradiol', 'beta-Estradiol', 'cis-estradiol', 'estra-1,3,5(10)-triene-3,17beta-diol', 'oestradiol'], 'definition': None, 'syn_in_text': 'Oestradiol', 'syn_in_stmt': '17beta-estradiol'}, 'HGNC:6251': {'name': 'KCNH2', 'synonyms': ['ERG', 'ERG-1', 'ERG1', 'Eag homolog', 'Eag-related protein 1', 'Ether-a-go-go-related gene potassium channel 1', 'Ether-a-go-go-related protein 1', 'H-ERG', 'HERG', 'KCNH2', 'Kv11.1', 'LQT2', 'Potassium voltage-gated channel subfamily H member 2', 'Voltage-gated potassium channel subunit Kv11.1', 'erg1', 'hERG-1', 'hERG1', 'human ether-a-go-go-related gene', 'long QT syndrome type 2', 'potassium voltage-gated channel subfamily H member 2', 'hERG'], 'definition': None, 'syn_in_text': 'HERG', 'syn_in_stmt': 'KCNH2'}}
ben.gyori@gmail.com	Mon, 07 Dec 2020 03:06:40 GMT		9682	22524995011032162		DB REST API	7741785396532122600	grounding	XREF_BIBR, XREF_BIBR DUSP1 is a ubiquitin ligase for ERK, and inhibition of DUSP1 by HES1 activates ERK.	GATD3B inhibits DUSP1.	{'UP:P30042': {'name': 'GATD3B', 'synonyms': ['GATD3B', 'Hes1'], 'definition': None, 'syn_in_text': 'Hes1', 'syn_in_stmt': 'GATD3B'}, 'HGNC:3064': {'name': 'DUSP1', 'synonyms': ['3CH134 Phosphatase', 'CL100', 'CL100 Phosphatase', 'DUSP1', 'Dual Specificity Phosphatase 1', 'Dual specificity protein phosphatase 1', 'Dual specificity protein phosphatase hVH1', 'Externally Regulated Phosphatase (ERP)', 'HVH1', 'MAP Phosphatase 1', 'MAP Phosphatase-1', 'MAP kinase phosphatase 1', 'MAPK Phosphatase', 'MKP 1 Phosphatase', 'MKP-1', 'MKP-1 Phosphatase', 'MKP1', 'Map Kinase Phosphatase 1', 'Mitogen Activated Protein Phosphatase 1', 'Mitogen-Activated Protein Phosphatase-1', 'Mitogen-activated protein kinase phosphatase 1', 'PTPN10', 'Phosphatase, 3CH134', 'Phosphatase, CL100', 'Phosphatase, MAPK', 'Phosphatase, MKP-1', 'Phosphatase-1, MAP', 'Phosphatase-1, Mitogen-Activated Protein', 'Protein Phosphatase-1, Mitogen-Activated', 'Protein-tyrosine phosphatase CL100', 'VH1', 'dual specificity phosphatase 1'], 'definition': None, 'syn_in_text': 'DUSP1', 'syn_in_stmt': 'DUSP1'}}
ben.gyori@gmail.com	Mon, 01 Jun 2020 16:19:59 GMT		4204	8026134538940567		bioexp_paper_trips	1920093159822621249	grounding	Conversely, Sir2 binds and deacetylates Foxo1 at residues acetylated by cAMP-response element-binding protein-binding protein.	SIRT1 deacetylates acetylated FOXO1.	{'HGNC:14929': {'name': 'SIRT1', 'synonyms': ['NAD-dependent protein deacetylase sirtuin-1', 'NAD-dependent protein deacylase sirtuin-1', 'Regulatory protein SIR2 homolog 1', 'SIR2-like protein 1', 'SIR2L1', 'SIRT1', 'Silent Mating Type Information Regulation 2 Homolog 1', 'Sirt1', 'Sirtuin 1', 'hSIR2', 'hSIRT1', 'sirtuin 1', 'SIR2'], 'definition': None, 'syn_in_text': 'SIR2', 'syn_in_stmt': 'SIRT1'}, 'HGNC:3819': {'name': 'FOXO1', 'synonyms': ['FKH1', 'FKHR', 'FOXO1', 'FOXO1 Protein', 'FOXO1A', 'Forkhead Box Protein O1', 'Forkhead box protein O1', 'Forkhead box protein O1A', 'Forkhead in Rhabdomyosarcoma Protein', 'Forkhead in rhabdomyosarcoma', 'FoxO1', 'forkhead box O1'], 'definition': None, 'syn_in_text': 'FOXO1', 'syn_in_stmt': 'FOXO1'}}
ben.gyori@gmail.com	Mon, 07 Dec 2020 16:38:55 GMT		9759	25098800411903503		DB REST API	-541780996159676403	grounding	Given that positive RPE is associated with the phasic firing of dopamine neurons, and that negative RPE is associated with LHb signaling, one would expect that the acquisition or maintenance phase of drug self-administration (a positive RPE paradigm) might be independent of LHb control.	RPE binds LHB.	{'HGNC:10293': {'name': 'RPE', 'synonyms': ['D-erythrose 4-phosphate isomerase', 'D-ribulose-5-phosphate-3-epimerase', 'RPE', 'Ribulose-5-phosphate-3-epimerase', 'Ribulose-phosphate 3-epimerase', 'pentose-5-phosphate 3-epimerase', 'ribulose-5-phosphate-3-epimerase', 'ribulosephosphate 3-epimerase'], 'definition': None, 'syn_in_text': 'RPE', 'syn_in_stmt': 'RPE'}, 'HGNC:6584': {'name': 'LHB', 'synonyms': ['CGB4', 'LH-B', 'LHB', 'LSH-B', 'LSH-beta', 'Luteinizing hormone subunit beta', 'Lutropin beta chain', 'Lutropin subunit beta', 'hLHB', 'interstitial cell stimulating hormone, beta chain', 'luteinizing hormone subunit beta', 'lutropin, beta chain', 'LHb'], 'definition': None, 'syn_in_text': 'LHB', 'syn_in_stmt': 'LHB'}}
ben.gyori@gmail.com	Wed, 26 Aug 2020 20:42:41 GMT		6196	14168923607278519		EMMAA	8267356379241603786	grounding	A4-6: LC-CD133 + ; arrows: tumor formation.	PROM1 binds LC.	{'HGNC:9454': {'name': 'PROM1', 'synonyms': ['AC133', 'AC133 1 Antigen', 'AC133 Antigen', 'AC133 antigen', 'AC133-1 Antigen', 'Antigen AC133', 'Antigen, AC133', 'Antigen, AC133-1', 'Antigen, CD133', 'CD antigen CD133', 'CD133', 'CD133 Antigen', 'CORD12', 'Fudenine', 'MCDR2', 'PROM1', 'PROML1', 'Prominin', 'Prominin 1', 'Prominin Like PROML1', 'Prominin-1', 'Prominin-Like PROML1', 'Prominin-like protein 1', 'RP41', 'Retinitis pigmentosa 41, Cone-rod dystrophy 12', 'STGD4', 'prominin 1'], 'definition': None, 'syn_in_text': 'CD133', 'syn_in_stmt': 'PROM1'}, 'UP:P07238': {'name': 'LC', 'synonyms': ['LC'], 'definition': None, 'syn_in_text': 'LC', 'syn_in_stmt': 'LC'}}
cthoyt@gmail.com	Mon, 09 May 2022 07:50:12 GMT		13408	-22272652848418757	{'belief': 1, 'enz': {'db_refs': {'HGNC': '9299', 'TEXT': 'protein phosphatase', 'UP': 'P67775'}, 'name': 'PPP2CA'}, 'id': 'c9c93831-a996-4210-98b4-504844913efc', 'matches_hash': '-22272652848418757', 'sub': {'db_refs': {'HGNC': '6893', 'TEXT': 'tau', 'UP': 'P10636'}, 'name': 'MAPT'}, 'type': 'Dephosphorylation'}	CoGEx	5147508080972540304	grounding	Dephosphorylation of AD p-tau by protein phosphatases restores its biological activity to promote assembly of MTs and inhibits its self-polymerization into PHF/straight filaments (SF; Wang et al., xref ; Wang J. Z. et al., xref ).	PPP2CA dephosphorylates MAPT.	{'HGNC:9299': {'name': 'PPP2CA', 'synonyms': ['PP2A-alpha', 'PP2AC', 'PP2Calpha', 'PPP2CA', 'RP-C', 'Replication protein C', 'Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform', 'protein phosphatase 2 catalytic subunit alpha', 'protein phosphatase 2A catalytic subunit, alpha isoform', 'protein phosphatase'], 'definition': None, 'syn_in_text': 'protein phosphatase', 'syn_in_stmt': 'PPP2CA'}, 'HGNC:6893': {'name': 'MAPT', 'synonyms': ['DDPAC', 'FLJ31424', 'FTDP-17', 'G protein beta1/gamma2 subunit-interacting factor 1', 'MAPT', 'MAPTL', 'MGC138549', 'MSTD', 'MTBT1', 'MTBT2', 'Microtubule-associated protein tau', 'Neurofibrillary tangle protein', 'PHF-tau', 'PPND', 'PPP1R103', 'Paired helical filament-tau', 'TAU', 'Tau-PHF6', 'Tau-derived paired helical filament hexapeptide', 'microtubule associated protein tau', 'microtubule-associated protein tau, isoform 4', 'protein phosphatase 1, regulatory subunit 103', 'tau', 'tau-40'], 'definition': None, 'syn_in_text': 'TAU', 'syn_in_stmt': 'MAPT'}}
bachmanjohn@gmail.com	Wed, 03 Jun 2020 21:49:16 GMT		4650	-32361625074942195		bioexp_paper_multi	-3149526873583397697	grounding	SEB and IFN-gamma activated NF-kappaB, which was inhibited by PDTC.	SETBP1 activates NFkappaB.	{'HGNC:15573': {'name': 'SETBP1', 'synonyms': ['KIAA0437', 'SEB', 'SET binding protein 1', 'SET-binding protein', 'SETBP1'], 'definition': None, 'syn_in_text': 'SEB', 'syn_in_stmt': 'SETBP1'}, 'FPLX:NFkappaB': {'name': 'NFkappaB', 'synonyms': ['Enhancer-Binding Protein, Immunoglobulin', 'Factor NF-kB, Transcription', 'Factor-Kappab, Nuclear', 'Immunoglobulin Enhancer Binding Protein', 'Immunoglobulin Enhancer-Binding Protein', 'NF kB', 'NF kappaB', 'NF-kB', 'NF-kB, Transcription Factor', 'NF-kappa B', 'NF-kappaB', 'NF-kappaB Factors', 'NF-kappaB TFs', 'NF-kappaB complexes', 'NF-kappaB dimers', 'NF-kappaB factors', 'NF-kappaB genes', 'NF-kappaB subunits', 'NF-kappaBs', 'NF-kappabeta', 'NF-κB', 'NF-κB Factors', 'NF-κB TFs', 'NF-κB complexes', 'NF-κB dimers', 'NF-κB factors', 'NF-κB genes', 'NF-κB subunits', 'NF-κBs', 'NF-κβ', 'NFkappaB', 'NFkappaB complexes', 'NFκB', 'NFκB complexes', 'Nuclear Factor Kappab', 'Nuclear Factor kappa B', 'Nuclear Factor-Kappab', 'Transcription Factor NF kB', 'Transcription Factor NF-kB', 'kappa B Enhancer Binding Protein'], 'definition': None, 'syn_in_text': 'NF-kappaB', 'syn_in_stmt': 'NFkappaB'}}
ben.gyori@gmail.com	Fri, 31 Jul 2020 16:23:23 GMT		5951	-26447717723955009		EMMAA	-2565989265446019754	grounding	Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide.Background Current geographic spread of documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections shows heterogeneity.	RENBP activates severe acute respiratory syndrome coronavirus 2.	{'HGNC:9959': {'name': 'RENBP', 'synonyms': ['AGE', 'GlcNAc 2-epimerase', 'N-acetyl-D-glucosamine 2-epimerase', 'N-acyl-D-glucosamine 2-epimerase', 'N-acylglucosamine 2-epimerase', 'RBP', 'RENBP', 'RNBP', 'Renin-binding protein', 'RnBP', 'renin binding protein', 'age'], 'definition': None, 'syn_in_text': 'AGE', 'syn_in_stmt': 'RENBP'}, 'MESH:C000656484': {'name': 'severe acute respiratory syndrome coronavirus 2', 'synonyms': ['severe acute respiratory syndrome coronavirus 2', 'SARS-CoV-2'], 'definition': None, 'syn_in_text': 'SARS-CoV-2', 'syn_in_stmt': 'severe acute respiratory syndrome coronavirus 2'}}
ben.gyori@gmail.com	Fri, 24 Apr 2020 13:02:19 GMT		2579	-6274726655298991		EMMAA	4222870257619274374	grounding	In 2017, AZ was found by a Chinese team at Wuhan to block VEGF and PAK1 dependent angiogenesis with IC 50 below 5muM [XREF_BIBR], strongly suggesting that AZ is also a PAK1-blocker.	Alizarin inhibits PAK1.	{'CHEBI:CHEBI:16866': {'name': 'alizarin', 'synonyms': ['1,2-Anthraquinonediol', '1,2-Dihydroxyanthraquinone', '1,2-dihydroxy-9,10-anthraquinone', '1,2-dihydroxyanthra-9,10-quinone', '1,2-dihydroxyanthracene-9,10-dione', '1,2-dihydroxyanthraquinone', 'Alizarin', 'Alizarin B', 'Alizarin Red', 'Az', 'C.I. 58000', 'Dihydroxy-9,10-anthracenedione', 'Dihydroxyanthraquinone', 'Mordant Red 11', 'Turkey Red', 'alizarin', 'alizarin red', 'alizarine', 'pigment red 83', 'AZ'], 'definition': None, 'syn_in_text': 'Az', 'syn_in_stmt': 'Alizarin'}, 'HGNC:8590': {'name': 'PAK1', 'synonyms': ['Alpha-PAK', 'PAK-1', 'PAK1', 'Pak1', 'STE20 homolog, yeast', 'Serine/threonine-protein kinase PAK 1', 'p21 (RAC1) activated kinase 1', 'p21-activated kinase 1', 'p65-PAK'], 'definition': None, 'syn_in_text': 'PAK1', 'syn_in_stmt': 'PAK1'}}
ben.gyori@gmail.com	Thu, 07 May 2020 21:31:58 GMT		2749	-24016126938688335		DB REST API	6130355471157667718	grounding	BB (10 microM) inhibited the beta-secretase activity of cathepsin B and reduced generation of two beta-secretase cleavage products of APP, Abeta and soluble APPbeta, via PI3K dependent pathway [XREF_BIBR].	Bandrowski's base inhibits CTSB.	"{'CHEBI:CHEBI:53109': {'name': ""Bandrowski's base"", 'synonyms': ['3,6-bis((p-aminophenyl)imino)-1,4-cyclohexadiene-1,4-diamine', '3,6-bis[(p-aminophenyl)imino ]cyclohexa-1,4-diene-1,4-diamine', 'BB', ""Bandrowski's base"", ""N',N'-bis(4-aminophenyl)-2,5-diamino-1,4-quinonediimine"", ""N(1),N(1)'-(2,5-diaminocyclohexa-2,5-diene-1,4-diylidene)dibenzene-1,4-diamine""], 'definition': None, 'syn_in_text': 'BB', 'syn_in_stmt': ""Bandrowski's base""}, 'HGNC:2527': {'name': 'CTSB', 'synonyms': ['APP secretase', 'APPS', 'CPSB', 'CTSB', 'Cathepsin B', 'Cathepsin B1', 'cathepsin B'], 'definition': None, 'syn_in_text': 'Cathepsin B', 'syn_in_stmt': 'CTSB'}}"
ben.gyori@gmail.com	Mon, 07 Dec 2020 17:26:45 GMT		9785	-29751891884909334		DB REST API	2589160841316049659	grounding	These pioneering findings have since then been confirmed by others, and include an association between CD like inflammation and AS, ReA, or PsA.	PHB2 binds KLK3.	{'HGNC:30306': {'name': 'PHB2', 'synonyms': ['B cell receptor associated protein 37', 'B-cell receptor-associated protein BAP37', 'BAP', 'BCAP37', 'Bap37', 'D-prohibitin', 'PHB2', 'Prohibitin-2', 'REA', 'Repressor of estrogen receptor activity', 'p22', 'prohibitin 2', 'ReA'], 'definition': None, 'syn_in_text': 'REA', 'syn_in_stmt': 'PHB2'}, 'HGNC:6364': {'name': 'KLK3', 'synonyms': ['APS', 'Gamma-seminoprotein', 'KLK3', 'Kallikrein hK3', 'Kallikrein, hK3', 'Kallikrein-3', 'P-30 antigen', 'PSA', 'Prostate Specific Antigen', 'Prostate-Specific Antigen', 'Prostate-specific antigen', 'Semenogelase', 'Seminin', 'gamma Seminoprotein', 'gamma-Seminoprotein', 'hK3 Kallikrein', 'kallikrein related peptidase 3', 'prostate specific antigen', 'PsA'], 'definition': None, 'syn_in_text': 'PSA', 'syn_in_stmt': 'KLK3'}}
petar.v.todorov@gmail.com	Fri, 16 Oct 2020 17:40:46 GMT		6681	-12060195149585352		DB REST API	7590495611334769288	grounding	Because EPR line broadening is induced by the spin interaction of O 2 with a nitroxide and is linearly proportional to tissue pO 2, the spectral-spatial images of linewidth can be transformed into linewidth images and pO 2 images.	GTF2I activates EREG.	{'HGNC:4659': {'name': 'GTF2I', 'synonyms': ['BAP-135', 'BAP135', 'BTK-associated protein 135', 'BTKAP1', 'Bruton tyrosine kinase-associated protein 135', 'DIWS', 'GTF2I', 'GTFII-I', 'General transcription factor II-I', 'IB291', 'SPIN', 'SRF-Phox1-interacting protein', 'TFII-I', 'WBSCR6', 'Williams-Beuren syndrome chromosomal region 6 protein', 'general transcription factor IIi', 'spin'], 'definition': None, 'syn_in_text': 'SPIN', 'syn_in_stmt': 'GTF2I'}, 'HGNC:3443': {'name': 'EREG', 'synonyms': ['ER', 'EREG', 'Epiregulin', 'Proepiregulin', 'epiregulin', 'EPR'], 'definition': None, 'syn_in_text': 'EPR', 'syn_in_stmt': 'EREG'}}
bachmanjohn@gmail.com	Wed, 21 Oct 2020 18:26:32 GMT		6745	-6557992872189025		EMMAA	-6091013983710529589	grounding	At 100 μM, P3 suppressed N protein expression in most cells.	SLC10A3 decreases the amount of N.	{'HGNC:22979': {'name': 'SLC10A3', 'synonyms': ['DXS253E', 'P3', 'P3 protein', 'SLC10A3', 'Solute carrier family 10 member 3', 'solute carrier family 10 member 3'], 'definition': None, 'syn_in_text': 'P3', 'syn_in_stmt': 'SLC10A3'}, 'UP:P0C797': {'name': 'N', 'synonyms': ['N', 'N protein'], 'definition': None, 'syn_in_text': 'N', 'syn_in_stmt': 'N'}}
rphair@integrativebioinformatics.com	Mon, 23 Aug 2021 22:40:14 GMT		12400	21086535350815750	{'belief': 1, 'enz': {'db_refs': {'HGNC': '3942', 'MESH': 'D058570', 'TEXT': 'mTOR', 'UP': 'P42345'}, 'name': 'MTOR'}, 'id': 'c3c07d89-ec45-4ea8-85a6-d02d9528311b', 'matches_hash': '21086535350815750', 'sub': {'db_refs': {'HGNC': '33904', 'TEXT': 'CAD', 'UP': 'A6NK06'}, 'name': 'ACOD1'}, 'type': 'Phosphorylation'}	DB REST API	-4477108299875941950	grounding	Taken the available evidence together, it is reasonable to conclude that CAD associated with mTORC1 through mLST8 is not phosphorylated directly by mTOR, but is recognized by S6 kinase that is activated by mTORC1.	MTOR phosphorylates ACOD1.	{'HGNC:3942': {'name': 'MTOR', 'synonyms': ['FK506 binding protein 12-rapamycin associated protein 2', 'FK506-binding protein 12-rapamycin complex-associated protein 1', 'FKBP-rapamycin associated protein', 'FKBP12-rapamycin complex-associated protein', 'FKBP12-rapamycin complex-associated protein 1', 'FLJ44809', 'FRAP', 'FRAP1', 'FRAP2', 'MTOR', 'Mammalian target of rapamycin', 'Mechanistic target of rapamycin', 'RAFT1', 'RAPT1', 'Rapamycin and FKBP12 target 1', 'Rapamycin target protein 1', 'Serine/threonine-protein kinase mTOR', 'dJ576K7.1 (FK506 binding protein 12-rapamycin associated protein 1)', 'mTOR', 'mammalian target of rapamycin', 'mechanistic target of rapamycin kinase', 'rapamycin and FKBP12 target 1', 'rapamycin associated protein FRAP2', 'rapamycin target protein'], 'definition': None, 'syn_in_text': 'MTOR', 'syn_in_stmt': 'MTOR'}, 'HGNC:33904': {'name': 'ACOD1', 'synonyms': ['ACOD1', 'Aconitate decarboxylase', 'Aconitate decarboxylase 1', 'CAD', 'Cis-aconitate decarboxylase', 'Cis-aconitic acid decarboxylase', 'IRG1', 'Immune-responsive gene 1 protein', 'aconitate decarboxylase', 'aconitate decarboxylase 1'], 'definition': None, 'syn_in_text': 'CAD', 'syn_in_stmt': 'ACOD1'}}
bachmanjohn@gmail.com	Tue, 08 Dec 2020 22:52:27 GMT		9887	23710501981094096		bioexp_psp	-8195619901627632141	grounding	In contrast, tyrosine phosphorylation of IRS1 (p-IRS1 (Y612)) was induced by ZSTK474 treatment in St-4 cells.	ST3GAL4 leads to the phosphorylation of IRS1 on Y612.	{'HGNC:10864': {'name': 'ST3GAL4', 'synonyms': ['Alpha 2,3-ST 4', 'Alpha 2,3-sialyltransferase IV', 'Beta-galactoside alpha-2,3-sialyltransferase 4', 'CGS23', 'CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4', 'FLJ11867', 'Gal-NAc6S', 'Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase', 'Gal-beta-1,4-GlcNAc-alpha-2,3-sialyltransferase', 'N-acetyllactosaminide alpha-2,3-sialyltransferase', 'NANTA3', 'SAT-3', 'SAT3', 'SIAT4', 'SIAT4-C', 'SIAT4C', 'ST-4', 'ST3 beta-galactoside alpha-2,3-sialyltransferase 4', 'ST3GAL4', 'ST3Gal IV', 'ST3GalA.2', 'ST3GalIV', 'STZ', 'Sialyltransferase 4C', 'St-4'], 'definition': None, 'syn_in_text': 'ST-4', 'syn_in_stmt': 'ST3GAL4'}, 'HGNC:6125': {'name': 'IRS1', 'synonyms': ['HIRS-1', 'IRS-1', 'IRS1', 'Insulin receptor substrate 1', 'insulin receptor substrate 1'], 'definition': None, 'syn_in_text': 'IRS1', 'syn_in_stmt': 'IRS1'}}
bachmanjohn@gmail.com	Wed, 10 Jun 2020 14:46:20 GMT		4726	22346067790205888		bioexp_paper_multi	-5696095477195122616	grounding	In chronic myelogenous leukemia CD34(+) cells, however, >80% of p27(Kip) is located in the cytoplasm even in fibronectin-adherent cells, and significantly less p27(Kip) is bound to cdk2.	CIB1 binds CDK2.	{'HGNC:16920': {'name': 'CIB1', 'synonyms': ['CIB', 'CIB1', 'CIBP', 'Calcium and integrin-binding protein 1', 'Calcium- and integrin-binding protein', 'Calmyrin', 'DNA-PKcs-interacting protein', 'KIP', 'Kinase-interacting protein', 'PRKDCIP', 'SIP2-28', 'SNK-interacting protein 2-28', 'calcium and integrin binding 1', 'calmyrin', 'Kip'], 'definition': None, 'syn_in_text': 'KIP', 'syn_in_stmt': 'CIB1'}, 'HGNC:1771': {'name': 'CDK2', 'synonyms': ['CDK2', 'CDK2 Protein', 'CDKN2', 'Cdc2 Related Protein Kinase', 'Cdc2-Related Protein Kinase', 'Cdk2', 'Cdk2 Protein Kinase', 'Cell division protein kinase 2', 'Cyclin Dependent Kinase 2', 'Cyclin-Dependent Kinase 2', 'Cyclin-dependent kinase 2', 'cdk2', 'cyclin dependent kinase 2', 'p33 protein kinase', 'p33cdk2 Kinase'], 'definition': None, 'syn_in_text': 'CDK2', 'syn_in_stmt': 'CDK2'}}
imke.ditters@gmail.com	Tue, 12 Apr 2022 15:17:58 GMT	{'annotations': {'agents': {'raw_text': [None, 'GAA']}, 'content_source': 'pmc_oa', 'prior_uuids': ['b115f744-3504-4dbf-a276-2ffa0faf2557']}, 'pmid': '33540766', 'source_api': 'sparser', 'source_hash': 8082564247071569000, 'text': 'Whether the location of the creatine transporter and enzyme responsible for the methylation of GAA to creatine facilitates maternal/fetal transfer of creatine or supports the metabolic activities intrinsic to syncytiotrophoblast function, or both, is yet to be fully determined.', 'text_refs': {'DOI': '10.3390/NU13020490', 'DOI_ID': 'NU13020490', 'DOI_NS': 3390, 'PII': '490', 'PMCID': 'PMC7912953', 'PMCID_NUM': 7912953, 'PMID': '33540766', 'PMID_NUM': 33540766, 'READER': 'SPARSER', 'RID': 20500059470348, 'SOURCE': 'pmc_oa', 'TCID': 59470348, 'TRID': 32764570}}	13085	-6390183319411711	{'belief': 1, 'id': '2becb743-d822-4d21-8f2c-3d307beec100', 'matches_hash': '-6390183319411711', 'sub': {'db_refs': {'HGNC': '4065', 'TEXT': 'GAA', 'UP': 'P10253'}, 'name': 'GAA'}, 'type': 'Methylation'}	DB REST API	8082564247071569059	grounding	Whether the location of the creatine transporter and enzyme responsible for the methylation of GAA to creatine facilitates maternal/fetal transfer of creatine or supports the metabolic activities intrinsic to syncytiotrophoblast function, or both, is yet to be fully determined.	GAA is methylated.	{'HGNC:4065': {'name': 'GAA', 'synonyms': ['Acid maltase', 'Aglucosidase alfa', 'GAA', 'Lysosomal alpha-glucosidase', 'Pompe disease', 'alpha glucosidase', 'glycogen storage disease type II'], 'definition': None, 'syn_in_text': 'GAA', 'syn_in_stmt': 'GAA'}}
bachmanjohn@gmail.com	Tue, 14 Apr 2020 17:38:35 GMT		2458	2560863705819459		DB REST API	-4932598483509198218	grounding	The BCR-ABL fusion gene was detected by FISH in 24 cases of chronic myeloid leukemia treated with imatinib.	Imatinib activates SH3PXD2A.	"{'CHEBI:CHEBI:45783': {'name': 'imatinib', 'synonyms': ['4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE', '4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide', 'STI 571', ""alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide"", 'imatinib'], 'definition': None, 'syn_in_text': 'imatinib', 'syn_in_stmt': 'imatinib'}, 'HGNC:23664': {'name': 'SH3PXD2A', 'synonyms': ['Adapter protein TKS5', 'FISH', 'Five SH3 domain-containing protein', 'KIAA0418', 'SH3 and PX domain-containing protein 2A', 'SH3 and PX domains 2A', 'SH3 multiple domains protein 1', 'SH3MD1', 'SH3PXD2A', 'TKS5', 'Tyrosine kinase substrate with five SH3 domains', 'five SH3 domains'], 'definition': None, 'syn_in_text': 'FISH', 'syn_in_stmt': 'SH3PXD2A'}}"
ben.gyori@gmail.com	Mon, 01 May 2023 00:52:23 GMT	{'annotations': {'agents': {'raw_text': ['DIO', 'glucose']}, 'content_source': 'pmc_oa', 'found_by': 'Positive_activation_syntax_1_verb', 'prior_uuids': ['8a882f9b-6ca6-4240-a945-43ed8890977e']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '25830094', 'source_api': 'reach', 'source_hash': 8452572561612091000, 'text': 'Adropin treatment of DIO mice enhances glucose tolerance, ameliorates insulin resistance and promotes preferential use of carbohydrate over fat in fuel selection.', 'text_refs': {'DOI': '10.1016/J.MOLMET.2015.01.005', 'DOI_ID': 'J.MOLMET.2015.01.005', 'DOI_NS': 1016, 'PMCID': 'PMC4354928', 'PMCID_NUM': 4354928, 'PMID': '25830094', 'PMID_NUM': 25830094, 'READER': 'REACH', 'RID': 10100019531518, 'SOURCE': 'pmc_oa', 'TCID': 19531518, 'TRID': 8058315}}	13609	-11277369599899502	{'belief': 1, 'id': 'e9582fa4-ae3d-4422-8833-ac4b99e65b36', 'matches_hash': '-11277369599899502', 'obj': {'db_refs': {'CHEBI': 'CHEBI:17234', 'TEXT': 'glucose'}, 'name': 'glucose'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'CHEBI': 'CHEBI:52032', 'PUBCHEM': '5706734', 'TEXT': 'DIO'}, 'name': 'diOC18(3) dye'}, 'type': 'Activation'}	DB REST API	8452572561612091708	grounding	Adropin treatment of DIO mice enhances glucose tolerance, ameliorates insulin resistance and promotes preferential use of carbohydrate over fat in fuel selection.	DiOC18(3) dye activates glucose.	"{'CHEBI:CHEBI:52032': {'name': 'diOC18(3) dye', 'synonyms': [""3,3'-dioctadecyloxacarbocyanine perchlorate"", '3-octadecyl-2-[3-(3-octadecyl-1,3-benzoxazol-2(3H)-ylidene)prop-1-en-1-yl]-1,3-benzoxazol-3-ium perchlorate', 'Benzoxazolium, 3-octadecyl-2-[3-(3-octadecyl-2(3H)-benzoxazolylidene)-1-propenyl]-, perchlorate', 'DiO', 'DiOC18(3)', 'diOC18(3) dye', 'DIO'], 'definition': None, 'syn_in_text': 'DiO', 'syn_in_stmt': 'DiO'}, 'CHEBI:CHEBI:17234': {'name': 'glucose', 'synonyms': ['DL-glucose', 'GL', 'Glc', 'Glucose', 'Glukose', 'HG', 'gluco-hexose', 'glucose'], 'definition': None, 'syn_in_text': 'Glucose', 'syn_in_stmt': 'Glucose'}}"
bachmanjohn@gmail.com	Sat, 14 Nov 2020 22:58:02 GMT		8349	-10976280158779649		EMMAA	1361268325551474417	grounding	"Adaptor
proteins, such as  Grb2/Sem5, bind to a Ras-activator protein (mSosl)
[65-  68] bringing it to the receptor to form a stable complex
[67,69,70]."	RAS binds JUN.	{'FPLX:RAS': {'name': 'RAS', 'synonyms': ['GTPase, ras', 'GTPases, ras', 'Gene Products, ras', 'Protein, ras', 'RAS', 'Ras', 'Ras GTPase', 'ras GTPase', 'ras GTPases', 'ras Gene Products', 'ras Protein', 'ras Proteins'], 'definition': None, 'syn_in_text': 'RAS', 'syn_in_stmt': 'RAS'}, 'HGNC:6204': {'name': 'JUN', 'synonyms': ['AP-1', 'AP1', 'Activator protein 1', 'JUN', 'Jun proto-oncogene, AP-1 transcription factor subunit', 'Proto-oncogene c-Jun', 'Transcription factor AP-1 subunit Jun', 'Transcription factor Jun', 'V-jun avian sarcoma virus 17 oncogene homolog', 'c-Jun', 'c-jun', 'p39'], 'definition': None, 'syn_in_text': None, 'syn_in_stmt': 'JUN'}}
ben.gyori@gmail.com	Tue, 17 Nov 2020 18:36:36 GMT		8585	-35939830319189660		DB REST API	-4396172351275076836	grounding	These results demonstrate that gem inhibits the LPS induced proinflammatory molecule expression via PPAR-beta, but not PPAR-gamma, in human microglia.	GEM inhibits PPARG.	{'HGNC:4234': {'name': 'GEM', 'synonyms': ['GEM', 'GTP binding protein overexpressed in skeletal muscle', 'GTP-binding mitogen-induced T-cell protein', 'GTP-binding protein GEM', 'KIR', 'RAS-like protein KIR', 'kinase-inducible Ras-like protein', 'Gem'], 'definition': None, 'syn_in_text': 'GEM', 'syn_in_stmt': 'GEM'}, 'HGNC:9236': {'name': 'PPARG', 'synonyms': ['NR1C3', 'Nuclear receptor subfamily 1 group C member 3', 'PPAR gamma', 'PPAR-gamma', 'PPAR-γ', 'PPARG', 'PPARG1', 'PPARG2', 'PPARgamma', 'PPARγ', 'Peroxisome Proliferator Activated Receptor gamma', 'Peroxisome Proliferator-Activated Receptor gamma', 'Peroxisome proliferator-activated receptor gamma', 'Receptor, Thiazolidinedione', 'Thiazolidinedione Receptor', 'peroxisome proliferator activated receptor gamma'], 'definition': None, 'syn_in_text': 'PPAR-gamma', 'syn_in_stmt': 'PPARG'}}
ben.gyori@gmail.com	Wed, 28 May 2025 23:22:32 GMT	{'annotations': {'agents': {'raw_text': ['MinK', 'hERG1']}, 'content_source': 'manuscripts', 'found_by': 'Positive_activation_syntax_1_verb', 'prior_uuids': ['e9829409-abf3-4ff4-b95d-8f20d9cdaa3a']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '20544339', 'source_api': 'reach', 'source_hash': 6451145915662711000, 'text': 'Although MinK most likely functions as the accessory subunit for KCNQ1 to form I Ks channels in the heart [XREF_BIBR, XREF_BIBR], MinK can also modulate hERG1 channel density when overexpressed in heterologous expression systems [XREF_BIBR, XREF_BIBR].', 'text_refs': {'DOI': '10.1007/S00424-009-0758-8', 'DOI_ID': 'S00424-009-0758-8', 'DOI_NS': 1007, 'MANUSCRIPT_ID': 'NIHMS163414', 'PMCID': 'PMC2886309', 'PMCID_NUM': 2886309, 'PMID': '20544339', 'PMID_NUM': 20544339, 'READER': 'REACH', 'RID': 10100019905693, 'SOURCE': 'manuscripts', 'TCID': 19905693, 'TRID': 27962907}}	16934	-7273051259377621	{'belief': 1, 'id': '8400ac27-64a5-468e-b7d7-2cb52a3b1b73', 'matches_hash': '-7273051259377621', 'obj': {'db_refs': {'HGNC': '6251', 'UP': 'Q12809'}, 'name': 'KCNH2'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '17565', 'UP': 'Q8N4C8'}, 'name': 'MINK1'}, 'type': 'Activation'}	DB REST API	6451145915662710517	grounding	Although MinK most likely functions as the accessory subunit for KCNQ1 to form I Ks channels in the heart [XREF_BIBR, XREF_BIBR], MinK can also modulate hERG1 channel density when overexpressed in heterologous expression systems [XREF_BIBR, XREF_BIBR].	MINK1 activates KCNH2.	{'HGNC:17565': {'name': 'MINK1', 'synonyms': ['B55', 'GCK family kinase MiNK', 'MAP4K6', 'MAPK/ERK kinase kinase kinase 6', 'MEK kinase kinase 6', 'MEKKK 6', 'MINK', 'MINK1', 'Misshapen-like kinase 1', 'Misshapen/NIK-related kinase', 'Mitogen-activated protein kinase kinase kinase kinase 6', 'YSK2', 'ZC3', 'misshapen like kinase 1', 'misshapen/NIK-related kinase'], 'definition': None, 'syn_in_text': 'MINK', 'syn_in_stmt': 'MINK1'}, 'HGNC:6251': {'name': 'KCNH2', 'synonyms': ['ERG', 'ERG-1', 'ERG1', 'Eag homolog', 'Eag-related protein 1', 'Ether-a-go-go-related gene potassium channel 1', 'Ether-a-go-go-related protein 1', 'H-ERG', 'HERG', 'KCNH2', 'Kv11.1', 'LQT2', 'Potassium voltage-gated channel subfamily H member 2', 'Voltage-gated potassium channel subunit Kv11.1', 'erg1', 'hERG-1', 'hERG1', 'human ether-a-go-go-related gene', 'long QT syndrome type 2', 'potassium voltage-gated channel subfamily H member 2'], 'definition': None, 'syn_in_text': 'hERG1', 'syn_in_stmt': 'KCNH2'}}
ben.gyori@gmail.com	Tue, 25 Aug 2020 15:06:12 GMT		6137	-16455921353276691		EMMAA	-6863305900816839634	grounding	Although the increased efferent output at the neuromuscular junction is not reduced , muscle relaxants induce their action by inhibiting the binding of acetylcholine at the motor endplate ( Figure II-59 ) .	Muscle relaxant activates fluthiacet-methyl.	{'CHEBI:CHEBI:51371': {'name': 'muscle relaxant', 'synonyms': ['muscle relaxant', 'muscle relaxants'], 'definition': None, 'syn_in_text': 'muscle relaxant', 'syn_in_stmt': 'muscle relaxant'}, 'CHEBI:CHEBI:5133': {'name': 'fluthiacet-methyl', 'synonyms': ['Action', 'CGA 248757', 'CGA-248757', 'KIH 9201', 'KIH-9201', 'fluthiacet-methyl', 'methyl 2-[[2-chloro-4-fluoro-5-[(tetrahydro-3-oxo-1H,3H-[1,3,4]thiadiazolo[3,4-a]pyridazin-1-ylidene)amino]phenyl]thio]acetate', 'methyl [(2-chloro-4-fluoro-5-{[(1Xi)-3-oxo-5,6,7,8-tetrahydro-1H,3H-[1,3,4]thiadiazolo[3,4-a]pyridazin-1-ylidene]amino}phenyl)sulfanyl]acetate', 'methyl [(2-chloro-4-fluoro-5-{[(1Xi)-3-oxotetrahydro[1,3,4]thiadiazolo[3,4-a]pyridazin-1-ylidene]amino}phenyl)thio]acetate', 'methyl {2-chloro-4-fluoro-5-[(EZ)-5,6,7,8-tetrahydro-3-oxo-1H,3H-[1,3,4]thiadiazolo[3,4-a]pyridazin-1-ylideneamino]phenylthio}acetate', 'action'], 'definition': None, 'syn_in_text': 'Action', 'syn_in_stmt': 'fluthiacet-methyl'}}
ben.gyori@gmail.com	Wed, 18 Aug 2021 14:48:37 GMT		12353	19110392348476033	{'belief': 1, 'id': '11ceec94-9792-46b5-82af-dd3dae8654ca', 'matches_hash': '19110392348476033', 'obj': {'db_refs': {'HGNC': '6294', 'TEXT': 'KCNQ1', 'UP': 'P51787'}, 'name': 'KCNQ1'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '17565', 'TEXT': 'MinK', 'UP': 'Q8N4C8'}, 'name': 'MINK1'}, 'type': 'Activation'}	DB REST API	8680431370497304803	grounding	The mechanism by which MinK modulates KvLQT1 gating is currently unknown.	MINK1 activates KCNQ1.	{'HGNC:17565': {'name': 'MINK1', 'synonyms': ['B55', 'GCK family kinase MiNK', 'MAP4K6', 'MAPK/ERK kinase kinase kinase 6', 'MEK kinase kinase 6', 'MEKKK 6', 'MINK', 'MINK1', 'Misshapen-like kinase 1', 'Misshapen/NIK-related kinase', 'Mitogen-activated protein kinase kinase kinase kinase 6', 'YSK2', 'ZC3', 'misshapen like kinase 1', 'misshapen/NIK-related kinase', 'MinK'], 'definition': None, 'syn_in_text': 'MINK', 'syn_in_stmt': 'MINK1'}, 'HGNC:6294': {'name': 'KCNQ1', 'synonyms': ['IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1', 'JLNS1', 'Jervell and Lange-Nielsen syndrome 1', 'KCNA8', 'KCNA9', 'KCNQ1', 'KQT-like 1', 'KVLQT1', 'Kv7.1', 'LQT', 'LQT1', 'Potassium voltage-gated channel subfamily KQT member 1', 'Voltage-gated potassium channel subunit Kv7.1', 'potassium voltage-gated channel subfamily Q member 1'], 'definition': None, 'syn_in_text': 'KVLQT1', 'syn_in_stmt': 'KCNQ1'}}
ben.gyori@gmail.com	Wed, 02 Feb 2022 03:21:54 GMT		12723	27635485097689678	{'belief': 1, 'id': 'e31a3ca9-d6fd-4412-819e-4ed488507d31', 'matches_hash': '27635485097689678', 'obj': {'db_refs': {'MESH': 'D003643', 'TEXT': 'death'}, 'name': 'Death'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'EGID': '7528', 'HGNC': '12856', 'MESH': 'C494698', 'TEXT': 'Delta', 'UP': 'P25490'}, 'name': 'YY1'}, 'type': 'Activation'}	EMMAA	-8843531062121257278	grounding	The Delta variant has substantially postponed the predicted herd immunity date, through a combination of reduced vaccine effectiveness, lowered recovery rate, and increased infection and death rates.	YY1 activates Death.	{'HGNC:12856': {'name': 'YY1', 'synonyms': ['DELTA', 'Delta transcription factor', 'INO80 complex subunit S', 'INO80S', 'NF-E1', 'Transcriptional repressor protein YY1', 'UCRBP', 'YIN-YANG-1', 'YY-1', 'YY1', 'YY1 transcription factor', 'Yin and Yang 1 protein', 'Yin and yang 1', 'Delta'], 'definition': None, 'syn_in_text': 'DELTA', 'syn_in_stmt': 'YY1'}, 'MESH:D003643': {'name': 'Death', 'synonyms': ['Death', 'End Of Life', 'End-Of-Life', 'death'], 'definition': None, 'syn_in_text': 'Death', 'syn_in_stmt': 'Death'}}
ben.gyori@gmail.com	Sun, 22 Nov 2020 03:54:28 GMT		8949	-15387500850766622		EMMAA	2144846269249384183	grounding	The presence of a BRAF V600E mutation and activation of ERK, MEK, S6, and AKT were assessed with immunohistochemistry in 35 conjunctival nevi and 31 melanomas.	BRAF activates RAC.	{'HGNC:1097': {'name': 'BRAF', 'synonyms': ['B-Raf', 'B-Raf proto-oncogene, serine/threonine kinase', 'BRAF', 'BRAF-1', 'BRAF1', 'Proto-oncogene B-Raf', 'RAFB1', 'Serine/threonine-protein kinase B-raf', 'p94', 'v-Raf murine sarcoma viral oncogene homolog B1'], 'definition': None, 'syn_in_text': 'BRAF', 'syn_in_stmt': 'BRAF'}, 'FPLX:RAC': {'name': 'RAC', 'synonyms': ['RAC', 'Rac', 'rac', 'ERK, MEK, S6, and AKT'], 'definition': None, 'syn_in_text': 'ERK, MEK, S6, and AKT', 'syn_in_stmt': 'RAC'}}
sambunga094@gmail.com	Tue, 11 Jan 2022 17:15:56 GMT		12675	2150129270544464	{'belief': 1, 'id': 'd9f8ca70-16a8-4a0c-93d5-8c51150a4657', 'matches_hash': '2150129270544464', 'members': [{'db_refs': {'CAS': '302-04-5', 'CHEBI': 'CHEBI:18022', 'HMDB': 'HMDB0001453', 'PUBCHEM': '9322', 'TEXT': 'NCs'}, 'name': 'thiocyanate'}, {'db_refs': {'HGNC': '5344', 'MESH': 'D018799', 'TEXT': 'ICAM-1', 'UP': 'P05362'}, 'name': 'ICAM1'}], 'type': 'Complex'}	panacea_enzyme	-3481980002383547082	grounding	For instance, binding of leukocytes to endothelial CAMs is known to regulate leukocyte-endothelial interactions during inflammation, including disengagement of both cell types after leukocyte extravasation.23, 34, 35, 36, 37 In this context, leukocyte binding to endothelial CAMs seems to result in both leukocyte and endothelial secretion of MMPs, as well as sICAM-1 release.4 Therefore, it is plausible that binding of ICAM-1-targeted NCs to endothelial ICAM-1 may result in a similar effect.	Thiocyanate binds ICAM1.	{'CHEBI:CHEBI:18022': {'name': 'thiocyanate', 'synonyms': ['N#C-S(-)', 'NCS-', 'Rhodanid', 'SCN(-)', 'THIOCYANATE ION', 'Thiozyanat', '[S-C#N](-)', 'nitridosulfidocarbonate(1-)', 'nitridothiocarbonate(1-)', 'nitridothiocarbonate(IV)', 'rhodanide', 'thiocyanate', 'thiocyanate ion', 'thiocyanate ion (1-)', 'NCs'], 'definition': None, 'syn_in_text': 'NCs', 'syn_in_stmt': 'thiocyanate'}, 'HGNC:5344': {'name': 'ICAM1', 'synonyms': ['Antigen, CD54', 'Antigens, CD54', 'BB2', 'CD antigen CD54', 'CD54', 'CD54 Antigen', 'CD54 Antigens', 'ICAM-1', 'ICAM1', 'Intercellular Adhesion Molecule 1', 'Intercellular Adhesion Molecule-1', 'Intercellular adhesion molecule 1', 'Major group rhinovirus receptor', 'human rhinovirus receptor', 'intercellular adhesion molecule 1'], 'definition': None, 'syn_in_text': 'ICAM-1', 'syn_in_stmt': 'ICAM1'}}
ca3261@nyu.edu	Mon, 19 May 2025 19:28:50 GMT	{'annotations': {'agents': {'raw_text': ['EP', 'ERK']}, 'content_source': 'pmc_oa', 'found_by': 'Negative_activation_syntax_1_verb', 'prior_uuids': ['38f02924-147c-4d71-910e-b0cb1972d12d']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '30761126', 'source_api': 'reach', 'source_hash': -8269899822002060000, 'text': 'Investigating EP mechanisms, we found that EP decreased glycolysis and mitochondrial respiration, upon and in absence of TLR stimulation, by reducing ERK, AKT, and nitric oxide (NO) activation.', 'text_refs': {'DOI': '10.3389/FIMMU.2019.00030', 'DOI_ID': 'FIMMU.2019.00030', 'DOI_NS': 3389, 'PMCID': 'PMC6362406', 'PMCID_NUM': 6362406, 'PMID': '30761126', 'PMID_NUM': 30761126, 'READER': 'REACH', 'RID': 10100022998923, 'SOURCE': 'pmc_oa', 'TCID': 22998923, 'TRID': 29882612}}	16717	-12003746433095425	{'belief': 1, 'id': '9e63f5c5-e4f4-4f6b-a5aa-6bebb5c5463e', 'matches_hash': '-12003746433095425', 'obj': {'db_refs': {'ECCODE': '2.7.11.24', 'FPLX': 'ERK', 'IP': 'IPR008349', 'MESH': 'D020928', 'NCIT': 'C16376', 'TEXT': 'ERK1/2'}, 'name': 'ERK'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '2690', 'MESH': 'D026261', 'TEXT': 'EP', 'UP': 'P07108'}, 'name': 'DBI'}, 'type': 'Activation'}	DB REST API	-8269899822002060088	grounding	Investigating EP mechanisms, we found that EP decreased glycolysis and mitochondrial respiration, upon and in absence of TLR stimulation, by reducing ERK, AKT, and nitric oxide (NO) activation.	DBI activates ERK.	{'HGNC:2690': {'name': 'DBI', 'synonyms': ['ACBD1', 'ACBP', 'Acyl CoA Binding Protein', 'Acyl-CoA-Binding Protein', 'Acyl-CoA-binding protein', 'Binding Inhibitor, Diazepam', 'DBI', 'DBI Peptide', 'Diazepam Binding Inhibitor', 'Diazepam-binding inhibitor', 'EP', 'Endozepine', 'EpDBI', 'Inhibitor, Diazepam Binding', 'Peptide, DBI', 'Protein, Acyl-CoA-Binding', 'diazepam binding inhibitor, acyl-CoA binding protein', 'endozepine'], 'definition': None, 'syn_in_text': 'EP', 'syn_in_stmt': 'DBI'}, 'FPLX:ERK': {'name': 'ERK', 'synonyms': ['ERK', 'ERK 1/2', 'ERK MAP Kinase', 'ERK MAP Kinases', 'ERK MAPK', 'ERK mitogen-activated protein kinase', 'ERK-1/2', 'ERK1/2', 'ERK1/2 MAPK', 'ERKs', 'Erk', 'Erk1/2', 'Extracellular Signal Regulated Kinase', 'Extracellular Signal Regulated Kinases', 'Extracellular Signal Regulated MAP Kinase', 'Extracellular Signal Regulated MAP Kinases', 'Extracellular Signal-Regulated Kinase', 'Extracellular Signal-Regulated Kinases', 'Extracellular Signal-Regulated MAP Kinase', 'Extracellular Signal-Regulated MAP Kinases', 'Kinase, ERK MAP', 'Kinase, Extracellular Signal-Regulated', 'Kinases, Extracellular Signal-Regulated', 'MAP Kinase, ERK', 'MAP Kinases, Extracellular Signal Regulated', 'MAP Kinases, Extracellular Signal-Regulated', 'Signal-Regulated Kinase, Extracellular', 'extracellular signal-regulated kinase', 'p42 and p38 MAP kinases', 'p42 and p38 MAPK', 'p42 and p38 MAPKs', 'p42 and p44', 'p42 and p44 MAPK', 'p42 and p44MAP kinase', 'p42(mapk) and p44(mapk)', 'p42/44', 'p44 and p42', 'phospho-ERK1/2'], 'definition': None, 'syn_in_text': 'ERK', 'syn_in_stmt': 'ERK'}}
ben.gyori@gmail.com	Fri, 19 Jan 2024 18:47:46 GMT	{'annotations': {'agents': {'raw_text': ['tumor necrosis factor', 'cl2']}, 'content_source': 'pmc_oa', 'found_by': 'Positive_activation_syntax_3_noun', 'prior_uuids': ['61cb7437-7e26-4e35-99f2-14775825d546']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '19401779', 'source_api': 'reach', 'source_hash': -7287410427223402000, 'text': 'As previously described for LPS stimulation XREF_BIBR, stimulation with Helicobacter bacteria did not appear to induce interleukin-6 nor tumor necrosis factor production in m-IC cl2 cells (data not shown).', 'text_refs': {'DOI': '10.1371/JOURNAL.PONE.0005396', 'DOI_ID': 'JOURNAL.PONE.0005396', 'DOI_NS': 1371, 'PMCID': 'PMC2671595', 'PMCID_NUM': 2671595, 'PMID': '19401779', 'PMID_NUM': 19401779, 'READER': 'REACH', 'RID': 10100018952258, 'SOURCE': 'pmc_oa', 'TCID': 18952258, 'TRID': 18604550}}	13840	5162062846843684	{'belief': 1, 'id': 'd617ae5a-751f-451a-acdd-43c249cfcece', 'matches_hash': '5162062846843684', 'obj': {'db_refs': {'HGNC': '19002', 'TEXT': 'cl2', 'UP': 'Q8N568'}, 'name': 'DCLK2'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '11892', 'MESH': 'D014409', 'TEXT': 'tumor necrosis factor', 'UP': 'P01375'}, 'name': 'TNF'}, 'type': 'Activation'}	DB REST API	-7287410427223402989	grounding	As previously described for LPS stimulation XREF_BIBR, stimulation with Helicobacter bacteria did not appear to induce interleukin-6 nor tumor necrosis factor production in m-IC cl2 cells (data not shown).	TNF activates DCLK2.	{'HGNC:11892': {'name': 'TNF', 'synonyms': ['Cachectin', 'Cachectin Tumor Necrosis Factor', 'Cachectin-Tumor Necrosis Factor', 'DIF', 'TNF', 'TNF Superfamily, Member 2', 'TNF superfamily, member 2', 'TNF-a', 'TNF-alpha', 'TNF-α', 'TNFA', 'TNFSF2', 'TNFalpha', 'TNFα', 'Tumor Necrosis Factor', 'Tumor Necrosis Factor Ligand Superfamily Member 2', 'Tumor Necrosis Factor alpha', 'Tumor Necrosis Factor-alpha', 'Tumor necrosis factor', 'Tumor necrosis factor ligand superfamily member 2', 'tumor necrosis factor'], 'definition': None, 'syn_in_text': 'Tumor Necrosis Factor', 'syn_in_stmt': 'TNF'}, 'HGNC:19002': {'name': 'DCLK2', 'synonyms': ['CL2', 'CLICK-II', 'CLICK2', 'CaMK-like CREB regulatory kinase 2', 'DCAMKL2', 'DCDC3', 'DCDC3B', 'DCK2', 'DCLK2', 'Doublecortin domain-containing protein 3B', 'Doublecortin-like and CAM kinase-like 2', 'Doublecortin-like kinase 2', 'MGC45428', 'Serine/threonine-protein kinase DCLK2', 'doublecortin like kinase 2', 'cl2'], 'definition': None, 'syn_in_text': 'CL2', 'syn_in_stmt': 'DCLK2'}}
ben.gyori@gmail.com	Tue, 09 Feb 2021 15:55:10 GMT		10851	-28772630142013331		EMMAA	-1973949814352197557	polarity	Both mutations did not modulate S protein binding to sialic acids, S protein activation by host cell proteases and inhibition of S protein driven entry by interferon induced transmembrane proteins.	Interferon activates Spike glycoprotein.	{'FPLX:Interferon': {'name': 'Interferon', 'synonyms': ['IFN', 'Interferon', 'Interferons', 'interferon'], 'definition': None, 'syn_in_text': 'Interferon', 'syn_in_stmt': 'Interferon'}, 'UP:P0DTC2': {'name': 'Spike glycoprotein', 'synonyms': ['Spike glycoprotein', 'S protein'], 'definition': None, 'syn_in_text': 'S protein', 'syn_in_stmt': 'Spike glycoprotein'}}
ben.gyori@gmail.com	Wed, 07 Apr 2021 02:07:09 GMT		11712	33616734172965507		bioexp_paper_medscan	7693990206846347165	polarity	These results indicate the presence of two parallel cell survival pathways in prostate cancer cells: a strong Akt-independent, but rapamycin-sensitive pathway downstream of mTORC1, and an androgen receptor-dependent pathway downstream of mTORC2 and Akt, that is stimulated by mTORC1 inhibition.	MTORC1 activates AKT1.	{'FPLX:mTORC1': {'name': 'mTORC1', 'synonyms': ['Complex, mTORC1', 'Mechanistic Target of Rapamycin Complex 1', 'TOR Complex 1', 'TORC1', 'Target of Rapamycin Complex 1', 'mTORC1', 'mTORC1 Complex'], 'definition': None, 'syn_in_text': 'mTORC1', 'syn_in_stmt': 'mTORC1'}, 'HGNC:391': {'name': 'AKT1', 'synonyms': ['AKT', 'AKT serine/threonine kinase 1', 'AKT1', 'Akt1', 'PKB', 'PKB alpha', 'PRKBA', 'Protein kinase B', 'Protein kinase B alpha', 'Proto-oncogene c-Akt', 'RAC', 'RAC-PK-alpha', 'RAC-alpha', 'RAC-alpha serine/threonine-protein kinase', 'protein kinase B'], 'definition': None, 'syn_in_text': 'AKT', 'syn_in_stmt': 'AKT1'}}
ben.gyori@gmail.com	Thu, 14 May 2020 04:45:38 GMT		2851	30933999547739842		EMMAA	-4243526629693778958	polarity	These observations suggest that the effect of ciclesonide was specific to coronavirus , suggesting this is a candidate drug for treatment of patients suffering MERS or COVID-19 .	Ciclesonide activates Coronavirus.	{'CHEBI:CHEBI:31397': {'name': 'Ciclesonide', 'synonyms': ['(R)-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate', 'Ciclesonide', 'ciclesonide'], 'definition': None, 'syn_in_text': 'Ciclesonide', 'syn_in_stmt': 'Ciclesonide'}, 'MESH:D017934': {'name': 'Coronavirus', 'synonyms': ['Coronavirus', 'Coronaviruses', 'coronavirus'], 'definition': None, 'syn_in_text': 'Coronavirus', 'syn_in_stmt': 'Coronavirus'}}
bachmanjohn@gmail.com	Fri, 06 Nov 2020 20:47:34 GMT		7916	21251782238373911		EMMAA	-6887715534426558255	polarity	Moreover, elimination of Snail using siRNA [XREF_BIBR] could induce p53 expression in H28.	SNAI1 increases the amount of TP53.	{'HGNC:11128': {'name': 'SNAI1', 'synonyms': ['Protein sna', 'Protein snail homolog 1', 'SLUGH2', 'SNA', 'SNAH', 'SNAI1', 'SNAIL', 'SNAIL1', 'Snail', 'Zinc finger protein SNAI1', 'snail family transcriptional repressor 1'], 'definition': None, 'syn_in_text': 'SNAIL', 'syn_in_stmt': 'SNAI1'}, 'HGNC:11998': {'name': 'TP53', 'synonyms': ['Antigen NY-CO-13', 'Cellular Tumor Antigen p53', 'Cellular tumor antigen p53', 'LFS1', 'Li-Fraumeni syndrome', 'Oncoprotein p53', 'P53', 'Phosphoprotein p53', 'Phosphoprotein, pp53', 'TP53', 'TP53 Protein', 'TRP53 Protein', 'Tumor Suppressor Protein p53', 'Tumor suppressor p53', 'mutp53', 'p53', 'p53 Antigen', 'p53 Tumor Suppressor Protein', 'pp53 Phosphoprotein', 'tumor protein p53'], 'definition': None, 'syn_in_text': 'P53', 'syn_in_stmt': 'TP53'}}
ben.gyori@gmail.com	Tue, 22 Apr 2025 23:01:31 GMT		16551	-34095893265185106	{'belief': 1, 'id': 'f7028f8d-19c9-4ba4-877f-182fcfe44331', 'matches_hash': '-34095893265185106', 'obj': {'db_refs': {'HGNC': '3430', 'MESH': 'D018719', 'TEXT': 'ERBB2', 'UP': 'P04626'}, 'name': 'ERBB2'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'CAS': '231277-92-2', 'CHEBI': 'CHEBI:49603', 'CHEMBL': '554', 'DRUGBANK': 'DB01259', 'HMDB': 'HMDB0015388', 'HMS-LINCS': '10051', 'LINCS': 'LSM-1051', 'MESH': 'D000077341', 'PUBCHEM': '208908', 'TEXT': 'lapatinib'}, 'name': 'lapatinib'}, 'type': 'Activation'}	CoGEx	-7755443473348978075	polarity	Lapatinib, which targets EGFR and ErbB-2, is being examined in both a phase 0 study treating vestibular schwannomas (NCT00863122) and a phase II (NCT00973739) trial for its effectiveness in all NF2 related tumor types.	Lapatinib activates ERBB2.	{'CHEBI:CHEBI:49603': {'name': 'lapatinib', 'synonyms': ['GW 572016', 'Lapatinib', 'N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine', 'N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine', 'N-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5-({[2-(methanesulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine', 'N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE', 'Tykerb', 'lapatinib'], 'definition': None, 'syn_in_text': 'Lapatinib', 'syn_in_stmt': 'Lapatinib'}, 'HGNC:3430': {'name': 'ERBB2', 'synonyms': ['Antigens, CD340', 'CD antigen CD340', 'CD340', 'CD340 Antigen', 'CD340 Antigens', 'ERBB2', 'Erb b2 Receptor Tyrosine Kinases', 'Erb-b2 Receptor Tyrosine Kinases', 'ErbB-2 Receptor', 'ErbB2', 'HER 2 Proto Oncogene Protein', 'HER-2', 'HER-2 Proto-Oncogene Protein', 'HER2', 'HER2 receptor', 'MLN 19', 'MLN-19', 'MLN19', 'Metastatic Lymph Node Gene 19 Protein', 'Metastatic lymph node gene 19 protein', 'NEU', 'NGL', 'Neu Receptor', 'Oncogene Protein HER 2', 'Oncogene Protein HER-2', 'Proto Oncogene Protein HER 2', 'Proto Oncogene Proteins c erbB 2', 'Proto-Oncogene Protein HER-2', 'Proto-Oncogene Protein p185(neu)', 'Proto-Oncogene Protein, HER-2', 'Proto-Oncogene Protein, erbB-2', 'Proto-Oncogene Protein, neu', 'Proto-Oncogene Proteins c-erbB-2', 'Proto-oncogene Neu', 'Proto-oncogene Protein Neu', 'Proto-oncogene c-ErbB-2', 'Receptor tyrosine-protein kinase erbB-2', 'Receptor, ErbB-2', 'Receptor, Neu', 'Receptors, erbB-2', 'Tyrosine Kinase type Cell Surface Receptor HER2', 'Tyrosine Kinase-type Cell Surface Receptor HER2', 'Tyrosine kinase-type cell surface receptor HER2', 'c erbB 2 Protein', 'c-ERB-2', 'c-ERB2', 'c-erbB-2 Protein', 'erb-b2 receptor tyrosine kinase 2', 'erbB 2 Proto Oncogene Protein', 'erbB 2 Receptor Protein Tyrosine Kinase', 'erbB-2 Proto-Oncogene Protein', 'erbB-2 Receptor Protein-Tyrosine Kinase', 'erbB-2 Receptors', 'human epidermal growth factor receptor 2', 'metastatic lymph node gene 19', 'neu Proto Oncogene Protein', 'neu Proto-Oncogene Protein', 'neuro/glioblastoma derived oncogene homolog', 'p185(c-neu)', 'p185(erbB2)', 'p185erbB2', 'p185erbB2 Protein'], 'definition': None, 'syn_in_text': None, 'syn_in_stmt': 'ERBB2'}}
bachmanjohn@gmail.com	Tue, 17 Nov 2020 19:17:53 GMT		8603	-4780775875848881		EMMAA	8901798639829728877	polarity	Abeta also produces a rapid and persistent downregulation of mTOR and p70S6K phosphorylation in murine neuroblastoma cells associated with caspase 3 activation in the cortex of double APP and PS1 transgenic mice compared with control mice [XREF_BIBR].	APP leads to the phosphorylation of RPS6KB1.	{'HGNC:620': {'name': 'APP', 'synonyms': ['A4', 'ABPP', 'AD1', 'APP', 'APPI', 'Abeta', 'Alzheimer disease amyloid A4 protein homolog', 'Alzheimer disease amyloid protein', 'Amyloid A4 Protein Precursor', 'Amyloid Protein Precursor', 'Amyloid beta Precursor Protein', 'Amyloid beta Protein Precursor', 'Amyloid beta-Protein Precursor', 'Amyloid precursor protein', 'Amyloid-beta (A4) precursor protein', 'Amyloid-beta A4 protein', 'Amyloid-beta precursor protein', 'Aβ', 'CVAP', 'Cerebral vascular amyloid peptide', 'Nexin 2, Protease', 'Nexin II, Protease', 'PN-II', 'PreA4', 'Protease Nexin 2', 'Protease Nexin II', 'Protease nexin-II', 'alpha-sAPP', 'amyloid beta', 'amyloid beta precursor protein', 'amyloid β', 'beta Amyloid Protein Precursor', 'beta-Amyloid Protein Precursor', 'beta-Protein Precursor, Amyloid', 'peptidase nexin-II'], 'definition': None, 'syn_in_text': 'APP', 'syn_in_stmt': 'APP'}, 'HGNC:10436': {'name': 'RPS6KB1', 'synonyms': ['70 kDa ribosomal protein S6 kinase 1', 'P70S6K1', 'PS6K', 'RPS6KB1', 'RPS6KB1 kinase', 'Ribosomal protein S6 kinase I', 'Ribosomal protein S6 kinase beta-1', 'S6 kinase 1alpha', 'S6K', 'S6K-beta-1', 'S6K1', 'STK14A', 'Serine/threonine-protein kinase 14A', 'p70', 'p70 S6 kinase alpha', 'p70 S6 kinase alpha2', 'p70 S6K-alpha', 'p70 S6KA', 'p70 ribosomal S6 kinase alpha', 'p70(S6K)-alpha', 'p70-S6K 1', 'p70S6 kinase', 'p70S6K', 'p70S6K1', 'ribosomal protein S6 kinase B1', 'ribosomal protein S6 kinase, 70kD, polypeptide 1', 'serine-threonine kinase 14 alpha'], 'definition': None, 'syn_in_text': 'p70S6K', 'syn_in_stmt': 'RPS6KB1'}}
ben.gyori@gmail.com	Wed, 18 Mar 2020 03:58:54 GMT		2188	-8227053839892263		DB REST API	8281090215138003961	polarity	The most significant cellular growth arrest and apoptotic effects were observed in the cells treated with 75muM of berberine for 72h.	Berberine activates cell growth.	{'CHEBI:CHEBI:16118': {'name': 'berberine', 'synonyms': ['5,6-dihydro-9,10-dimethoxy-1,3-benzodioxolo[5,6-a]benzo[g]quinolizinium', '7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-[methylenebis(oxy)]berbinium', '9,10-dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetradehydroberbinium', '9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium', 'BERBERINE', 'Berberin', 'Berberine', 'Umbellatine', 'berberine'], 'definition': None, 'syn_in_text': 'BERBERINE', 'syn_in_stmt': 'BERBERINE'}, 'GO:GO:0016049': {'name': 'cell growth', 'synonyms': ['Cell Growth Processes', 'Processes, Cell Growth', 'cell expansion', 'cell growth', 'cellular growth', 'growth of cell', 'metabolic process resulting in cell growth', 'metabolism resulting in cell growth', 'non-developmental cell growth', 'non-developmental growth of a unicellular organism'], 'definition': None, 'syn_in_text': 'cellular growth', 'syn_in_stmt': 'cell growth'}}
ben.gyori@gmail.com	Thu, 18 Jun 2020 01:51:15 GMT		5557	-35641109739258101		bioexp_paper_medscan	4916030657741763992	polarity	We treated cells with MG132 to accumulate ubiquitinated proteins and show that Nnmt overexpression lowers Sirt1 ubiquitination ( ) but does not affect general proteasome activity ( ).	NNMT inhibits SIRT1.	{'HGNC:7861': {'name': 'NNMT', 'synonyms': ['Methylase, Nicotinamide', 'Methyltransferase, Nicotinamide', 'Methyltransferase, Nicotinamide-S-Adenosylmethionine', 'N-Methyltransferase, Nicotinamide', 'NNMT', 'Nicotinamide Methylase', 'Nicotinamide Methyltransferase', 'Nicotinamide N Methyltransferase', 'Nicotinamide N-Methyltransferase', 'Nicotinamide N-methyltransferase', 'Nicotinamide S Adenosylmethionine Methyltransferase', 'Nicotinamide-S-Adenosylmethionine Methyltransferase', 'nicotinamide N-methyltransferase'], 'definition': None, 'syn_in_text': 'NNMT', 'syn_in_stmt': 'NNMT'}, 'HGNC:14929': {'name': 'SIRT1', 'synonyms': ['NAD-dependent protein deacetylase sirtuin-1', 'NAD-dependent protein deacylase sirtuin-1', 'Regulatory protein SIR2 homolog 1', 'SIR2-like protein 1', 'SIR2L1', 'SIRT1', 'Silent Mating Type Information Regulation 2 Homolog 1', 'Sirt1', 'Sirtuin 1', 'hSIR2', 'hSIRT1', 'sirtuin 1', 'SirT1'], 'definition': None, 'syn_in_text': 'SIRT1', 'syn_in_stmt': 'SIRT1'}}
ben.gyori@gmail.com	Tue, 12 May 2020 14:18:25 GMT		2766	-32228027965245578		bioexp_paper_rlimsp	-1918179709732362038	polarity	Thus, it is biologically plausible that the inactivation of CDC25A by E2-induced ROS is responsible for ERK phosphorylation in MCF-7 cells.	CDC25A phosphorylates ERK.	{'HGNC:1725': {'name': 'CDC25A', 'synonyms': ['CDC25 homolog A (S. pombe)', 'CDC25A', 'Dual specificity phosphatase Cdc25A', 'M-phase inducer phosphatase 1', 'cell division cycle 25A'], 'definition': None, 'syn_in_text': 'CDC25A', 'syn_in_stmt': 'CDC25A'}, 'FPLX:ERK': {'name': 'ERK', 'synonyms': ['ERK', 'ERK 1/2', 'ERK MAP Kinase', 'ERK MAP Kinases', 'ERK MAPK', 'ERK mitogen-activated protein kinase', 'ERK-1/2', 'ERK1/2', 'ERK1/2 MAPK', 'ERKs', 'Erk', 'Erk1/2', 'Extracellular Signal Regulated Kinase', 'Extracellular Signal Regulated Kinases', 'Extracellular Signal Regulated MAP Kinase', 'Extracellular Signal Regulated MAP Kinases', 'Extracellular Signal-Regulated Kinase', 'Extracellular Signal-Regulated Kinases', 'Extracellular Signal-Regulated MAP Kinase', 'Extracellular Signal-Regulated MAP Kinases', 'Kinase, ERK MAP', 'Kinase, Extracellular Signal-Regulated', 'Kinases, Extracellular Signal-Regulated', 'MAP Kinase, ERK', 'MAP Kinases, Extracellular Signal Regulated', 'MAP Kinases, Extracellular Signal-Regulated', 'Signal-Regulated Kinase, Extracellular', 'extracellular signal-regulated kinase', 'p42 and p38 MAP kinases', 'p42 and p38 MAPK', 'p42 and p38 MAPKs', 'p42 and p44', 'p42 and p44 MAPK', 'p42 and p44MAP kinase', 'p42(mapk) and p44(mapk)', 'p42/44', 'p44 and p42', 'phospho-ERK1/2'], 'definition': None, 'syn_in_text': 'ERK', 'syn_in_stmt': 'ERK'}}
ben.gyori@gmail.com	Wed, 11 Nov 2020 16:34:39 GMT		8175	13593194659880980		EMMAA	3182061787687577157	polarity	Unterstab et al. ( 2005 ) demonstrated that the BDV P protein antagonizes TBK1 to prevent IFNbeta induction during infection .	TBK1 inhibits IFNB.	{'HGNC:11584': {'name': 'TBK1', 'synonyms': ['NAK', 'NF-kappa-B-activating kinase', 'Serine/threonine-protein kinase TBK1', 'T2K', 'TANK binding kinase 1', 'TANK-binding kinase 1', 'TBK1'], 'definition': None, 'syn_in_text': 'TBK1', 'syn_in_stmt': 'TBK1'}, 'FPLX:IFNB': {'name': 'IFNB', 'synonyms': ['Fibroblast Interferon', 'IFN-beta', 'IFN-β', 'Interferon beta', 'Interferon β', 'Interferon, Fibroblast', 'Interferon, beta', 'Interferon-beta', 'beta Interferon', 'beta interferons', 'beta-Interferon', 'interferon beta', 'interferon β', 'β interferons', 'IFNB', 'IFNβ'], 'definition': None, 'syn_in_text': 'IFNB', 'syn_in_stmt': 'IFNB'}}
ben.gyori@gmail.com	Fri, 15 Oct 2021 22:57:59 GMT		12454	15455372673805946	{'belief': 1, 'id': '3cbe812a-22de-497a-b666-594129fb8c2f', 'matches_hash': '15455372673805946', 'obj': {'db_refs': {'MESH': 'D000086402', 'TEXT': 'SARS-CoV-2'}, 'name': 'SARS-CoV-2'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'EGID': '4780', 'HGNC': '7782', 'MESH': 'C495635', 'TEXT': 'Nrf2', 'UP': 'Q16236'}, 'name': 'NFE2L2'}, 'type': 'Activation'}	EMMAA	738635474303491959	polarity	This antiviral response against SARS-CoV-2 elicited by NRF2 activation was not restricted to only chemical inducers; activation of NRF2 by ablating KEAP1 using KEAP1 siRNA was also influential in limiting viral replication.	NFE2L2 activates SARS-CoV-2.	{'HGNC:7782': {'name': 'NFE2L2', 'synonyms': ['HEBP1', 'NF E2 Related Factor 2', 'NF-E2-Related Factor 2', 'NF-E2-related factor 2', 'NFE2 like bZIP transcription factor 2', 'NFE2-related factor 2', 'NFE2L2', 'NRF-2', 'NRF2', 'Nfe2l2 Protein', 'Nrf-2', 'Nrf2', 'Nuclear Factor (Erythroid-Derived 2)-Like 2 Protein', 'Nuclear Factor E2 Related Factor 2', 'Nuclear Factor E2-Related Factor 2', 'Nuclear factor erythroid 2-related factor 2', 'Nuclear factor, erythroid derived 2, like 2'], 'definition': None, 'syn_in_text': 'NRF2', 'syn_in_stmt': 'NFE2L2'}, 'MESH:D000086402': {'name': 'SARS-CoV-2', 'synonyms': ['2019 Novel Coronavirus', '2019 Novel Coronaviruses', '2019-nCoV', 'COVID 19 Virus', 'COVID-19 Virus', 'COVID-19 Viruses', 'COVID19 Virus', 'COVID19 Viruses', 'Coronavirus 2, SARS', 'Coronavirus Disease 2019 Virus', 'Coronavirus, 2019 Novel', 'Coronavirus, Wuhan', 'Novel Coronavirus, 2019', 'SARS CoV 2 Virus', 'SARS Coronavirus 2', 'SARS-CoV-2', 'SARS-CoV-2 Virus', 'SARS-CoV-2 Viruses', 'Severe Acute Respiratory Syndrome Coronavirus 2', 'Virus, COVID-19', 'Virus, COVID19', 'Virus, SARS-CoV-2', 'Viruses, COVID19', 'Wuhan Coronavirus', 'Wuhan Seafood Market Pneumonia Virus'], 'definition': None, 'syn_in_text': 'SARS-CoV-2', 'syn_in_stmt': 'SARS-CoV-2'}}
bachmanjohn@gmail.com	Wed, 11 Nov 2020 18:32:03 GMT		8238	-28994425515373733		EMMAA	3655909538886279423	polarity	In addition, p53 reduction and p-Erk induction by silica and Snail (XREF_SUPPLEMENTARY) were abolished by NF2 transfection.	SNAI1 inhibits ERK.	{'HGNC:11128': {'name': 'SNAI1', 'synonyms': ['Protein sna', 'Protein snail homolog 1', 'SLUGH2', 'SNA', 'SNAH', 'SNAI1', 'SNAIL', 'SNAIL1', 'Snail', 'Zinc finger protein SNAI1', 'snail family transcriptional repressor 1'], 'definition': None, 'syn_in_text': 'SNAIL', 'syn_in_stmt': 'SNAI1'}, 'FPLX:ERK': {'name': 'ERK', 'synonyms': ['ERK', 'ERK 1/2', 'ERK MAP Kinase', 'ERK MAP Kinases', 'ERK MAPK', 'ERK mitogen-activated protein kinase', 'ERK-1/2', 'ERK1/2', 'ERK1/2 MAPK', 'ERKs', 'Erk', 'Erk1/2', 'Extracellular Signal Regulated Kinase', 'Extracellular Signal Regulated Kinases', 'Extracellular Signal Regulated MAP Kinase', 'Extracellular Signal Regulated MAP Kinases', 'Extracellular Signal-Regulated Kinase', 'Extracellular Signal-Regulated Kinases', 'Extracellular Signal-Regulated MAP Kinase', 'Extracellular Signal-Regulated MAP Kinases', 'Kinase, ERK MAP', 'Kinase, Extracellular Signal-Regulated', 'Kinases, Extracellular Signal-Regulated', 'MAP Kinase, ERK', 'MAP Kinases, Extracellular Signal Regulated', 'MAP Kinases, Extracellular Signal-Regulated', 'Signal-Regulated Kinase, Extracellular', 'extracellular signal-regulated kinase', 'p42 and p38 MAP kinases', 'p42 and p38 MAPK', 'p42 and p38 MAPKs', 'p42 and p44', 'p42 and p44 MAPK', 'p42 and p44MAP kinase', 'p42(mapk) and p44(mapk)', 'p42/44', 'p44 and p42', 'phospho-ERK1/2', 'p-Erk'], 'definition': None, 'syn_in_text': 'p-Erk', 'syn_in_stmt': 'ERK'}}
ben.gyori@gmail.com	Tue, 02 Mar 2021 19:29:03 GMT		11535	-20169504557885214		EMMAA	4633587048613990818	polarity	However, lack of J chain inhibits transepithelial transport of IgA and abrogates the development of intestinal antitoxic protection in knockout mice (Lycke et al., 1999).	JCHAIN inhibits transepithelial transport.	{'HGNC:5713': {'name': 'JCHAIN', 'synonyms': ['IGCJ', 'IGJ', 'IgJ chain', 'Immunoglobulin J chain', 'J chain', 'JCH', 'JCHAIN', 'Joining chain of multimeric IgA and IgM', 'immunoglobulin J chain', 'joining chain of multimeric IgA and IgM'], 'definition': None, 'syn_in_text': 'J chain', 'syn_in_stmt': 'JCHAIN'}, 'GO:GO:0070633': {'name': 'transepithelial transport', 'synonyms': ['transepithelial transport'], 'definition': None, 'syn_in_text': 'transepithelial transport', 'syn_in_stmt': 'transepithelial transport'}}
imke.ditters@gmail.com	Mon, 09 May 2022 12:01:58 GMT	{'annotations': {'agents': {'raw_text': ['α-glucosidase deficiency', 'Pompe disease']}, 'content_source': 'cord19_pmc_xml', 'found_by': 'Positive_activation_syntax_2_verb', 'prior_uuids': ['2803861d-4b00-4540-9163-97efdf60f1ca']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '31477883', 'source_api': 'reach', 'source_hash': -5574107550949639000, 'text': 'In patients with Pompe disease, which is caused by α-glucosidase deficiency, the high levels of non-degraded glycogen that accumulate in muscles could explain the observed myopathy69,70.', 'text_refs': {'DOI': '10.1038/S41573-019-0036-1', 'DOI_ID': 'S41573-019-0036-1', 'DOI_NS': 1038, 'PMCID': 'PMC7097195', 'PMCID_NUM': 7097195, 'PMID': '31477883', 'PMID_NUM': 31477883, 'READER': 'REACH', 'RID': 10200055787834, 'SOURCE': 'cord19_pmc_xml', 'TCID': 55787834, 'TRID': 30590947}}	13445	23442461971061455	{'belief': 1, 'id': '8c35464f-a13b-44c0-a67f-6ceb67d08f4c', 'matches_hash': '23442461971061455', 'obj': {'db_refs': {'DOID': 'DOID:2752', 'MESH': 'D006009', 'TEXT': 'Pompe disease'}, 'name': 'Glycogen Storage Disease Type II'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'TEXT': 'α-glucosidase deficiency'}, 'name': 'α-glucosidase deficiency'}, 'type': 'Inhibition'}	DB REST API	-5574107550949638884	polarity	In patients with Pompe disease, which is caused by α-glucosidase deficiency, the high levels of non-degraded glycogen that accumulate in muscles could explain the observed myopathy69,70.	Α-glucosidase deficiency inhibits Glycogen Storage Disease Type II.	"{'MESH:D006009': {'name': 'Glycogen Storage Disease Type II', 'synonyms': ['Acid Alpha Glucosidase Deficiency', 'Acid Alpha-Glucosidase Deficiencies', 'Acid Alpha-Glucosidase Deficiency', 'Acid Maltase Deficiency Disease', 'Alpha-Glucosidase Deficiencies', 'Alpha-Glucosidase Deficiencies, Acid', 'Alpha-Glucosidase Deficiency', 'Alpha-Glucosidase Deficiency, Acid', 'Deficiencies, Acid Alpha-Glucosidase', 'Deficiencies, GAA', 'Deficiency Disease, Acid Maltase', 'Deficiency Disease, Lysosomal alpha-1,4-Glucosidase', 'Deficiency of Alpha Glucosidase', 'Deficiency of Alpha-Glucosidase', 'Deficiency, Acid Alpha-Glucosidase', 'Deficiency, GAA', 'Disease, Pompe', ""Disease, Pompe's"", 'GAA Deficiencies', 'GAA Deficiency', 'GSD II', 'GSD2', 'GSD2s', 'Generalized Glycogenoses', 'Generalized Glycogenosis', 'Generalized glycogenosis', 'Glycogen Storage Disease II', 'Glycogen Storage Disease Type 2', 'Glycogen Storage Disease Type II', 'Glycogen storage disease 2', 'Glycogen storage disease, type II', 'Glycogenoses, Generalized', 'Glycogenosis 2', 'Glycogenosis Type II', 'Glycogenosis, Generalized', 'Glycogenosis, type 2', 'Lysosomal alpha 1,4 Glucosidase Deficiency Disease', 'Lysosomal alpha-1,4-Glucosidase Deficiency Disease', 'Lysosomal alpha-1,4-glucosidase deficiency', 'Pompe Disease', ""Pompe's Disease"", ""Pompe's disease"", 'Pompes Disease', 'Type II, Glycogenosis', 'Type IIs, Glycogenosis', 'acid maltase deficiency', 'deficiency of glucoamylase', 'deficiency of maltase', 'glycogen storage disease II', 'glycogen storage disease type II', 'Pompe disease'], 'definition': None, 'syn_in_text': 'Pompe Disease', 'syn_in_stmt': 'Glycogen Storage Disease Type II'}}"
bachmanjohn@gmail.com	Thu, 29 Oct 2020 12:26:15 GMT		7245	17534491214687965		DB REST API	-6605031849418291633	polarity	Nf1 Knockdown Activates Ras and Enhances EC Proliferation and Vessel Like Network Formation.	NF1 activates RAS.	{'HGNC:7765': {'name': 'NF1', 'synonyms': ['NF 1 Protein', 'NF-1 Protein', 'NF1', 'NF1 GAP Related Protein', 'NF1 GRP', 'NF1 Protein', 'NF1-GAP-Related Protein', 'Neurofibromatosis Type 1 Gene Product', 'Neurofibromatosis Type 1 Protein', 'Neurofibromatosis-related protein NF-1', 'Neurofibromin', 'Neurofibromin 1', 'Watson disease', 'neurofibromatosis', 'neurofibromin 1', 'von Recklinghausen disease', 'neurofibromin'], 'definition': None, 'syn_in_text': 'NF1', 'syn_in_stmt': 'NF1'}, 'FPLX:RAS': {'name': 'RAS', 'synonyms': ['GTPase, ras', 'GTPases, ras', 'Gene Products, ras', 'Protein, ras', 'RAS', 'Ras', 'Ras GTPase', 'ras GTPase', 'ras GTPases', 'ras Gene Products', 'ras Protein', 'ras Proteins'], 'definition': None, 'syn_in_text': 'RAS', 'syn_in_stmt': 'RAS'}}
bachmanjohn@gmail.com	Sat, 07 Nov 2020 23:28:29 GMT		8053	-4605392174666956		EMMAA	-7419853515220344710	polarity	Pharmacologic inhibitors of the PDGF receptor and c-Raf likewise effectively inhibit the proliferation of human schwannoma cells [ xref ].	RAF1 inhibits cell population proliferation.	{'HGNC:9829': {'name': 'RAF1', 'synonyms': ['C-Raf proto-oncogene, serine/threonine kinase', 'CRAF', 'Proto-oncogene c-RAF', 'RAF', 'RAF proto-oncogene serine/threonine-protein kinase', 'RAF1', 'Raf-1', 'Raf-1 proto-oncogene, serine/threonine kinase', 'c-Raf', 'cRaf'], 'definition': None, 'syn_in_text': 'c-Raf', 'syn_in_stmt': 'RAF1'}, 'GO:GO:0008283': {'name': 'cell population proliferation', 'synonyms': ['Cell Growth in Number', 'Cell Multiplication', 'Cell Number Growth', 'Cell Proliferation', 'Cellular Proliferation', 'Growth, Cell Number', 'Multiplication, Cell', 'Number Growth, Cell', 'Proliferation', 'Proliferation, Cell', 'Proliferation, Cellular', 'cell population proliferation', 'cell proliferation', 'proliferation'], 'definition': None, 'syn_in_text': 'Proliferation', 'syn_in_stmt': 'Proliferation'}}
bachmanjohn@gmail.com	Tue, 10 Nov 2020 22:06:36 GMT		8130	18463363854530802		EMMAA	-3928812830155045278	polarity	Indeed, by interacting with LIMK2, Nf1, via its SecPH domain, seems able to inhibit LIMK2 activation by ROCK and its subsequent activity on cofilin.	ROCK inhibits Cofilin.	{'FPLX:ROCK': {'name': 'ROCK', 'synonyms': ['Coiled-Coil Kinase, rho-Associated', 'Protein Kinases, ROCK', 'ROCK', 'ROCK Protein Kinases', 'ROK Kinase', 'Rho kinase', 'rho Associated Coiled Coil Kinase', 'rho Associated Kinase', 'rho Associated Kinases', 'rho Kinase', 'rho-Associated Coiled-Coil Kinase', 'rho-Associated Kinase', 'rho-Associated Kinases', 'rho-Kinase'], 'definition': None, 'syn_in_text': 'ROCK', 'syn_in_stmt': 'ROCK'}, 'FPLX:Cofilin': {'name': 'Cofilin', 'synonyms': ['AC', 'ADF Proteins (Actin Depolymerizing Factors)', 'Actin Depolymerizing Factors', 'Actin Depolymerizing Protein', 'Actin Depolymerizing Proteins', 'Cofilin', 'Cofilin Proteins', 'Cofilins', 'Depolymerizing Factors, Actin', 'Depolymerizing Protein, Actin', 'Depolymerizing Proteins, Actin', 'Protein, Actin Depolymerizing', 'cofilin'], 'definition': None, 'syn_in_text': 'Cofilin', 'syn_in_stmt': 'Cofilin'}}
keats.jiang@gmail.com	Tue, 04 Feb 2025 17:01:10 GMT	{'annotations': {'agents': {'raw_text': ['TNF-alpha', 'NF-kappaB']}, 'content_source': 'elsevier', 'found_by': 'Positive_activation_token_2_noun', 'prior_uuids': ['a20b795e-d7ca-491d-a5e9-cdeaee6ec682']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '10656992', 'source_api': 'reach', 'source_hash': 2962886472202999000, 'text': 'Induction of E2F-1 in these Saos-2 cells also blocked the activation of NF-kappaB by TNF-alpha.', 'text_refs': {'DOI': '10.1016/S0304-419X(99)00036-0', 'DOI_ID': 'S0304-419X(99)00036-0', 'DOI_NS': 1016, 'PMID': '10656992', 'PMID_NUM': 10656992, 'READER': 'REACH', 'RID': 10100020909754, 'SOURCE': 'elsevier', 'TCID': 20909754, 'TRID': 16172547}}	14634	25206530006599070	{'belief': 1, 'id': '35c1d844-c896-4173-8580-c112208a05dc', 'matches_hash': '25206530006599070', 'obj': {'db_refs': {'FPLX': 'NFkappaB', 'IP': 'IPR000451', 'MESH': 'D016328', 'NCIT': 'C17380', 'TEXT': 'NF-kappaB'}, 'name': 'NFkappaB'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '11892', 'MESH': 'D014409', 'TEXT': 'TNFalpha', 'UP': 'P01375'}, 'name': 'TNF'}, 'type': 'Inhibition'}	DB REST API	2962886472202998745	polarity	Induction of E2F-1 in these Saos-2 cells also blocked the activation of NF-kappaB by TNF-alpha.	TNF inhibits NFkappaB.	{'HGNC:11892': {'name': 'TNF', 'synonyms': ['Cachectin', 'Cachectin Tumor Necrosis Factor', 'Cachectin-Tumor Necrosis Factor', 'DIF', 'TNF', 'TNF Superfamily, Member 2', 'TNF superfamily, member 2', 'TNF-a', 'TNF-alpha', 'TNF-α', 'TNFA', 'TNFSF2', 'TNFalpha', 'TNFα', 'Tumor Necrosis Factor', 'Tumor Necrosis Factor Ligand Superfamily Member 2', 'Tumor Necrosis Factor alpha', 'Tumor Necrosis Factor-alpha', 'Tumor necrosis factor', 'Tumor necrosis factor ligand superfamily member 2', 'tumor necrosis factor'], 'definition': None, 'syn_in_text': 'TNF-alpha', 'syn_in_stmt': 'TNF'}, 'FPLX:NFkappaB': {'name': 'NFkappaB', 'synonyms': ['Enhancer-Binding Protein, Immunoglobulin', 'Factor NF-kB, Transcription', 'Factor-Kappab, Nuclear', 'Immunoglobulin Enhancer Binding Protein', 'Immunoglobulin Enhancer-Binding Protein', 'NF kB', 'NF kappaB', 'NF-kB', 'NF-kB, Transcription Factor', 'NF-kappa B', 'NF-kappaB', 'NF-kappaB Factors', 'NF-kappaB TFs', 'NF-kappaB complexes', 'NF-kappaB dimers', 'NF-kappaB factors', 'NF-kappaB genes', 'NF-kappaB subunits', 'NF-kappaBs', 'NF-kappabeta', 'NF-κB', 'NF-κB Factors', 'NF-κB TFs', 'NF-κB complexes', 'NF-κB dimers', 'NF-κB factors', 'NF-κB genes', 'NF-κB subunits', 'NF-κBs', 'NF-κβ', 'NFkappaB', 'NFkappaB complexes', 'NFκB', 'NFκB complexes', 'Nuclear Factor Kappab', 'Nuclear Factor kappa B', 'Nuclear Factor-Kappab', 'Transcription Factor NF kB', 'Transcription Factor NF-kB', 'kappa B Enhancer Binding Protein'], 'definition': None, 'syn_in_text': 'NF-kappaB', 'syn_in_stmt': 'NFkappaB'}}
bachmanjohn@gmail.com	Tue, 03 Nov 2020 13:51:06 GMT		7726	16983731626394817		EMMAA	6892780886138567941	polarity	Loss and knockdown of merlin leads to mTORC1 activation in malignant mesothelioma, meningioma, and schwannoma and increased meningioma and schwannoma growth [XREF_BIBR, XREF_BIBR].	NF2 activates mTORC1.	{'HGNC:7773': {'name': 'NF2', 'synonyms': ['ACN', 'BANF', 'Gene Product, NF2', 'Merlin', 'Moesin Ezrin Radixin Like Protein', 'Moesin-Ezrin-Radixin-Like Protein', 'Moesin-ezrin-radixin-like protein', 'NF2', 'NF2 Gene Product', 'NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor', 'Neurofibromatosis 2 Gene Product', 'Neurofibromatosis Type 2 Protein', 'Neurofibromin 2', 'Neurofibromin-2', 'Protein, Schwannomin', 'SCH', 'Schwannomerlin', 'Schwannomin', 'Schwannomin Protein', 'bilateral acoustic neurofibromatosis', 'merlin', 'merlin-1', 'moesin-ezrin-radixin like', 'schwannomin'], 'definition': None, 'syn_in_text': 'Merlin', 'syn_in_stmt': 'NF2'}, 'FPLX:mTORC1': {'name': 'mTORC1', 'synonyms': ['Complex, mTORC1', 'Mechanistic Target of Rapamycin Complex 1', 'TOR Complex 1', 'TORC1', 'Target of Rapamycin Complex 1', 'mTORC1', 'mTORC1 Complex'], 'definition': None, 'syn_in_text': 'mTORC1', 'syn_in_stmt': 'mTORC1'}}
ben.gyori@gmail.com	Thu, 07 May 2020 21:02:09 GMT		2738	17524079013656139		DB REST API	-1128663634748002593	polarity	Potassium Intake Prevents the Induction of the Renin-Angiotensin System and Increases Medullary ACE2 and COX-2 in the Kidneys of Angiotensin II Dependent Hypertensive Rats.	Potassium(1+) inhibits ACE2.	{'CHEBI:CHEBI:29103': {'name': 'potassium(1+)', 'synonyms': ['K(+)', 'K+', 'POTASSIUM ION', 'potassium cation', 'potassium(1+)', 'potassium(1+) ion', 'potassium(I) cation', 'Potassium'], 'definition': None, 'syn_in_text': 'Potassium', 'syn_in_stmt': 'Potassium'}, 'HGNC:13557': {'name': 'ACE2', 'synonyms': ['ACE Related Carboxypeptidase', 'ACE-Related Carboxypeptidase', 'ACE-related carboxypeptidase', 'ACE2', 'ACE2 Angiotensin Converting Enzyme Protein 2', 'ACE2 Angiotensin-Converting Enzyme Protein 2', 'ACE2 Enzyme', 'ACE2 Protein', 'ACEH', 'Angiotensin Converting Enzyme 2', 'Angiotensin Converting Enzyme Related Carboxypeptidase', 'Angiotensin-Converting Enzyme 2', 'Angiotensin-Converting Enzyme-Related Carboxypeptidase', 'Angiotensin-converting enzyme 2', 'Angiotensin-converting enzyme homolog', 'Angiotensin-converting enzyme-related carboxypeptidase', 'Carboxypeptidase, ACE-Related', 'Carboxypeptidase, Angiotensin-Converting Enzyme-Related', 'Metalloprotease MPROT15', 'angiotensin converting enzyme 2', 'peptidyl-dipeptidase A'], 'definition': None, 'syn_in_text': 'ACE2', 'syn_in_stmt': 'ACE2'}}
bachmanjohn@gmail.com	Wed, 10 Jun 2020 14:55:38 GMT		4734	33537189156702708		bioexp_paper_multi	-6403739351157028191	polarity	On the other hand, activated AKT phosphorylates and inactivates GSK-3β to decrease phosphorylation of cyclin D1, and accordingly, triggering cell proliferation .	AKT leads to the phosphorylation of CCND1.	{'FPLX:AKT': {'name': 'AKT', 'synonyms': ['AKT', 'AKT family', 'Akt', 'PKB', 'PKB-Akt', 'PKB/Akt'], 'definition': None, 'syn_in_text': 'AKT', 'syn_in_stmt': 'AKT'}, 'HGNC:1582': {'name': 'CCND1', 'synonyms': ['B-cell CLL/lymphoma 1', 'B-cell lymphoma 1 protein', 'BCL-1', 'BCL-1 oncogene', 'BCL1', 'CCND1', 'CCND1 Protein', 'Cyclin D1', 'D11S287E', 'G1/S-specific cyclin D1', 'G1/S-specific cyclin-D1', 'PRAD1', 'PRAD1 Protein', 'PRAD1 oncogene', 'Proto Oncogene Products bcl 1', 'Proto Oncogene Protein bcl 1', 'Proto Oncogene Proteins c bcl 1', 'Proto-Oncogene Products bcl-1', 'Proto-Oncogene Products, bcl-1', 'Proto-Oncogene Protein bcl-1', 'Proto-Oncogene Proteins c-bcl-1', 'Proto-Oncogene Proteins, bcl-1', 'Proto-Oncogene Proteins, bcl1', 'U21B31', 'bcl 1 Proto Oncogene Products', 'bcl 1 Proto Oncogene Proteins', 'bcl-1 Proto-Oncogene Products', 'bcl-1 Proto-Oncogene Proteins', 'bcl-1, Proto-Oncogene Protein', 'bcl1 Proto Oncogene Proteins', 'bcl1 Proto-Oncogene Proteins', 'c bcl 1 Proteins', 'c-bcl-1 Proteins', 'c-bcl-1, Proto-Oncogene Proteins', 'cyclin D1', 'parathyroid adenomatosis 1'], 'definition': None, 'syn_in_text': 'Cyclin D1', 'syn_in_stmt': 'CCND1'}}
ben.gyori@gmail.com	Thu, 17 Sep 2020 20:17:28 GMT		6386	2293123368837272		EMMAA	378768334758663835	polarity	5, 12, 55 Thus, milder SARS-CoV-2 infection in children may be driven by intrinsically lower levels of inflammation, higher lymphocyte to neutrophil ratio in blood, and less predominantly monocytic infiltration than adults.Recent reports have demonstrated that neonates less than 1 year of age (<1 year) are more susceptible to severe COVID-19 disease compared to older children (1-18 years).	Inflammatory response inhibits severe acute respiratory syndrome coronavirus 2.	{'GO:GO:0006954': {'name': 'inflammatory response', 'synonyms': ['Inflammation', 'Inflammations', 'inflammation', 'inflammatory response'], 'definition': None, 'syn_in_text': 'Inflammation', 'syn_in_stmt': 'inflammatory response'}, 'MESH:C000656484': {'name': 'severe acute respiratory syndrome coronavirus 2', 'synonyms': ['severe acute respiratory syndrome coronavirus 2', 'SARS-CoV-2'], 'definition': None, 'syn_in_text': 'SARS-CoV-2', 'syn_in_stmt': 'severe acute respiratory syndrome coronavirus 2'}}
bachmanjohn@gmail.com	Wed, 11 Nov 2020 10:56:49 GMT		8168	-9238221181162362		EMMAA	-2164458733107844701	polarity	Knockdown of PTPRS in MPNST cell lines increased migration and invasion and EMT processes were induced with increased N-cadherin and decreased E-cadherin, which indicated PTPRS may serve as a tumor suppressor in MPNST.	PTPRS inhibits CDH1.	{'HGNC:9681': {'name': 'PTPRS', 'synonyms': ['PTPRS', 'R-PTP-S', 'R-PTP-sigma', 'Receptor-type tyrosine-protein phosphatase S', 'Receptor-type tyrosine-protein phosphatase sigma', 'protein tyrosine phosphatase receptor type S'], 'definition': None, 'syn_in_text': 'PTPRS', 'syn_in_stmt': 'PTPRS'}, 'HGNC:1748': {'name': 'CDH1', 'synonyms': ['CAM 120/80', 'CD antigen CD324', 'CD324', 'CDH1', 'CDHE', 'Cadherin-1', 'E-Cadherin', 'E-cadherin', 'Epithelial cadherin', 'UVO', 'Uvomorulin', 'cadherin 1', 'uvomorulin'], 'definition': None, 'syn_in_text': 'E-Cadherin', 'syn_in_stmt': 'CDH1'}}
ben.gyori@gmail.com	Mon, 07 Jun 2021 20:46:15 GMT	{'annotations': {'agents': {'raw_text': ['EphA6', 'metastasis']}, 'content_source': 'pmc_oa', 'found_by': 'Negative_activation_syntax_1_verb', 'prior_uuids': ['c01ee6ff-e92e-4beb-b975-8e3402c2c19f']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '26041887', 'source_api': 'reach', 'source_hash': -8840964689070692000, 'text': 'EphA6 knock-down in human PC-3M cells causes decreased invasion in vitro and reduced lung and lymph node metastasis in vivo.', 'text_refs': {'DOI': '10.18632/ONCOTARGET.4088', 'DOI_ID': 'ONCOTARGET.4088', 'DOI_NS': 18632, 'PMCID': 'PMC4673184', 'PMCID_NUM': 4673184, 'PMID': '26041887', 'PMID_NUM': 26041887, 'READER': 'REACH', 'RID': 10100017866737, 'SOURCE': 'pmc_oa', 'TCID': 17866737, 'TRID': 2919392}}	12043	2578295806437625	{'belief': 1, 'id': 'c3794f02-75a2-4153-8425-f527723260f8', 'matches_hash': '2578295806437625', 'obj': {'db_refs': {'EFO': '0009708', 'MESH': 'D009362', 'TEXT': 'metastasis'}, 'name': 'Neoplasm Metastasis'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '19296', 'TEXT': 'EphA6', 'UP': 'Q9UF33'}, 'name': 'EPHA6'}, 'type': 'Inhibition'}	DB REST API	-8840964689070691977	polarity	EphA6 knock-down in human PC-3M cells causes decreased invasion in vitro and reduced lung and lymph node metastasis in vivo.	EPHA6 inhibits Neoplasm Metastasis.	{'HGNC:19296': {'name': 'EPHA6', 'synonyms': ['EHK-2', 'EHK2', 'EK12', 'EPH homology kinase 2', 'EPH receptor A6', 'EPH-like kinase 12', 'EPHA6', 'Ephrin type-A receptor 6', 'FLJ35246', 'HEK12', 'EphA6'], 'definition': None, 'syn_in_text': 'EPHA6', 'syn_in_stmt': 'EPHA6'}, 'MESH:D009362': {'name': 'Neoplasm Metastasis', 'synonyms': ['Metastase', 'Metastases', 'Metastases, Neoplasm', 'Metastasis', 'Metastasis, Neoplasm', 'Neoplasm Metastases', 'Neoplasm Metastasis', 'cancer metastasis', 'metastasis', 'neoplasm metastasis', 'tumor cell migration', 'tumor metastasis'], 'definition': None, 'syn_in_text': 'Metastasis', 'syn_in_stmt': 'Metastasis'}}
bachmanjohn@gmail.com	Sat, 24 Oct 2020 21:11:54 GMT		7186	6023921719409540		bioexp_refinements	5529543302057574126	polarity	Specifically, Akt activation was prevented by inhibition of NAD(P)H oxidase.	NADPH_oxidase inhibits AKT.	{'FPLX:NADPH_oxidase': {'name': 'NADPH_oxidase', 'synonyms': ['NAD(P)H Oxidases', 'NAD(P)H oxidase', 'NAD(P)H-oxidase', 'NADPH Oxidase', 'NADPH Oxidases', 'NADPH oxidase', 'Nox Proteins', 'Oxidase, NADPH', 'Oxidases, NADPH', 'NADPH_oxidase'], 'definition': None, 'syn_in_text': 'NAD(P)H oxidase', 'syn_in_stmt': 'NADPH_oxidase'}, 'FPLX:AKT': {'name': 'AKT', 'synonyms': ['AKT', 'AKT family', 'Akt', 'PKB', 'PKB-Akt', 'PKB/Akt'], 'definition': None, 'syn_in_text': 'AKT', 'syn_in_stmt': 'AKT'}}
ben.gyori@gmail.com	Fri, 20 Mar 2020 15:56:28 GMT		2236	-34751684164539180		DB REST API	2699405860048343712	polarity	Metformin represses enzalutamide induced STAT3 activation and TGF-beta1 expression.	Enzalutamide decreases the amount of TGFB1.	{'CHEBI:CHEBI:68534': {'name': 'enzalutamide', 'synonyms': ['4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-benzamide', '4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluoro-N-methylbenzamide', 'MDV 3100', 'MDV-3100', 'MDV3100', 'XTANDI', 'enzalutamide'], 'definition': None, 'syn_in_text': 'enzalutamide', 'syn_in_stmt': 'enzalutamide'}, 'HGNC:11766': {'name': 'TGFB1', 'synonyms': ['CED', 'Camurati-Engelmann disease', 'DPD1', 'Diaphyseal dysplasia 1, progressive', 'TGF beta 1', 'TGF-beta-1', 'TGF-beta1', 'TGF-β1', 'TGFB', 'TGFB1', 'TGFbeta', 'TGFbeta1', 'TGFβ1', 'Transforming Growth Factor beta I', 'Transforming Growth Factor beta1', 'Transforming Growth Factor-beta1', 'Transforming growth factor beta-1 proprotein', 'prepro-transforming growth factor beta-1', 'transforming growth factor beta 1'], 'definition': None, 'syn_in_text': 'TGF-beta1', 'syn_in_stmt': 'TGFB1'}}
bachmanjohn@gmail.com	Fri, 22 May 2020 18:39:08 GMT		3587	-1409606189539046		DB REST API	-8775599565230535402	polarity	Left panels: Expression of Kindlin-1 downregulates N-cadherin and Knockdown of Kindlin-2 downregulates N-cadherin.	FERMT2 inhibits CDH2.	{'HGNC:15767': {'name': 'FERMT2', 'synonyms': ['FERM domain containing kindlin 2', 'FERMT2', 'Fermitin family homolog 2', 'KIND2', 'Kindlin-2', 'MIG-2', 'MIG2', 'Mitogen-inducible gene 2 protein', 'PH domain-containing family C member 1', 'PLEKHC1', 'Pleckstrin homology domain-containing family C member 1', 'UNC112B', 'kindlin-2', 'mig-2', 'mitogen inducible gene-2'], 'definition': None, 'syn_in_text': 'Kindlin-2', 'syn_in_stmt': 'FERMT2'}, 'HGNC:1759': {'name': 'CDH2', 'synonyms': ['CD antigen CD325', 'CD325', 'CDH2', 'CDHN', 'CDw325', 'Cadherin-2', 'N-cadherin', 'NCAD', 'Neural cadherin', 'cadherin 2'], 'definition': None, 'syn_in_text': 'N-cadherin', 'syn_in_stmt': 'CDH2'}}
ben.gyori@gmail.com	Thu, 03 Sep 2020 00:56:33 GMT		6226	17458023362301140		DB REST API	8891176890207937685	polarity	Conversely, siRNA mediated loss of p62 protein in C4-2 PCa cells did not prevent the down regulation of AR induced by IL-1beta (XREF_FIG).	IL1B activates AR.	{'HGNC:5992': {'name': 'IL1B', 'synonyms': ['Catabolin', 'IL-1 beta', 'IL-1B', 'IL-1beta', 'IL-1β', 'IL1-BETA', 'IL1B', 'IL1F2', 'Interleukin 1 beta', 'Interleukin 1beta', 'Interleukin-1 beta', 'Interleukin-1beta', 'interleukin 1 beta'], 'definition': None, 'syn_in_text': 'IL-1beta', 'syn_in_stmt': 'IL1B'}, 'HGNC:644': {'name': 'AR', 'synonyms': ['5 alpha Dihydrotestosterone Receptor', '5 alpha-Dihydrotestosterone Receptor', 'AIS', 'AR', 'Androgen Receptor', 'Androgen Receptors', 'Androgen receptor', 'Androgens Receptors', 'DHTR', 'Dihydrotestosterone Receptors', 'Dihydrotestosterone receptor', 'HUMARA', 'Kennedy disease', 'NR3C4', 'Nuclear receptor subfamily 3 group C member 4', 'Receptor, 5 alpha-Dihydrotestosterone', 'Receptor, Androgen', 'Receptor, Stanolone', 'Receptor, Testosterone', 'Receptors, Androgen', 'Receptors, Androgens', 'Receptors, Dihydrotestosterone', 'Receptors, Stanolone', 'SBMA', 'SMAX1', 'Stanolone Receptor', 'Stanolone Receptors', 'Testosterone Receptor', 'alpha-Dihydrotestosterone Receptor, 5', 'androgen receptor', 'testicular feminization'], 'definition': None, 'syn_in_text': 'AR', 'syn_in_stmt': 'AR'}}
ben.gyori@gmail.com	Thu, 18 Jun 2020 02:01:08 GMT		5569	-34080130013144337		bioexp_paper_medscan	5500381287923079830	polarity	Lastly, PD-1 ligation is more effective in suppressing CD3/CD28-induced changes in the T-cell transcriptional profile, suggesting that differential regulation of phosphatidylinositol 3-kinase activation by PD-1 and CTLA-4 ligation results in distinct cellular phenotypes.	PDCD1 activates PI3K.	{'HGNC:8760': {'name': 'PDCD1', 'synonyms': ['Antigen, CD279', 'Antigens, CD279', 'CD antigen CD279', 'CD279', 'CD279 Antigen', 'CD279 Antigens', 'PD 1 Protein', 'PD 1 Receptor', 'PD-1', 'PD-1 Protein', 'PD-1 Receptor', 'PD1', 'PD1 Receptor', 'PDCD1', 'Programmed Cell Death 1 Protein', 'Programmed Cell Death 1 Receptor', 'Programmed Cell Death Protein 1', 'Programmed cell death protein 1', 'Protein PD-1', 'Receptor, PD-1', 'Receptor, PD1', 'SLEB2', 'hPD-1', 'hSLE1', 'programmed cell death 1'], 'definition': None, 'syn_in_text': 'PD-1', 'syn_in_stmt': 'PDCD1'}, 'FPLX:PI3K': {'name': 'PI3K', 'synonyms': ['PI 3-kinase', 'PI 3-kinases', 'PI-3-K', 'PI3 K', 'PI3-K', 'PI3-Kinase', 'PI3-kinase', 'PI3K', 'PI3Kinase', 'PI3Ks', 'Phosphoinositide 3-kinase', 'Ptdins 3-Kinase', 'Ptdins 3-kinase', 'phosphatidylinositol 3-kinase', 'phosphoinositide 3-kinase', 'phosphoinositide-3 kinase'], 'definition': None, 'syn_in_text': 'phosphatidylinositol 3-kinase', 'syn_in_stmt': 'PI3K'}}
ben.gyori@gmail.com	Tue, 08 Dec 2020 21:08:05 GMT		9859	-29950914389316304		bioexp_psp	-1300266981055867583	mod_site	In cells, the casein kinase II beta-subunit is phosphorylated at an autophosphorylation site and at a site (Ser-209) that is maximally phosphorylated in mitotic cells.	CSNK2B phosphorylates CSNK2B on S209.	{'HGNC:2460': {'name': 'CSNK2B', 'synonyms': ['CK II beta', 'CK2N', 'CSNK2B', 'Casein kinase II subunit beta', 'Ckb1', 'Ckb2', 'G5A', 'Phosphovitellin', 'Phosvitin', 'Protein G5a', 'casein kinase 2 beta', 'casein kinase II beta-subunit'], 'definition': None, 'syn_in_text': 'casein kinase II beta-subunit', 'syn_in_stmt': 'CSNK2B'}}
ben.gyori@gmail.com	Tue, 17 Nov 2020 22:06:32 GMT		8635	17681796354219824		DB REST API	1937655903082247767	entity_boundaries	This can be done by binding of vitamin B12 and insulin.	TNFAIP1 binds INS.	{'HGNC:11894': {'name': 'TNFAIP1', 'synonyms': ['B12', 'B61', 'BACURD2', 'BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2', 'BTB/POZ domain-containing protein TNFAIP1', 'BTBD34', 'EDP1', 'MGC2317', 'Protein B12', 'TNF alpha induced protein 1', 'TNFAIP1', 'Tumor necrosis factor, alpha-induced protein 1, endothelial', 'hBACURD2'], 'definition': None, 'syn_in_text': 'B12', 'syn_in_stmt': 'TNFAIP1'}, 'HGNC:6081': {'name': 'INS', 'synonyms': ['IDDM1', 'IDDM2', 'INS', 'Insulin', 'PI', 'insulin'], 'definition': None, 'syn_in_text': 'Insulin', 'syn_in_stmt': 'INS'}}
ben.gyori@gmail.com	Tue, 17 Nov 2020 18:13:27 GMT		8547	-10209639329845055		DB REST API	1210964761414703358	entity_boundaries	Morus alba root bark extract was produced by 70% ethanol extraction of the ground root bark powder with no less than 10% total bioflavonoids including kuwanon G and albanin G and morusin.	Ethanol activates AFM.	{'CHEBI:CHEBI:16236': {'name': 'ethanol', 'synonyms': ['1-hydroxyethane', 'AE', 'AEs', 'Aethanol', 'Aethylalkohol', 'Alcohol, Ethyl', 'Alcohol, Grain', 'Alkohol', 'C2H5OH', 'Dehydrated ethanol', 'EA', 'ETHANOL', 'EtOH', 'Ethanol', 'Ethyl Alcohol', 'Ethyl alcohol', 'Grain Alcohol', 'Methylcarbinol', '[CH2Me(OH)]', '[OEtH]', 'alcohol', 'alcohol etilico', 'alcool ethylique', 'etanol', 'ethanol', 'hydroxyethane', 'spiritus vini'], 'definition': None, 'syn_in_text': 'ETHANOL', 'syn_in_stmt': 'ETHANOL'}, 'HGNC:316': {'name': 'AFM', 'synonyms': ['AFM', 'ALB2', 'ALBA', 'Afamin', 'Alpha-Alb', 'Alpha-albumin', 'afamin', 'alpha-albumin', 'vitamin E binding protein', 'alba'], 'definition': None, 'syn_in_text': 'ALBA', 'syn_in_stmt': 'AFM'}}
ben.gyori@gmail.com	Sun, 02 Aug 2020 20:25:43 GMT		5970	-7088485299542102		EMMAA	9183936340984383476	entity_boundaries	In contrast, the PM density of wild-type CFTR or G551D-CFTR was not reduced by prolonged VX-770 exposure (XREF_FIG).	Ivacaftor inhibits pyridoxamine.	{'CHEBI:CHEBI:66901': {'name': 'ivacaftor', 'synonyms': ['3-quinolinecarboxamide, N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-1,4-dihydro-4-oxo-', 'Kalydeco', 'N-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide', 'N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide', 'VX-770', 'ivacaftor', 'ivacaftorum'], 'definition': None, 'syn_in_text': 'VX-770', 'syn_in_stmt': 'ivacaftor'}, 'CHEBI:CHEBI:16410': {'name': 'pyridoxamine', 'synonyms': ['4-(AMINOMETHYL)-5-(HYDROXYMETHYL)-2-METHYLPYRIDIN-3-OL', '4-(aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol', 'PM', 'PMs', 'Pyridoxamine', 'pyridoxamine'], 'definition': None, 'syn_in_text': 'PM', 'syn_in_stmt': 'Pyridoxamine'}}
ben.gyori@gmail.com	Wed, 07 Oct 2020 17:25:47 GMT		6518	-8906886486854731		bioexp_paper_medscan	7901061017127629237	entity_boundaries	Upon contact of C. difficile with the host cell, the actin-ADP-ribosylating toxin C. difficile transferase induces an Orai/STIM1-dependent Ca2+ influx resulting in the enrichment of the reticulum-Plasma Membrane in adhesion molecules leading to an increase in C. difficile adhesion and invasion.	Actin activates STIM1.	{'FPLX:Actin': {'name': 'Actin', 'synonyms': ['AF', 'actin', 'actins', 'Actin'], 'definition': None, 'syn_in_text': 'actin', 'syn_in_stmt': 'actin'}, 'HGNC:11386': {'name': 'STIM1', 'synonyms': ['D11S4896E', 'GOK', 'STIM1', 'STIM1 Protein', 'Stromal Interaction Molecule 1', 'Stromal interaction molecule 1', 'stromal interaction molecule 1'], 'definition': None, 'syn_in_text': 'STIM1', 'syn_in_stmt': 'STIM1'}}
ben.gyori@gmail.com	Wed, 23 Feb 2022 03:09:47 GMT	{'annotations': {'agents': {'raw_text': ['~0.05 points', 'degree of depression']}, 'content_source': 'pmc_oa', 'found_by': 'advcl_by_verb-Causal', 'obj_adjectives': [], 'obj_context': {}, 'obj_polarity': 1, 'prior_uuids': ['8298d732-4cb9-4ed5-8eb2-3a707d42ae6b'], 'provenance': [{'@type': 'Provenance', 'document': {'@id': '_:Document_1'}, 'documentCharPositions': [{'@type': 'Interval', 'end': 16950, 'start': 16901}], 'sentence': {'@id': '_:Sentence_100'}, 'sentenceWordPositions': [{'@type': 'Interval', 'end': 39, 'start': 31}]}], 'subj_adjectives': [], 'subj_context': {}, 'subj_polarity': None}, 'pmid': '33575236', 'source_api': 'eidos', 'source_hash': 2599518188554344000, 'text': 'In Model 1 , the age of first childbirth was significantly and positively correlated with the degree of depression ; an increase of 1 in the age of first childbirth increased the degree of depression by ~ 0.05 points .', 'text_refs': {'DOI': '10.3389/FPUBH.2020.570832', 'DOI_ID': 'FPUBH.2020.570832', 'DOI_NS': 3389, 'PMCID': 'PMC7870999', 'PMCID_NUM': 7870999, 'PMID': '33575236', 'PMID_NUM': 33575236, 'READER': 'EIDOS', 'RID': 50000059455643, 'SOURCE': 'pmc_oa', 'TCID': 59455643, 'TRID': 32796813}}	12748	17980390054611460	{'belief': 1, 'id': 'a1f3286f-6f84-4fc7-b61f-6a096b527d56', 'matches_hash': '17980390054611460', 'obj': {'db_refs': {'DOID': 'DOID:1596', 'MESH': 'D003863', 'TEXT': 'degree of depression', 'TEXT_NORM': 'depression'}, 'name': 'Depression'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'TEXT': '~0.05 points', 'TEXT_NORM': '~ points'}, 'name': '~ points'}, 'type': 'Activation'}	DB REST API	2599518188554344017	entity_boundaries	In Model 1 , the age of first childbirth was significantly and positively correlated with the degree of depression ; an increase of 1 in the age of first childbirth increased the degree of depression by ~ 0.05 points .	~ points activates Depression.	{'MESH:D003863': {'name': 'Depression', 'synonyms': ['Depression', 'depression', 'depressive disorder', 'mental depression', 'degree of depression'], 'definition': None, 'syn_in_text': 'Depression', 'syn_in_stmt': 'Depression'}}
ben.gyori@gmail.com	Tue, 17 Nov 2020 18:14:39 GMT		8564	8536302210923656		DB REST API	-6665808552827764322	entity_boundaries	Both Glycyrrhiza uralensis and Morus alba are able to inhibit viral enzymes (PR, RT1 and IN), glycoproteins (gp120 and gp41) and two host proteins (CycT1 and CXCR4).	AFM inhibits env.	{'HGNC:316': {'name': 'AFM', 'synonyms': ['AFM', 'ALB2', 'ALBA', 'Afamin', 'Alpha-Alb', 'Alpha-albumin', 'afamin', 'alpha-albumin', 'vitamin E binding protein', 'alba'], 'definition': None, 'syn_in_text': 'ALBA', 'syn_in_stmt': 'AFM'}, 'UP:P04578': {'name': 'env', 'synonyms': ['gp120', 'env'], 'definition': None, 'syn_in_text': 'gp120', 'syn_in_stmt': 'env'}}
ben.gyori@gmail.com	Wed, 17 Nov 2021 02:32:51 GMT		12517	15666466423454133	{'belief': 1, 'id': 'f088e6c5-1234-4f69-897a-5577b67dcabf', 'matches_hash': '15666466423454133', 'obj': {'db_refs': {'EFO': '0009625', 'MESH': 'D005157', 'TEXT': 'Facial pain'}, 'name': 'Facial Pain'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'PF': 'PF07897', 'TEXT': 'ear'}, 'name': 'ear'}, 'type': 'Activation'}	EMMAA	-1569035030294818177	entity_boundaries	Facial pain of different localization may be caused by ear, nose or throat inflammation, tumors, anatomic deviations of ENT organs, their traumatic lesions or surgical interventions or may be of psychogenic origin.	Ear activates Facial Pain.	{'MESH:D005157': {'name': 'Facial Pain', 'synonyms': ['Face Pain', 'Facial Pain', 'Pain, Face', 'Pain, Facial', 'facial pain', 'Facial pain'], 'definition': None, 'syn_in_text': 'Facial Pain', 'syn_in_stmt': 'Facial Pain'}}
ben.gyori@gmail.com	Sun, 28 Feb 2021 00:57:25 GMT		11419	-32719632436713255		bioexp_sparser	4572310859383701603	entity_boundaries	While Robo1-cc3 binding to the isolated SH3 domain has very fast on- and off-rates, much slower rates were measured for the 2RS and 2BRS constructs.	ROBO1 binds HTATIP2.	{'HGNC:10249': {'name': 'ROBO1', 'synonyms': ['DUTT1', 'Deleted in U twenty twenty', 'FLJ21882', 'H-Robo-1', 'ROBO1', 'Roundabout homolog 1', 'SAX3', 'roundabout guidance receptor 1', 'Robo1'], 'definition': None, 'syn_in_text': 'ROBO1', 'syn_in_stmt': 'ROBO1'}, 'HGNC:16637': {'name': 'HTATIP2', 'synonyms': ['30 kDa HIV-1 TAT-interacting protein', 'CC3', 'FLJ26963', 'HIV-1 TAT-interactive protein 2', 'HIV-1 Tat interactive protein 2', 'HTATIP2', 'Oxidoreductase HTATIP2', 'SDR44U1', 'TIP30', 'Tat-interacting protein (30kD)', 'short chain dehydrogenase/reductase family 44U, member 1'], 'definition': None, 'syn_in_text': 'CC3', 'syn_in_stmt': 'HTATIP2'}}
ben.gyori@gmail.com	Wed, 09 Sep 2020 20:27:03 GMT		6272	-5559172548467151		DB REST API	-3038734700372463535	entity_boundaries	Stimulation with IL-1beta (10ng/mL) led to increases in the levels of the cytokines IFN-alpha, IL-6, IL-8, IL-15, the cytokine antagonist IL-1RA, and the chemokines monocyte chemoattractant protein-1 (MCP-1), interferon-gamma-inducible protein 10 (IP-10) and regulated on activation, normal T cell expressed and secreted (RANTES) (XREF_TABLE).	10ng/mL increases the amount of IL15.	{'HGNC:5977': {'name': 'IL15', 'synonyms': ['IL-15', 'IL15', 'Interleukin 15', 'Interleukin-15', 'MGC9721', 'interleukin 15'], 'definition': None, 'syn_in_text': 'IL-15', 'syn_in_stmt': 'IL15'}}
ben.gyori@gmail.com	Mon, 10 Jan 2022 22:34:00 GMT		12595	-7998057680393194	{'belief': 1, 'id': 'e22ac441-d5f9-4739-a324-4f26a2a59dcb', 'matches_hash': '-7998057680393194', 'members': [{'db_refs': {'CAS': '7440-23-5', 'CHEBI': 'CHEBI:26708', 'PUBCHEM': '5360545', 'TEXT': 'Na'}, 'name': 'sodium atom'}, {'db_refs': {'HGNC': '637', 'MESH': 'D051401', 'TEXT': 'AQP4', 'UP': 'P55087'}, 'name': 'AQP4'}], 'type': 'Complex'}	panacea_enzyme	8048044797942304843	entity_boundaries	However, the spatio-temporal functional interactions between AQP4 and Na + -permeable channels that drive swelling are poorly understood.	Sodium atom binds AQP4.	{'CHEBI:CHEBI:26708': {'name': 'sodium atom', 'synonyms': ['11Na', 'Na', 'Natrium', 'natrium', 'sodio', 'sodium', 'sodium atom'], 'definition': None, 'syn_in_text': 'Na', 'syn_in_stmt': 'sodium'}, 'HGNC:637': {'name': 'AQP4', 'synonyms': ['AQP-4', 'AQP4', 'Aquaporin-4', 'MIWC', 'Mercurial-insensitive water channel', 'WCH4', 'aquaporin 4', 'hAQP4'], 'definition': None, 'syn_in_text': 'AQP4', 'syn_in_stmt': 'AQP4'}}
ben.gyori@gmail.com	Tue, 18 Aug 2020 00:12:13 GMT		6115	-30728140747558687		DB REST API	3658117851104909792	entity_boundaries	Indeed, it has been reported that CCL2 expression is associated with accumulation of an activated memory subset of T cells during tissue injury or infection [XREF_BIBR], and studies by Castellino et al have shown that blockade of CCL3 and CCL4 can markedly reduce the ability of CD4 + T cells to promote memory OT-I (CD8 +) generation [XREF_BIBR].	CCL4 activates CD4.	{'HGNC:10630': {'name': 'CCL4', 'synonyms': ['ACT-2', 'AT744.1', 'Act-2', 'C-C motif chemokine 4', 'C-C motif chemokine ligand 4', 'CCL4', 'CCL4 Chemokine', 'CCL4, Chemokine', 'Chemokine CCL4', 'Chemokine, CCL4', 'G-26 T-lymphocyte-secreted protein', 'HC21', 'LAG-1', 'LAG1', 'Lymphocyte activation gene 1 protein', 'MIP 1beta', 'MIP-1-beta', 'MIP-1-beta(1-69)', 'MIP-1beta', 'MIP1B', 'Macrophage Inflammatory Protein 1 beta', 'Macrophage Inflammatory Protein 1-beta', 'Macrophage inflammatory protein 1-beta', 'PAT 744', 'Protein H400', 'SCYA4', 'SIS-gamma', 'Small-inducible cytokine A4', 'T-cell activation protein 2'], 'definition': None, 'syn_in_text': 'CCL4', 'syn_in_stmt': 'CCL4'}, 'HGNC:1678': {'name': 'CD4', 'synonyms': ['Antigen, CD4', 'Antigens, CD4', 'Antigens, T-Cell T4', 'CD antigen CD4', 'CD4', 'CD4 Antigen', 'CD4 Antigens', 'CD4 Molecule', 'CD4 Receptor', 'CD4 Receptor, Surface', 'CD4 Receptors', 'CD4 Receptors, Surface', 'CD4 molecule', 'Leu-3', 'Receptor, CD4', 'Receptors, CD4', 'Receptors, Surface CD4', 'Surface CD4 Receptor', 'Surface CD4 Receptors', 'T-Cell T4 Antigens', 'T-cell surface antigen T4/Leu-3', 'T-cell surface glycoprotein CD4', 'T4', 'T4 Antigens, T Cell', 'T4 Antigens, T-Cell'], 'definition': None, 'syn_in_text': 'CD4', 'syn_in_stmt': 'CD4'}}
ben.gyori@gmail.com	Tue, 17 Nov 2020 18:14:32 GMT		8562	23025897738413122		DB REST API	-6634639234188146715	entity_boundaries	Morus alba extract modulates blood pressure homeostasis through eNOS signaling.	AFM activates homeostatic process.	{'HGNC:316': {'name': 'AFM', 'synonyms': ['AFM', 'ALB2', 'ALBA', 'Afamin', 'Alpha-Alb', 'Alpha-albumin', 'afamin', 'alpha-albumin', 'vitamin E binding protein', 'alba'], 'definition': None, 'syn_in_text': 'ALBA', 'syn_in_stmt': 'AFM'}, 'GO:GO:0042592': {'name': 'homeostatic process', 'synonyms': ['Autoregulation', 'Homeostasis', 'homeostasis', 'homeostatic process', 'negative regulation of homeostatic process', 'positive regulation of homeostatic process', 'regulation of homeostatic process'], 'definition': None, 'syn_in_text': 'Homeostasis', 'syn_in_stmt': 'homeostatic process'}}
ben.gyori@gmail.com	Tue, 24 Nov 2020 21:54:55 GMT		9013	-24031040192969568		EMMAA	2071062315749536544	entity_boundaries	However, the perilesional CD8 + T cells induced more extensive apoptosis in the autologous melanocytes, suggesting higher cytotoxicity.	CD8 activates apoptotic process.	{'FPLX:CD8': {'name': 'CD8', 'synonyms': ['CD8'], 'definition': None, 'syn_in_text': 'CD8', 'syn_in_stmt': 'CD8'}, 'GO:GO:0006915': {'name': 'apoptotic process', 'synonyms': ['Apoptosis', 'Apoptosis, Classic', 'Apoptosis, Classical', 'Classic Apoptoses', 'Classic Apoptosis', 'Classical Apoptosis', 'PA', 'Programmed Cell Death, Type I', 'apoptosis', 'apoptosis activator activity', 'apoptotic cell death', 'apoptotic process', 'apoptotic programmed cell death', 'caspase-dependent programmed cell death', 'commitment to apoptosis', 'induction of apoptosis', 'induction of apoptosis by p53', 'programmed cell death by apoptosis', 'signaling (initiator) caspase activity'], 'definition': None, 'syn_in_text': 'Apoptosis', 'syn_in_stmt': 'apoptotic process'}}
imke.ditters@gmail.com	Sun, 10 Apr 2022 09:23:49 GMT	"{'annotations': {'agents': {'raw_text': ['lysosomal alpha-glucosidase', 'Glycogen']}, 'content_source': 'pubmed', 'found_by': 'Positive_activation_syntax_2_verb', 'prior_uuids': ['f1ec0d2b-3d6c-4292-a945-b0f46a11f9eb']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '7881422', 'source_api': 'reach', 'source_hash': -565323039336653950, 'text': ""Glycogen storage disease type II (GSDII, Pompe 's disease) is caused by an autosomal recessive inheritance of lysosomal alpha-glucosidase deficiency."", 'text_refs': {'DOI': '10.1093/HMG/3.12.2213', 'DOI_ID': 'HMG/3.12.2213', 'DOI_NS': 1093, 'PMID': '7881422', 'PMID_NUM': 7881422, 'READER': 'REACH', 'RID': 10100017236629, 'SOURCE': 'pubmed', 'TCID': 17236629, 'TRID': 27409786}}"	13005	-17994651596617708	{'belief': 1, 'id': '399c29a4-2e40-4047-b007-e2be161f92d9', 'matches_hash': '-17994651596617708', 'obj': {'db_refs': {'PUBCHEM': '439177', 'TEXT': 'Glycogen'}, 'name': 'Glycogen'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '4065', 'TEXT': 'lysosomal alpha-glucosidase', 'UP': 'P10253'}, 'name': 'GAA'}, 'type': 'Activation'}	DB REST API	-565323039336653920	entity_boundaries	Glycogen storage disease type II (GSDII, Pompe 's disease) is caused by an autosomal recessive inheritance of lysosomal alpha-glucosidase deficiency.	GAA activates Glycogen.	{'HGNC:4065': {'name': 'GAA', 'synonyms': ['Acid maltase', 'Aglucosidase alfa', 'GAA', 'Lysosomal alpha-glucosidase', 'Pompe disease', 'alpha glucosidase', 'glycogen storage disease type II', 'lysosomal alpha-glucosidase'], 'definition': None, 'syn_in_text': 'Lysosomal alpha-glucosidase', 'syn_in_stmt': 'GAA'}}
ben.gyori@gmail.com	Mon, 16 Nov 2020 17:46:58 GMT		8416	-28321162014347366		DB REST API	-8139148276807892472	entity_boundaries	The LDLR gene is regulated by SREBP-2, also known as sterol regulatory element binding transcription factor 2 (SREBF-2), and we found that the expression of Srebf2 was also downregulated in GF mice (XREF_FIG).	SREBF2 binds HNF1B.	{'HGNC:11290': {'name': 'SREBF2', 'synonyms': ['BHLHD2', 'Class D basic helix-loop-helix protein 2', 'SREBF2', 'SREBP-2', 'SREBP2', 'Sterol regulatory element-binding protein 2', 'Sterol regulatory element-binding transcription factor 2', 'bHLHd2', 'sterol regulatory element binding transcription factor 2'], 'definition': None, 'syn_in_text': 'SREBF2', 'syn_in_stmt': 'SREBF2'}, 'HGNC:11630': {'name': 'HNF1B', 'synonyms': ['HNF 1beta', 'HNF-1-beta', 'HNF-1B', 'HNF-1beta', 'HNF1 homeobox B', 'HNF1B', 'HNF1beta', 'HNF1β', 'Hepatocyte Nuclear Factor 1 beta', 'Hepatocyte Nuclear Factor 1-beta', 'Hepatocyte Nuclear Factor 1beta', 'Hepatocyte Nuclear Factor-1beta', 'Hepatocyte nuclear factor 1-beta', 'Homeoprotein LFB3', 'LFB3', 'Liver Specific Transcription Factor LF B3', 'Liver Specific Transcription Factor LF-B3', 'MODY5', 'TCF-2', 'TCF2', 'Transcription factor 2', 'VHNF1', 'Variant Hepatic Nuclear Factor 1', 'Variant hepatic nuclear factor 1', 'hepatocyte nuclear factor 1 beta', 'vHNF1', 'transcription factor 2'], 'definition': None, 'syn_in_text': 'Transcription factor 2', 'syn_in_stmt': 'HNF1B'}}
ben.gyori@gmail.com	Tue, 17 Nov 2020 18:16:35 GMT		8567	-22254348760066245		DB REST API	-5376123979475658710	entity_boundaries	Lack of Smad2 in T cells reduces TGF-beta-induced upregulation of forkhead box p3 (Foxp3), a master regulator of Treg differentiation [XREF_BIBR, XREF_BIBR].	SMAD2 inhibits SLC10A3.	{'HGNC:6768': {'name': 'SMAD2', 'synonyms': ['JV18-1', 'MAD homolog 2', 'MADH2', 'MADR2', 'Mad-related protein 2', 'Mothers against DPP homolog 2', 'Mothers against decapentaplegic homolog 2', 'SMAD 2', 'SMAD family member 2', 'SMAD2', 'Smad2', 'hMAD-2', 'hSMAD2', 'smad2'], 'definition': None, 'syn_in_text': 'SMAD2', 'syn_in_stmt': 'SMAD2'}, 'HGNC:22979': {'name': 'SLC10A3', 'synonyms': ['DXS253E', 'P3', 'P3 protein', 'SLC10A3', 'Solute carrier family 10 member 3', 'solute carrier family 10 member 3', 'p3'], 'definition': None, 'syn_in_text': 'P3', 'syn_in_stmt': 'SLC10A3'}}
ben.gyori@gmail.com	Mon, 02 Nov 2020 14:51:34 GMT		7537	19551559151540498		EMMAA	9023343783541835136	entity_boundaries	(I-J) Western blot analysis of IFITM3 expression by WT B6 CD8 + T cells and (I) IFNγ KO CD8 + T cells or (J) IFNAR KO CD8 + T cells before (0) and 1 and 2 days after infection with influenza virus strain X-31 (moi = 1).	CD8 increases the amount of IFITM3.	{'FPLX:CD8': {'name': 'CD8', 'synonyms': ['CD8'], 'definition': None, 'syn_in_text': 'CD8', 'syn_in_stmt': 'CD8'}, 'HGNC:5414': {'name': 'IFITM3', 'synonyms': ['1-8U', 'DSPA2b', 'Dispanin subfamily A member 2b', 'IFITM3', 'Interferon-induced transmembrane protein 3', 'Interferon-inducible protein 1-8U', 'dispanin subfamily A member 2b', 'interferon induced transmembrane protein 3'], 'definition': None, 'syn_in_text': 'IFITM3', 'syn_in_stmt': 'IFITM3'}}
bachmanjohn@gmail.com	Thu, 10 Dec 2020 02:23:53 GMT		9953	13789983949709177		DB REST API	-4008453002993885049	entity_boundaries	It was previously shown that GAP-43 can interact with actin filaments and microtubule-associated proteins ( Chakravarthy et al., 2008; Ollom and Denny, 2008 ), and involved G protein signaling ( Arni et al., 1998; Denny, 2006; Yang et al., 2009 ).	Actin binds GAP43, MAP, and filament.	{'FPLX:Actin': {'name': 'Actin', 'synonyms': ['AF', 'actin', 'actins', 'Actin'], 'definition': None, 'syn_in_text': 'actin', 'syn_in_stmt': 'actin'}, 'HGNC:4140': {'name': 'GAP43', 'synonyms': ['Axonal membrane protein GAP-43', 'B 50 Protein', 'B-50', 'B-50 Protein', 'GAP 43 Protein', 'GAP-43', 'GAP-43 Protein', 'GAP43', 'GAP43 Protein', 'Growth Associated Protein 43', 'Growth-Associated Protein 43', 'Growth-associated protein 43', 'Nerve Growth Cone Membrane Protein GAP 43', 'Nerve Growth Cone Membrane Protein GAP-43', 'Neural phosphoprotein B-50', 'Neuromodulin', 'PP46', 'Phosphoprotein B 50', 'Phosphoprotein B-50', 'Phosphoprotein F1', 'Phosphoprotein pp46', 'axonal membrane protein GAP-43', 'calmodulin-binding protein P-57', 'growth associated protein 43', 'nerve growth-related peptide GAP43', 'neural phosphoprotein B-50', 'neuromodulin', 'neuron growth-associated protein 43', 'pp46', 'protein F1'], 'definition': None, 'syn_in_text': 'GAP-43', 'syn_in_stmt': 'GAP43'}}
ben.gyori@gmail.com	Wed, 22 Apr 2020 19:05:08 GMT		2542	5923214834052419		EMMAA	-7606022975296992357	entity_boundaries	Among these PAK1-blockers, at least CQ and Ivermectin have been proven to block the replication of COVID-19 in Vero cell culture with IC 50 ranging 1-3muM, and a combination of HQ and AZ or ciclesonide alone have been shown clinically to ease the pathogenic symptom of this virus.	CQ activates IC 50  ranging 1-3muM.	{}
ben.gyori@gmail.com	Mon, 01 Jun 2020 15:36:49 GMT		4173	21214119480469023		bioexp_paper_trips	1876438925471444509	entity_boundaries	Hence the pathway by which Stat 5B is activated by insulin is different from that used by GH.	INS activates STAT.	{'HGNC:6081': {'name': 'INS', 'synonyms': ['IDDM1', 'IDDM2', 'INS', 'Insulin', 'PI', 'insulin'], 'definition': None, 'syn_in_text': 'Insulin', 'syn_in_stmt': 'INS'}, 'FPLX:STAT': {'name': 'STAT', 'synonyms': ['STAT', 'STATs'], 'definition': None, 'syn_in_text': 'STAT', 'syn_in_stmt': 'STAT'}}
ben.gyori@gmail.com	Mon, 16 Nov 2020 17:47:02 GMT		8417	-11195049870633084		DB REST API	-3888123091049028054	entity_boundaries	G4 +/- HF IU fetal liver had significantly decreased expression of sterol regulatory element binding transcription factor 2 (SREBF2) compared with G4 +/- C IU (XREF_TABLE).	SREBF2 binds HNF1B and G4.	{'HGNC:11290': {'name': 'SREBF2', 'synonyms': ['BHLHD2', 'Class D basic helix-loop-helix protein 2', 'SREBF2', 'SREBP-2', 'SREBP2', 'Sterol regulatory element-binding protein 2', 'Sterol regulatory element-binding transcription factor 2', 'bHLHd2', 'sterol regulatory element binding transcription factor 2'], 'definition': None, 'syn_in_text': 'SREBF2', 'syn_in_stmt': 'SREBF2'}, 'HGNC:11630': {'name': 'HNF1B', 'synonyms': ['HNF 1beta', 'HNF-1-beta', 'HNF-1B', 'HNF-1beta', 'HNF1 homeobox B', 'HNF1B', 'HNF1beta', 'HNF1β', 'Hepatocyte Nuclear Factor 1 beta', 'Hepatocyte Nuclear Factor 1-beta', 'Hepatocyte Nuclear Factor 1beta', 'Hepatocyte Nuclear Factor-1beta', 'Hepatocyte nuclear factor 1-beta', 'Homeoprotein LFB3', 'LFB3', 'Liver Specific Transcription Factor LF B3', 'Liver Specific Transcription Factor LF-B3', 'MODY5', 'TCF-2', 'TCF2', 'Transcription factor 2', 'VHNF1', 'Variant Hepatic Nuclear Factor 1', 'Variant hepatic nuclear factor 1', 'hepatocyte nuclear factor 1 beta', 'vHNF1', 'transcription factor 2'], 'definition': None, 'syn_in_text': 'Transcription factor 2', 'syn_in_stmt': 'HNF1B'}}
ben.gyori@gmail.com	Tue, 17 Nov 2020 22:06:13 GMT		8633	-27066836186373759		DB REST API	-399244632559582550	entity_boundaries	Nitrous oxide inactivates vitamin B12, decreasing conversion of homocysteine to methionine, ultimately resulting in demyelination within the central and peripheral nervous systems. xref This classically results in subacute combined degeneration, especially around the dorsal columns of the spinal cord. xref Clinically, chronic nitrous oxide abuse may present with peripheral neuropathic effects, including tingling and numbness all the way up to loss of dexterity, poor balance, and leg weakness. xref Although the neurologic changes may be irreversible, some function may be restored through cessation and B12 supplementation. xref 	Oxide inhibits TNFAIP1.	{'CHEBI:25741': {'name': 'oxide', 'synonyms': ['oxide'], 'definition': None, 'syn_in_text': 'oxide', 'syn_in_stmt': 'oxide'}, 'HGNC:11894': {'name': 'TNFAIP1', 'synonyms': ['B12', 'B61', 'BACURD2', 'BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2', 'BTB/POZ domain-containing protein TNFAIP1', 'BTBD34', 'EDP1', 'MGC2317', 'Protein B12', 'TNF alpha induced protein 1', 'TNFAIP1', 'Tumor necrosis factor, alpha-induced protein 1, endothelial', 'hBACURD2'], 'definition': None, 'syn_in_text': 'B12', 'syn_in_stmt': 'TNFAIP1'}}
ben.gyori@gmail.com	Tue, 15 Dec 2020 06:27:43 GMT		10298	9645360838970078		EMMAA	-6052228495913458994	entity_boundaries	To determine whether CD8 + T cells with this phenotype can actively suppress MOG 35-55 specific CD4 + T cells in vitro, CD4 + T cells from MOG immunized were co-cultured either with total CD8 + T cells or purified CD8 + CD44 + CD122 + Ly49 + (Ly49 +) or CD8 + CD44 + CD122 + Ly49 - (Ly49 -) T cells from MOG + SP immunized mice.	CD8 inhibits CD4.	{'FPLX:CD8': {'name': 'CD8', 'synonyms': ['CD8'], 'definition': None, 'syn_in_text': 'CD8', 'syn_in_stmt': 'CD8'}, 'HGNC:1678': {'name': 'CD4', 'synonyms': ['Antigen, CD4', 'Antigens, CD4', 'Antigens, T-Cell T4', 'CD antigen CD4', 'CD4', 'CD4 Antigen', 'CD4 Antigens', 'CD4 Molecule', 'CD4 Receptor', 'CD4 Receptor, Surface', 'CD4 Receptors', 'CD4 Receptors, Surface', 'CD4 molecule', 'Leu-3', 'Receptor, CD4', 'Receptors, CD4', 'Receptors, Surface CD4', 'Surface CD4 Receptor', 'Surface CD4 Receptors', 'T-Cell T4 Antigens', 'T-cell surface antigen T4/Leu-3', 'T-cell surface glycoprotein CD4', 'T4', 'T4 Antigens, T Cell', 'T4 Antigens, T-Cell'], 'definition': None, 'syn_in_text': 'CD4', 'syn_in_stmt': 'CD4'}}
ben.gyori@gmail.com	Mon, 07 Dec 2020 19:23:19 GMT		9816	27052151590649317		DB REST API	3941974118078696204	entity_boundaries	This study identifies three global inducers of sIL-15 complexes in vivo , IFN-α, VSV infection, and CD40 stimulation which can now be included among TLR stimulation and lymphodepletion as events inducing sIL-15 complexes.	IFNA binds STIL.	{'FPLX:IFNA': {'name': 'IFNA', 'synonyms': ['IFN-a', 'IFN-alpha', 'IFN-α', 'IFNalpha', 'IFNα', 'IFNA'], 'definition': None, 'syn_in_text': 'IFN-α', 'syn_in_stmt': 'IFNA'}, 'HGNC:10879': {'name': 'STIL', 'synonyms': ['MCPH7', 'SCL-interrupting locus protein', 'SIL', 'STIL', 'STIL centriolar assembly protein', 'TAL-1-interrupting locus protein', 'sIL'], 'definition': None, 'syn_in_text': 'SIL', 'syn_in_stmt': 'STIL'}}
cthoyt@gmail.com	Thu, 17 Jun 2021 20:20:09 GMT		12094	25623132319847608	{'belief': 1, 'id': 'd13990b1-e0e0-482b-a5e3-74781a3c3a11', 'matches_hash': '25623132319847608', 'obj': {'db_refs': {'HGNC': '18318', 'TEXT': 'ASXL1', 'UP': 'Q8IXJ9'}, 'name': 'ASXL1'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '950', 'TEXT': 'BAP1', 'UP': 'Q92560'}, 'name': 'BAP1'}, 'type': 'Activation'}	DB REST API	-4030672889860598834	entity_boundaries	Reduced BAP1 activity prevents ASXL1 truncation driven myeloid malignancy in vivo.	BAP1 activates ASXL1.	{'HGNC:950': {'name': 'BAP1', 'synonyms': ['BAP1', 'BRCA1 associated protein 1', 'BRCA1-associated protein 1', 'Cerebral protein 6', 'KIAA0272', 'UCHL2', 'Ubiquitin carboxyl-terminal hydrolase BAP1', 'hucep-6', 'ubiquitin carboxy-terminal hydrolase'], 'definition': None, 'syn_in_text': 'BAP1', 'syn_in_stmt': 'BAP1'}, 'HGNC:18318': {'name': 'ASXL1', 'synonyms': ['ASXL transcriptional regulator 1', 'ASXL1', 'Additional sex combs-like protein 1', 'KIAA0978', 'Polycomb group protein ASXL1'], 'definition': None, 'syn_in_text': 'ASXL1', 'syn_in_stmt': 'ASXL1'}}
ben.gyori@gmail.com	Fri, 14 Aug 2020 12:34:07 GMT		6090	27333944557826697		EMMAA	-29264291209842421	entity_boundaries	Available evidence suggests that road traffic is likely to be the largest source of CO and NO2 concentrations in Chinese cities while electricity generation and coal burning will be the largest sources of SO2 .	Electricity activates sulfur dioxide.	{'MESH:D004560': {'name': 'Electricity', 'synonyms': ['Electricity', 'electricity generation'], 'definition': None, 'syn_in_text': 'Electricity', 'syn_in_stmt': 'Electricity'}, 'CHEBI:CHEBI:18422': {'name': 'sulfur dioxide', 'synonyms': ['R-764', 'SO2', 'SULFUR DIOXIDE', 'Schwefel(IV)-oxid', 'Schwefeldioxid', 'Sulfur Dioxide', 'Sulfur dioxide', 'Sulfurous Anhydride', '[SO2]', 'dioxidosulfur', 'sulfur dioxide', 'sulfurous anhydride', 'sulfurous oxide', 'sulphur dioxide'], 'definition': None, 'syn_in_text': 'SO2', 'syn_in_stmt': 'SULFUR DIOXIDE'}}
ben.gyori@gmail.com	Tue, 04 Aug 2020 14:05:39 GMT		5990	11546731450971388		EMMAA	959929282720485803	entity_boundaries	Transcription factor enrichment analysis unravels multiple transcription factors modulating the deregulated genes in SARS-CoV-2 infected cells.	Transcription, DNA-templated activates severe acute respiratory syndrome coronavirus 2.	{'GO:GO:0006351': {'name': 'transcription, DNA-templated', 'synonyms': ['DNA-dependent transcription', 'DNA-templated transcription', 'Genetic Transcription', 'RT', 'RTs', 'Transcription, Genetic', 'transcription', 'transcription, DNA-dependent', 'transcription, DNA-templated'], 'definition': None, 'syn_in_text': 'transcription', 'syn_in_stmt': 'transcription'}, 'MESH:C000656484': {'name': 'severe acute respiratory syndrome coronavirus 2', 'synonyms': ['severe acute respiratory syndrome coronavirus 2', 'SARS-CoV-2'], 'definition': None, 'syn_in_text': 'SARS-CoV-2', 'syn_in_stmt': 'severe acute respiratory syndrome coronavirus 2'}}
ben.gyori@gmail.com	Tue, 18 Aug 2020 14:15:25 GMT		6116	16522692537143494		DB REST API	-9199179256811905519	entity_boundaries	While TNFα-producing CD4 + T cells were not independently associated with future protection, the absence of cells producing this inflammatory cytokine was associated with the phenotype of asymptomatic infection.	TNF binds CD4.	{'HGNC:11892': {'name': 'TNF', 'synonyms': ['Cachectin', 'Cachectin Tumor Necrosis Factor', 'Cachectin-Tumor Necrosis Factor', 'DIF', 'TNF', 'TNF Superfamily, Member 2', 'TNF superfamily, member 2', 'TNF-a', 'TNF-alpha', 'TNF-α', 'TNFA', 'TNFSF2', 'TNFalpha', 'TNFα', 'Tumor Necrosis Factor', 'Tumor Necrosis Factor Ligand Superfamily Member 2', 'Tumor Necrosis Factor alpha', 'Tumor Necrosis Factor-alpha', 'Tumor necrosis factor', 'Tumor necrosis factor ligand superfamily member 2', 'tumor necrosis factor'], 'definition': None, 'syn_in_text': 'TNF', 'syn_in_stmt': 'TNF'}, 'HGNC:1678': {'name': 'CD4', 'synonyms': ['Antigen, CD4', 'Antigens, CD4', 'Antigens, T-Cell T4', 'CD antigen CD4', 'CD4', 'CD4 Antigen', 'CD4 Antigens', 'CD4 Molecule', 'CD4 Receptor', 'CD4 Receptor, Surface', 'CD4 Receptors', 'CD4 Receptors, Surface', 'CD4 molecule', 'Leu-3', 'Receptor, CD4', 'Receptors, CD4', 'Receptors, Surface CD4', 'Surface CD4 Receptor', 'Surface CD4 Receptors', 'T-Cell T4 Antigens', 'T-cell surface antigen T4/Leu-3', 'T-cell surface glycoprotein CD4', 'T4', 'T4 Antigens, T Cell', 'T4 Antigens, T-Cell'], 'definition': None, 'syn_in_text': 'CD4', 'syn_in_stmt': 'CD4'}}
ben.gyori@gmail.com	Mon, 16 Nov 2020 17:35:49 GMT		8402	35426568228592371		DB REST API	6372419435284304819	entity_boundaries	They postulated that long-term plastic changes and newly formed mature dentate gyrus cells are implicated in such positive findings [ xref ].	DISC1 binds ESR1.	{'HGNC:2888': {'name': 'DISC1', 'synonyms': ['DISC1', 'DISC1 scaffold protein', 'Disrupted in schizophrenia 1 protein', 'KIAA0457', 'dentate'], 'definition': None, 'syn_in_text': 'dentate', 'syn_in_stmt': 'DISC1'}, 'HGNC:3467': {'name': 'ESR1', 'synonyms': ['E2 receptor alpha', 'ER', 'ER-alpha', 'ERalpha', 'ERα', 'ESR', 'ESR1', 'Era', 'Estradiol receptor', 'Estrogen receptor', 'NR3A1', 'Nuclear receptor subfamily 3 group A member 1', 'estradiol receptor', 'estrogen receptor', 'estrogen receptor 1', 'estrogen receptor alpha', 'nuclear receptor subfamily 3 group A member 1', 'oestrogen receptor alpha', 'gyrus'], 'definition': None, 'syn_in_text': 'gyrus', 'syn_in_stmt': 'ESR1'}}
ben.gyori@gmail.com	Tue, 17 Nov 2020 21:59:18 GMT		8619	-18537876658844040		DB REST API	5441507718652189330	entity_boundaries	Exchange using 1.0 mg/ml phosphorylated cTn complex in failing cardiomyocytes increased mono- and bis-phosphorylated cTnI and resulted in a similar distribution as found in control donor cells ( xref ).	BAG3 phosphorylates Troponin_C.	{'HGNC:939': {'name': 'BAG3', 'synonyms': ['BAG cochaperone 3', 'BAG family molecular chaperone regulator 3', 'BAG-3', 'BAG3', 'BIS', 'Bcl-2-associated athanogene 3', 'Bcl-2-binding protein Bis', 'Docking protein CAIR-1', 'bis'], 'definition': None, 'syn_in_text': 'BIS', 'syn_in_stmt': 'BAG3'}, 'FPLX:Troponin_C': {'name': 'Troponin_C', 'synonyms': ['TN-C', 'TnC', 'Troponin C', 'Troponin-C', 'cTnC', 'troponin C', 'Troponin_C', 'cTnI'], 'definition': None, 'syn_in_text': 'cTnI', 'syn_in_stmt': 'Troponin_C'}}
bachmanjohn@gmail.com	Fri, 05 Jun 2020 17:08:43 GMT		4695	29087590431951980		bioexp_paper_multi	6599769698505575646	entity_boundaries	The selective G protein-coupled receptor (GPR)30 agonist G1 actually interacts with ER-alpha36.	G_protein binds ESR1.	{'FPLX:G_protein': {'name': 'G_protein', 'synonyms': ['G protein', 'G proteins', 'G_protein'], 'definition': None, 'syn_in_text': 'G protein', 'syn_in_stmt': 'G_protein'}, 'HGNC:3467': {'name': 'ESR1', 'synonyms': ['E2 receptor alpha', 'ER', 'ER-alpha', 'ERalpha', 'ERα', 'ESR', 'ESR1', 'Era', 'Estradiol receptor', 'Estrogen receptor', 'NR3A1', 'Nuclear receptor subfamily 3 group A member 1', 'estradiol receptor', 'estrogen receptor', 'estrogen receptor 1', 'estrogen receptor alpha', 'nuclear receptor subfamily 3 group A member 1', 'oestrogen receptor alpha'], 'definition': None, 'syn_in_text': 'ER', 'syn_in_stmt': 'ESR1'}}
ben.gyori@gmail.com	Fri, 16 Oct 2020 16:12:02 GMT		6687	9560550476928599		EMMAA	-3545777925439582223	entity_boundaries	Sorafenib pre-treatment also significantly inhibited the ability of CD4+ and CD8+ T cells to secrete IFN-gamma at 72 hours in response to stimulation with CD3 and CD28 beads (XREF_FIG).	Sorafenib inhibits CD8+.	"{'CHEBI:CHEBI:50924': {'name': 'sorafenib', 'synonyms': ['4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide', '4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide', ""N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea"", 'Sorafenib', 'sorafenib', 'sorafenibum'], 'definition': None, 'syn_in_text': 'Sorafenib', 'syn_in_stmt': 'Sorafenib'}}"
ben.gyori@gmail.com	Sun, 09 May 2021 18:29:04 GMT		11958	43225104182069		EMMAA	-1645443600282116994	entity_boundaries	The second-generation EGFR-tyrosine kinase inhibitor (TKI), afatinib, was administered to the patient, and partial remission, including smaller metastatic brain tumors, was noted.	EGFR binds protein tyrosine kinase.	{'HGNC:3236': {'name': 'EGFR', 'synonyms': ['EGF receptor', 'EGFR', 'EGFRvIII', 'ERBB', 'ERBB1', 'ERRP', 'Epidermal growth factor receptor', 'HER1', 'Proto-oncogene c-ErbB-1', 'Receptor tyrosine-protein kinase erbB-1', 'epidermal growth factor receptor', 'epidermal growth factor receptor VIII', 'erb-b2 receptor tyrosine kinase 1', 'erythroblastic leukemia viral (v-erb-b) oncogene homolog (avian)'], 'definition': None, 'syn_in_text': 'EGFR', 'syn_in_stmt': 'EGFR'}}
ben.gyori@gmail.com	Tue, 17 Nov 2020 22:02:58 GMT		8623	-5276308851481722		DB REST API	-3230474331705245063	entity_boundaries	Salt had no discernable effect on the binding of ZapC to FtsZ; however, bis-ANS inhibited the binding of ZapC to FtsZ suggesting that the interaction was predominantly hydrophobic in nature.	BAG3 inhibits binding.	{'HGNC:939': {'name': 'BAG3', 'synonyms': ['BAG cochaperone 3', 'BAG family molecular chaperone regulator 3', 'BAG-3', 'BAG3', 'BIS', 'Bcl-2-associated athanogene 3', 'Bcl-2-binding protein Bis', 'Docking protein CAIR-1', 'bis'], 'definition': None, 'syn_in_text': 'BIS', 'syn_in_stmt': 'BAG3'}}
ben.gyori@gmail.com	Mon, 07 Dec 2020 00:33:36 GMT		9642	-4615577085442455		DB REST API	3640168024663321407	entity_boundaries	Modules from Comparison of AT 1 R Interaction with AT 1 R ARBs.	SLC33A1 binds alrB.	{'HGNC:95': {'name': 'SLC33A1', 'synonyms': ['ACATN', 'AT-1', 'AT1', 'Acetyl-CoA transporter 1', 'Acetyl-coenzyme A transporter 1', 'SLC33A1', 'SPG42', 'Solute carrier family 33 member 1', 'solute carrier family 33 member 1', 'AT 1'], 'definition': None, 'syn_in_text': 'AT 1', 'syn_in_stmt': 'SLC33A1'}, 'UP:Q54NZ7': {'name': 'alrB', 'synonyms': ['ARB', 'Aldehyde reductase B', 'Aldose reductase B', 'alrB', 'ARBs'], 'definition': None, 'syn_in_text': 'ARBs', 'syn_in_stmt': 'alrB'}}
ben.gyori@gmail.com	Mon, 10 Feb 2020 15:00:35 GMT		1691	18099431078800861		bioexp_paper_reach	689969312702698459	entity_boundaries	TCR stimulation recruits ESC proteins to activate the mitogen activated protein kinase ERK (extracellular-signal-regulated kinase).	TCR activates MAPK.	{'FPLX:TCR': {'name': 'TCR', 'synonyms': ['TCR', 'TcR'], 'definition': None, 'syn_in_text': 'TCR', 'syn_in_stmt': 'TCR'}, 'FPLX:MAPK': {'name': 'MAPK', 'synonyms': ['Kinase, Mitogen-Activated Protein', 'Kinases, Mitogen-Activated Protein', 'MAP kinase', 'MAP kinases', 'MAPK', 'MAPKs', 'Mitogen Activated Protein Kinase', 'Mitogen Activated Protein Kinases', 'Mitogen-Activated Protein Kinase', 'Mitogen-Activated Protein Kinases', 'Protein Kinase, Mitogen-Activated', 'Protein Kinases, Mitogen-Activated', 'mitogen activated protein kinase', 'mitogen activated protein kinases', 'mitogen-activated protein kinase', 'mitogen-activated protein kinases'], 'definition': None, 'syn_in_text': 'Mitogen Activated Protein Kinase', 'syn_in_stmt': 'MAPK'}}
ben.gyori@gmail.com	Mon, 31 Aug 2020 14:02:06 GMT		6207	-9678327212593131		EMMAA	1548402728873145040	entity_boundaries	MKK3 and MKK6 are the most common MAP2Ks responsible by activating p38 MAPKs, although MKK3 is not able to activate p38beta [XREF_BIBR].	MAP2K3 activates p38beta [.	{'HGNC:6843': {'name': 'MAP2K3', 'synonyms': ['Dual Specificity Mitogen Activated Protein Kinase Kinase 3', 'Dual Specificity Mitogen-Activated Protein Kinase Kinase 3', 'Dual specificity mitogen-activated protein kinase kinase 3', 'MAP Kinase Kinase 3', 'MAP kinase kinase 3', 'MAP2K3', 'MAPK/ERK kinase 3', 'MAPKK 3', 'MAPKK3', 'MEK 3', 'MEK 3 Protein Kinase', 'MEK-3 Protein Kinase', 'MEK3', 'MEK3 Protein Kinase', 'MKK 3 Protein Kinase', 'MKK-3 Protein Kinase', 'MKK3', 'MKK3 Protein Kinase', 'Mitogen Activated Protein Kinase Kinase 3', 'Mitogen-Activated Protein Kinase Kinase 3', 'PRKMK3', 'Protein Kinase, MEK3', 'Protein Kinase, MKK-3', 'Protein Kinase, MKK3', 'SAPK kinase 2', 'SAPKK-2', 'SAPKK2', 'SKK2', 'Stress-activated protein kinase kinase 2', 'dual specificity mitogen activated protein kinase kinase 3', 'mitogen-activated protein kinase kinase 3', 'stress-activated protein kinase kinase 2'], 'definition': None, 'syn_in_text': 'MKK3', 'syn_in_stmt': 'MAP2K3'}}
bachmanjohn@gmail.com	Fri, 20 Dec 2019 21:28:00 GMT		1007	-19591295563234627		DB REST API	-8766277464407216759	entity_boundaries	Moreover, acetylation of the glycolytic enzyme Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has been shown to increase GAPDH activity as well as promote glycolysis [XREF_BIBR].	Glyceraldehyde 3-phosphate activates GAPDH.	{'CHEBI:CHEBI:17138': {'name': 'glyceraldehyde 3-phosphate', 'synonyms': ['2-hydroxy-3-(phosphonooxy)propanal', '2-hydroxy-3-oxopropyl dihydrogen phosphate', '3 Phosphoglyceraldehyde', '3-Phosphoglyceraldehyde', '3-phosphoglyceraldehyde', 'DL-Glyceraldehyde 3-phosphate', 'GAP', 'Glyceraldehyde 3 Phosphate', 'Glyceraldehyde 3-Phosphate', 'Glyceraldehyde 3-phosphate', 'Glycerinaldehyd-3-phosphat', 'Glyzerinaldehyd-3-phosphat', 'gliceraldehido-3-fosfato', 'glyceraldehyde 3-(dihydrogen phosphate)', 'glyceraldehyde 3-phosphate', 'glyceraldehyde-3-phosphate', 'Glyceraldehyde-3-phosphate'], 'definition': None, 'syn_in_text': 'GAP', 'syn_in_stmt': 'GAP'}, 'HGNC:4141': {'name': 'GAPDH', 'synonyms': ['Dehydrogenase, Glyceraldehyde-3-Phosphate', 'Dehydrogenase, Glyceraldehydephosphate', 'Dehydrogenase, Phosphoglyceraldehyde', 'Dehydrogenase, Triosephosphate', 'Dehydrogenases, Glyceraldehyde-3-Phosphate', 'GAPD', 'GAPDH', 'Glyceraldehyde 3 Phosphate Dehydrogenase', 'Glyceraldehyde-3-Phosphate Dehydrogenase', 'Glyceraldehyde-3-Phosphate Dehydrogenases', 'Glyceraldehyde-3-phosphate dehydrogenase', 'Glyceraldehydephosphate Dehydrogenase', 'Peptidyl-cysteine S-nitrosylase GAPDH', 'Phosphoglyceraldehyde Dehydrogenase', 'Triosephosphate Dehydrogenase', 'glyceraldehyde-3-phosphate dehydrogenase'], 'definition': None, 'syn_in_text': 'GAPDH', 'syn_in_stmt': 'GAPDH'}}
ben.gyori@gmail.com	Wed, 25 Nov 2020 04:02:06 GMT		9091	-21702383867530862		EMMAA	1015865778670578336	entity_boundaries	Short-term treatment with anti-CD122 inhibits T RM production of interferon-gamma (IFNgamma), and long-term treatment depletes T RM from skin lesions.	Arg-Met activates IFNG.	{'CHEBI:CHEBI:73817': {'name': 'Arg-Met', 'synonyms': ['Arg-Met', 'Arginyl-Methionine', 'L-Arg-L-Met', 'L-arginyl-L-methionine', 'arginylmethionine', 'RM'], 'definition': None, 'syn_in_text': 'RM', 'syn_in_stmt': 'Arg-Met'}, 'HGNC:5438': {'name': 'IFNG', 'synonyms': ['IFN-gamma', 'IFN-γ', 'IFNG', 'IFNgamma', 'IFNγ', 'Immune Interferon', 'Immune interferon', 'Interferon Type II', 'Interferon gamma', 'Interferon, Immune', 'Interferon, Type II', 'Interferon, gamma', 'Interferon-gamma', 'Type II Interferon', 'gamma-Interferon', 'interferon gamma'], 'definition': None, 'syn_in_text': 'IFNgamma', 'syn_in_stmt': 'IFNG'}}
bachmanjohn@gmail.com	Wed, 10 Jun 2020 14:47:21 GMT		4729	30421049368209039		bioexp_paper_multi	8035620387586994627	entity_boundaries	Shc interacts with insulin receptor via Shc-amino-terminal (N) domain, whereas Shc associates with epidermal growth factor (EGF) receptor through both Shc-N and -SH2 domains.	SHC binds EGF.	{'FPLX:SHC': {'name': 'SHC', 'synonyms': ['SHC', 'Shc', 'Shc family'], 'definition': None, 'syn_in_text': 'SHC', 'syn_in_stmt': 'SHC'}, 'HGNC:3229': {'name': 'EGF', 'synonyms': ['EGF', 'Epidermal Growth Factor', 'Epidermal Growth Factor-Urogastrone', 'Growth Factor, Epidermal', 'Growth Factor-Urogastrone, Epidermal', 'Human Urinary Gastric Inhibitor', 'Pro-epidermal growth factor', 'Urogastrone', 'beta Urogastrone', 'beta-Urogastrone', 'epidermal growth factor'], 'definition': None, 'syn_in_text': 'EGF', 'syn_in_stmt': 'EGF'}}
ben.gyori@gmail.com	Thu, 21 Jan 2021 15:56:17 GMT		10717	32484138573383300		DB REST API	2620265569480585494	entity_boundaries	"Intheproton-dependenteffect
inthedihydropyridinereceptor(41,42),thezinceffectinthe cardiac
batrachotoxin-modified voltage-activated sodium
channel(39,43),andthebovinepancreatictrypsininhibitor effect inthe
large conductance Ca2+-activated K+ channel (44, 45) the conductance
changewas representedby an al-
lostericmodelinwhichthereisaconformationalequilibrium
betweentheopenstateandsubstatelevels,atransitionhighly favored in the
presence ofblocker."	Pyraclofos activates SCN10A.	{'CHEBI:CHEBI:38876': {'name': 'pyraclofos', 'synonyms': ['Boltage', 'O-(1-(4-chlorophenyl)-4-pyrazolyl) O-ethyl S-propyl phosphorothioate', 'O-[1-(4-chlorophenyl)-1H-pyrazol-4-yl] O-ethyl S-propyl phosphorothioate', 'O-[1-(4-chlorophenyl)-1H-pyrazol-4-yl] O-ethyl S-propyl thiophosphate', 'Phosphorothioic acid, O-(1-(4-chlorophenyl)-1H-pyrazol-4-yl) O-ethyl S-propyl ester', 'Voltage', 'pyraclofos', 'voltage'], 'definition': None, 'syn_in_text': 'Voltage', 'syn_in_stmt': 'pyraclofos'}, 'HGNC:10582': {'name': 'SCN10A', 'synonyms': ['NAV1.8 Voltage Gated Sodium Channel', 'NAV1.8 Voltage-Gated Sodium Channel', 'Nav1.8', 'PN3', 'PN3 Sodium Channel', 'Peripheral Nerve Sodium Channel 3', 'Peripheral nerve sodium channel 3', 'SCN10A', 'SNS', 'Sodium Channel Protein Type X', 'Sodium Channel, PN3', 'Sodium channel protein type 10 subunit alpha', 'Sodium channel protein type X subunit alpha', 'Type 10 Voltage Gated Sodium Channel', 'Type 10 Voltage-Gated Sodium Channel', 'Voltage Gated Sodium Channel Type 10', 'Voltage-Gated Sodium Channel Type 10', 'Voltage-gated sodium channel subunit alpha Nav1.8', 'hPN3', 'peripheral nerve sodium channel 3', 'sensory neuron sodium channel', 'sodium voltage-gated channel alpha subunit 10', 'sodium\nchannel'], 'definition': None, 'syn_in_text': 'sodium\nchannel', 'syn_in_stmt': 'SCN10A'}}
marta.iannuccelli@gmail.com	Thu, 21 Mar 2024 10:59:52 GMT		14275	-18488163181447580	{'belief': 1, 'enz': {'db_refs': {'HGNC': '9642', 'TEXT': 'PTP1B', 'UP': 'P18031'}, 'name': 'PTPN1'}, 'id': '3e3fc27d-8697-48b8-9722-8b2438f0396d', 'matches_hash': '-18488163181447580', 'sub': {'db_refs': {'HGNC': '3503', 'TEXT': 'p210', 'UP': 'Q92817'}, 'name': 'EVPL'}, 'type': 'Dephosphorylation'}	signor_dephos	-4813759847795258399	entity_boundaries	Consistent with the trapping data, we observed dephosphorylation of p210 bcr-abl, but not v-Abl, by PTP1B in vivo.	PTPN1 dephosphorylates EVPL.	{'HGNC:9642': {'name': 'PTPN1', 'synonyms': ['PTP-1B', 'PTP1B', 'PTPN1', 'Protein-tyrosine phosphatase 1B', 'Tyrosine-protein phosphatase non-receptor type 1', 'protein tyrosine phosphatase non-receptor type 1'], 'definition': None, 'syn_in_text': 'PTP1B', 'syn_in_stmt': 'PTPN1'}, 'HGNC:3503': {'name': 'EVPL', 'synonyms': ['210 kDa cornified envelope precursor protein', '210 kDa paraneoplastic pemphigus antigen', 'EVPK', 'EVPL', 'Envoplakin', 'envoplakin', 'p210'], 'definition': None, 'syn_in_text': 'p210', 'syn_in_stmt': 'EVPL'}}
ben.gyori@gmail.com	Thu, 07 May 2020 20:59:55 GMT		2731	33088662104014759		DB REST API	1840881176885105379	entity_boundaries	We hypothesized that AT 1 Rs in the brain of chronically hypertensive mice reduce ACE2 activity, thus impairing baroreflex function and contributing to the maintenance of hypertension.	Arg-Ser inhibits ACE2.	{'CHEBI:CHEBI:73819': {'name': 'Arg-Ser', 'synonyms': ['Arg-Ser', 'Arginyl-Serine', 'L-Arg-L-Ser', 'L-arginyl-L-serine', 'arginylserine', 'Rs'], 'definition': None, 'syn_in_text': 'Rs', 'syn_in_stmt': 'Arg-Ser'}, 'HGNC:13557': {'name': 'ACE2', 'synonyms': ['ACE Related Carboxypeptidase', 'ACE-Related Carboxypeptidase', 'ACE-related carboxypeptidase', 'ACE2', 'ACE2 Angiotensin Converting Enzyme Protein 2', 'ACE2 Angiotensin-Converting Enzyme Protein 2', 'ACE2 Enzyme', 'ACE2 Protein', 'ACEH', 'Angiotensin Converting Enzyme 2', 'Angiotensin Converting Enzyme Related Carboxypeptidase', 'Angiotensin-Converting Enzyme 2', 'Angiotensin-Converting Enzyme-Related Carboxypeptidase', 'Angiotensin-converting enzyme 2', 'Angiotensin-converting enzyme homolog', 'Angiotensin-converting enzyme-related carboxypeptidase', 'Carboxypeptidase, ACE-Related', 'Carboxypeptidase, Angiotensin-Converting Enzyme-Related', 'Metalloprotease MPROT15', 'angiotensin converting enzyme 2', 'peptidyl-dipeptidase A'], 'definition': None, 'syn_in_text': 'ACE2', 'syn_in_stmt': 'ACE2'}}
ben.gyori@gmail.com	Tue, 17 Nov 2020 18:14:28 GMT		8561	15716164147778917		DB REST API	-5407707078870129969	entity_boundaries	For example, while oxyresveratrol showed suppression of T-cell migration and inhibition of CXCR-4-mediated chemotaxis and MEK/ERK pathways,[ xref ] M. alba extract showed inhibition of a disintegrin and metalloprotease with thrombospondin type I motifs-1 (ADAMTS1).[ xref ]	AFM inhibits metalloproteinase.	{'HGNC:316': {'name': 'AFM', 'synonyms': ['AFM', 'ALB2', 'ALBA', 'Afamin', 'Alpha-Alb', 'Alpha-albumin', 'afamin', 'alpha-albumin', 'vitamin E binding protein', 'alba'], 'definition': None, 'syn_in_text': 'ALBA', 'syn_in_stmt': 'AFM'}}
ben.gyori@gmail.com	Mon, 08 Feb 2021 16:35:00 GMT		10750	27203218575845982		DB REST API	8187199818782516691	entity_boundaries	2014), and the voltage activated sodium Nav1.1 channels that have recently been suggested as a therapeutic target for cognitive disorders in schizophrenia (Jensen etal.	Pyraclofos activates NAV1.	{'CHEBI:CHEBI:38876': {'name': 'pyraclofos', 'synonyms': ['Boltage', 'O-(1-(4-chlorophenyl)-4-pyrazolyl) O-ethyl S-propyl phosphorothioate', 'O-[1-(4-chlorophenyl)-1H-pyrazol-4-yl] O-ethyl S-propyl phosphorothioate', 'O-[1-(4-chlorophenyl)-1H-pyrazol-4-yl] O-ethyl S-propyl thiophosphate', 'Phosphorothioic acid, O-(1-(4-chlorophenyl)-1H-pyrazol-4-yl) O-ethyl S-propyl ester', 'Voltage', 'pyraclofos', 'voltage'], 'definition': None, 'syn_in_text': 'Voltage', 'syn_in_stmt': 'pyraclofos'}, 'HGNC:15989': {'name': 'NAV1', 'synonyms': ['DKFZp781D0314', 'FLJ12560', 'FLJ14203', 'KIAA1151', 'KIAA1213', 'MGC14961', 'NAV1', 'Neuron navigator 1', 'POMFIL3', 'Pore membrane and/or filament-interacting-like protein 3', 'STEERIN1', 'Steerin-1', 'Unc-53 homolog 1', 'neuron navigator 1', 'neuron navigator-1', 'pore membrane and/or filament interacting like protein 3', 'steerin-1', 'unc53H1', 'Nav1'], 'definition': None, 'syn_in_text': 'NAV1', 'syn_in_stmt': 'NAV1'}}
ben.gyori@gmail.com	Thu, 09 Sep 2021 13:12:28 GMT	{'annotations': {'agents': {'raw_text': ['medRxiv', 'TMPRSS2']}, 'content_source': 'cord19_pdf', 'found_by': 'Negative_activation_syntax_1_verb', 'prior_uuids': ['781e4e10-1fa1-47fe-bb04-1930af70ca8e']}, 'epistemics': {'direct': False, 'hypothesis': True, 'section_type': None}, 'source_api': 'reach', 'source_hash': -2010142105935210200, 'text': 'https://doi.org/10.1101/2020.05.25.20110890 doi: medRxiv preprint simultaneously blocking the activity of TMPRSS2 and the cysteine proteases CATHEPSIN B/L cannot completely inhibit the entry of SARS-CoV-2 in vitro, suggesting the possible involvement of additional proteases in the priming of SARS-CoV-2 10 .', 'text_refs': {'DOI': '10.1101/2020.05.25.20110890', 'DOI_ID': '2020.05.25.20110890', 'DOI_NS': 1101, 'READER': 'REACH', 'RID': 10200056432662, 'SOURCE': 'cord19_pdf', 'TCID': 56432662, 'TRID': 31652365}}	12431	24202856310480175	{'belief': 1, 'id': '32e90d25-f356-4298-9e5e-e7418d9307b5', 'matches_hash': '24202856310480175', 'obj': {'db_refs': {'HGNC': '11876', 'TEXT': 'TMPRSS2', 'UP': 'O15393'}, 'name': 'TMPRSS2'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'TEXT': 'medRxiv'}, 'name': 'medRxiv'}, 'type': 'Inhibition'}	DB REST API	-2010142105935210113	entity_boundaries	https://doi.org/10.1101/2020.05.25.20110890 doi: medRxiv preprint simultaneously blocking the activity of TMPRSS2 and the cysteine proteases CATHEPSIN B/L cannot completely inhibit the entry of SARS-CoV-2 in vitro, suggesting the possible involvement of additional proteases in the priming of SARS-CoV-2 10 .	MedRxiv inhibits TMPRSS2.	{'HGNC:11876': {'name': 'TMPRSS2', 'synonyms': ['PRSS10', 'Serine protease 10', 'TMPRSS2', 'Transmembrane protease serine 2', 'transmembrane serine protease 2'], 'definition': None, 'syn_in_text': 'TMPRSS2', 'syn_in_stmt': 'TMPRSS2'}}
ben.gyori@gmail.com	Tue, 04 Aug 2020 14:10:28 GMT		6002	21847677433013188		EMMAA	-6726503873877647133	entity_boundaries	On March 28, 2020 the United States Food and Drug Administration (US FDA) issued an Emergency Use Authorization allowing hydroxychloroquine sulfate and chloroquine phosphate to be used for hospitalized patients with COVID-19.	Drug activates chloroquine phosphate.	{'CHEBI:CHEBI:23888': {'name': 'drug', 'synonyms': ['drug', 'drugs', 'medicine', 'Drug'], 'definition': None, 'syn_in_text': 'drug', 'syn_in_stmt': 'drug'}}
ben.gyori@gmail.com	Tue, 12 Jan 2021 17:33:28 GMT		10618	-1875648306188824		EMMAA	-2848035393511955094	entity_boundaries	In the SCL-1 skin cell line of human squamous cell carcinoma (SCC), a group of authors recently showed that ATRA inhibited the expression of the cyclin D1 / CDK4 and cyclin E/CDK2 complexes, and also increased the expression of the cyclin dependent kinase inhibitors p21 and p27.	Cyclin inhibits CDKN1A.	{'FPLX:Cyclin': {'name': 'Cyclin', 'synonyms': ['Cyclin', 'Cyclins', 'cyclin', 'cyclin family', 'cyclins'], 'definition': None, 'syn_in_text': 'Cyclin', 'syn_in_stmt': 'Cyclin'}, 'HGNC:1784': {'name': 'CDKN1A', 'synonyms': ['CAP20', 'CDK-interacting protein 1', 'CDK2 Associated Protein 20 kDa', 'CDK2-Associated Protein 20 kDa', 'CDKN1', 'CDKN1 Protein', 'CDKN1A', 'CDKN1A Protein', 'CIP1', 'Cdk Interacting Protein 1', 'Cdk-Interacting Protein 1', 'Cdk-interacting protein 1', 'Cdk2 Inhibitor Protein', 'Cell Cycle Regulator p21', 'Cyclin Dependent Kinase Inhibitor 1A Protein', 'Cyclin Dependent Kinase Inhibitor p21', 'Cyclin Kinase Inhibitor p21', 'Cyclin-Dependent Kinase Inhibitor 1A Protein', 'Cyclin-Dependent Kinase Inhibitor p21', 'Cyclin-dependent kinase inhibitor 1', 'MDA-6', 'MDA6', 'Melanoma differentiation-associated protein 6', 'P21', 'PIC1', 'SDI1', 'Senescent Cell Derived Inhibitor Protein 1', 'Senescent Cell-Derived Inhibitor Protein 1', 'WAF1', 'cyclin dependent kinase inhibitor 1A', 'p21', 'p21 Cell Cycle Regulator', 'p21 Cip1', 'p21 Cyclin Kinase Inhibitor', 'p21 WAF1', 'p21CIP1', 'p21Cip1/Waf1'], 'definition': None, 'syn_in_text': 'P21', 'syn_in_stmt': 'CDKN1A'}}
ben.gyori@gmail.com	Thu, 17 Sep 2020 20:21:14 GMT		6396	-2695598291755169		EMMAA	-5794246050064635224	entity_boundaries	Initial results show that a bacterial cytochrome, CYPBM3, encapsulated within CCMV, could efficiently activate the pro-drugs tamoxifen and resveratrol [77].	Cytochrome activates resveratrol.	"{'CHEBI:CHEBI:4056': {'name': 'cytochrome', 'synonyms': ['Cytochrome', 'Cytochromes', 'cytochrome', 'cytochromes'], 'definition': None, 'syn_in_text': 'Cytochrome', 'syn_in_stmt': 'Cytochrome'}, 'CHEBI:CHEBI:27881': {'name': 'resveratrol', 'synonyms': [""3,4',5-Stilbenetriol"", ""3,4',5-Trihydroxystilbene"", ""3,5,4'-Trihydroxystilbene"", '5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol', 'Resveratrol', 'resveratrol'], 'definition': None, 'syn_in_text': 'Resveratrol', 'syn_in_stmt': 'Resveratrol'}}"
ben.gyori@gmail.com	Tue, 11 Aug 2020 14:59:35 GMT		6062	-32333161850317873		EMMAA	1057493159830509090	entity_boundaries	Warm weather, high humidity and UV index, sunlight mediated immunity, fresh air circulations, low pollutions, food habit and heterologous immunity might have reduced the transmission capabilities of SARS-CoV-2.	Food inhibits severe acute respiratory syndrome coronavirus 2.	{'CHEBI:CHEBI:33290': {'name': 'food', 'synonyms': ['food', 'food material', 'food materials', 'food role', 'foods', 'foodstuff', 'foodstuffs', 'Food'], 'definition': None, 'syn_in_text': 'food', 'syn_in_stmt': 'food'}, 'MESH:C000656484': {'name': 'severe acute respiratory syndrome coronavirus 2', 'synonyms': ['severe acute respiratory syndrome coronavirus 2', 'SARS-CoV-2'], 'definition': None, 'syn_in_text': 'SARS-CoV-2', 'syn_in_stmt': 'severe acute respiratory syndrome coronavirus 2'}}
ben.gyori@gmail.com	Wed, 07 Apr 2021 02:32:36 GMT		11723	35804755320661903		bioexp_paper_medscan	3964485999911109163	wrong_relation	Activated CXCR4 induces ubiquitination of HRS and STAM, suggesting that CXCR4 regulates its own down-regulation by regulating the ubiquitination status of the sorting machinery.	CXCR4 activates STAM.	{'HGNC:2561': {'name': 'CXCR4', 'synonyms': ['C-X-C chemokine receptor type 4', 'C-X-C motif chemokine receptor 4', 'CD antigen CD184', 'CD184', 'CXC Chemokine Receptor 4', 'CXC-R4', 'CXCR-4', 'CXCR4', 'CXCR4 Receptor', 'CXCR4 Receptors', 'D2S201E', 'FB22', 'Fusin', 'HM89', 'HSY3RR', 'LAP-3', 'LCR1', 'LESTR', 'LESTR Receptor', 'LPS-associated protein 3', 'Leukocyte Derived Seven Transmembrane Domain Receptor', 'Leukocyte-Derived Seven-Transmembrane Domain Receptor', 'Leukocyte-derived seven transmembrane domain receptor', 'Lipopolysaccharide-associated protein 3', 'NPY3R', 'NPYR', 'NPYRL', 'NPYY3R', 'Receptor, CXCR4', 'Receptor, LESTR', 'Receptors, CXCR4', 'SDF-1 receptor', 'Stromal cell-derived factor 1 receptor', 'fusin'], 'definition': None, 'syn_in_text': 'CXCR4', 'syn_in_stmt': 'CXCR4'}, 'HGNC:11357': {'name': 'STAM', 'synonyms': ['HSE1 homolog (S. cerevisiae)', 'STAM', 'STAM-1', 'STAM1', 'Signal transducing adapter molecule 1', 'signal transducing adaptor molecule'], 'definition': None, 'syn_in_text': 'STAM', 'syn_in_stmt': 'STAM'}}
bachmanjohn@gmail.com	Sat, 14 Nov 2020 18:28:31 GMT		8338	17623915741995242		EMMAA	-5060100056502184049	wrong_relation	Indeed, both hypo- and hyperphosphorylated forms of Merlin are associated with EGFR ( xref , xref ), suggesting that S518 phosphorylation may regulate Merlin-associated EGFRs.	EGFR binds EGFR and NF2.	{'HGNC:3236': {'name': 'EGFR', 'synonyms': ['EGF receptor', 'EGFR', 'EGFRvIII', 'ERBB', 'ERBB1', 'ERRP', 'Epidermal growth factor receptor', 'HER1', 'Proto-oncogene c-ErbB-1', 'Receptor tyrosine-protein kinase erbB-1', 'epidermal growth factor receptor', 'epidermal growth factor receptor VIII', 'erb-b2 receptor tyrosine kinase 1', 'erythroblastic leukemia viral (v-erb-b) oncogene homolog (avian)'], 'definition': None, 'syn_in_text': 'EGFR', 'syn_in_stmt': 'EGFR'}, 'HGNC:7773': {'name': 'NF2', 'synonyms': ['ACN', 'BANF', 'Gene Product, NF2', 'Merlin', 'Moesin Ezrin Radixin Like Protein', 'Moesin-Ezrin-Radixin-Like Protein', 'Moesin-ezrin-radixin-like protein', 'NF2', 'NF2 Gene Product', 'NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor', 'Neurofibromatosis 2 Gene Product', 'Neurofibromatosis Type 2 Protein', 'Neurofibromin 2', 'Neurofibromin-2', 'Protein, Schwannomin', 'SCH', 'Schwannomerlin', 'Schwannomin', 'Schwannomin Protein', 'bilateral acoustic neurofibromatosis', 'merlin', 'merlin-1', 'moesin-ezrin-radixin like', 'schwannomin'], 'definition': None, 'syn_in_text': 'Merlin', 'syn_in_stmt': 'NF2'}}
bachmanjohn@gmail.com	Tue, 17 Nov 2020 17:15:24 GMT		8498	1445757693480503		EMMAA	-2274456310756295477	wrong_relation	Importantly, shRNA mediated knockdown of alpha-catenin expression eliminated the association of Merlin with E-cadherin (XREF_FIG).	CTNNA activates NF2.	{'FPLX:CTNNA': {'name': 'CTNNA', 'synonyms': ['a-cathenin', 'alpha catenin', 'alpha-catenin', 'catenin alpha', 'catenin α', 'α catenin', 'α-catenin', 'CTNNA'], 'definition': None, 'syn_in_text': 'alpha-catenin', 'syn_in_stmt': 'CTNNA'}, 'HGNC:7773': {'name': 'NF2', 'synonyms': ['ACN', 'BANF', 'Gene Product, NF2', 'Merlin', 'Moesin Ezrin Radixin Like Protein', 'Moesin-Ezrin-Radixin-Like Protein', 'Moesin-ezrin-radixin-like protein', 'NF2', 'NF2 Gene Product', 'NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor', 'Neurofibromatosis 2 Gene Product', 'Neurofibromatosis Type 2 Protein', 'Neurofibromin 2', 'Neurofibromin-2', 'Protein, Schwannomin', 'SCH', 'Schwannomerlin', 'Schwannomin', 'Schwannomin Protein', 'bilateral acoustic neurofibromatosis', 'merlin', 'merlin-1', 'moesin-ezrin-radixin like', 'schwannomin'], 'definition': None, 'syn_in_text': 'Merlin', 'syn_in_stmt': 'NF2'}}
samuel_bunga@hms.harvard.edu	Tue, 16 Feb 2021 14:57:38 GMT		10962	3109740522255792		DB REST API	-6613424761358492327	wrong_relation	Trauma-hemorrhage increased the production of IL-6, IL-10, IL-12 and TNF-alpha enhanced the expression of TLR4, MyD88 as well as the activation of MAPK proteins (p38, ERK and JNK) in epidermal keratinocytes.	IL10 increases the amount of TLR4.	{'HGNC:5962': {'name': 'IL10', 'synonyms': ['CSIF', 'CSIF-10', 'Cytokine Synthesis Inhibitory Factor', 'Cytokine synthesis inhibitory factor', 'IL-10', 'IL10', 'IL10A', 'Interleukin 10', 'Interleukin-10', 'T-cell growth inhibitory factor', 'TGIF', 'cytokine synthesis inhibitory factor', 'interleukin 10'], 'definition': None, 'syn_in_text': 'IL-10', 'syn_in_stmt': 'IL10'}, 'HGNC:11850': {'name': 'TLR4', 'synonyms': ['ARMD10', 'CD antigen CD284', 'CD284', 'Receptor, TLR4', 'TLR-4', 'TLR4', 'TLR4 Receptor', 'Toll 4 Receptor', 'Toll Like Receptor 4', 'Toll-4 Receptor', 'Toll-Like Receptor 4', 'Toll-like receptor 4', 'hToll', 'toll like receptor 4', 'TLR2 and TLR4'], 'definition': None, 'syn_in_text': 'TLR4', 'syn_in_stmt': 'TLR4'}}
ben.gyori@gmail.com	Wed, 28 May 2025 23:25:52 GMT	{'annotations': {'agents': {'raw_text': ['MINK1', 'GR']}, 'content_source': 'pmc_oa', 'prior_uuids': ['e822b35a-4ae4-4ea1-956f-ec544024e047']}, 'pmid': '33744286', 'source_api': 'sparser', 'source_hash': -4371130540626369000, 'text': 'Thus, the screening showed that MINK1 and ROCK1 can phosphorylate GR T524 and S617, respectively, in\xa0vitro .', 'text_refs': {'DOI': '10.1016/J.JBC.2021.100551', 'DOI_ID': 'J.JBC.2021.100551', 'DOI_NS': 1016, 'PII': 'S0021-9258(21)00329-X', 'PMCID': 'PMC8080530', 'PMCID_NUM': 8080530, 'PMID': '33744286', 'PMID_NUM': 33744286, 'READER': 'SPARSER', 'RID': 20500060400344, 'SOURCE': 'pmc_oa', 'TCID': 60400344, 'TRID': 32977916}}	16938	1708420044946713	{'belief': 1, 'enz': {'db_refs': {'EGID': '50488', 'HGNC': '17565', 'MESH': 'C497353', 'TEXT': 'MINK1', 'UP': 'Q8N4C8'}, 'name': 'MINK1'}, 'id': 'ccf42a7c-04fa-4f93-8f38-a22e9634575a', 'matches_hash': '1708420044946713', 'position': '617', 'residue': 'S', 'sub': {'db_refs': {'EGID': '2908', 'HGNC': '7978', 'MESH': 'C497713', 'TEXT': 'GR', 'UP': 'P04150'}, 'name': 'NR3C1'}, 'type': 'Phosphorylation'}	DB REST API	-4371130540626369128	wrong_relation	Thus, the screening showed that MINK1 and ROCK1 can phosphorylate GR T524 and S617, respectively, in vitro .	MINK1 phosphorylates NR3C1 on S617.	{'HGNC:17565': {'name': 'MINK1', 'synonyms': ['B55', 'GCK family kinase MiNK', 'MAP4K6', 'MAPK/ERK kinase kinase kinase 6', 'MEK kinase kinase 6', 'MEKKK 6', 'MINK', 'MINK1', 'Misshapen-like kinase 1', 'Misshapen/NIK-related kinase', 'Mitogen-activated protein kinase kinase kinase kinase 6', 'YSK2', 'ZC3', 'misshapen like kinase 1', 'misshapen/NIK-related kinase'], 'definition': None, 'syn_in_text': 'MINK1', 'syn_in_stmt': 'MINK1'}, 'HGNC:7978': {'name': 'NR3C1', 'synonyms': ['GR', 'GRL', 'Glucocorticoid Receptor', 'Glucocorticoid Receptors', 'Glucocorticoid receptor', 'Glucocorticoids Receptor', 'Glucocorticoids Receptors', 'NR3C1', 'Nuclear receptor subfamily 3 group C member 1', 'Receptor, Glucocorticoid', 'Receptor, Glucocorticoids', 'Receptors, Glucocorticoid', 'Receptors, Glucocorticoids', 'nuclear receptor subfamily 3 group C member 1'], 'definition': None, 'syn_in_text': 'GR', 'syn_in_stmt': 'NR3C1'}}
ben.gyori@gmail.com	Mon, 10 Feb 2020 17:42:46 GMT		1765	35870951963986230		bioexp_paper_reach	-7136596792606073235	wrong_relation	CHD5 is bound to the WEE1 promoter.	WEE1 binds GET1.	{'HGNC:12761': {'name': 'WEE1', 'synonyms': ['WEE1', 'WEE1 G2 checkpoint kinase', 'WEE1A', 'WEE1hu', 'Wee1-like protein kinase', 'Wee1A kinase'], 'definition': None, 'syn_in_text': 'WEE1', 'syn_in_stmt': 'WEE1'}, 'HGNC:12790': {'name': 'GET1', 'synonyms': ['CHD5', 'Congenital heart disease 5 protein', 'GET1', 'Guided entry of tail-anchored proteins factor 1', 'Tail-anchored protein insertion receptor WRB', 'Tryptophan-rich basic protein', 'WRB', 'guided entry of tail-anchored proteins factor 1'], 'definition': None, 'syn_in_text': 'CHD5', 'syn_in_stmt': 'GET1'}}
ben.gyori@gmail.com	Wed, 16 Sep 2020 21:03:36 GMT		6354	-8483761560406863		EMMAA	8101233430638642314	wrong_relation	Non-invasive ventilation, high flow oxygen therapy, intubation/extubation, nebulization, open suctioning of airway secretions, bronchoscopy, induction of sputum, bag and mask ventilation, cardiopulmonary resuscitation, etc. are the principal causes of SARS-CoV-2 aerosol release in airflow (CDC 2020d).	Dioxygen activates severe acute respiratory syndrome coronavirus 2.	{'CHEBI:CHEBI:15379': {'name': 'dioxygen', 'synonyms': ['Disauerstoff', 'E 948', 'E-948', 'E948', 'O2', 'OXYGEN MOLECULE', 'Oxygen', 'Oxygen 16', 'Oxygen-16', '[OO]', 'dioxygen', 'dioxygene', 'molecular oxygen', 'oxygen'], 'definition': None, 'syn_in_text': 'Oxygen', 'syn_in_stmt': 'dioxygen'}, 'MESH:C000656484': {'name': 'severe acute respiratory syndrome coronavirus 2', 'synonyms': ['severe acute respiratory syndrome coronavirus 2', 'SARS-CoV-2'], 'definition': None, 'syn_in_text': 'SARS-CoV-2', 'syn_in_stmt': 'severe acute respiratory syndrome coronavirus 2'}}
bachmanjohn@gmail.com	Thu, 10 Dec 2020 14:25:40 GMT		9990	11731572000205633		bioexp_biogrid	-5228002587087438282	wrong_relation	In this study, high IDO1 or TDO2 protein expression was associated with characteristic of more aggressive tumoral phenotypes.	TDO2 binds IDO1.	{'HGNC:11708': {'name': 'TDO2', 'synonyms': ['TDO', 'TDO2', 'TO', 'TPH2', 'TRPO', 'Tryptamin 2,3-dioxygenase', 'Tryptophan 2,3-dioxygenase', 'Tryptophan oxygenase', 'Tryptophan pyrrolase', 'Tryptophanase', 'tryptophan 2,3-dioxygenase'], 'definition': None, 'syn_in_text': 'TDO2', 'syn_in_stmt': 'TDO2'}, 'HGNC:6059': {'name': 'IDO1', 'synonyms': ['IDO', 'IDO-1', 'IDO1', 'INDO', 'Indoleamine 2,3-dioxygenase 1', 'Indoleamine-pyrrole 2,3-dioxygenase', 'indoleamine 2,3-dioxygenase 1'], 'definition': None, 'syn_in_text': 'IDO1', 'syn_in_stmt': 'IDO1'}}
ben.gyori@gmail.com	Tue, 15 Dec 2020 17:32:14 GMT		10498	9618426235110183		EMMAA	245824438139736846	wrong_relation	In our study, we examined the association of cox-2 and p53 expression, with age, stage, histopathological subtype, and survival in HL.	TP53 binds PTGS2.	{'HGNC:11998': {'name': 'TP53', 'synonyms': ['Antigen NY-CO-13', 'Cellular Tumor Antigen p53', 'Cellular tumor antigen p53', 'LFS1', 'Li-Fraumeni syndrome', 'Oncoprotein p53', 'P53', 'Phosphoprotein p53', 'Phosphoprotein, pp53', 'TP53', 'TP53 Protein', 'TRP53 Protein', 'Tumor Suppressor Protein p53', 'Tumor suppressor p53', 'mutp53', 'p53', 'p53 Antigen', 'p53 Tumor Suppressor Protein', 'pp53 Phosphoprotein', 'tumor protein p53'], 'definition': None, 'syn_in_text': 'P53', 'syn_in_stmt': 'TP53'}, 'HGNC:9605': {'name': 'PTGS2', 'synonyms': ['COX 2 Prostaglandin Synthase', 'COX-2', 'COX-2 Prostaglandin Synthase', 'COX2', 'Cyclo Oxygenase II', 'Cyclo-Oxygenase II', 'Cyclooxygenase 2', 'Cyclooxygenase-2', 'PGH synthase 2', 'PGHS-2', 'PHS II', 'PTGS2', 'Prostaglandin G/H synthase 2', 'Prostaglandin H Synthase 2', 'Prostaglandin H Synthase-2', 'Prostaglandin H2 synthase 2', 'Prostaglandin Synthase, COX-2', 'Prostaglandin-endoperoxide synthase 2', 'Synthase, COX-2 Prostaglandin', 'cyclooxygenase 2', 'prostaglandin G/H synthase 2', 'prostaglandin-endoperoxide synthase 2'], 'definition': None, 'syn_in_text': 'COX-2', 'syn_in_stmt': 'PTGS2'}}
ben.gyori@gmail.com	Wed, 18 Nov 2020 03:35:36 GMT		8656	-25119736958693023		EMMAA	-5809168507270600997	wrong_relation	While neurofibromin loss and activation of MEK and ERK can lead to increased proliferation through ERK activation of transcriptional factors [XREF_BIBR], it can also increase cell proliferation through a 90 kDa ribosomal S6 kinase (p90-RSK)/mechanistic target of rapamycin (mTOR)-dependent manner [XREF_BIBR].	RPS6 activates sirolimus.	{'HGNC:10429': {'name': 'RPS6', 'synonyms': ['40S ribosomal protein S6', 'Phosphoprotein NP33', 'Protein S6, Ribosomal', 'RPS6', 'Ribosomal Protein S6', 'S6', 'Small ribosomal subunit protein eS6', 'eS6', 'phosphoprotein NP33', 'ribosomal protein S6'], 'definition': None, 'syn_in_text': 'S6', 'syn_in_stmt': 'RPS6'}, 'CHEBI:CHEBI:9168': {'name': 'sirolimus', 'synonyms': ['(-)-Rapamycin', '(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone', '(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone', 'Antibiotic AY 22989', 'RA', 'Rapamune', 'Rapamycin', 'Sirolimus', 'rapamycin', 'sirolimus', 'sirolimusum'], 'definition': None, 'syn_in_text': 'Rapamycin', 'syn_in_stmt': 'Sirolimus'}}
marta.iannuccelli@gmail.com	Wed, 20 Mar 2024 10:53:20 GMT		14187	-17278657582729040	{'belief': 1, 'enz': {'db_refs': {'HGNC': '3065', 'TEXT': 'DUSP10', 'UP': 'Q9Y6W6'}, 'name': 'DUSP10'}, 'id': 'b1a613b0-2af4-4bd7-bc73-98d5c592510b', 'matches_hash': '-17278657582729040', 'sub': {'db_refs': {'HGNC': '4172', 'TEXT': 'GATA3', 'UP': 'P23771'}, 'name': 'GATA3'}, 'type': 'Dephosphorylation'}	signor_dephos	-911659306957659572	wrong_relation	These results indicate that DUSP10 suppresses phosphorylation of GATA3 through the inhibition of p38 phosphorylation.	DUSP10 leads to the dephosphorylation of GATA3.	{'HGNC:3065': {'name': 'DUSP10', 'synonyms': ['DUSP10', 'Dual specificity protein phosphatase 10', 'MAP kinase phosphatase 5', 'MKP-5', 'MKP5', 'Mitogen-activated protein kinase phosphatase 5', 'dual specificity phosphatase 10'], 'definition': None, 'syn_in_text': 'DUSP10', 'syn_in_stmt': 'DUSP10'}, 'HGNC:4172': {'name': 'GATA3', 'synonyms': ['GATA binding protein 3', 'GATA-binding factor 3', 'GATA3', 'HDR', 'Trans-acting T-cell-specific transcription factor GATA-3'], 'definition': None, 'syn_in_text': 'GATA3', 'syn_in_stmt': 'GATA3'}}
ben.gyori@gmail.com	Mon, 18 May 2020 21:45:40 GMT		2895	-22015053290246643		bioexp_paper_rlimsp	-6112315160789760279	wrong_relation	These results suggest a potential mechanism to account, in part, for the inhibition GSK3 phosphorylation of β-catenin by the activated LRP6.	LRP6 phosphorylates GSK3.	{'HGNC:6698': {'name': 'LRP6', 'synonyms': ['ADCAD2', 'LDL receptor related protein 6', 'LRP-6', 'LRP6', 'Low-density lipoprotein receptor-related protein 6'], 'definition': None, 'syn_in_text': 'LRP6', 'syn_in_stmt': 'LRP6'}, 'FPLX:GSK3': {'name': 'GSK3', 'synonyms': ['GSK-3', 'GSK3', 'Glycogen Synthase Kinase 3', 'gsk-3 Gene Product'], 'definition': None, 'syn_in_text': 'GSK3', 'syn_in_stmt': 'GSK3'}}
bachmanjohn@gmail.com	Fri, 30 Jul 2021 15:46:08 GMT		12301	-1273246512736934	{'belief': 1, 'id': '8e6f1c71-f696-40e5-88fa-deeb253a6fc7', 'matches_hash': '-1273246512736934', 'members': [{'db_refs': {'HGNC': '1511', 'MESH': 'D053453', 'TEXT': 'caspase-9', 'UP': 'P55211'}, 'name': 'CASP9'}, {'db_refs': {'HGNC': '18279', 'TEXT': 'HCA66', 'UP': 'Q9NYH9'}, 'name': 'UTP6'}], 'type': 'Complex'}	EMMAA	-3666977534330366795	wrong_relation	Using a cell-free system, we showed that reduction of HCA66 expression was associated with a diminished amount of caspase-9 in the apoptosome, resulting in a lower ability of the apoptosome to activate caspase-3.	CASP9 binds UTP6.	{'HGNC:1511': {'name': 'CASP9', 'synonyms': ['APAF-3', 'Apoptotic Protease Activating Factor 3', 'Apoptotic protease Mch-6', 'Apoptotic protease-activating factor 3', 'CASP-9', 'CASP9', 'Caspase 9', 'Caspase-9', 'ICE LAP6 Protein', 'ICE Like Apoptotic Protease 6', 'ICE-LAP6', 'ICE-LAP6 Protein', 'ICE-Like Apoptotic Protease 6', 'ICE-like apoptotic protease 6', 'MCH6', 'PPP1R56', 'caspase 9', 'caspase-9', 'protein phosphatase 1, regulatory subunit 56'], 'definition': None, 'syn_in_text': 'Caspase-9', 'syn_in_stmt': 'CASP9'}, 'HGNC:18279': {'name': 'UTP6', 'synonyms': ['C17orf40', 'HCA66', 'Hepatocellular carcinoma-associated antigen 66', 'MHAT', 'Multiple hat domains protein', 'U3 small nucleolar RNA-associated protein 6 homolog', 'UTP6', 'UTP6 small subunit processome component', 'hepatocellular carcinoma associated antigen 66'], 'definition': None, 'syn_in_text': 'HCA66', 'syn_in_stmt': 'UTP6'}}
ben.gyori@gmail.com	Fri, 25 Jun 2021 08:18:36 GMT		12096	8660110745669112	{'belief': 1, 'id': 'fba30347-9e05-441e-8d43-078c5e6454c7', 'matches_hash': '8660110745669112', 'obj': {'db_refs': {'FPLX': 'RAS', 'NCIT': 'C17061', 'PF': 'PF00071', 'TEXT': 'Ras'}, 'name': 'RAS'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '646', 'TEXT': 'Araf', 'UP': 'P10398'}, 'name': 'ARAF'}, 'type': 'Inhibition'}	DB REST API	5756575629882068628	wrong_relation	Results : Araf-tv2, a kinase deficient isoform of zebrafish Araf, can inhibit developmental functions of Fgf and Ras signaling.	ARAF inhibits RAS.	{'HGNC:646': {'name': 'ARAF', 'synonyms': ['A-Raf', 'A-Raf proto-oncogene, serine/threonine kinase', 'ARAF', 'ARAF1', 'PKS', 'PKS2', 'Proto-oncogene A-Raf', 'Proto-oncogene A-Raf-1', 'Proto-oncogene Pks', 'Serine/threonine-protein kinase A-Raf', 'Araf'], 'definition': None, 'syn_in_text': 'ARAF', 'syn_in_stmt': 'ARAF'}, 'FPLX:RAS': {'name': 'RAS', 'synonyms': ['GTPase, ras', 'GTPases, ras', 'Gene Products, ras', 'Protein, ras', 'RAS', 'Ras', 'Ras GTPase', 'ras GTPase', 'ras GTPases', 'ras Gene Products', 'ras Protein', 'ras Proteins'], 'definition': None, 'syn_in_text': 'RAS', 'syn_in_stmt': 'RAS'}}
bachmanjohn@gmail.com	Wed, 24 Feb 2021 18:35:02 GMT		11264	-25725881202629826		bioexp_biogrid	815401891292696997	wrong_relation	This difference was associated with reduced IL-1β and IL-18 production in serum and impaired caspase-1 activation in brain tissue ( Figures S6 C and S6D), suggesting that dysregulation of NLRP3 inflammasome contributes to the development of MPTP-induced loss of nigral dopaminergic neurons.	CASP1 binds IL18 and IL1B.	{'HGNC:1499': {'name': 'CASP1', 'synonyms': ['CASP-1', 'CASP1', 'CASP1 Caspase', 'Caspase 1', 'Caspase, CASP1', 'Caspase-1', 'Convertase, IL-1 beta', 'Converting Enzyme, Interleukin-1', 'Converting Enzyme, Interleukin-1beta', 'ICE', 'ICE Protease', 'IL 1 beta Convertase', 'IL 1 beta Converting Enzyme', 'IL-1 beta Convertase', 'IL-1 beta-Converting Enzyme', 'IL-1 beta-converting enzyme', 'IL-1BC', 'IL1BC', 'IL1BC Enzyme', 'IL1BCE', 'Interleukin 1 Converting Enzyme', 'Interleukin 1beta Converting Enzyme', 'Interleukin-1 Converting Enzyme', 'Interleukin-1 beta convertase', 'Interleukin-1 beta-converting enzyme', 'Interleukin-1beta Converting Enzyme', 'beta Convertase, IL-1', 'beta-Converting Enzyme, IL-1', 'caspase 1', 'caspase-1', 'interleukin 1, beta, convertase', 'p45'], 'definition': None, 'syn_in_text': 'Caspase-1', 'syn_in_stmt': 'CASP1'}, 'HGNC:5986': {'name': 'IL18', 'synonyms': ['IFN gamma Inducing Factor', 'IFN-gamma Inducing Factor', 'IFN-gamma-Inducing Factor', 'IFN-gamma-inducing factor', 'IGIF', 'IL-1 gamma', 'IL-18', 'IL-1g', 'IL18', 'IL1F4', 'Iboctadekin', 'Inducing Factor, IFN-gamma', 'Inducing Factor, Interferon-gamma', 'Interferon gamma Inducing Factor', 'Interferon gamma-inducing factor', 'Interferon-gamma Inducing Factor', 'Interferon-gamma-Inducing Factor', 'Interleukin 18', 'Interleukin-1 gamma', 'Interleukin-18', 'interferon-gamma-inducing factor', 'interleukin 18'], 'definition': None, 'syn_in_text': 'IL-18', 'syn_in_stmt': 'IL18'}, 'HGNC:5992': {'name': 'IL1B', 'synonyms': ['Catabolin', 'IL-1 beta', 'IL-1B', 'IL-1beta', 'IL-1β', 'IL1-BETA', 'IL1B', 'IL1F2', 'Interleukin 1 beta', 'Interleukin 1beta', 'Interleukin-1 beta', 'Interleukin-1beta', 'interleukin 1 beta'], 'definition': None, 'syn_in_text': 'IL-1β', 'syn_in_stmt': 'IL1B'}}
marta.iannuccelli@gmail.com	Wed, 29 Jan 2025 08:14:24 GMT		14600	-21769219245421728	{'belief': 1, 'enz': {'db_refs': {'HGNC': '13890', 'TEXT': 'Itch', 'UP': 'Q96J02'}, 'name': 'ITCH'}, 'id': 'b105e010-96f3-44c7-96b7-6f3106d593b1', 'matches_hash': '-21769219245421728', 'sub': {'db_refs': {'HGNC': '6205', 'TEXT': 'JunB', 'UP': 'P17275'}, 'name': 'JUNB'}, 'type': 'Ubiquitination'}	signor_ubiq	6237825536112789544	wrong_relation	JunB ubiquitination was promoted by Itch induced neddylation, whereas this effect did not happen by Itch C830A mutant.	ITCH ubiquitinates JUNB.	{'HGNC:13890': {'name': 'ITCH', 'synonyms': ['AIP4', 'Atrophin-1-interacting protein 4', 'E3 ubiquitin-protein ligase Itchy homolog', 'HECT-type E3 ubiquitin transferase Itchy homolog', 'ITCH', 'Itch', 'NAPP1', 'NFE2-associated polypeptide 1', 'itchy E3 ubiquitin protein ligase'], 'definition': None, 'syn_in_text': 'ITCH', 'syn_in_stmt': 'ITCH'}, 'HGNC:6205': {'name': 'JUNB', 'synonyms': ['JUNB', 'JunB proto-oncogene, AP-1 transcription factor subunit', 'Transcription factor AP-1 subunit JunB', 'Transcription factor JunB', 'JunB'], 'definition': None, 'syn_in_text': 'JUNB', 'syn_in_stmt': 'JUNB'}}
ben.gyori@gmail.com	Mon, 07 Jun 2021 20:22:42 GMT	{'annotations': {'agents': {'raw_text': ['EPHA6', 'LDL']}, 'content_source': 'pmc_oa', 'found_by': 'BIO-ASSOCIATE', 'prior_uuids': ['f301b155-a9f0-4161-90ff-767027aa6254']}, 'pmid': '29208002', 'source_api': 'sparser', 'source_hash': 1756420268147552800, 'text': 'The results of this study suggest that the EPHA6 rs4857055 C\u2009>\u2009T SNP could be a novel candidate gene for hypertension; moreover, the EPHA6 rs4857055 TT genotype could be associated with hypertriglyceridemia and small LDL particle size in hypertension.', 'text_refs': {'DOI': '10.1186/S12944-017-0620-5', 'DOI_ID': 'S12944-017-0620-5', 'DOI_NS': 1186, 'PMCID': 'PMC5718072', 'PMCID_NUM': 5718072, 'PMID': '29208002', 'PMID_NUM': 29208002, 'READER': 'SPARSER', 'RID': 20300019370638, 'SOURCE': 'pmc_oa', 'TCID': 19370638, 'TRID': 28369793}}	12041	-14891607074808888	{'belief': 1, 'id': '64b90040-68c7-4cf1-a561-5dc41cb1a7a2', 'matches_hash': '-14891607074808888', 'members': [{'db_refs': {'CHEBI': 'CHEBI:39026', 'NCIT': 'C25187', 'TEXT': 'LDL'}, 'name': 'low-density lipoprotein'}, {'db_refs': {'HGNC': '19296', 'TEXT': 'EPHA6', 'UP': 'Q9UF33'}, 'name': 'EPHA6'}], 'type': 'Complex'}	DB REST API	1756420268147552726	wrong_relation	The results of this study suggest that the EPHA6 rs4857055 C > T SNP could be a novel candidate gene for hypertension; moreover, the EPHA6 rs4857055 TT genotype could be associated with hypertriglyceridemia and small LDL particle size in hypertension.	Low-density lipoprotein binds EPHA6.	{'CHEBI:CHEBI:39026': {'name': 'low-density lipoprotein', 'synonyms': ['LDL', 'beta-lipoproteins', 'low-density lipoprotein', 'low-density lipoproteins'], 'definition': None, 'syn_in_text': 'LDL', 'syn_in_stmt': 'low-density lipoprotein'}, 'HGNC:19296': {'name': 'EPHA6', 'synonyms': ['EHK-2', 'EHK2', 'EK12', 'EPH homology kinase 2', 'EPH receptor A6', 'EPH-like kinase 12', 'EPHA6', 'Ephrin type-A receptor 6', 'FLJ35246', 'HEK12'], 'definition': None, 'syn_in_text': 'EPHA6', 'syn_in_stmt': 'EPHA6'}}
bachmanjohn@gmail.com	Fri, 06 Nov 2020 20:54:02 GMT		7926	9951114949867561		EMMAA	-3041678709845456349	wrong_relation	We recently reported that Nf2 -deficient livers (Alb-Cre;Nf2 flox2/flox2 ) display reduced Lats1/2 and YAP phosphorylation, supporting the view that NF2 is normally required for Hippo signaling in mammals ( xref ).	YAP1 phosphorylates NF2.	{'HGNC:16262': {'name': 'YAP1', 'synonyms': ['Protein yorkie homolog', 'Transcriptional coactivator YAP1', 'YAP', 'YAP-1', 'YAP1', 'YAP65', 'Yes-associated protein 1', 'Yes-associated protein YAP65 homolog', 'Yes1 associated transcriptional regulator', 'Lats1/2 and YAP'], 'definition': None, 'syn_in_text': 'YAP', 'syn_in_stmt': 'YAP1'}, 'HGNC:7773': {'name': 'NF2', 'synonyms': ['ACN', 'BANF', 'Gene Product, NF2', 'Merlin', 'Moesin Ezrin Radixin Like Protein', 'Moesin-Ezrin-Radixin-Like Protein', 'Moesin-ezrin-radixin-like protein', 'NF2', 'NF2 Gene Product', 'NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor', 'Neurofibromatosis 2 Gene Product', 'Neurofibromatosis Type 2 Protein', 'Neurofibromin 2', 'Neurofibromin-2', 'Protein, Schwannomin', 'SCH', 'Schwannomerlin', 'Schwannomin', 'Schwannomin Protein', 'bilateral acoustic neurofibromatosis', 'merlin', 'merlin-1', 'moesin-ezrin-radixin like', 'schwannomin', 'Nf2'], 'definition': None, 'syn_in_text': 'NF2', 'syn_in_stmt': 'NF2'}}
ben.gyori@gmail.com	Tue, 09 Feb 2021 05:14:32 GMT		10827	10243932894765790		DB REST API	-2596354043918117267	wrong_relation	XREF_BIBR, XREF_BIBR, XREF_BIBR Of note, unlike the present study using A549 cells, TGF-beta inhibited the oxidative stress response by Nrf2 through the induction of Maf family transcription factors in cooperation with Bach1 in mammary gland epithelial cells.	NFE2L2 inhibits BACH1.	{'HGNC:7782': {'name': 'NFE2L2', 'synonyms': ['HEBP1', 'NF E2 Related Factor 2', 'NF-E2-Related Factor 2', 'NF-E2-related factor 2', 'NFE2 like bZIP transcription factor 2', 'NFE2-related factor 2', 'NFE2L2', 'NRF-2', 'NRF2', 'Nfe2l2 Protein', 'Nrf-2', 'Nrf2', 'Nuclear Factor (Erythroid-Derived 2)-Like 2 Protein', 'Nuclear Factor E2 Related Factor 2', 'Nuclear Factor E2-Related Factor 2', 'Nuclear factor erythroid 2-related factor 2', 'Nuclear factor, erythroid derived 2, like 2'], 'definition': None, 'syn_in_text': 'NRF2', 'syn_in_stmt': 'NFE2L2'}, 'HGNC:935': {'name': 'BACH1', 'synonyms': ['BACH-1', 'BACH1', 'BTB and CNC homolog 1', 'BTB domain and CNC homolog 1', 'BTBD24', 'HA2303', 'Transcription regulator protein BACH1', 'Bach1'], 'definition': None, 'syn_in_text': 'BACH1', 'syn_in_stmt': 'BACH1'}}
ben.gyori@gmail.com	Wed, 25 Aug 2021 05:31:45 GMT	{'annotations': {'agents': {'raw_text': ['JNK1', 'JNK']}, 'content_source': 'elsevier', 'found_by': 'Positive_activation_syntax_1_verb', 'prior_uuids': ['dcbbf469-a191-45d2-9ead-45dbd88f7820']}, 'epistemics': {'direct': False, 'section_type': None}, 'pmid': '18182317', 'source_api': 'reach', 'source_hash': 1981138253719434200, 'text': 'Higher amounts of JNK1 and JNK2 increased JNK activity but also resulted in a higher non specific background.PKC has been recently identified as a positive regulator of JNK via phosphorylation of S129 (Liu et al., 2006; Lopez-Bergami et al., 2005).', 'text_refs': {'DOI': '10.1016/J.BIOCEL.2007.11.011', 'DOI_ID': 'J.BIOCEL.2007.11.011', 'DOI_NS': 1016, 'PMCID': 'PMC2327215', 'PMCID_NUM': 2327215, 'PMID': '18182317', 'PMID_NUM': 18182317, 'READER': 'REACH', 'RID': 10100022555332, 'SOURCE': 'elsevier', 'TCID': 22555332, 'TRID': 19017459}}	12414	-23303868022189135	{'belief': 1, 'id': 'd8efe696-9337-4381-960e-91d61439b6f2', 'matches_hash': '-23303868022189135', 'obj': {'db_refs': {'FPLX': 'JNK', 'IP': 'IPR008351', 'MESH': 'D048031', 'TEXT': 'JNK'}, 'name': 'JNK'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '6881', 'MESH': 'D048055', 'TEXT': 'JNK1', 'UP': 'P45983'}, 'name': 'MAPK8'}, 'type': 'Activation'}	DB REST API	1981138253719434261	wrong_relation	Higher amounts of JNK1 and JNK2 increased JNK activity but also resulted in a higher non specific background.PKC has been recently identified as a positive regulator of JNK via phosphorylation of S129 (Liu et al., 2006; Lopez-Bergami et al., 2005).	MAPK8 activates JNK.	{'HGNC:6881': {'name': 'MAPK8', 'synonyms': ['JNK', 'JNK-46', 'JNK1', 'JNK1 Kinase', 'JUN N-terminal kinase', 'MAP kinase 8', 'MAPK 8', 'MAPK8', 'MAPK8 Mitogen Activated Protein Kinase', 'MAPK8 Mitogen-Activated Protein Kinase', 'Mitogen Activated Protein Kinase 8', 'Mitogen-Activated Protein Kinase 8', 'Mitogen-activated protein kinase 8', 'PRKM8', 'SAP Kinase 1', 'SAP Kinase-1', 'SAPK1', 'SAPK1 Mitogen Activated Protein Kinase', 'SAPK1 Mitogen-Activated Protein Kinase', 'SAPK1C', 'SAPK1c', 'Stress Activated Protein Kinase 1', 'Stress Activated Protein Kinase JNK1', 'Stress Activated Protein Kinase gamma', 'Stress-Activated Protein Kinase 1', 'Stress-Activated Protein Kinase JNK1', 'Stress-Activated Protein Kinase gamma', 'Stress-activated protein kinase 1c', 'Stress-activated protein kinase JNK1', 'c jun Kinase 1', 'c jun N Terminal Kinase 1', 'c-Jun N-terminal kinase 1', 'c-jun Kinase-1', 'c-jun N-Terminal Kinase 1', 'mitogen-activated protein kinase 8'], 'definition': None, 'syn_in_text': 'JNK', 'syn_in_stmt': 'JNK'}, 'FPLX:JNK': {'name': 'JNK', 'synonyms': ['JNK', 'JNK MAPK', 'JNK1/2', 'JNKs', 'SAPK', 'c-JNK', 'c-Jun N-terminal kinase', 'c-Jun NH2-terminal kinase'], 'definition': None, 'syn_in_text': 'JNK', 'syn_in_stmt': 'JNK'}}
bachmanjohn@gmail.com	Fri, 06 Nov 2020 19:02:45 GMT		7895	24767232518736759		DB REST API	-8836553570495580472	wrong_relation	Furthermore, PAK1 specific inhibitors CEP-1347 and WR-PAK18 selectively inhibit the growth of NF2 deficient cancer cells, but not NF2 positive cells.	PAK1 activates NF2.	{'HGNC:8590': {'name': 'PAK1', 'synonyms': ['Alpha-PAK', 'PAK-1', 'PAK1', 'Pak1', 'STE20 homolog, yeast', 'Serine/threonine-protein kinase PAK 1', 'p21 (RAC1) activated kinase 1', 'p21-activated kinase 1', 'p65-PAK'], 'definition': None, 'syn_in_text': 'PAK1', 'syn_in_stmt': 'PAK1'}, 'HGNC:7773': {'name': 'NF2', 'synonyms': ['ACN', 'BANF', 'Gene Product, NF2', 'Merlin', 'Moesin Ezrin Radixin Like Protein', 'Moesin-Ezrin-Radixin-Like Protein', 'Moesin-ezrin-radixin-like protein', 'NF2', 'NF2 Gene Product', 'NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor', 'Neurofibromatosis 2 Gene Product', 'Neurofibromatosis Type 2 Protein', 'Neurofibromin 2', 'Neurofibromin-2', 'Protein, Schwannomin', 'SCH', 'Schwannomerlin', 'Schwannomin', 'Schwannomin Protein', 'bilateral acoustic neurofibromatosis', 'merlin', 'merlin-1', 'moesin-ezrin-radixin like', 'schwannomin'], 'definition': None, 'syn_in_text': 'NF2', 'syn_in_stmt': 'NF2'}}
marta.iannuccelli@gmail.com	Wed, 20 Mar 2024 12:07:13 GMT		14213	20345187129918263	{'belief': 1, 'enz': {'db_refs': {'HGNC': '6079', 'TEXT': 'SHIP-1', 'UP': 'Q92835'}, 'name': 'INPP5D'}, 'id': '77febc8f-a7eb-431b-ba97-6dfe4ecfd90e', 'matches_hash': '20345187129918263', 'sub': {'db_refs': {'HGNC': '12731', 'MESH': 'D051316', 'TEXT': 'WASP', 'UP': 'P42768'}, 'name': 'WAS'}, 'type': 'Dephosphorylation'}	signor_dephos	8493432147559962958	wrong_relation	This study shows that SHIP-1 inhibits WASP phosphorylation, counteracting against Btk.	INPP5D leads to the dephosphorylation of WAS.	"{'HGNC:6079': {'name': 'INPP5D', 'synonyms': ['INPP5D', 'Inositol polyphosphate-5-phosphatase D', 'Inositol polyphosphate-5-phosphatase of 145 kDa', 'Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1', 'Phosphatidylinositol 4,5-bisphosphate 5-phosphatase', ""SH2 domain-containing inositol 5'-phosphatase 1"", 'SH2 domain-containing inositol phosphatase 1', 'SHIP', 'SHIP-1', 'SHIP1', 'SIP-145', 'hp51CN', 'inositol polyphosphate-5-phosphatase D', 'p150Ship'], 'definition': None, 'syn_in_text': 'SHIP-1', 'syn_in_stmt': 'INPP5D'}, 'HGNC:12731': {'name': 'WAS', 'synonyms': ['Actin nucleation-promoting factor WAS', 'IMD2', 'THC', 'WAS', 'WASP', 'WASP Protein', 'WASP actin nucleation promoting factor', 'WASPA', 'WASp', 'Wiskott Aldrich Syndrome Protein', 'Wiskott-Aldrich Syndrome Protein', 'Wiskott-Aldrich syndrome protein', 'eczema-thrombocytopenia'], 'definition': None, 'syn_in_text': 'WASP', 'syn_in_stmt': 'WAS'}}"
fabian_froehlich@hms.harvard.edu	Fri, 26 Jun 2020 19:26:41 GMT		5684	-8044214334799239		DB REST API	-3147808609261317502	wrong_relation	Taken together, these findings suggest that HMGA1 induced cellular proliferation in soft agar growth is independent of MEK and ERK signaling.	HMGA1 activates ERK.	{'HGNC:5010': {'name': 'HMGA1', 'synonyms': ['HMG-I(Y)', 'HMGA1', 'HMGIY', 'High mobility group AT-hook protein 1', 'High mobility group protein A1', 'High mobility group protein HMG-I/HMG-Y', 'High mobility group protein R', 'high mobility group AT-hook 1'], 'definition': None, 'syn_in_text': 'HMGA1', 'syn_in_stmt': 'HMGA1'}, 'FPLX:ERK': {'name': 'ERK', 'synonyms': ['ERK', 'ERK 1/2', 'ERK MAP Kinase', 'ERK MAP Kinases', 'ERK MAPK', 'ERK mitogen-activated protein kinase', 'ERK-1/2', 'ERK1/2', 'ERK1/2 MAPK', 'ERKs', 'Erk', 'Erk1/2', 'Extracellular Signal Regulated Kinase', 'Extracellular Signal Regulated Kinases', 'Extracellular Signal Regulated MAP Kinase', 'Extracellular Signal Regulated MAP Kinases', 'Extracellular Signal-Regulated Kinase', 'Extracellular Signal-Regulated Kinases', 'Extracellular Signal-Regulated MAP Kinase', 'Extracellular Signal-Regulated MAP Kinases', 'Kinase, ERK MAP', 'Kinase, Extracellular Signal-Regulated', 'Kinases, Extracellular Signal-Regulated', 'MAP Kinase, ERK', 'MAP Kinases, Extracellular Signal Regulated', 'MAP Kinases, Extracellular Signal-Regulated', 'Signal-Regulated Kinase, Extracellular', 'extracellular signal-regulated kinase', 'p42 and p38 MAP kinases', 'p42 and p38 MAPK', 'p42 and p38 MAPKs', 'p42 and p44', 'p42 and p44 MAPK', 'p42 and p44MAP kinase', 'p42(mapk) and p44(mapk)', 'p42/44', 'p44 and p42', 'phospho-ERK1/2'], 'definition': None, 'syn_in_text': 'ERK', 'syn_in_stmt': 'ERK'}}
livia.perfetto@gmail.com	Thu, 16 Nov 2023 05:23:46 GMT		13695	-21430179467444739	{'belief': 1, 'id': 'e0744347-6850-4d20-b5fe-b5570d5996cd', 'matches_hash': '-21430179467444739', 'obj': {'db_refs': {'HGNC': '6091', 'TEXT': 'IR', 'UP': 'P06213'}, 'name': 'INSR'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '9650', 'MESH': 'D054578', 'TEXT': 'TCPTP', 'UP': 'P17706'}, 'name': 'PTPN2'}, 'type': 'Activation'}	signor_dephos	-3553695075435962694	wrong_relation	This would suggest that TCPTP deletion, or decreased TCPTP in POMC neurons in response to feeding, represses HGP by enhancing IR signaling and permitting POMC neurons to be activated by insulin.	PTPN2 activates INSR.	{'HGNC:9650': {'name': 'PTPN2', 'synonyms': ['PTPN2', 'PTPT', 'Protein Tyrosine Phosphatase, Non Receptor Type 2', 'Protein Tyrosine Phosphatase, Non-Receptor Type 2', 'T Cell Protein Tyrosine Phosphatase', 'T-Cell Protein Tyrosine Phosphatase', 'T-cell protein-tyrosine phosphatase', 'TC-PTP', 'TC45', 'TC48', 'TCELLPTP', 'TCPTP', 'TCPTP Enzyme', 'Tyrosine-protein phosphatase non-receptor type 2', 'protein tyrosine phosphatase non-receptor type 2'], 'definition': None, 'syn_in_text': 'TCPTP', 'syn_in_stmt': 'PTPN2'}, 'HGNC:6091': {'name': 'INSR', 'synonyms': ['CD antigen CD220', 'CD220', 'HIR', 'INSR', 'IR', 'Insulin Receptor', 'Insulin Receptor Protein Tyrosine Kinase', 'Insulin Receptor Protein-Tyrosine Kinase', 'Insulin Receptors', 'Insulin receptor', 'Insulin-Dependent Tyrosine Protein Kinase', 'Receptor, Insulin', 'Receptors, Insulin', 'insulin receptor'], 'definition': None, 'syn_in_text': 'IR', 'syn_in_stmt': 'INSR'}}
bachmanjohn@gmail.com	Fri, 06 Nov 2020 17:28:02 GMT		7877	-24759238737191770		EMMAA	5467091033228941939	wrong_relation	Furthermore, exogenous wild-type and S518A merlin, but not the S518D mutant substantially reduced p-MLK3 and p-JNK levels in SKOV3 cells.	NF2-S518A decreases the amount of MAP3K11.	{'HGNC:7773': {'name': 'NF2', 'synonyms': ['ACN', 'BANF', 'Gene Product, NF2', 'Merlin', 'Moesin Ezrin Radixin Like Protein', 'Moesin-Ezrin-Radixin-Like Protein', 'Moesin-ezrin-radixin-like protein', 'NF2', 'NF2 Gene Product', 'NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor', 'Neurofibromatosis 2 Gene Product', 'Neurofibromatosis Type 2 Protein', 'Neurofibromin 2', 'Neurofibromin-2', 'Protein, Schwannomin', 'SCH', 'Schwannomerlin', 'Schwannomin', 'Schwannomin Protein', 'bilateral acoustic neurofibromatosis', 'merlin', 'merlin-1', 'moesin-ezrin-radixin like', 'schwannomin'], 'definition': None, 'syn_in_text': 'Merlin', 'syn_in_stmt': 'NF2'}, 'HGNC:6850': {'name': 'MAP3K11', 'synonyms': ['MAP3K11', 'MEKK11', 'MLK3', 'Mitogen-Activated Protein Kinase Kinase Kinase 11', 'Mitogen-activated protein kinase kinase kinase 11', 'Mixed Lineage Kinase 3', 'Mixed Lineage Kinase-3', 'Mixed lineage kinase 3', 'PTK1', 'SPRK', 'Src-homology 3 domain-containing proline-rich kinase', 'mitogen-activated protein kinase kinase kinase 11', 'p-MLK3'], 'definition': None, 'syn_in_text': 'p-MLK3', 'syn_in_stmt': 'MAP3K11'}}
ben.gyori@gmail.com	Tue, 15 Dec 2020 06:18:14 GMT		10266	-19952367157294119		EMMAA	7706421689836768425	wrong_relation	Chromatin immunoprecipitation assay (ChIP) revealed the binding of activated c-Jun to the p53 promoter region.	TP53 binds JUN.	{'HGNC:11998': {'name': 'TP53', 'synonyms': ['Antigen NY-CO-13', 'Cellular Tumor Antigen p53', 'Cellular tumor antigen p53', 'LFS1', 'Li-Fraumeni syndrome', 'Oncoprotein p53', 'P53', 'Phosphoprotein p53', 'Phosphoprotein, pp53', 'TP53', 'TP53 Protein', 'TRP53 Protein', 'Tumor Suppressor Protein p53', 'Tumor suppressor p53', 'mutp53', 'p53', 'p53 Antigen', 'p53 Tumor Suppressor Protein', 'pp53 Phosphoprotein', 'tumor protein p53'], 'definition': None, 'syn_in_text': 'P53', 'syn_in_stmt': 'TP53'}, 'HGNC:6204': {'name': 'JUN', 'synonyms': ['AP-1', 'AP1', 'Activator protein 1', 'JUN', 'Jun proto-oncogene, AP-1 transcription factor subunit', 'Proto-oncogene c-Jun', 'Transcription factor AP-1 subunit Jun', 'Transcription factor Jun', 'V-jun avian sarcoma virus 17 oncogene homolog', 'c-Jun', 'c-jun', 'p39'], 'definition': None, 'syn_in_text': 'c-Jun', 'syn_in_stmt': 'JUN'}}
bachmanjohn@gmail.com	Mon, 02 Mar 2020 14:20:45 GMT		2116	-23531997240565065		DB REST API	-7836187096931535859	wrong_relation	Mitochondrial carrier homolog 2 is a target of tBID in cells signaled to die by tumor necrosis factor alpha.	BID decreases the amount of MTCH2.	{'HGNC:1050': {'name': 'BID', 'synonyms': ['BH3 interacting domain death agonist', 'BH3-interacting domain death agonist', 'BID', 'Bid', 'p22 BID', 'tBID'], 'definition': None, 'syn_in_text': 'tBID', 'syn_in_stmt': 'BID'}, 'HGNC:17587': {'name': 'MTCH2', 'synonyms': ['MIMP', 'MTCH2', 'Met-induced mitochondrial protein', 'Mitochondrial carrier homolog 2', 'SLC25A50', 'mitochondrial carrier 2', 'solute carrier family 25, member 50'], 'definition': None, 'syn_in_text': 'Mitochondrial carrier homolog 2', 'syn_in_stmt': 'MTCH2'}}
bachmanjohn@gmail.com	Thu, 19 Nov 2020 11:26:42 GMT		8783	-28086937138588686		EMMAA	-5429333402883233487	wrong_relation	In an attempt to elucidate the mechanism of SecPH inhibition of cofilin phosphorylation by ROCK activated LIMK2, we postulated that SecPH might prevent LIMK2 from interacting with ROCK.	Cofilin activates LIMK2.	{'FPLX:Cofilin': {'name': 'Cofilin', 'synonyms': ['AC', 'ADF Proteins (Actin Depolymerizing Factors)', 'Actin Depolymerizing Factors', 'Actin Depolymerizing Protein', 'Actin Depolymerizing Proteins', 'Cofilin', 'Cofilin Proteins', 'Cofilins', 'Depolymerizing Factors, Actin', 'Depolymerizing Protein, Actin', 'Depolymerizing Proteins, Actin', 'Protein, Actin Depolymerizing', 'cofilin'], 'definition': None, 'syn_in_text': 'Cofilin', 'syn_in_stmt': 'Cofilin'}, 'HGNC:6614': {'name': 'LIMK2', 'synonyms': ['LIM domain kinase 2', 'LIMK-2', 'LIMK2'], 'definition': None, 'syn_in_text': 'LIMK2', 'syn_in_stmt': 'LIMK2'}}
bachmanjohn@gmail.com	Fri, 06 Nov 2020 20:53:20 GMT		7924	21701163061434298		EMMAA	8125204372744749059	wrong_relation	Ectopic expression of Merlin in NF2 -/- MPM cells inhibited invasion, decreased FAK Tyr397 phosphorylation and impaired FAK interaction with its binding partners Src and p85.	SRC leads to the dephosphorylation of PTK2 on Y397.	{'HGNC:11283': {'name': 'SRC', 'synonyms': ['ASV', 'Proto-oncogene c-Src', 'Proto-oncogene tyrosine-protein kinase Src', 'SRC', 'SRC proto-oncogene, non-receptor tyrosine kinase', 'SRC1', 'Src', 'Src kinase', 'c-Src', 'c-src', 'p60-Src', 'pp60c-src'], 'definition': None, 'syn_in_text': 'SRC', 'syn_in_stmt': 'SRC'}, 'HGNC:9611': {'name': 'PTK2', 'synonyms': ['Endogenous Substrate pp120', 'FADK', 'FADK 1', 'FAK', 'FAK1', 'FRNK', 'Focal Adhesion Associated Protein Tyrosine Kinase pp125FAK', 'Focal Adhesion Kinase 1', 'Focal Adhesion-Associated Protein-Tyrosine Kinase pp125FAK', 'Focal adhesion kinase 1', 'Focal adhesion kinase-related nonkinase', 'PPP1R71', 'PTK2', 'Protein Tyrosine Kinase 2', 'Protein phosphatase 1 regulatory subunit 71', 'Protein-tyrosine kinase 2', 'p125FAK', 'p125FAK Protein', 'pp125FAK', 'protein phosphatase 1, regulatory subunit 71', 'protein tyrosine kinase 2'], 'definition': None, 'syn_in_text': 'FAK', 'syn_in_stmt': 'PTK2'}}
ben.gyori@gmail.com	Mon, 12 Apr 2021 14:05:42 GMT		11862	2354546446436711		DB REST API	-948321095845435139	wrong_relation	We investigated the association of IL15 rs10833 or SCARB1 rs10846744 polymorphisms with treatment responses in patients with chronic HCV (CHC).	SCARB1 binds IL15.	{'HGNC:1664': {'name': 'SCARB1', 'synonyms': ['CD antigen CD36', 'CD36 and LIMPII analogous 1', 'CD36 antigen-like 1', 'CD36L1', 'CLA-1', 'CLA1', 'Collagen type I receptor, thrombospondin receptor-like 1', 'SCARB1', 'SR-BI', 'SRB1', 'Scavenger receptor class B member 1', 'scavenger receptor class B member 1'], 'definition': None, 'syn_in_text': 'SCARB1', 'syn_in_stmt': 'SCARB1'}, 'HGNC:5977': {'name': 'IL15', 'synonyms': ['IL-15', 'IL15', 'Interleukin 15', 'Interleukin-15', 'MGC9721', 'interleukin 15'], 'definition': None, 'syn_in_text': 'IL15', 'syn_in_stmt': 'IL15'}}
ben.gyori@gmail.com	Tue, 28 Jan 2020 23:08:51 GMT		1438	-6978799638840707		DB REST API	-7933190655011460456	wrong_relation	BRAF is a downstream target of KRAS.	BRAF activates KRAS.	{'HGNC:1097': {'name': 'BRAF', 'synonyms': ['B-Raf', 'B-Raf proto-oncogene, serine/threonine kinase', 'BRAF', 'BRAF-1', 'BRAF1', 'Proto-oncogene B-Raf', 'RAFB1', 'Serine/threonine-protein kinase B-raf', 'p94', 'v-Raf murine sarcoma viral oncogene homolog B1'], 'definition': None, 'syn_in_text': 'BRAF', 'syn_in_stmt': 'BRAF'}, 'HGNC:6407': {'name': 'KRAS', 'synonyms': ['GTPase KRas', 'K-Ras', 'K-Ras 2', 'K-Ras4B', 'KRAS', 'KRAS proto-oncogene, GTPase', 'KRAS1', 'KRAS2', 'Ki-Ras', 'Kras', 'RASK2', 'c-K-ras', 'c-Ki-ras'], 'definition': None, 'syn_in_text': 'KRAS', 'syn_in_stmt': 'KRAS'}}
bachmanjohn@gmail.com	Wed, 18 Nov 2020 14:48:15 GMT		8740	30878810445945737		EMMAA	568379888292955641	wrong_relation	Consistent with Akt/GSK3β/CREB hyperactivation as the responsible pathway underlying Ccl5-mediated o-GSC survival, Akt inhibition (MK2206) following Ccl5 treatment attenuated Akt, GSK3β, and CREB activation (using phospho-specific antibodies), as well as increased o-GSC apoptosis (TUNEL) (Fig.  xref ).	GSK3B activates CCL5.	{'HGNC:4617': {'name': 'GSK3B', 'synonyms': ['GSK 3beta', 'GSK-3 beta', 'GSK-3beta', 'GSK-3β', 'GSK3B', 'GSK3B Protein', 'GSK3beta', 'GSK3β', 'Glycogen Synthase Kinase 3 beta', 'Glycogen synthase kinase-3 beta', 'Serine/threonine-protein kinase GSK3B', 'glycogen synthase kinase 3 beta'], 'definition': None, 'syn_in_text': 'GSK3β', 'syn_in_stmt': 'GSK3B'}, 'HGNC:10632': {'name': 'CCL5', 'synonyms': ['C-C motif chemokine 5', 'C-C motif chemokine ligand 5', 'CCL5', 'CCL5 Chemokine', 'CCL5, Chemokine', 'Chemokine CCL5', 'Chemokine, CCL5', 'D17S136E', 'EoCP', 'Eosinophil chemotactic cytokine', 'MGC17164', 'RANTES', 'RANTES Protein, T Cell', 'RANTES Protein, T-Cell', 'SCYA5', 'SIS-delta', 'SISd', 'Small-inducible cytokine A5', 'T cell-specific protein P228', 'T-Cell RANTES Protein', 'T-cell specific RANTES protein', 'T-cell specific protein p288', 'T-cell-specific protein RANTES', 'TCP228', 'beta-chemokine RANTES', 'regulated upon activation, normally T-expressed, and presumably secreted', 'small inducible cytokine subfamily A (Cys-Cys), member 5', 'Ccl5'], 'definition': None, 'syn_in_text': 'CCL5', 'syn_in_stmt': 'CCL5'}}
bachmanjohn@gmail.com	Fri, 30 Oct 2020 17:54:24 GMT		7377	-4854262310656348		EMMAA	1327507240062160867	wrong_relation	One possibility is that inappropriate Ras activation in NF1 mutant flies inhibits cyclase activation, either upstream or at the level of cyclase itself and/or as a result of a negative feedback pathway.	RAS activates mutated NF1.	{'FPLX:RAS': {'name': 'RAS', 'synonyms': ['GTPase, ras', 'GTPases, ras', 'Gene Products, ras', 'Protein, ras', 'RAS', 'Ras', 'Ras GTPase', 'ras GTPase', 'ras GTPases', 'ras Gene Products', 'ras Protein', 'ras Proteins'], 'definition': None, 'syn_in_text': 'RAS', 'syn_in_stmt': 'RAS'}, 'HGNC:7765': {'name': 'NF1', 'synonyms': ['NF 1 Protein', 'NF-1 Protein', 'NF1', 'NF1 GAP Related Protein', 'NF1 GRP', 'NF1 Protein', 'NF1-GAP-Related Protein', 'Neurofibromatosis Type 1 Gene Product', 'Neurofibromatosis Type 1 Protein', 'Neurofibromatosis-related protein NF-1', 'Neurofibromin', 'Neurofibromin 1', 'Watson disease', 'neurofibromatosis', 'neurofibromin 1', 'von Recklinghausen disease'], 'definition': None, 'syn_in_text': 'NF1', 'syn_in_stmt': 'NF1'}}
ben.gyori@gmail.com	Fri, 31 Jul 2020 17:42:19 GMT		5953	-33086831678629642		EMMAA	7663893983142264051	wrong_relation	"Templates in these reactions: lane 1: water; lane 2: 10 3 copies of influenza A DNA; lane 3:
Primers for RPA and RT-RPA."	RPA binds RNA-Directed DNA Polymerase.	{'FPLX:RPA': {'name': 'RPA', 'synonyms': ['DNA Replication Factor A', 'RPA', 'Replication Factor A', 'Replication Factor A Single Stranded DNA Binding Protein', 'Replication Factor A Single-Stranded DNA-Binding Protein', 'Replication Protein A', 'Replication protein A', 'Single Strand Binding Protein RP A', 'Single-Strand Binding Protein RP-A', 'replication protein A'], 'definition': None, 'syn_in_text': 'RPA', 'syn_in_stmt': 'RPA'}, 'MESH:D012194': {'name': 'RNA-Directed DNA Polymerase', 'synonyms': ['DNA Polymerase, RNA Directed', 'DNA Polymerase, RNA-Dependent', 'DNA Polymerase, RNA-Directed', 'RNA Dependent DNA Polymerase', 'RNA Directed DNA Polymerase', 'RNA Transcriptase', 'RNA-Dependent DNA Polymerase', 'RNA-Directed DNA Polymerase', 'RT', 'RTs', 'Reverse Transcriptase', 'Revertase'], 'definition': None, 'syn_in_text': 'RT', 'syn_in_stmt': 'RNA-Directed DNA Polymerase'}}
livia.perfetto@gmail.com	Wed, 22 Nov 2023 08:01:54 GMT		13728	24659485126807685	{'belief': 1, 'id': 'f8d5a450-53ea-45ae-8ee2-7541c3fc839f', 'matches_hash': '24659485126807685', 'obj': {'db_refs': {'HGNC': '1726', 'TEXT': 'Cdc25B', 'UP': 'P30305'}, 'name': 'CDC25B'}, 'obj_activity': 'activity', 'subj': {'db_refs': {'HGNC': '1718', 'TEXT': 'Cdc14A', 'UP': 'Q9UNH5'}, 'name': 'CDC14A'}, 'type': 'Activation'}	signor_dephos	8561697516935368503	wrong_relation	In summary, we show that depletion of Cdc14A accelerates the timing of mitotic entry through deregulation of Cdc25A and Cdc25B at the G2/M transition.	CDC14A activates CDC25B.	{'HGNC:1718': {'name': 'CDC14A', 'synonyms': ['CDC14 cell division cycle 14 homolog A', 'CDC14A', 'Cdc14A1', 'Cdc14A2', 'DFNB105', 'DFNB32', 'Dual specificity protein phosphatase CDC14A', 'cdc14', 'cell division cycle 14A', 'Cdc14A'], 'definition': None, 'syn_in_text': 'CDC14A', 'syn_in_stmt': 'CDC14A'}, 'HGNC:1726': {'name': 'CDC25B', 'synonyms': ['CDC25 homolog B (S. pombe)', 'CDC25B', 'CDC25HU2', 'Dual specificity phosphatase Cdc25B', 'M-phase inducer phosphatase 2', 'cell division cycle 25B', 'Cdc25B'], 'definition': None, 'syn_in_text': 'CDC25B', 'syn_in_stmt': 'CDC25B'}}
bachmanjohn@gmail.com	Thu, 03 Dec 2020 20:52:28 GMT		9235	31656513502467640		bioexp_biogrid	3837041270822933684	wrong_relation	Binding of AR to the Nanog promoter in the absence of ligand does not show enrichment of DNA over the IgG negative control (XREF_FIG).	NANOG binds AR.	{'HGNC:20857': {'name': 'NANOG', 'synonyms': ['FLJ12581', 'FLJ40451', 'Homeobox protein NANOG', 'Homeobox transcription factor Nanog', 'NANOG', 'Nanog homeobox', 'hNanog', 'Nanog'], 'definition': None, 'syn_in_text': 'NANOG', 'syn_in_stmt': 'NANOG'}, 'HGNC:644': {'name': 'AR', 'synonyms': ['5 alpha Dihydrotestosterone Receptor', '5 alpha-Dihydrotestosterone Receptor', 'AIS', 'AR', 'Androgen Receptor', 'Androgen Receptors', 'Androgen receptor', 'Androgens Receptors', 'DHTR', 'Dihydrotestosterone Receptors', 'Dihydrotestosterone receptor', 'HUMARA', 'Kennedy disease', 'NR3C4', 'Nuclear receptor subfamily 3 group C member 4', 'Receptor, 5 alpha-Dihydrotestosterone', 'Receptor, Androgen', 'Receptor, Stanolone', 'Receptor, Testosterone', 'Receptors, Androgen', 'Receptors, Androgens', 'Receptors, Dihydrotestosterone', 'Receptors, Stanolone', 'SBMA', 'SMAX1', 'Stanolone Receptor', 'Stanolone Receptors', 'Testosterone Receptor', 'alpha-Dihydrotestosterone Receptor, 5', 'androgen receptor', 'testicular feminization'], 'definition': None, 'syn_in_text': 'AR', 'syn_in_stmt': 'AR'}}
bachmanjohn@gmail.com	Mon, 09 Nov 2020 19:51:44 GMT		8117	6685443886171540		EMMAA	3388538022493365503	wrong_relation	The EGFR inhibitor erlotinib was the first targeted agent used in a histology specific phase II trial for MPNST [XREF_BIBR], based on the compelling preclinical observation that EGFR amplification was observed in MPNSTs and that Nf1 and p53 murine MPNST were stimulated by EGF and inhibited by EGFR inhibitors [XREF_BIBR].	EGF activates TP53.	{'HGNC:3229': {'name': 'EGF', 'synonyms': ['EGF', 'Epidermal Growth Factor', 'Epidermal Growth Factor-Urogastrone', 'Growth Factor, Epidermal', 'Growth Factor-Urogastrone, Epidermal', 'Human Urinary Gastric Inhibitor', 'Pro-epidermal growth factor', 'Urogastrone', 'beta Urogastrone', 'beta-Urogastrone', 'epidermal growth factor'], 'definition': None, 'syn_in_text': 'EGF', 'syn_in_stmt': 'EGF'}, 'HGNC:11998': {'name': 'TP53', 'synonyms': ['Antigen NY-CO-13', 'Cellular Tumor Antigen p53', 'Cellular tumor antigen p53', 'LFS1', 'Li-Fraumeni syndrome', 'Oncoprotein p53', 'P53', 'Phosphoprotein p53', 'Phosphoprotein, pp53', 'TP53', 'TP53 Protein', 'TRP53 Protein', 'Tumor Suppressor Protein p53', 'Tumor suppressor p53', 'mutp53', 'p53', 'p53 Antigen', 'p53 Tumor Suppressor Protein', 'pp53 Phosphoprotein', 'tumor protein p53'], 'definition': None, 'syn_in_text': 'P53', 'syn_in_stmt': 'TP53'}}
ben.gyori@gmail.com	Thu, 18 Jun 2020 02:17:50 GMT		5587	-30125113955423340		bioexp_paper_medscan	7813584846106130808	wrong_relation	Moreover, in SESN2 knockdown cells we found a reduced nuclear translocation of TFEB following tranylcypromine treatment ( ), indicating that SESN2 knockdown prevents the LSD1 inhibition-mediated autophagy.	SESN2 inhibits KDM1A.	{'HGNC:20746': {'name': 'SESN2', 'synonyms': ['DKFZp761M0212', 'HI95', 'Hi95', 'Hypoxia-induced gene', 'SES2', 'SESN2', 'SEST2', 'Sestrin-2', 'sestrin 2'], 'definition': None, 'syn_in_text': 'SESN2', 'syn_in_stmt': 'SESN2'}, 'HGNC:29079': {'name': 'KDM1A', 'synonyms': ['AOF2', 'BHC110', 'BRAF35-HDAC complex protein BHC110', 'Flavin-containing amine oxidase domain-containing protein 2', 'KDM1', 'KDM1A', 'KIAA0601', 'LSD1', 'Lysine-specific histone demethylase 1A', '[histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A', 'lysine demethylase 1A'], 'definition': None, 'syn_in_text': 'LSD1', 'syn_in_stmt': 'KDM1A'}}
ben.gyori@gmail.com	Sun, 09 May 2021 18:27:22 GMT		11952	11505152399130314		EMMAA	5119497697675830400	wrong_relation	It has been observed that hnRNP K binds to the CT-rich regions of the MYC promoter, enhancing transcription of this gene ( xref – xref ).	HNRNPK binds MYC.	{'HGNC:5044': {'name': 'HNRNPK', 'synonyms': ['CSBP', 'HNRNPK', 'HNRPK', 'Heterogeneous Nuclear Ribonucleoprotein K', 'Heterogeneous nuclear ribonucleoprotein K', 'Heterogeneous-Nuclear Ribonucleoprotein K', 'Ribonucleoprotein K, Heterogeneous-Nuclear', 'TUNP', 'Transformation up-regulated nuclear protein', 'heterogeneous nuclear ribonucleoprotein K', 'hnRNP K', 'transformation upregulated nuclear protein'], 'definition': None, 'syn_in_text': 'hnRNP K', 'syn_in_stmt': 'HNRNPK'}, 'HGNC:7553': {'name': 'MYC', 'synonyms': ['BHLHE39', 'Class E basic helix-loop-helix protein 39', 'MYC', 'MYC proto-oncogene, bHLH transcription factor', 'MYCC', 'Myc', 'Myc proto-oncogene protein', 'Proteins myc, Proto-Oncogene', 'Proto Oncogene Products c myc', 'Proto Oncogene Proteins c myc', 'Proto Oncogene Proteins myc', 'Proto-Oncogene Products c-myc', 'Proto-Oncogene Proteins c-myc', 'Proto-Oncogene Proteins myc', 'Proto-Oncogene Proteins, myc', 'Proto-oncogene c-Myc', 'Transcription factor p64', 'bHLHe39', 'c myc Proteins', 'c-MYC', 'c-Myc', 'c-myc', 'c-myc Proteins', 'c-myc oncogene', 'c-myc proteins', 'myc Proto Oncogene Product p62', 'myc Proto Oncogene Proteins', 'myc Proto-Oncogene Product p62', 'myc Proto-Oncogene Proteins', 'myc, Proto-Oncogene Proteins', 'p62 c myc', 'p62 c-myc', 'p62(c-myc)'], 'definition': None, 'syn_in_text': 'MYC', 'syn_in_stmt': 'MYC'}}
marta.iannuccelli@gmail.com	Thu, 21 Mar 2024 10:52:19 GMT		14264	-4169802165040038	{'belief': 1, 'enz': {'db_refs': {'HGNC': '9588', 'TEXT': 'PTEN', 'UP': 'P60484'}, 'name': 'PTEN'}, 'id': '35937549-ec6b-4949-a617-1c1d4c6691da', 'matches_hash': '-4169802165040038', 'sub': {'db_refs': {'HGNC': '1925', 'MESH': 'D000071877', 'TEXT': 'Chk1', 'UP': 'O14757'}, 'name': 'CHEK1'}, 'type': 'Dephosphorylation'}	signor_dephos	-2036815298721955665	wrong_relation	In normal human epidermal keratinocytes (NHEK), PTEN knockdown increases Chk1 phosphorylation, gamma-H2AX formation and p53 accumulation, but not Chk2 phosphorylation similar to the response of HaCaT cells and primary mouse keratinocytes (XREF_FIG, XREF_SUPPLEMENTARY).	PTEN leads to the dephosphorylation of CHEK1.	{'HGNC:9588': {'name': 'PTEN', 'synonyms': ['BZS', 'Inositol polyphosphate 3-phosphatase', 'MHAM', 'MMAC1', 'Mutated in multiple advanced cancers 1', 'PTEN', 'PTEN1', 'Phosphatase and tensin homolog', 'Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN', 'Pten', 'TEP1', 'mutated in multiple advanced cancers 1', 'phosphatase and tensin homolog'], 'definition': None, 'syn_in_text': 'PTEN', 'syn_in_stmt': 'PTEN'}, 'HGNC:1925': {'name': 'CHEK1', 'synonyms': ['CHEK1', 'CHK1', 'CHK1 checkpoint homolog', 'Cell cycle checkpoint kinase', 'Checkpoint Kinase 1', 'Checkpoint kinase-1', 'Checkpoint-1 Kinase', 'Chk1', 'Chk1 Kinase', 'Chk1 Protein Kinase', 'Chkl', 'Protein Kinase, Chk1', 'Serine/threonine-protein kinase Chk1', 'checkpoint kinase 1'], 'definition': None, 'syn_in_text': 'CHK1', 'syn_in_stmt': 'CHEK1'}}
ben.gyori@gmail.com	Wed, 14 Apr 2021 14:20:31 GMT		11914	-19411795501317517		EMMAA	6820326953962406923	wrong_relation	mTOR is a downstream target of Akt1, and to examine the importance of mTOR in mediating FGFR1 induced VSMC phenotypic modulation, we used a specific mTOR inhibitor, rapamycin [XREF_BIBR].	MTOR activates AKT1.	{'HGNC:3942': {'name': 'MTOR', 'synonyms': ['FK506 binding protein 12-rapamycin associated protein 2', 'FK506-binding protein 12-rapamycin complex-associated protein 1', 'FKBP-rapamycin associated protein', 'FKBP12-rapamycin complex-associated protein', 'FKBP12-rapamycin complex-associated protein 1', 'FLJ44809', 'FRAP', 'FRAP1', 'FRAP2', 'MTOR', 'Mammalian target of rapamycin', 'Mechanistic target of rapamycin', 'RAFT1', 'RAPT1', 'Rapamycin and FKBP12 target 1', 'Rapamycin target protein 1', 'Serine/threonine-protein kinase mTOR', 'dJ576K7.1 (FK506 binding protein 12-rapamycin associated protein 1)', 'mTOR', 'mammalian target of rapamycin', 'mechanistic target of rapamycin kinase', 'rapamycin and FKBP12 target 1', 'rapamycin associated protein FRAP2', 'rapamycin target protein'], 'definition': None, 'syn_in_text': 'MTOR', 'syn_in_stmt': 'MTOR'}, 'HGNC:391': {'name': 'AKT1', 'synonyms': ['AKT', 'AKT serine/threonine kinase 1', 'AKT1', 'Akt1', 'PKB', 'PKB alpha', 'PRKBA', 'Protein kinase B', 'Protein kinase B alpha', 'Proto-oncogene c-Akt', 'RAC', 'RAC-PK-alpha', 'RAC-alpha', 'RAC-alpha serine/threonine-protein kinase', 'protein kinase B'], 'definition': None, 'syn_in_text': 'AKT1', 'syn_in_stmt': 'AKT1'}}
ben.gyori@gmail.com	Fri, 19 Jun 2020 14:20:29 GMT		5608	23645443489360859		EMMAA	3475354836650780848	wrong_relation	Over the past 17 years , three previously unknown zoonotic coronaviruses , the Severe Acute Respiratory Syndrome ( SARS ) coronavirus ( SARS-CoV ) , the Middle East Respiratory Syndrome ( MERS ) coronavirus ( MERS-CoV ) , and SARS coronavirus 2 ( SARS-CoV-2 ) have focused global attention due to their epidemic potential and high mortality rates ( WHO , 2019a , b ) .	Mortality activates SARS Virus.	{'MESH:D009026': {'name': 'Mortality', 'synonyms': ['Death Rate', 'Death Rates', 'Mortalities', 'Mortality', 'Mortality Rate', 'Mortality Rates', 'Rate, Death', 'Rate, Mortality', 'mortality', 'mortality measurement', 'mortality rate', 'high mortality rates'], 'definition': None, 'syn_in_text': 'Mortality', 'syn_in_stmt': 'Mortality'}, 'MESH:D045473': {'name': 'SARS Virus', 'synonyms': ['Coronavirus, SARS-Associated', 'Coronavirus, SARS-Related', 'Coronavirus, Urbani SARS-Associated', 'HCoV-SARS', 'SARS Associated Coronavirus', 'SARS Related Coronavirus', 'SARS Virus', 'SARS like coronavirus', 'SARS-Associated Coronavirus', 'SARS-Associated Coronavirus, Urbani', 'SARS-CoV-1', 'SARS-Related Coronavirus', 'SARS-like coronavirus', 'SARS-like coronaviruses', 'SARSr-CoV', 'SARSrCoV', 'SARSrCoVs', 'Severe acute respiratory syndrome related coronavirus', 'Severe acute respiratory syndrome-related coronavirus', 'Urbani SARS Associated Coronavirus', 'Urbani SARS-Associated Coronavirus', 'SARS coronavirus 2'], 'definition': None, 'syn_in_text': 'SARS coronavirus 2', 'syn_in_stmt': 'SARS Virus'}}
ben.gyori@gmail.com	Thu, 03 Dec 2020 20:18:50 GMT		9214	11545850640863790		bioexp_biogrid	6892536364107124822	wrong_relation	In light with these studies, our ChIP-PCR confirmed that c-Myc directly binds to the promoter of NEK2 in c-Myc overexpressing P493-6 cells.	MYC binds NEK2.	{'HGNC:7553': {'name': 'MYC', 'synonyms': ['BHLHE39', 'Class E basic helix-loop-helix protein 39', 'MYC', 'MYC proto-oncogene, bHLH transcription factor', 'MYCC', 'Myc', 'Myc proto-oncogene protein', 'Proteins myc, Proto-Oncogene', 'Proto Oncogene Products c myc', 'Proto Oncogene Proteins c myc', 'Proto Oncogene Proteins myc', 'Proto-Oncogene Products c-myc', 'Proto-Oncogene Proteins c-myc', 'Proto-Oncogene Proteins myc', 'Proto-Oncogene Proteins, myc', 'Proto-oncogene c-Myc', 'Transcription factor p64', 'bHLHe39', 'c myc Proteins', 'c-MYC', 'c-Myc', 'c-myc', 'c-myc Proteins', 'c-myc oncogene', 'c-myc proteins', 'myc Proto Oncogene Product p62', 'myc Proto Oncogene Proteins', 'myc Proto-Oncogene Product p62', 'myc Proto-Oncogene Proteins', 'myc, Proto-Oncogene Proteins', 'p62 c myc', 'p62 c-myc', 'p62(c-myc)'], 'definition': None, 'syn_in_text': 'c-MYC', 'syn_in_stmt': 'MYC'}, 'HGNC:7745': {'name': 'NEK2', 'synonyms': ['HSPK 21', 'HsPK 21', 'NEK2', 'NEK2A', 'NIMA related kinase 2', 'NLK1', 'Never in mitosis A-related kinase 2', 'NimA-like protein kinase 1', 'NimA-related protein kinase 2', 'PPP1R111', 'RP67', 'Serine/threonine-protein kinase Nek2', 'protein phosphatase 1, regulatory subunit 111'], 'definition': None, 'syn_in_text': 'NEK2', 'syn_in_stmt': 'NEK2'}}
bachmanjohn@gmail.com	Tue, 02 Jun 2020 14:00:19 GMT		4538	-2899839493396440		bioexp_paper_trips	5677373933215055279	wrong_relation	Therefore, TGFbeta accumulates nuclear p27 by preventing its degradation to enable G(1) arrest in HEC-1A cells.	TGFB binds CDKN1B.	{'FPLX:TGFB': {'name': 'TGFB', 'synonyms': ['Bone Derived Transforming Growth Factor', 'Bone-Derived Transforming Growth Factor', 'Factor, Milk Growth', 'Growth Factor, Milk', 'Milk Growth Factor', 'Platelet Transforming Growth Factor', 'TGF beta', 'TGF β', 'TGF-b', 'TGF-beta', 'TGF-beta family', 'TGF-β', 'TGFB', 'TGFB family', 'TGFbeta', 'TGFβ', 'Transforming Growth Factor beta', 'transforming growth factor beta', 'transforming growth factor β', 'transforming growth factor-beta', 'transforming growth factor-β'], 'definition': None, 'syn_in_text': 'TGFbeta', 'syn_in_stmt': 'TGFB'}, 'HGNC:1785': {'name': 'CDKN1B', 'synonyms': ['CDK Inhibitor p27', 'CDK Inhibitor, p27', 'CDKN1B', 'CDKN1B Protein', 'CDKN4 Protein', 'Cyclin Dependent Kinase Inhibitor 1B', 'Cyclin Dependent Kinase Inhibitor p27', 'Cyclin-Dependent Kinase Inhibitor 1B', 'Cyclin-Dependent Kinase Inhibitor p27', 'Cyclin-dependent kinase inhibitor 1B', 'Cyclin-dependent kinase inhibitor p27', 'KIP1', 'Kip1 Protein, p27', 'P27KIP1', 'cyclin dependent kinase inhibitor 1B', 'p27', 'p27 CDK Inhibitor', 'p27 Kip1', 'p27 Kip1 Protein', 'p27, CDK Inhibitor', 'p27Kip1', 'p27Kip1 Protein'], 'definition': None, 'syn_in_text': 'p27', 'syn_in_stmt': 'CDKN1B'}}
marta.iannuccelli@gmail.com	Thu, 21 Mar 2024 11:18:13 GMT		14280	29189146052414232	{'belief': 1, 'enz': {'db_refs': {'HGNC': '9642', 'TEXT': 'PTP1B', 'UP': 'P18031'}, 'mods': [{'is_modified': True, 'mod_type': 'modification'}], 'name': 'PTPN1'}, 'id': '1f1bbc88-ba7c-4f89-b7e6-e09d44e9296b', 'matches_hash': '29189146052414232', 'sub': {'db_refs': {'HGNC': '9644', 'TEXT': 'SHP2', 'UP': 'Q06124'}, 'name': 'PTPN11'}, 'type': 'Dephosphorylation'}	signor_dephos	4771068151024397433	wrong_relation	Consistently PTP1B overexpression down-regulates the phosphorylation of PLC-gamma1, Gab1, and SHP2, after insulin or EGF stimulation (XREF_FIG).	Modified PTPN1 leads to the dephosphorylation of PTPN11.	{'HGNC:9642': {'name': 'PTPN1', 'synonyms': ['PTP-1B', 'PTP1B', 'PTPN1', 'Protein-tyrosine phosphatase 1B', 'Tyrosine-protein phosphatase non-receptor type 1', 'protein tyrosine phosphatase non-receptor type 1'], 'definition': None, 'syn_in_text': 'PTP1B', 'syn_in_stmt': 'PTPN1'}, 'HGNC:9644': {'name': 'PTPN11', 'synonyms': ['BPTP3', 'NS1', 'PTP-1D', 'PTP-2C', 'PTP2C', 'PTPN11', 'Phosphatase, SHP2', 'Phosphotyrosine Phosphatase Syp', 'Protein Tyrosine Phosphatase 2C', 'Protein Tyrosine Phosphatase PTP3', 'Protein Tyrosine Phosphatase, Non Receptor Type 11', 'Protein Tyrosine Phosphatase, Non-Receptor Type 11', 'Protein-Tyrosine-Phosphatase 2C', 'Protein-tyrosine phosphatase 1D', 'Protein-tyrosine phosphatase 2C', 'SH-PTP2', 'SH-PTP3', 'SH2 domain-containing protein tyrosine phosphatase 2', 'SHP-2', 'SHP-2 Protein-Tyrosine Phosphatase', 'SHP2', 'SHP2 Phosphatase', 'SHPTP2', 'Shp 2 Tyrosine Phosphatase', 'Shp-2 Tyrosine Phosphatase', 'Shp2', 'Tyrosine Phosphatase, Shp-2', 'Tyrosine-protein phosphatase non-receptor type 11', 'protein tyrosine phosphatase non-receptor type 11'], 'definition': None, 'syn_in_text': 'SHP2', 'syn_in_stmt': 'PTPN11'}}
ben.gyori@gmail.com	Thu, 03 Sep 2020 19:20:02 GMT		6255	31995805879524120		DB REST API	-5209622268029583204	wrong_relation	TNF treatment of AML cells was associated with enhanced c-kit mRNA expression in all specimens.	TNF binds KIT and runx1.	{'HGNC:11892': {'name': 'TNF', 'synonyms': ['Cachectin', 'Cachectin Tumor Necrosis Factor', 'Cachectin-Tumor Necrosis Factor', 'DIF', 'TNF', 'TNF Superfamily, Member 2', 'TNF superfamily, member 2', 'TNF-a', 'TNF-alpha', 'TNF-α', 'TNFA', 'TNFSF2', 'TNFalpha', 'TNFα', 'Tumor Necrosis Factor', 'Tumor Necrosis Factor Ligand Superfamily Member 2', 'Tumor Necrosis Factor alpha', 'Tumor Necrosis Factor-alpha', 'Tumor necrosis factor', 'Tumor necrosis factor ligand superfamily member 2', 'tumor necrosis factor'], 'definition': None, 'syn_in_text': 'TNF', 'syn_in_stmt': 'TNF'}, 'HGNC:6342': {'name': 'KIT', 'synonyms': ['Antigens, CD117', 'C-Kit', 'CD antigen CD117', 'CD117', 'CD117 Antigen', 'CD117 Antigens', 'KIT', 'KIT proto-oncogene, receptor tyrosine kinase', 'Mast/stem cell growth factor receptor Kit', 'PBT', 'Piebald trait protein', 'Proto Oncogene Protein c kit', 'Proto Oncogene Protein kit', 'Proto Oncogene Proteins c kit', 'Proto-Oncogene Protein c-kit', 'Proto-Oncogene Protein kit', 'Proto-Oncogene Protein, kit', 'Proto-Oncogene Proteins c-kit', 'Proto-oncogene c-Kit', 'Receptor, Stem Cell Factor', 'SCF Receptor', 'SCFR', 'Stem Cell Factor Receptor', 'Tyrosine-protein kinase Kit', 'c kit Protein', 'c kit Receptor', 'c-kit Protein', 'c-kit Receptor', 'c-kit, Proto-Oncogene Protein', 'c-kit, Proto-Oncogene Proteins', 'c-kit, p145', 'kit Proto Oncogene Protein', 'kit Proto-Oncogene Protein', 'mast/stem cell growth factor receptor Kit', 'p145 c kit', 'p145 c-kit', 'p145(c-kit)', 'p145c kit', 'p145c-kit', 'v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog', 'c-kit'], 'definition': None, 'syn_in_text': 'C-Kit', 'syn_in_stmt': 'KIT'}, 'UP:Q6PF39': {'name': 'runx1', 'synonyms': ['runx1', 'AML'], 'definition': None, 'syn_in_text': 'AML', 'syn_in_stmt': 'runx1'}}
petar.v.todorov@gmail.com	Wed, 14 Oct 2020 21:11:43 GMT		6650	-26804439260150162		DB REST API	-4829931885688251903	wrong_relation	Deficiency of Lipoprotein Lipase in Neurons Decreases AMPA Receptor Phosphorylation and Leads to Neurobehavioral Abnormalities in Mice.	LPL leads to the dephosphorylation of AMPA Receptor.	{'HGNC:6677': {'name': 'LPL', 'synonyms': ['Diacylglycerol Lipase', 'Diglyceride Lipase', 'Factor, Heparin-Clearing', 'Factor, Lipemia-Clearing', 'Heparin Clearing Factor', 'Heparin-Clearing Factor', 'LIPD', 'LPL', 'Lipase, Diacylglycerol', 'Lipase, Diglyceride', 'Lipase, Lipoprotein', 'Lipase, Post-Heparin', 'Lipase, Postheparin', 'Lipase, Postheparin Lipoprotein', 'Lipemia Clearing Factor', 'Lipemia-Clearing Factor', 'Lipoprotein Lipase', 'Lipoprotein Lipase, Postheparin', 'Lipoprotein lipase', 'Phospholipase A1', 'Post Heparin Lipase', 'Post-Heparin Lipase', 'Postheparin Lipase', 'Postheparin Lipoprotein Lipase', 'lipoprotein lipase'], 'definition': None, 'syn_in_text': 'Lipoprotein Lipase', 'syn_in_stmt': 'LPL'}}
ben.gyori@gmail.com	Sun, 11 Apr 2021 16:37:07 GMT		11814	31369516642116740		bioexp_paper_medscan	2574933636777089572	wrong_relation	CYLD was immunoprecipitated using an anti-Myc antibody and blotted using the anti-IκB kinaseε phospho-substrate antibody. shows that CYLD was efficiently phosphorylated in cells transfected with IκB kinaseε.	IKBKE decreases the amount of CYLD.	{'HGNC:14552': {'name': 'IKBKE', 'synonyms': ['I-kappa-B kinase epsilon', 'IKBKE', 'IKK-E', 'IKK-epsilon', 'IKK-i', 'IKKE', 'IKKI', 'IkBKE', 'Inducible I kappa-B kinase', 'Inhibitor of nuclear factor kappa-B kinase subunit epsilon', 'KIAA0151', 'inhibitor of nuclear factor kappa B kinase subunit epsilon', 'IκB kinaseε'], 'definition': None, 'syn_in_text': 'IκB kinaseε', 'syn_in_stmt': 'IKBKE'}, 'HGNC:2584': {'name': 'CYLD', 'synonyms': ['CYLD', 'CYLD Protein', 'CYLD lysine 63 deubiquitinase', 'CYLD, Deubiquitinating Enzyme', 'CYLD1', 'Cylindromatosis Protein', 'Cylindromatosis, Deubiquitinating Enzyme', 'Deubiquitinating Enzyme CYLD', 'Deubiquitinating Enzyme Cylindromatosis', 'Deubiquitinating enzyme CYLD', 'KIAA0849', 'USPL2', 'Ubiquitin carboxyl-terminal hydrolase CYLD', 'Ubiquitin thioesterase CYLD', 'Ubiquitin-specific-processing protease CYLD', 'ubiquitin specific peptidase like 2'], 'definition': None, 'syn_in_text': 'CYLD', 'syn_in_stmt': 'CYLD'}}
bachmanjohn@gmail.com	Fri, 06 Nov 2020 15:11:41 GMT		7831	-21301831111695895		EMMAA	3696590798589442626	wrong_relation	Lovastatins decreases ERK constitutive activation in Nf1 -/- osteoblasts in vitro.	ERK activates NF1.	{'FPLX:ERK': {'name': 'ERK', 'synonyms': ['ERK', 'ERK 1/2', 'ERK MAP Kinase', 'ERK MAP Kinases', 'ERK MAPK', 'ERK mitogen-activated protein kinase', 'ERK-1/2', 'ERK1/2', 'ERK1/2 MAPK', 'ERKs', 'Erk', 'Erk1/2', 'Extracellular Signal Regulated Kinase', 'Extracellular Signal Regulated Kinases', 'Extracellular Signal Regulated MAP Kinase', 'Extracellular Signal Regulated MAP Kinases', 'Extracellular Signal-Regulated Kinase', 'Extracellular Signal-Regulated Kinases', 'Extracellular Signal-Regulated MAP Kinase', 'Extracellular Signal-Regulated MAP Kinases', 'Kinase, ERK MAP', 'Kinase, Extracellular Signal-Regulated', 'Kinases, Extracellular Signal-Regulated', 'MAP Kinase, ERK', 'MAP Kinases, Extracellular Signal Regulated', 'MAP Kinases, Extracellular Signal-Regulated', 'Signal-Regulated Kinase, Extracellular', 'extracellular signal-regulated kinase', 'p42 and p38 MAP kinases', 'p42 and p38 MAPK', 'p42 and p38 MAPKs', 'p42 and p44', 'p42 and p44 MAPK', 'p42 and p44MAP kinase', 'p42(mapk) and p44(mapk)', 'p42/44', 'p44 and p42', 'phospho-ERK1/2'], 'definition': None, 'syn_in_text': 'ERK', 'syn_in_stmt': 'ERK'}, 'HGNC:7765': {'name': 'NF1', 'synonyms': ['NF 1 Protein', 'NF-1 Protein', 'NF1', 'NF1 GAP Related Protein', 'NF1 GRP', 'NF1 Protein', 'NF1-GAP-Related Protein', 'Neurofibromatosis Type 1 Gene Product', 'Neurofibromatosis Type 1 Protein', 'Neurofibromatosis-related protein NF-1', 'Neurofibromin', 'Neurofibromin 1', 'Watson disease', 'neurofibromatosis', 'neurofibromin 1', 'von Recklinghausen disease', 'Nf1'], 'definition': None, 'syn_in_text': 'NF1', 'syn_in_stmt': 'NF1'}}
ben.gyori@gmail.com	Sun, 22 Nov 2020 03:43:08 GMT		8902	-5653807448447202		DB REST API	-6973575719059341369	wrong_relation	Shp2 inhibition suppresses EGFR mutant induced lung adenocarcinoma by attenuating ERK1/2 and Src activation [XREF_BIBR].	PTPN11 activates mutated EGFR.	{'HGNC:9644': {'name': 'PTPN11', 'synonyms': ['BPTP3', 'NS1', 'PTP-1D', 'PTP-2C', 'PTP2C', 'PTPN11', 'Phosphatase, SHP2', 'Phosphotyrosine Phosphatase Syp', 'Protein Tyrosine Phosphatase 2C', 'Protein Tyrosine Phosphatase PTP3', 'Protein Tyrosine Phosphatase, Non Receptor Type 11', 'Protein Tyrosine Phosphatase, Non-Receptor Type 11', 'Protein-Tyrosine-Phosphatase 2C', 'Protein-tyrosine phosphatase 1D', 'Protein-tyrosine phosphatase 2C', 'SH-PTP2', 'SH-PTP3', 'SH2 domain-containing protein tyrosine phosphatase 2', 'SHP-2', 'SHP-2 Protein-Tyrosine Phosphatase', 'SHP2', 'SHP2 Phosphatase', 'SHPTP2', 'Shp 2 Tyrosine Phosphatase', 'Shp-2 Tyrosine Phosphatase', 'Shp2', 'Tyrosine Phosphatase, Shp-2', 'Tyrosine-protein phosphatase non-receptor type 11', 'protein tyrosine phosphatase non-receptor type 11'], 'definition': None, 'syn_in_text': 'SHP2', 'syn_in_stmt': 'PTPN11'}, 'HGNC:3236': {'name': 'EGFR', 'synonyms': ['EGF receptor', 'EGFR', 'EGFRvIII', 'ERBB', 'ERBB1', 'ERRP', 'Epidermal growth factor receptor', 'HER1', 'Proto-oncogene c-ErbB-1', 'Receptor tyrosine-protein kinase erbB-1', 'epidermal growth factor receptor', 'epidermal growth factor receptor VIII', 'erb-b2 receptor tyrosine kinase 1', 'erythroblastic leukemia viral (v-erb-b) oncogene homolog (avian)'], 'definition': None, 'syn_in_text': 'EGFR', 'syn_in_stmt': 'EGFR'}}
